You are on page 1of 647

99

CANCER REGISTRY ANNUAL REPORT, 2010


TAIWAN


102 2
BUREAU OF HEALTH PROMOTION
DEPARTMENT OF HEALTH
THE EXECUTIVE YUAN
TAIWAN
FEBRUARY 2013

.......................................................................................... x
99 ........................................................................ xii

................................................................................................................. xiii

.....................................................................................xv
.................................................................................... xvi
........................................................................................ xxi
99 ......................................................................... 1
................................................................................................................... 2
10 ............................................................... 3
( ICD-O-3 C00 - C14 C07 - C08 C11 ) ....... 6
( ICD-O-3 C00 - C06 ) .............................................................................. 8
( ICD-O-3 C00 C44.0 ) ................................................ 10
( ICD-O-3 C01 - C02 ) ......................................................................... 11
( ICD-O-3 C03 ) ............................................................................. 12
( ICD-O-3 C04 ) ............................................................................. 13
( ICD-O-3 C05 - C06 ) .............................. 14
( ICD-O-3 C09 - C10 ) ............................................................................ 15
( ICD-O-3 C12 - C13 ) ............................................................................ 16
( ICD-O-3 C14 ) ...................................... 17
Head and Neck Surgery and Oncology, 3rd ............................... 18
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 19
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 20
( ICD-O-3 Head and Neck Surgery and Oncology, 3rd ed.) .............. 21
( ICD-O-3 C07 - C08 ) ............................................................................ 22
( ICD-O-3 C11 ) ........................................................................................... 24
( ICD-O-3 C15 - C26C48 )
( ICD-O-3 C15 ) .................................................................................... 26
( ICD-O-3 C16 ) ........................................................................................ 28
( ICD-O-3 C17 ) .................................................................................... 30

-i-

( ICD-O-3 C18 - C21 ) .......................... 32


( ICD-O-3 C18 ) ............................................................................. 34
( ICD-O-3 C19 - C21 ) .............................. 36
( ICD-O-3 C22 ) ...................................................................... 38
( ICD-O-3 C23 - C24 ) .......................................................... 40
( ICD-O-3 C25 ) ........................................................................................ 42
( ICD-O-3 C48 ) .................................................................. 44
( ICD-O-3 C26 ) ........................ 46
( ICD-O-3 C30 - C39 )
( ICD-O-3 C30 - C31 ) ............................................ 48
( ICD-O-3 C32 ) ........................................................................................ 50
( ICD-O-3 C33 - C34 ) ....................................................... 52
( ICD-O-3 C38.4 ) .................................................................................. 54
( ICD-O-3 C37 - C38.3C38.8 ) ......................................... 56
( ICD-O-3 M-980 - M-999 ) ........................................... 58
................................................................................. 60
........................................................................................ 62
........................................................................................ 64
........................................................................................ 66
( ICD-O-3 C40 - C41 ) .......................................................... 68
( ICD-O-3 C47C49 ) ..................................... 70
( ICD-O-3 C44 ) ........................................................................................... 72
( ICD-O-3 C44 M-87203 - M-87903 ) .............................. 74
( ICD-O-3 C44 M-87203 - M-87903 ) .................... 76
( ICD-O-3 C50 ) ........................................................................................... 78
( ICD-O-3 C51 - C58 )
( ICD-O-3 C53 ) ................................................................................. 80
( ICD-O-3 C54 ) ................................................................................. 82
( ICD-O-3 C56C57.0 - C57.4 ) .................................. 84
( ICD-O-3 C51 - C52
C57.7 - C57.9 ).................. 86

- ii -

( ICD-O-3 C60 - C63 )


( ICD-O-3 C61 ) ................................................................................. 88
( ICD-O-3 C62 ) .................................................................................... 90
( ICD-O-3 C60C63 ) ............................................ 92
( ICD-O-3 C64 - C68 )
( ICD-O-3 C67 ) .................................................................................... 94
( ICD-O-3 C64 ) ........................................................................................ 96
( ICD-O-3 C65 - C66C68 ) ........................................... 98
( ICD-O-3 C69 ) .................................................................................. 100
( ICD-O-3 C70 - C72 )
( ICD-O-3 C71 ) ...................................................................................... 102
( ICD-O-3 C70C72 ) ............................... 104
( ICD-O-3 C73 ) ...................................................................................... 106
( ICD-O-3 C74 - C75 ) ................................................................... 108
( ICD-O-3 M-959 - M-976)
( ICD-O-3 C77 M-95903 - M-97643 ) ................................ 110
( ICD-O-3 C00 -C80 ( C77 ) M-95903 - M-97643 ) .. 112
............................. 114
......................................................................................... 116
...................................................................................... 118
.................................................................................................. 120
( ICD-O-3 C80 ) ........................................................................... 122
99 .................................................................................... 125
99 ....................... 126
( ICD-O-3 C18 - C21 ) ................. 130
( ICD-O-3 C50 ) ........................................................................... 132
( ICD-O-3 C53 ) ...................................................................... 134
( ICD-O-3 C67 ) ......................................................................... 136

- iii -

99 ........................................................... 139

...................... 140

WHO 2008 ....................................................... 154

10 ....................................................... 164

99 WHO 2008 ............................................... 174

...................... 184

......................... 248

.................. 256

......................... 260

.................. 268

10 ....................... 272

...................... 276

......................... 398

.................. 406

......................... 410

72 99 .............................................................................. 478

ICD-O-3 ...................................................... 490

() ................................. 494

99 ....................................................... 495

1976 2000 .................. ...................................... 496

WHO 2008 ............................................................... 497

- iv -

99 15 ........................................... 499

................................................................................................................ 501

....................................................................................... 506
99 ...................................... 513
..................................................... 517
................................. 517
..................................................... 517
...................................... 518
1
0~39 ....................... 518

40~59 ....................... 519


60 1 ................... 519
..................................................... 521

................................. 521

..................................................... 521
...................................... 522
0~39 1 ....................... 522
40~59 ....................... 523
1
60 ................... 523

..................................................... 525
................................. 525
..................................................... 525
...................................... 526
0~39 1 ....................... 526
40~59 ....................... 527
60 1 ................... 527
.............................................. 529
.......................... 529
.............................................. 529

................................................................................................ 530
0~49 .................. 531

-v-

50~69 1 ............. 531


70 ............... 532
..................................................... 533

................................. 533

...................................... 534
0~49 ......................... 534
50~69 ....................... 535
70 ...................... 535
..................................................... 537
................................. 537
..................................................... 537
................. 538
0~49 ......................... 539
50~69 1 ..................... 539
70 ...................... 540
........................................................ 541
..................................... 541
........................................................ 541
..................... 542
0~49 ............................. 543
50~69 1 ........................ 543
70 ......................... 544
..................................................... 545
................................. 545
..................................................... 545
...................................... 546
0~49 1 ....................... 546
50~69 ....................... 547
70 1 ................... 547
MAC .......................................... 548
..................................................... 549

- vi -

................................. 549
..................................................... 549
...................................... 550
1
0~49 ....................... 550

50~69 ....................... 551


70 1 ................... 551

MAC .......................................... 552

........................................................ 553
..................................... 553
........................................................ 553
(C220)
................................................................................................... 554
(C220)0~49 .................. 556
(C220)50~64 1 2 ............ 556
(C220)65 ........ 558
(C221) 2
................................................................................................... 558
(C221)0~49 .................. 560
(C221)50~64 ................ 561
(C221)65 1 2
................................................................................................ 561
BCLC(C220) ................. 562
..................................................... 565
................................. 565
..................................................... 565
() .................. 566
() 0~49 1 .. 566
() 50~69 ... 567
() 70
................................................................................................ 567
()

- vii -

................................................................................................ 568
..................................................... 569
................................. 569
..................................................... 569
...................................... 570
0~34 1 ....................... 570
35~49 ....................... 572
50~69 1 ..................... 572
70 ...................... 574
.............................................. 577
FIGO ............................................ 577
............ 578
.............................................. 578
FIGO ............................ 579
0~29 FIGO ............................. 580
30~49 FIGO ............ 581
50~69 FIGO ............ 582
70 FIGO ........... 583
............................... 584
0~29 1 .......................... 584
30~49 ............ 585
50~69 1 .......... 585
70 ........... 586
.............................................. 587
.......................... 587
.............................................. 587
............................... 588
0~39 1 ............... 588
40~59 ................ 589
60 1 ............ 589
FIGO ............................ 590

- viii -

................................................. 591

............................. 591

................................................. 591
................................... 592
0~39 1 ................... 592
40~59 ................... 593
60 1 ................ 593
FIGO ............................... 594
.............................................. 595
.......................... 595
.............................................. 595
.......... 596
0~59 .................. 598
60~74 1 ............. 598
................................................. 603
............................. 603
................................................. 603
............. 604
0~49 ..................... 606
50~69 1 ................. 606
70 .................. 608
.......................................... 611
Ann Arbor ................................... 611
Ann Arbor ................. 612
0~39 Ann Arbor
............................................................................................... 613
40~59 Ann Arbor
................................................................................................ 614
60 Ann Arbor
................................................................................................ 615

- ix -

-x-

- xi -

99

- xii -

71 10 3

92 5

68 50

2
1

101 5 206 50 99

68 1 1
International Classification of Diseases for Oncology
ICD-O 5 2 3

68 90
ICD-O, Field Trial EditionICD-O-FT 91 1 1
ICD-O, Third EditionICD-O-3

International Agency for Research on Cancer, IARC

- xiii -


()

99
100

()

99 8

36912
12
95

96 1 1
95 33 50
93

97 98

()

- xiv -

()

1.

2.

- xv -

1.
2.
a.
b.
c.
d.
3.
4.

1.
2.

- xvi -

()
15

101 5 99
120,389 8,628
90,649
50,892 39,757
ICD-O-3 99
29,740

99

129,017

120,389

16,568

112,449

16,131

104,258

787

111,662

787

103,471

12,825

98,837

11,855

91,616

689

98,148

658

90.958

312

97,836

309

90,649

LymphomaLeukemia
Kaposi Sarcoma

99
%

97,836

90,649

31,181

29,740

24.17%

24.70%

99
10 391.37
437.40 344.91

- xvii -

1976 2000 2000


10 296.67
340.66 256.23

99 90,649 98 88,820 1,829


2.06% 5 2,696
147.40%
99 5

1.
2.
3.
4.
5.

98

99

12,663
9,041
4,083
1,515
2,064

14,040
9,655
4,392
1,737
2,238

1,377
614
309
222
174

*
10.87%
6.79%
7.57%
14.65%
8.43%

*= - 100%

88

91

93
94

IARC
Percentage of Death Certificate Only Cases,
DCO%Percentage of
Morphologically Verified Cases, MV%
IARC DCO% MV%
()

- xviii -


90
91.28% 99 97.00%
93
23 17
() DCO%

DCO% 87 8.78% 99
0.85% 97-99 DCO%
97-99
97 *

98 *

DCO

**

99

DCO

DCO

**

**

9,341

22

0.23%

10,356

23

0.22%

11,295

21

0.19%

11,812

94

0.79%

13,377

89

0.66%

15,012

60

0.40%

11,077

267

2.35%

11,456

266

2.27%

11,043

184

1.64%

9,868

216

2.14%

10,943

198

1.78%

10,676

179

1.65%

3,690

23

0.62%

4,088

41

0.99%

4,398

39

0.88%

6,112

17

0.28%

6,741

16

0.24%

6,739

18

0.27%

3,890

43

1.09%

4,145

43

1.03%

4,092

29

0.70%

5,159

16

0.31%

5,369

14

0.26%

5,018

10

0.20%

2,896

0.21%

3,310

0.15%

3,346

0.27%

1,436

0.07%

1,518

0.07%

1,743

0.06%

87,604

1,040

1.17%

97,338

1,077

1.09%

97,836

839

0.86%

* 97 98 101 6
** DCO%=DCO DCO 100%

() MV%

MV%MV%

- xix -

MV%
99 MV% 91.11% 89.09%
93.42%

91
92

96

97
Head and Neck Surgery and Oncology, 3rd
WHO 2008
97
97

99 WHO 2008 2010

92 93
92 SARS

http://tcr.cph.ntu.edu.tw/main.php?Page=A5B3

- xx -


1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.

51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76. ()
77.
78.
79.
80.
81.
82.
83.
84.
85.
86.
87.
88.
89.
90.
91.
92.
93.
94.
95.
96.
97.
98.
99.
100.

- xxi -


101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.
113.
114.
115.
116.
117.
118.
119.
120.
121.
122.
123.
124.
125.
126.
127.
128.
129.
130.
131.
132.
133.
134.
135.
136.
137.
138.
139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.

151.
152.
153.
154.
155.
156.
157.
158.
159.
160.
161.
162.
163.
164.
165.
166.
167.
168.
169.
170.
171.
172.
173.
174.
175.
176.
177.
178.
179.
180.
181.
182.
183.
184.
185.
186.
187.
188.
189.
190.
191.
192.
193.
194.
195.
196.
197.
198.
199.
200.

- xxii -


201.
202.
203.

204.
205.
206.

- xxiii -

99

-1-


71 10 99 41,046
28.36% 10 177.21
10 3 129.62
90,649 10 391.37 10 3
296.67 10

()

50,892

39,757

64

60

437.40

344.91

( 10 )
2

( 10 )
3

( 10 )
()

303.57

231.31

340.66

256.23

1.33

()

26,022

15,024

69

70

223.65

130.34

146.88

79.97

169.28

92.27

1.83

( 10 )
2

( 10 )
3

( 10 )
()

1. 96
2. 3.2 1976 3 2000

-2-

10

2b

10 10 99
ICD-O-3
1
2
3
4
5
6

7
8
9
10

C50
C18-C21
C22
C33-C34
C61
C00-C143

6a

2a

2b

58.63
40.34
32.41
29.10
24.17
20.07

63.16
45.32
36.07
33.61
28.77
21.68

9,655
14,040
11,023
10,615
4,392
6,560

83.76
60.62
47.59
45.83
37.75
28.32

4,392

18.96

13.48

14.59

1,169

5.05

3.58

3.85

999

4.31

3.01

3.25

C16
C54
C53
C444

3,854
1,737
1,680
2,978

16.64
15.07
14.57
12.86

10.30
10.47
9.74
7.85

12.03
11.25
10.81
9.29

C00-C80

90,649

391.37

265.83

296.67

2a

2b

6b

6a
6a

10 10 99
ICD-O-3
1

2
3
4

5
6
7

8
9
10

C50

6a

11,234

97.46

68.32

73.45

C50

1,579

13.70

6a

9.69

10.29

C50

9,655

83.76

6a

58.63

63.16

14,975
11,029
5,017

64.65
47.62
43.52

43.24
32.43
30.84

48.44
36.08
34.15

C53

3,337

28.95

6a

21.10

23.34

C53

1,680

14.57

6a

9.74

10.81

10,626
4,396
6,607

45.88
37.78
28.53

29.13
24.19
20.22

33.64
28.79
21.84

4,422

19.09

13.57

14.69

1,178

5.09

3.61

3.88

1,007

4.35

3.04

3.28

C16
C54
C444

3,888
1,741
3,271

16.79
15.10
14.12

10.40
10.49
8.62

12.14
11.27
10.21

C00-C80

97,836

422.40

288.07

321.09

2a

2b

C18-C21
C22
C53

C33-C34
C61
C00-C143

6a

6b

6a

10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10

C33-C34
C22
C18-C21
C50
C00-C143
C16
C61
C15
C25
C53

C00-C97

8,194
7,744
4,676
1,706
2,370
2,261
1,021
1,563
1,470
704

35.38
33.43
20.19
14.80
10.23
9.76
8.78
6.75
6.35
6.11

41,046

177.21

6a

6b

6a

21.43
21.82
12.18
9.98
7.12
5.76
4.67
4.56
3.97
3.79

25.38
24.84
14.41
10.86
7.74
6.87
6.04
5.02
4.62
4.34

112.37

129.62

1. 96 ICD-O-3 M-CODE p.497


2a
2b
2. 1976 2000

3. ICD-O-3 & ICD-10C00-C06C09-C10C12-14 p.18


4.
5. 5 2
6. (a) 10 (b) 10

-3-

10

2b

10 10 99
ICD-O-3

2a

2b

C18-C21

8,143

69.99

48.58

54.39

C22

7,751

66.62

47.52

52.34

C33-C34

6,697

57.56

37.49

43.68

C00-C143

6,028

51.81

37.62

40.56

3,967

34.09

24.82

26.80

1,086

9.33

6.78

7.27

975

8.38

6.01

6.48

C61

4,392

37.75

24.17

28.77

C16

2,415

20.76

13.14

15.43

C15

2,091

17.97

12.77

13.81

C444

1,575

13.54

8.62

10.20

C67

1,427

12.26

7.88

9.24

10

C11

1,194

10.26

7.54

8.22

C00-C80

50,892

437.40

303.57

340.66

2a

2b

8,736
7,752
6,705
6,069

75.08
66.63
57.63
52.16

52.42
47.52
37.52
37.87

58.50
52.35
43.73
40.84

3,991

34.30

24.97

26.97

1,095

9.41

6.84

7.34

983

8.45

6.07

6.54

10 10 99
ICD-O-3
1
2
3
4

5
6
7
8
9
10

C18-C21
C22
C33-C34
C00-C143

C61
C16
C15
C67
C444
C11

4,396
2,436
2,113
1,868
1,733
1,194

37.78
20.94
18.16
16.05
14.89
10.26

24.19
13.26
12.90
10.42
9.50
7.54

28.79
15.57
13.96
12.16
11.24
8.22

C00-C80

52,308

449.57

312.14

350.21

2a

2b

5,454
5,412
2,719
2,198
1,457
1,446
1,021
855
628
582

46.87
46.51
23.37
18.89
12.52
12.43
8.78
7.35
5.40
5.00

32.36
29.07
14.67
13.58
8.80
7.56
4.67
4.81
3.51
3.59

36.34
34.63
17.35
14.71
9.62
9.04
6.04
5.57
4.07
4.02

26,022

223.65

146.88

169.28

10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10

C22
C33-C34
C18-C21
C00-C143
C15
C16
C61
C25
C82-C85
C91-C95

C00-C97

1. 96 ICD-O-3 M-CODE p.497


2a
2b
2. 1976 2000

3. ICD-O-3 & ICD-10C00-C06C09-C10C12-14 p.18


4.
5. 5 2

-4-

10

2b

10 10 99
ICD-O-3
1
2
3
4
5
6
7
8
9
10

C50
C18-C21
C33-C34
C22
C73
C54
C53
C16
C56, C57.0-C57.4
C443

C00-C80

2a

2b

9,655
5,897
3,918
3,272
1,838
1,737
1,680
1,439
1,245
1,403

83.76
51.16
33.99
28.39
15.95
15.07
14.57
12.48
10.80
12.17

58.63
32.65
21.38
18.00
11.96
10.47
9.74
7.66
7.83
7.13

63.16
36.84
24.27
20.54
12.91
11.25
10.81
8.85
8.46
8.44

39,757

344.91

231.31

256.23

10 10 99
ICD-O-3
1

2
3

C50

2a

2b

11,234

97.46

68.32

73.45

C50

1,579

13.70

9.69

10.29

C50

9,655

83.76

58.63

63.16

C18-C21

6,239

54.13

34.69

39.04

C53

5,017

43.52

30.84

34.15

C53

3,337

28.95

21.10

23.34

C53

1,680

14.57

9.74

10.81

C33-C34

3,921

34.02

21.40

24.29

C22

3,277

28.43

18.03

20.57

C73

1,838

15.95

11.96

12.91

C54

1,741

15.10

10.49

11.27

C443

1,538

13.34

7.79

9.24

C16

1,452

12.60

7.73

8.93

10

C56, C57.0-C57.4

1,248

10.83

7.85

8.48

C00-C80

45,528

394.97

266.99

295.29

2a

2b

2,782
2,290
1,957
1,706
815
704
615
434
386
363

24.13
19.87
16.98
14.80
7.07
6.11
5.34
3.77
3.35
3.15

14.35
11.85
9.87
9.98
4.09
3.79
3.17
2.53
2.38
1.82

16.76
13.95
11.68
10.86
4.84
4.34
3.72
2.79
2.62
2.19

15,024

130.34

79.97

92.27

10 10 99
ICD-10
1
2
3
4
5
6
7
8
9
10

C33-C34
C22
C18-C21
C50
C16
C53
C25
C56, C57.0-C57.4
C91-C95
C82-C85

C00-C97

1. 96 ICD-O-3 M-CODE p.497


2a
2b
2. 1976 2000

3.
4. 5 2

-5-

()
ICD-O-FT
ICD-O-3
ICD-9
ICD-10

T-140 - T-149 (T-142T-147)


C00 - C14 (C07 - C08C11)
140-149 (142147)
C00 - C14 (C07 - C08C11)

99
7.24% 5.77%
4 15 4
16 99
6,560 2,370

()

6,028

532

53

60

51.81

4.62

(10)
2

(10)
3

37.62

3.09

(10)

40.56

3.41

()

11.89

()

2,198

172

56

69

18.89

1.49

13.58

0.92

(10)

14.71

1.05

()

14.01

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

-6-


6,560
6,48898.90%98.89%99.06%

93.45%84.77%

5,633

93.45

5,626

99.88

451

84.77

451

100.00

204

3.38

204

100.00

11

2.07

11

100.00

10

0.17

10

100.00

0.56

100.00

37

0.61

37

100.00

43

8.08

43

100.00

32

0.53

32

100.00

0.56

100.00

40

0.66

27

67.50

1.32

85.71

0.08

100.00

1.50

100.00

11

0.18

11

100.00

0.19

100.00

0.07

100.00

52

0.86

9.62

0.94

20.00

74

73

98.65

58

58

100.00

5,961

98.89

532

527

99.06

6,028

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

6,560
66.43%

3,981

66.04

377

70.86

4,358

66.43

3,156

52.36

198

37.22

3,354

51.13

2,997

49.72

179

33.65

3,176

48.41

0.19

0.19

537

8.91

38

7.14

575

8.77

331

5.49

36

6.77

367

5.59

-7-

()

ICD-O-FT

T-140 - T-145 (T-142)

ICD-O-3
ICD-9

C00 - C06
140-145 (142)

ICD-10

C00 - C06

99 5.42 %
4.02% 99
4,911
1,650

()

4,453

458

53

60

38.27

3.97

(10)
2

(10)
3

27.86

2.68

(10)

30.07

2.95

()

10.19

()

1,499

151

56

69

12.88

1.31

9.32

0.81

(10)

10.07

0.92

()

10.95

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

-8-


4,9114,875
99.27%99.26%99.34%

92.77%83.62%

4,131

92.77

4,130

99.98

383

83.62

383

100.00

203

4.56

203

100.00

11

2.40

11

100.00

0.04

100.00

0.44

100.00

32

0.72

32

100.00

43

9.39

43

100.00

18

0.40

18

100.00

0.44

100.00

22

0.49

14

63.64

1.09

80.00

0.11

100.00

1.75

100.00

0.20

100.00

0.22

100.00

0.07

100.00

28

0.63

14.29

0.66

33.33

24

24

100.00

17

17

100.00

4,420

99.26

458

455

99.34

4,453

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

4,911
78.40%
*

3,496

78.51

354

77.29

3,850

78.40

1,944

43.66

145

31.66

2,089

42.54

1,806

40.56

129

28.17

1,935

39.40

0.22

0.22

316

7.10

27

5.90

343

6.98

243

5.46

28

6.11

271

5.52

-9-

( C44.0 )

ICD-O-FT
ICD-O-3

T-140
C00

99 228
3.48%

()

210

18

57

71

1.80

0.16

1.36

0.10

(10)

1.45

0.11

()

13.18

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 10 -

ICD-O-FT
ICD-O-3

T-141
C01 - C02

99 1,805
27.52%

()

1,583

222

52

56

13.61

1.93

9.90

1.34

(10)

10.72

1.46

()

7.34

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 11 -

ICD-O-FT
ICD-O-3

T-143
C03

99 445
6.78%

()

384

61

55

66

3.30

0.53

2.35

0.34

(10)

2.56

0.38

()

6.74

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 12 -

ICD-O-FT
ICD-O-3

T-144
C04

99 164
2.50%

()

151

13

53

55

1.30

0.11

0.92

0.07

(10)

0.99

0.08

()

12.38

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 13 -

ICD-O-FT
ICD-O-3

T-145
C05 - C06

99
2,269 34.59%

()

2,125

144

53

64

18.26

1.25

13.33

0.83

(10)

14.34

0.92

()

15.59

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 14 -

ICD-O-FT
ICD-O-3

T-146
C09 - C10

99 635
9.68%

()

586

49

53

55

5.04

0.43

3.66

0.28

(10)

3.92

0.31

()

12.65

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 15 -

ICD-O-FT
ICD-O-3

T-148
C12 - C13

99 942
14.36%

()

921

21

56

58

7.92

0.18

5.68

0.12

(10)

6.12

0.13

()

47.08

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 16 -

ICD-O-FT
ICD-O-3

T-149
C14

99
72 1.10%

()

68

55

67

0.58

0.03

0.42

0.02

(10)

0.45

0.02

()

22.50

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 17 -

Head and Neck Surgery and Oncology, 3rd


ICD-O-3Head and Neck
Surgery and Oncology, 3rd

Head and Neck


Surgery and Oncology,
3rd (p.19-p.21)

Oral cavity

C00

Lip

C02
C03

Other and unspecified parts of


tongue (excludes C024)
Gum

C04

Floor of mouth

ICD-O-3
(p.6-p.17)

C050 Hard palate


C058 Overlapping lesion of palate
C059 Palate, NOS
C06
C01

Oral cavity

Other and unspecified parts of


mouth
Base of tongue

C024 Lingual tonsil


C051 Soft palate, NOS
(excludes nasopharyngeal
surface of soft palate C113)
C052 Uvula
Oropharynx

C09

Tonsil

C10

Oropharynx

C142 Waldeyer ring


C148 Overlappinf lesion of lip, oral
cavity and pharynx

Hypopharynx

C12

Pyriform sinus

C13

Hypopharynx

C140 Pharynx, NOS

- 18 -

Oropharynx

Pharynx and
ill-defined sites in
lip, oral cavity and
pharynx
Hypopharynx
Pharynx and
ill-defined sites in
lip, oral cavity and
pharynx

(Head and Neck Surgery and Oncology, 3

rd

T-140 T-141(T-1410T-1416) T-143


T-144T-145(T-1453T-1454)
C00C02(C024)C03C04C050
C058C059C06

ICD-O-FT
ICD-O-3

99
4.85%994,392

()

3,967

425

53

61

34.09

3.69

24.82

2.47

(10)

26.80

2.73

()

9.82

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 19 -

(Head and Neck Surgery and Oncology, 3


ICD-O-FT

rd

T-1410T-1416T-1453T-1454T-146T1491T-1498
C01C024C051C052C09C10C142

ICD-O-3

C148
99
1.29%991,169

()

1,086

83

54

54

9.33

0.72

6.78

0.49

(10)

7.27

0.53

()

13.72

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 20 -

(Head and Neck Surgery and Oncology, 3

rd

ICD-O-FT T-148T-1490
ICD-O-3
C12C13C140
99
1.10%99999

()

975

24

56

58

8.38

0.21

6.01

0.13

(10)

6.48

0.15

()

43.20

( 10 )
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 21 -

ICD-O-FT

T-142

ICD-O-3
ICD-9
ICD-10

C07 - C08
142
C07 - C08

99
0.26%0.15%
252728
3399236
62

()

131

105

54

50

1.13

0.91

(10)
2

(10)
3

0.80

0.66

(10)

0.89

0.73

()

1.22

()

40

22

63

62

0.34

0.19

0.25

0.11

(10)

0.27

0.13

()

2.08

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 22 -


236232
98.31%98.47%98.10%

17.56%30.48%

21

16.03

21

100.00

19

18.10

19

100.00

12

9.16

12

100.00

0.95

100.00

21

16.03

21

100.00

3.81

100.00

23

17.56

23

100.00

32

30.48

32

100.00

11

8.40

11

100.00

21

20.00

21

100.00

6.11

100.00

7.62

100.00

12

9.16

12

100.00

3.81

100.00

1.53

100.00

17

12.98

17

100.00

13

12.38

13

100.00

1.53

100.00

0.95

100.00

1.53

1.90

11

100.00

12

12

100.00

129

98.47

105

103

98.10

11
131

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

236
81.36%

105

80.15

87

82.86

192

81.36

77

58.78

54

51.43

131

55.51

44

33.59

19

18.10

63

26.69

5.34

2.86

10

4.24

5.34

10

9.52

17

7.20

- 23 -

ICD-O-FT

T-147

ICD-O-3
ICD-9
ICD-10

C11
147
C11

99
1.73%1.60%
101811
17991,571
658

()

1,194

377

51

50

10.26

3.27

(10)
2

(10)
3

7.54

2.30

(10)

8.22

2.52

()

3.26

()

505

153

58

58

4.34

1.33

3.17

0.89

(10)

3.43

0.99

()

3.46

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 24 -


1,5711,555
98.98%98.83%99.47%

66.00%59.15%

19

1.59

19

100.00

11

2.92

11

100.00

34

2.85

34

100.00

2.12

100.00

788

66.00

788

100.00

223

59.15

223

100.00

289

24.20

289

100.00

117

31.03

117

100.00

0.34

100.00

0.27

100.00

17

1.42

17

100.00

0.53

100.00

30

2.51

27

90.00

12

3.18

11

91.67

0.08

100.00

12

1.01

8.33

0.80

66.67

17

17

100.00

23

22

95.65

1,180

98.83

377

375

99.47

1,194

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,571
89.56%

0.34

1.33

0.57

1,059

88.69

348

92.31

1,407

89.56

983

82.33

315

83.55

1,298

82.62

95

7.96

26

6.90

121

7.70

73

6.11

11

2.92

84

5.35

- 25 -

ICD-O-FT

T-150

ICD-O-3
ICD-9
ICD-10

C15
150
C15

992.47%
3.81%
724520
992,238(ICD-O-3 C15 C26C48)6.53%1,563

()

2,091

147

56

69

17.97

1.28

(10)
2

(10)
3

12.77

13.81

0.90

()

15.34

()

1,457

106

58

75

12.52

0.92

8.80

0.51

(10)

9.62

0.61

()

15.77

(10)
2

(10)

0.77

(10)

1. 96
2. 3.2 1976 3 2000

- 26 -


2,2382,202
98.39%98.42%97.96%

91.49%80.95%

1,913

91.49

1,911

99.90

119

80.95

119

100.00

76

3.63

75

98.68

16

10.88

16

100.00

0.24

100.00

31

1.48

31

100.00

3.40

100.00

26

1.24

26

100.00

2.04

66.67

0.19

100.00

0.10

100.00

0.05

100.00

0.68

100.00

33

1.58

9.09

2.04

33.33

2,091

100.00

2,058

98.42

147

100.00

144

97.96

1. 96ICD-O-3 M-CODEp.497

2,238
68.81%
*

657

31.42

36

24.49

693

30.97

1,458

69.73

82

55.78

1,540

68.81

1,421

67.96

76

51.70

1,497

66.89

0.05

0.05

627

29.99

41

27.89

668

29.85

185

8.85

23

15.65

208

9.29

- 27 -

ICD-O-FT

T-151

ICD-O-3
ICD-9
ICD-10

C16
151
C16

994.25%
5.51%
6865
993,854(ICD-O-3
C15 - C26C48)11.25%2,261

()

2,415

1,439

71

69

20.76

12.48

(10)
2

(10)
3

13.14

7.66

(10)

15.43

8.85

()

1.74

()

1,446

815

75

73

12.43

7.07

7.56

4.09

(10)

9.04

4.84

()

1.87

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 28 -


3,8543,784
98.18%98.14%98.26%

88.61%85.20%

2,140

88.61

2,132

99.63

1,226

85.20

1,224

99.84

0.21

100.00

0.14

100.00

32

1.33

32

100.00

0.21

100.00

47

1.95

47

100.00

16

1.11

16

100.00

31

1.28

24

77.42

17

1.18

17

100.00

0.08

50.00

0.14

100.00

127

5.26

124

97.64

151

10.49

146

96.69

0.08

100.00

0.07

100.00

29

1.20

10.34

21

1.46

14.29

92

92

100.00

112

112

100.00

27

27

100.00

41

41

100.00

2,370

98.14

1,439

1,414

98.26

2,415

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

3,85461.00%

1,449

60.00

902

62.68

2,351

61.00

265

10.97

94

6.53

359

9.31

1,031

42.69

589

40.93

1,620

42.03

0.04

0.04

506

20.95

278

19.32

784

20.34

351

14.53

191

13.27

542

14.06

- 29 -

ICD-O-FT

T-152

ICD-O-3
ICD-9
ICD-10

C17
152
C17

99
0.36%0.33%
232522
2999325
(ICD-O-3 C15 - C26C48)0.95%
135

()

(10)
2

(10)
3

(10)
()

190

135

64

67

1.63

1.17

1.14
1.27
1.48

0.78
0.86
1

()

91

44

71

75

0.78

0.38

0.52

0.22

(10)

0.60

0.26

()

2.31

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 30 -


325318
97.85%97.37%98.52%

43.68%52.59%

77

40.53

76

98.70

44

32.59

44

100.00

2.63

100.00

4.44

100.00

3.68

100.00

4.44

100.00

4.21

100.00

0.74

100.00

0.74

100.00

83

43.68

82

98.80

71

52.59

71

100.00

1.58

100.00

1.48

100.00

0.53

100.00

0.74

100.00

3.16

50.00

2.22

33.33

43

100.00

21

21

100.00

185

97.37

135

133

98.52

43
190

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

325
68.31%
*

119

62.63

103

76.30

222

68.31

13

6.84

2.22

16

4.92

64

33.68

42

31.11

106

32.62

43

22.63

16

11.85

59

18.15

28

14.74

14

10.37

42

12.92

- 31 -


ICD-O-FT
ICD-O-3
ICD-9
ICD-10

T-153T-154
C18 - C21
153154
C18 - C21

99
15.49%
11.39%12
3399
14,040(ICD-O-3 C15 C26C48)40.99%
4,676

()

8,143

5,897

66

67

69.99

51.16

(10)
2

(10)
3

48.58

32.65

(10)

54.39

36.84

()

1.48

()

2,719

1,957

73

73

23.37

16.98

14.67

9.87

(10)

17.35

11.68

()

1.49

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 32 -


14,040
13,69097.51%97.59%
97.39%

94.95%94.47%
99
593342130131

7,732

94.95

7,718

99.82

5,571

94.47

5,559

99.78

78

0.96

76

97.44

59

1.00

58

98.31

56

0.69

56

100.00

64

1.09

63

98.44

73

0.90

49

67.12

42

0.71

24

57.14

20

0.25

19

95.00

17

0.29

16

94.12

0.02

100.00

0.01

100.00

0.10

100.00

181

2.22

26

14.36

138

2.34

17

12.32

27

100.00

10

10

100.00

7,947

97.59

5,897

5,743

97.39

27
8,143

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

14,040
78.94%
*

6,413

78.75

4,670

79.19

11,083

78.94

1,122

13.78

651

11.04

1,773

12.63

4,295

52.74

3,073

52.11

7,368

52.48

825

10.13

654

11.09

1,479

10.53

760

9.33

538

9.12

1,298

9.25

- 33 -

ICD-O-FT

T-153

ICD-O-3
ICD-9
ICD-10

C18
153
C18

99
9.53%8.05%99
8,635(ICD-O-3 C15 C26C48)25.21%3,306

()

4,871

3,764

67

67

41.86

32.65

(10)
2

(10)
3

28.75

20.75

(10)

32.36

23.48

()

1.38

()

1,880

1,426

74

74

16.16

12.37

10.06

7.15

(10)

11.96

8.48

()

1.41

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 34 -


8,6358,353
96.73%96.90%96.52%
95.13%
95.19%

4,634

95.13

4,624

99.78

3,583

95.19

3,574

99.75

12

0.25

11

91.67

12

0.32

12

100.00

21

0.43

21

100.00

14

0.37

14

100.00

51

1.05

34

66.67

31

0.82

17

54.84

0.16

100.00

0.08

100.00

0.02

100.00

144

2.96

21

14.58

121

3.21

13

10.74

24

100.00

100.00

4,720

96.90

3,764

3,633

96.52

24
4,871

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

8,635
78.38%

3,800

78.01

2,968

78.85

6,768

78.38

140

2.87

87

2.31

227

2.63

2,398

49.23

1,897

50.40

4,295

49.74

507

10.41

428

11.37

935

10.83

515

10.57

374

9.94

889

10.30

- 35 -

ICD-O-FT

T-154

ICD-O-3
ICD-9
ICD-10

C19 - C21
154
C19 - C21

99
5.96%
3.34%99
5,405(ICD-O-3 C15 - C26C48)15.78%
1,370

()

3,272

2,133

65

66

28.12

18.50

(10)
2

(10)
3

19.83

11.90

(10)

22.04

13.35

()

1.65

()

839

531

72

73

7.21

4.61

4.60

2.71

(10)

5.38

3.20

()

1.68

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 36 -


5,405
5,33798.74%98.62%98.92%
94.68%
93.20%

3,098

94.68

3,094

99.87

1,988

93.20

1,985

99.85

66

2.02

65

98.48

47

2.20

46

97.87

35

1.07

35

100.00

50

2.34

49

98.00

12

0.37

12

100.00

38

1.78

37

97.37

22

0.67

15

68.18

11

0.52

63.64

12

0.37

11

91.67

14

0.66

13

92.86

0.03

100.00

0.03

100.00

0.28

100.00

37

1.13

13.51

17

0.80

23.53

100.00

100.00

3,227

98.62

2,133

2,110

98.92

3
3,272

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

5,405
79.83%

2,613

79.86

1,702

79.79

4,315

79.83

982

30.01

564

26.44

1,546

28.60

1,897

57.98

1,176

55.13

3,073

56.85

318

9.72

226

10.60

544

10.06

245

7.49

164

7.69

409

7.57

- 37 -

ICD-O-FT

T-155

ICD-O-3
ICD-9
ICD-10

C22
155
C22

99
12.16%18.87%
241
29911,023
(ICD-O-3 C15 - C26C48)32.18%
7,744

()

(10)
2

(10)
3

(10)
()

7,751

3,272

62

70

66.62

28.39

47.52
52.34
2.55

18.00
20.54
1

()

5,454

2,290

65

73

46.87

19.87

32.36

11.85

(10)

36.34

13.95

()

2.61

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 38 -


11,023
5,26747.78%48.73%45.54%

91.87%86.22%

7,121

91.87

3,307

46.44

2,821

86.22

1,163

41.23

471

6.08

336

71.34

381

11.64

271

71.13

53

0.68

52

98.11

14

0.43

14

100.00

24

0.31

24

100.00

19

0.58

19

100.00

12

0.15

12

100.00

0.15

80.00

16

0.21

16

100.00

0.21

100.00

13

0.17

12

92.31

0.03

100.00

13

0.17

11

84.62

0.18

100.00

0.06

100.00

0.09

100.00

0.01

100.00

0.06

100.00

22

0.28

4.55

13

0.40

100.00

100.00

3,777

48.73

3,272

1,490

45.54

9
7,751

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

11,023
23.64%
*

( PEIT/PAIT, RFA )

20.75
13.72

2,606
1,182

23.64
10.72

1,927
733

24.86
9.46

PEIT/PAIT

165

2.13

89

2.72

254

2.30

RFA

567

7.32

359

10.97

926

8.40

TAE/TACE
TAE
TACE

( TAE,
PEIT/PAIT, RFA )

679
449

0.01

0.03

0.02

2,191

28.27

874

26.71

3,065

27.81

501

6.46

183

5.59

684

6.21

1,765

22.77

716

21.88

2,481

22.51

210

2.71

96

2.93

306

2.78

676
908
138
1,576
1,282

8.72
11.71
1.78
20.33
16.54

202
243
27
616
623

6.17
7.43
0.83
18.83
19.04

878
1,151
165
2,192
1,905

7.97
10.44
1.50
19.89
17.28

- 39 -

ICD-O-FT

T-156

ICD-O-3
ICD-9
ICD-10

C23 - C24
156
C23 - C24

99
1.02%1.29%
191714
1299924
(ICD-O-3 C15 - C26C48)2.70%
529

()

486

438

71

72

4.18

3.80

(10)
2

(10)
3

2.70

2.28

(10)

3.14

2.67

()

1.18

()

283

246

73

73

2.43

2.13

1.56

1.27

(10)

1.83

1.49

()

1.23

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 40 -


924750
81.17%80.04%82.42%

81.69%84.93%

397

81.69

343

86.40

372

84.93

329

88.44

11

2.26

11

100.00

1.37

100.00

25

5.14

25

100.00

18

4.11

18

100.00

16

3.29

50.00

13

2.97

46.15

0.23

100.00

37

7.61

5.41

28

6.39

3.57

100.00

389

80.04

438

361

82.42

4
486

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

924
51.41%

241

49.59

234

53.42

475

51.41

64

13.17

55

12.56

119

12.88

128

26.34

98

22.37

226

24.46

150

30.86

135

30.82

285

30.84

89

18.31

79

18.04

168

18.18

- 41 -

ICD-O-FT

T-157

ICD-O-3
ICD-9
ICD-10

C25
157
C25

991.81%
3.58%
131487
991,643(ICDO-3 C15 - C26C48)4.80%1,470

()

(10)
2

(10)
3

(10)
()

937

706

68

71

8.05

6.12

5.39
6.13
1.42

3.73
4.33
1

()

855

615

70

73

7.35

5.34

4.81

3.17

(10)

5.57

3.72

()

1.50

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 42 -


1,6431,119
68.11%69.58%66.15%

60.41%59.21%

566

60.41

539

95.23

418

59.21

392

93.78

0.32

100.00

0.57

100.00

0.11

100.00

0.71

100.00

47

5.02

47

100.00

36

5.10

34

94.44

90

9.61

53

58.89

53

7.51

22

41.51

0.21

100.00

0.28

100.00

0.21

100.00

0.14

100.00

226

24.12

2.21

187

26.49

3.74

100.00

652

69.58

706

467

66.15

6
937

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,643
43.34%

185

19.74

143

20.25

328

19.96

141

15.05

110

15.58

251

15.28

413

44.08

299

42.35

712

43.34

403

43.01

327

46.32

730

44.43

197

21.02

125

17.71

322

19.60

- 43 -

ICD-O-FT

T-158

ICD-O-3
ICD-9
ICD-10

C48
158
C48

99
0.17%0.22%
303029
2699157
(ICD-O-3 C15 - C26C48)0.46%
91

()

80

77

57

58

0.69

0.67

(10)
2

(10)
3

0.58

0.51

(10)

0.60

0.54

()

1.11

()

35

56

66

67

0.30

0.49

0.22

0.32

(10)

0.24

0.36

()

0.67

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 44 -


157141
89.81%86.25%93.51%

36.25%25.97%

29

36.25

29

100.00

20

25.97

20

100.00

5.00

100.00

15

19.48

15

100.00

6.25

100.00

2.60

100.00

2.50

100.00

5.19

100.00

18

22.50

12

66.67

3.90

100.00

8.75

100.00

12

15.58

12

100.00

6.25

100.00

10

12.99

10

100.00

2.50

100.00

7.79

83.33

10.00

37.50

6.49

20.00

100.00

100.00

69

86.25

77

72

93.51

80

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

157
70.06%

52

65.00

58

75.32

110

70.06

27

33.75

12

15.58

39

24.84

22

27.50

24

31.17

46

29.30

1.30

1.30

10.00

10.39

16

10.19

- 45 -


ICD-O-FT
ICD-O-3
ICD-9
ICD-10

T-159
C26
159
C26

99
0.06%
0.52%3636
192399
51(ICD-O-3 C15 - C26C48)0.15%
212

()

(10)
2

(10)
3

(10)
()

19

32

60

60

0.16

0.28

0.11
0.12
0.57

0.19
0.21
1

()

139

73

72

74

1.19

0.63

0.78

0.37

(10)

0.90

0.44

()

2.05

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 46 -


5148
94.12%89.47%96.88%
63.16%
53.13%

5.26

100.00

17

53.13

17

100.00

5.26

100.00

3.13

100.00

15.79

100.00

6.25

100.00

12

63.16

11

91.67

12

37.50

11

91.67

10.53

50.00

100.00

17

89.47

32

31

96.88

19

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

51
52.94%

10

52.63

14

43.75

24

47.06

9.38

9.38

42.11

19

59.38

27

52.94

26.32

18.75

11

21.57

21.05

6.25

11.76

- 47 -

ICD-O-FT T-160
ICD-O-3
ICD-9
ICD-10

C30 - C31
160
C30 - C31

99
0.19%
0.09%2731
313499
172(ICD-O-3 C30 - C39)
1.46%36

()

119

53

59

56

1.02

0.46

(10)
2

(10)
3

0.73

0.34

(10)

0.80

0.36

()

2.22

()

22

14

65

59

0.19

0.12

0.14

0.08

(10)

0.15

0.09

()

1.67

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 48 -


172
16897.67%97.48%98.11%

57.98%37.74%

69

57.98

67

97.10

20

37.74

20

100.00

6.72

100.00

13.21

100.00

2.52

100.00

1.89

100.00

2.52

100.00

5.66

100.00

11

9.24

11

100.00

15.09

100.00

13

10.92

13

100.00

11.32

100.00

2.52

100.00

5.66

100.00

5.88

100.00

7.55

75.00

1.68

50.00

1.89

100.00

31

100.00

21

20

95.24

116

97.48

53

52

98.11

31
119

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

172
63.37%

75

63.03

34

64.15

109

63.37

72

60.50

23

43.40

95

55.23

55

46.22

14

26.42

69

40.12

0.84

1.89

1.16

10

8.40

7.55

14

8.14

11

9.24

16.98

20

11.63

- 49 -

ICD-O-FT

T-161

ICD-O-3
ICD-9
ICD-10

C32
161
C32

990.70%
0.45%
17361738
99635
(ICD-O-3 C30 - C39)5.40%186

()

602

33

62

65

(10)
2

(10)
3

5.17
3.62

0.29
0.18

(10)

4.00

0.21

()

19.05

()

178

70

60

1.53

0.07

0.96

0.05

(10)

1.13

0.05

()

22.60

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 50 -


635 625
98.43%98.50%96.97%

96.35%84.85%

580

96.35

580

100.00

28

84.85

28

100.00

0.50

100.00

0.83

100.00

6.06

100.00

1.00

66.67

3.03

100.00

3.03

100.00

1.33

12.50

3.03

100.00

100.00

593

98.50

33

32

96.97

602

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

63559.37%

290

48.17

18

54.55

308

48.50

357

59.30

20

60.61

377

59.37

206

34.22

21.21

213

33.54

31

5.15

3.03

32

5.04

63

10.47

6.06

65

10.24

- 51 -

ICD-O-FT

T-162

ICD-O-3
ICD-9
ICD-10

C33 - C34
162
C33 - C34

99
11.71%
19.96%33
2199
10,615(ICD-O-3 C30 - C39)90.26%
8,194

()

(10)
2

(10)
3

(10)
()

6,697

3,918

71

67

57.56

33.99

37.49
43.68
1.80

21.38
24.27
1

()

5,412

2,782

74

72

46.51

24.13

29.07

14.35

(10)

34.63

16.76

()

2.07

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 52 -


10,615
9,88493.11%92.68%93.85%

44.11%74.86%

1,660

24.79

1,649

99.34

234

5.97

232

99.15

2,954

44.11

2,936

99.39

2,933

74.86

2,919

99.52

49

0.73

47

95.92

41

1.05

41

100.00

43

0.64

43

100.00

21

0.54

21

100.00

784

11.71

777

99.11

91

2.32

90

98.90

64

0.96

64

100.00

20

0.51

20

100.00

45

0.67

45

100.00

46

1.17

46

100.00

15

0.22

15

100.00

26

0.66

26

100.00

472

7.05

458

97.03

211

5.39

201

95.26

421

6.29

407

96.67

197

5.03

187

94.92

182

2.72

138

75.82

81

2.07

58

71.60

0.09

83.33

0.05

100.00

0.12

100.00

0.08

100.00

415

6.20

22

5.30

209

5.33

18

8.61

29

100.00

21

21

100.00

6,207

92.68

3,918

3,677

93.85

29
6,697

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

10,615
61.13%
*

1,073

16.02

981

25.04

2,054

19.35

2,005

29.94

882

22.51

2,887

27.20

4,075

60.85

2,414

61.61

6,489

61.13

11

0.16

0.10

15

0.14

2,327

34.75

1,251

31.93

3,578

33.71

1,059

15.81

475

12.12

1,534

14.45

- 53 -

ICD-O-FT

T-163

ICD-O-3
ICD-9
ICD-10

C38.4
163
C38.4

99
0.07%0.05%
323735
369962
(ICD-O-3 C30 - C39)0.53%
22

()

(10)
2

(10)
3

(10)
()

43

19

64

66

0.37

0.16

0.26
0.29
2.42

0.11
0.12
1

()

10

12

72

75

0.09

0.10

0.06

0.05

0.07

0.07

(10)
2

(10)
3

(10)
()

1. 96
2. 3.2 1976 3 2000

- 54 -


6259
95.16%97.67%89.47%

88.37%84.21%

38

88.37

38

100.00

16

84.21

15

93.75

11.63

80.00

15.79

66.67

100.00

42

97.67

19

17

89.47

43

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

6259.68%

20.93

31.58

15

24.19

9.30

10.53

9.68

31

72.09

31.58

37

59.68

12

27.91

31.58

18

29.03

18.60

31.58

14

22.58

- 55 -

ICD-O-FT T-164
ICD-O-3

C37 - C38(C38.4)

ICD-9
ICD-10

164
C37 - C38(C38.4)

99
0.30%
0.33%2427
222799
276(ICD-O-3 C30 - C39)2.35%
134

()

168

108

56

56

1.44

0.94

(10)
2

(10)
3

1.09

0.68

(10)

1.20

0.73

()

1.64

()

87

47

61

61

0.75

0.41

0.55

0.28

(10)

0.60

0.31

()

1.94

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 56 -


276
25893.48%92.86%94.44%

56.55%77.78%

95

56.55

91

95.79

84

77.78

83

98.81

21

12.50

21

100.00

0.93

100.00

22

13.10

21

95.45

8.33

100.00

4.17

100.00

2.78

100.00

2.38

100.00

3.70

100.00

5.36

100.00

0.93

100.00

1.19

100.00

0.93

100.00

4.76

12.50

4.63

31

100.00

22

22

100.00

156

92.86

108

102

94.44

31
168

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

276
52.17%

84

50.00

60

55.56

144

52.17

67

39.88

54

50.00

121

43.84

80

47.62

40

37.04

120

43.48

25

14.88

18

16.67

43

15.58

19

11.31

16

14.81

35

12.68

- 57 -

ICD-O-FT p.497
ICD-O-3

p.497

ICD-9

204-208

ICD-10

C91 - C95

992.01%
2.36%
1212109
991,823968

()

1,087

736

61

59

9.34

6.39

(10)
2

(10)
3

7.30

5.29

(10)

7.91

5.48

()

1.44

()

582

386

68

66

5.00

3.35

3.59

2.38

(10)

4.02

2.62

()

1.53

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 58 -


1,8231,802
98.85%99.08%98.51%

39.10%41.98%

425

39.10

425

100.00

309

41.98

308

99.68

131

12.05

131

100.00

104

14.13

104

100.00

148

13.62

148

100.00

77

10.46

75

97.40

89

8.19

89

100.00

46

6.25

45

97.83

19

1.75

19

100.00

16

2.17

15

93.75

135

12.42

133

98.52

95

12.91

92

96.84

124

11.41

118

95.16

76

10.33

74

97.37

0.18

100.00

0.27

100.00

0.46

100.00

1.09

87.50

0.83

77.78

0.41

100.00

1,087

100.00

1,077

99.08

736

100.00

725

98.51

96ICD-O-3 M-CODEp.497

1,82370.98%

0.09

0.09

30

2.76

20

2.72

50

2.74

767

70.56

527

71.60

1,294

70.98

139

12.79

109

14.81

248

13.60

0.18

0.82

0.44

59

5.43

38

5.16

97

5.32

154

14.17

113

15.35

267

14.65

30

2.76

16

2.17

46

2.52

- 59 -

ICD-O-FT

p.497

ICD-O-3

p.497

99 223
12.89%

()

131

104

24

25

1.13

0.90

1.45

1.45

(10)

1.33

1.23

()

1.08

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 60 -


210
93.19%

12

9.16

14

13.46

26

11.06

122

93.13

97

93.27

219

93.19

84

64.12

72

69.23

156

66.38

18

13.74

11

10.58

29

12.34

5.34

11

10.58

18

7.66

0.76

0.96

0.85

- 61 -

ICD-O-FT

p.497

ICD-O-3

p.497

99 135
7.41%

()

89

46

69

65

0.76

0.40

0.53

0.27

(10)

0.60

0.29

()

2.07

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 62 -


135
58.52%

54

60.67

25

54.35

79

58.52

22

24.72

10

21.74

32

23.70

4.49

2.17

3.70

3.37

6.52

4.44

- 63 -

ICD-O-FT

p.497

ICD-O-3

p.497

99 734
40.26%

()

425

309

62

58

3.65

2.68

2.70

1.94

(10)

2.99

2.13

()

1.40

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 64 -


734
78.75%

0.24

0.24

11

2.59

1.29

15

2.04

328

77.18

250

80.91

578

78.75

23

5.41

23

7.44

46

6.27

0.47

0.97

0.68

32

7.53

27

8.74

59

8.04

95

22.35

56

18.12

151

20.57

1.65

1.29

11

1.50

- 65 -

ICD-O-FT

p.497

ICD-O-3

p.497

99 225
12.34%

()

148

77

51

51

1.27

0.67

0.95

0.49

(10)

1.05

0.54

()

1.94

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 66 -


225
91.56%

3.38

3.38

135

91.22

71

92.21

206

91.56

1.30

1.30

2.70

2.70

6.08

7.79

15

6.67

1.35

1.30

1.33

- 67 -

ICD-O-FT

T-170

ICD-O-3
ICD-9
ICD-10

C40 - C41
170
C40 - C41

99
0.18%
0.26%2828
242599
163108

()

89

74

32

35

0.76

0.64

(10)
2

(10)
3

0.77

0.63

(10)

0.77

0.65

()

1.18

()

58

50

61

54

0.50

0.43

0.40

0.38

(10)

0.43

0.39

()

1.10

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 68 -


163
15595.09%94.38%95.95%

41.57%51.35%

37

41.57

37

100.00

38

51.35

38

100.00

19

21.35

18

94.74

12

16.22

12

100.00

1.12

2.70

100.00

12

13.48

12

100.00

9.46

100.00

5.62

100.00

1.35

100.00

1.35

100.00

8.99

100.00

8.11

100.00

3.37

100.00

5.41

100.00

4.49

25.00

4.05

10

100.00

100.00

84

94.38

74

71

95.95

Ewing

10
89

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

163
71.17%

62

69.66

54

72.97

116

71.17

19

21.35

13

17.57

32

19.63

51

57.30

45

60.81

96

58.90

10

11.24

8.11

16

9.82

12

13.48

10.81

20

12.27

- 69 -


ICD-O-FT
ICD-O-3

T-171
C47C49

ICD-9
ICD-10

171
C47C49

99
0.56%
0.40%2021
202499
508
166

()

276

232

56

55

2.37

2.01

(10)
2

(10)
3

1.75

1.51

(10)

1.93

1.63

()

1.18

()

107

59

57

64

0.92

0.51

0.68

0.36

(10)

0.76

0.41

()

1.85

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 70 -


508
49797.83%97.83%
97.84%

30.43%21.12%

50

18.12

50

100.00

38

16.38

38

100.00

84

30.43

82

97.62

46

19.83

45

97.83

17

6.16

17

100.00

18

7.76

18

100.00

3.26

100.00

12

5.17

12

100.00

20

7.25

20

100.00

19

8.19

19

100.00

11

3.99

11

100.00

15

6.47

15

100.00

( Schwann ) 12

4.35

12

100.00

3.45

100.00

3.26

100.00

1.72

100.00

37

13.41

37

100.00

49

21.12

49

100.00

22

7.97

21

95.45

18

7.76

16

88.89

0.36

100.00

1.45

25.00

2.16

60.00

21

100.00

16

16

100.00

270

97.83

232

227

97.84

21

276

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

508
75.98%
*

211

76.45

175

75.43

386

75.98

110

39.86

80

34.48

190

37.40

42

15.22

49

21.12

91

17.91

0.43

0.43

19

6.88

15

6.47

34

6.69

26

9.42

27

11.64

53

10.43

- 71 -

ICD-O-FT

T-173

ICD-O-3
ICD-9

C44
172173

ICD-10

C43 - C44

99
3.29%0.50%
81021
21992,978
206

()

1,575

1,403

73

74

13.54

12.17

(10)
2

(10)
3

8.62

7.13

(10)

10.20

8.44

()

1.21

()

113

93

67

75

0.97

0.81

0.65

0.46

(10)

0.74

0.54

()

1.37

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 72 -


2,9782,958
99.33%99.43%99.22%

42.79%52.74%
99293128-129

674

42.79

672

99.70

740

52.74

738

99.73

504

32.00

502

99.60

391

27.87

388

99.23

77

4.89

77

100.00

51

3.64

51

100.00

125

7.94

124

99.20

87

6.20

84

96.55

23

1.46

23

100.00

25

1.78

25

100.00

10

0.63

90.00

0.21

100.00

154

9.78

154

100.00

104

7.41

102

98.08

0.06

100.00

0.44

57.14

0.14

50.00

45

100.00

30

30

100.00

1,566

99.43

1,403

1,392

99.22

45
1,575

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

2,978
89.46%
*

1,403

89.08

1,261

89.88

2,664

89.46

120

7.62

82

5.84

202

6.78

53

3.37

22

1.57

75

2.52

10

0.63

0.43

16

0.54

32

2.03

23

1.64

55

1.85

110

6.98

99

7.06

209

7.02

- 73 -

ICD-O-FT

T-173

( M-87203 - M-87903 )

ICD-O-3
ICD-9
ICD-10

C44
172
C43

( M-87203 - M-87903 )

99
0.23%0.28%
99212
116

()

125

87

66

67

1.07

0.75

(10)
2

(10)
3

0.74

0.47

(10)

0.85

0.54

()

1.57

()

65

51

67

68

0.56

0.44

0.38

0.27

(10)

0.43

0.31

()

1.39

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 74 -


212
81.13%

102

81.60

70

80.46

172

81.13

22

17.60

10.34

31

14.62

18

14.40

8.05

25

11.79

6.40

4.60

12

5.66

10

8.00

2.30

12

5.66

12

9.60

11

12.64

23

10.85

- 75 -

ICD-O-FT

T-173 ( M-87203 - M-87903 )

ICD-O-3

C44

ICD-9
ICD-10

173
C44

( M-87203 - M-87903 )

99
3.05%
0.22%992,766
90

()

1,450

1,316

73

74

12.46

11.42

(10)
2

(10)
3

7.88

6.66

(10)

9.35

7.90

()

1.18

()

48

42

68

84

0.41

0.36

0.27

0.19

(10)

0.31

0.23

()

1.35

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 76 -


2,7662,750
99.42%99.38%99.47%

46.48%56.23%

674

46.48

672

99.70

740

56.23

738

99.73

504

34.76

502

99.60

391

29.71

388

99.23

77

5.31

77

100.00

51

3.88

51

100.00

23

1.59

23

100.00

25

1.90

25

100.00

10

0.69

90.00

0.23

100.00

154

10.62

154

100.00

104

7.90

102

98.08

0.07

100.00

0.48

57.14

0.15

50.00

45

100.00

30

30

100.00

1,442

99.45

1,316

1,308

99.39

45
1,450

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

2,766
90.09%

1,301

89.72

1,191

90.50

2,492

90.09

98

6.76

73

5.55

171

6.18

35

2.41

15

1.14

50

1.81

0.14

0.15

0.14

22

1.52

21

1.60

43

1.55

98

6.76

88

6.69

186

6.72

- 77 -

ICD-O-FT

T-174T-175

ICD-O-3
ICD-9

C50
174175

ICD-10

C50

99
10.65%0.04%
4.16%0.03%134
43599
9,65539
1,70612

()

39

9,655

66

52

(10)
2

(10)
3

(10)
()

0.34
0.21

83.76
58.63

()

12

1,706

77

57

0.10

14.80

0.06

9.98

0.07

10.86

155.14

(10)
2

(10)
3

0.24

63.16

(10)

263.17

()

1. 96
2. 3.2 1976 3 2000

- 78 -


9,6559,608
99.51%39
39100%

89.33%82.05%
9931,579
132133

32

82.05

32

100.00

8,625

89.33

8,622

99.97

242

2.51

242

100.00

47

0.49

47

100.00

364

3.77

364

100.00

54

0.56

54

100.00

Paget

16

0.17

16

100.00

12.82

100.00

179

1.85

178

99.44

2.56

100.00

64

0.66

56

87.50

2.56

100.00

18

0.19

18

100.00

46

0.48

11

23.91

19

19

100.00

39

100.00

9,655

9,608

99.51

39

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

9,694
91.20%
*

84.62
23.08
46.15
71.79
5.13
7.69

8,808
4,344
6,521
6,068
298
255

91.23
44.99
67.54
62.85
3.09
2.64

8,841
4,353
6,539
6,096
300
258

91.20
44.90
67.45
62.88
3.09
2.66

33
9
18
28
2
3

- 79 -

ICD-O-FT

T-180

ICD-O-3
ICD-9
ICD-10

C53
179180
C53C55

99
1.85%1.72%
7699
1,680(ICD-O-3 C51 - C58)
34.84%704

()

1,680

()

704

56

65

(10)
2

(10)
3

(10)

(10)

14.57

(10)

9.74

(10)

10.81

6.11
3.79
4.34

1. 96
2. 3.2 1976 3 2000

- 80 -


1,6801,670
99.40%
1,68074.97%
993,337134135

1,254

74.64

1,252

99.84

50

2.98

50

100.00

275

16.37

275

100.00

0.48

100.00

41

2.44

41

100.00

40

2.38

39

97.50

12

0.71

41.67

100.00

1,670

99.40

1,680

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,680
55.95%

878

52.26

940

55.95

720

42.86

0.18

0.18

108

6.43

120

7.14

- 81 -

ICD-O-FT

T-182

ICD-O-3
ICD-9
ICD-10

C54
182
C54

99
1.92%0.46%
61499
1,737(ICD-O-3 C51 C58)36.02%189

()

1,737

()

189

54

58

(10)
2

(10)
3

(10)

(10)

15.07

(10)

10.47

(10)

11.25

1.64
1.11
1.21

1. 96
2. 3.2 1976 3 2000

- 82 -


1,7371,731
99.65%
1,73775.79%

1,313

75.59

1,312

99.92

34

1.96

34

100.00

0.17

100.00

163

9.38

163

100.00

0.52

88.89

58

3.34

58

100.00

47

2.71

47

100.00

Muller

95

5.47

95

100.00

0.12

100.00

0.40

100.00

0.35

33.33

100.00

1,731

99.65

1,737

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,737
90.96%

1,580

90.96

500

28.79

395

22.74

160

9.21

12

0.69

39

2.25

68

3.91

- 83 -

ICD-O-FT

T-183

ICD-O-3

C56C57.0 -

C57.4
ICD-9
ICD-10

183
C56C57.0 -

C57.4
99
1.37%
1.06%98
991,245
(ICD-O-3 C51 - C58)25.82%
434

()

1,245

()

434

52

59

(10)
2

(10)
3

(10)

(10)

10.80

(10)

7.83

(10)

8.46

3.77
2.53
2.79

1. 96
2. 3.2 1976 3 2000

- 84 -


1,245
1,17994.70%
1,24530.28%

159

12.77

145

91.19

377

30.28

375

99.47

159

12.77

159

100.00

169

13.57

169

100.00

51

4.10

51

100.00

37

2.97

32

86.49

0.16

100.00

209

16.79

205

98.09

27

2.17

21

77.78

15

1.20

14

93.33

0.16

100.00

38

3.05

10.53

100.00

1,179

94.70

1,245

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,245
88.59%

1,103

88.59

24

1.93

925

74.30

17

1.37

0.40

64

5.14

52

4.18

- 85 -


ICD-O-FT
ICD-O-3

T-184
C51 - C52C57.7 - C57.9

ICD-9
ICD-10

184
C51 - C52C57.7 - C57.9

99
0.17%
0.09%23
3199
152(ICD-O-3 C51 - C58)
3.15%
37

()

152

()

37

63

70

(10)
2

(10)
3

(10)

(10)

1.32

(10)

0.88

(10)

0.98

0.32
0.19
0.23

1. 96
2. 3.2 1976 3 2000

- 86 -


152
14998.03%
15257.72%

86

56.58

86

100.00

5.92

100.00

5.26

100.00

14

9.21

14

100.00

5.92

100.00

1.32

100.00

12

7.89

12

100.00

3.95

100.00

0.66

100.00

3.29

40.00

152

100.00

149

98.03

Paget

1. 96ICD-O-3 M-CODEp.497

152
54.61%

83

54.61

51

33.55

39

25.66

13

8.55

30

19.74

- 87 -

()

ICD-O-FT
ICD-O-3
ICD-9
ICD-10

T-185
C61
185
C61

99()
4.85%2.49%
5799
()4,392(ICD-O-3 C60
C63)94.23%()1,021

()

4,392

()

1,021

74

80

(10)

(10)

37.75

(10)

(10)

24.17

(10)

8.78

4.67

(10)

28.77

6.04

1. 96
2. 3.2 1976 3 2000

- 88 -


4,392()
4,30498.00%
4,39297.18%

4,268

97.18

4,262

99.86

27

0.61

27

100.00

19

0.43

12

63.16

0.05

100.00

76

1.73

1.32

100.00

4,304

98.00

4,392

100.00

1. 96ICD-O-3 M-CODEp.497

2.

4,392()
61.43%
*

**

1,873

42.65

1,272

28.96

46

1.05

2,698

61.43

***

269

6.12

374

8.52

339

7.72

*
**prostatectomy, cryoprostatectomy, hyperthermia, TURP
***

- 89 -

ICD-O-FT

T-186

ICD-O-3
ICD-9
ICD-10

C62
186
C62

99
0.20%0.04%
223299
178(ICD-O-3 C60
C63)3.82%17

()

178

()

17

28

30

(10)
2

(10)
3

(10)

1.53
1.49
1.54

(10)
2

(10)
3

(10)

0.15
0.12
0.13

1. 96
2. 3.2 1976 3 2000

- 90 -


178177
99.44%
17851.12%

91

51.12

91

100.00

2.25

100.00

3.37

100.00

54

30.34

54

100.00

14

7.87

14

100.00

0.56

100.00

2.25

100.00

1.69

100.00

0.56

12

100.00

177

99.44

12

178

100.00

1. 96ICD-O-3 M-CODEp.497

2.

178
89.89%

160

89.89

43

24.16

61

34.27

1.12

1.69

1.69

2.25

- 91 -

ICD-O-FT

T-187

ICD-O-3

C60C63

ICD-9
ICD-10

187
C60C63

99
0.10%
0.04%30
339991
(ICD-O-3 C60 C63)1.95%
17

()

91

()

17

66

56

(10)
2

(10)
3

(10)

(10)

0.78

(10)

0.53

(10)

0.60

0.15
0.10
0.11

1. 96
2. 3.2 1976 3 2000

- 92 -


91
8997.80%
9152.75%

48

52.75

48

100.00

6.59

100.00

Paget

22

24.18

22

100.00

2.20

100.00

1.10

100.00

9.89

100.00

3.30

33.33

100.00

89

97.80

91

100.00

1. 96ICD-O-3 M-CODEp.497

2.

91
87.91%

80

87.91

9.89

12

13.19

1.10

3.30

5.49

- 93 -

ICD-O-FT

T-188

ICD-O-3
ICD-9
ICD-10

C67
188
C67

99
2.17%1.79%
91612
13991,964
(ICD-O-3 C64 C68)44.22%735

()

1,427

537

72

72

12.26

4.66

(10)
2

(10)
3

7.88

2.80

(10)

9.24

3.28

()

2.82

()

504

231

78

77

4.33

2.00

2.47

1.08

(10)

3.08

1.34

()

2.30

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 94 -


1,964
1,93098.27%98.25%98.32%

93.06%92.18%
99441168
136137

1,328

93.06

1,316

99.10

495

92.18

491

99.19

36

2.52

36

100.00

14

2.61

14

100.00

0.63

100.00

10

1.86

10

100.00

20

1.40

20

100.00

10

1.86

10

100.00

11

0.77

11

100.00

0.28

100.00

0.19

100.00

19

1.33

31.58

1.30

28.57

100.00

1,402

98.25

537

528

98.32

3
1,427

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,964
88.49%

1,253

87.81

485

90.32

1,738

88.49

136

9.53

52

9.68

188

9.57

695

48.70

260

48.42

955

48.63

0.07

0.07

300

21.02

94

17.50

394

20.06

76

5.33

44

8.19

120

6.11

86

6.03

23

4.28

109

5.55

- 95 -

ICD-O-FT

T-189.0

ICD-O-3
ICD-9
ICD-10

C64
189.0
C64

991.13%
1.19%
14201415
991,028(ICD-O-3 C64 - C68)
23.15%490

()

678

350

61

63

5.83

3.04

(10)
2

(10)
3

4.20

2.05

(10)

4.60

2.27

()

2.03

()

289

201

74

77

2.48

1.74

1.54

1.00

(10)

1.83

1.20

()

1.53

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 96 -


1,028916
89.11%89.97%87.43%

92.04%89.71%

624

92.04

574

91.99

314

89.71

282

89.81

1.03

100.00

0.86

100.00

10

1.47

90.00

10

2.86

10

100.00

13

1.92

10

76.92

10

2.86

80.00

0.88

100.00

0.29

100.00

0.15

100.00

17

2.51

17.65

12

3.43

16.67

100.00

100.00

610

89.97

350

306

87.43

2
678

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,028
71.89%

490

72.27

249

71.14

739

71.89

35

5.16

11

3.14

46

4.47

99

14.60

37

10.57

136

13.23

0.29

0.29

12

1.77

1.14

16

1.56

59

8.70

33

9.43

92

8.95

102

15.04

48

13.71

150

14.59

- 97 -

ICD-O-FT
ICD-O-3
ICD-9
ICD-10

T-189.1 - T-189.9
C65 - C66C68
189.1-189.9
C65 - C66C68

99
1.60%
0.76%1513
181899
1,449(ICD-O-3 C64 - C68)32.63%
313

()

675

774

68

71

5.80

6.71

(10)
2

(10)
3

4.03

4.17

(10)

4.56

4.79

()

0.95

()

149

164

76

76

1.28

1.42

0.80

0.79

0.96

0.96

(10)
2

(10)
3

(10)
()

1. 96
2. 3.2 1976 3 2000

- 98 -


1,449
1,40496.89%96.89%96.90%

85.19%91.47%

575

85.19

560

97.39

708

91.47

692

97.74

15

2.22

15

100.00

1.16

100.00

60

8.89

60

100.00

35

4.52

35

100.00

1.04

100.00

10

1.48

10

100.00

1.16

88.89

0.39

100.00

0.15

100.00

0.13

100.00

1.04

14.29

1.16

22.22

100.00

100.00

654

96.89

774

750

96.90

675

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

1,449
76.60%

516

76.44

594

76.74

1,110

76.60

70

10.37

66

8.53

136

9.39

216

32.00

194

25.06

410

28.30

10

1.48

14

1.81

24

1.66

66

9.78

71

9.17

137

9.45

78

11.56

101

13.05

179

12.35

- 99 -

ICD-O-FT

T-190

ICD-O-3
ICD-9
ICD-10

C69
190
C69

99
0.07%0.02%
313438
399961
8

()

39

22

40

44

0.34

0.19

(10)
2

(10)
3

0.49

0.27

(10)

0.42

0.23

()

1.83

()

83

72

0.03

0.04

0.01

0.05

(10)

0.02

0.04

()

0.50

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 100 -


6147
77.05%84.62%63.64%

33.33%
40.91%

13

33.33

61.54

31.82

14.29

10

25.64

10

100.00

40.91

77.78

12.82

100.00

9.09

100.00

12.82

100.00

9.09

100.00

2.56

100.00

5.13

100.00

2.56

100.00

9.09

100.00

2.56

100.00

2.56

17

100.00

29

29

100.00

33

84.62

22

14

63.64

17
39

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

61
72.13%

31

79.49

13

59.09

44

72.13

15.38

27.27

12

19.67

23.08

36.36

17

27.87

5.13

4.55

4.92

- 101 -

ICD-O-FT

T-191

ICD-O-3
ICD-9
ICD-10

C71
191
C71

99
0.81%1.22%
181913
1199734
(ICD-O-3 C71 C72)93.03%501

()

420

314

51

52

(10)
2

(10)
3

3.61
3.29

2.72
2.41

(10)

3.35

2.47

()

1.36

()

286

215

55

58

2.46

1.87

1.89

1.53

(10)

2.06

1.59

()

1.30

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 102 -


734632
86.10%87.14%84.71%

41.43%39.81%

74

17.62

71

95.95

54

17.20

53

98.15

174

41.43

165

94.83

125

39.81

111

88.80

12

2.86

10

83.33

2.55

87.50

23

5.48

23

100.00

24

7.64

23

95.83

42

10.00

29

69.05

33

10.51

25

75.76

15

3.57

15

100.00

2.23

100.00

10

2.38

10

100.00

2.87

77.78

11

2.62

11

100.00

2.55

100.00

23

5.48

19

82.61

2.87

77.78

1.90

87.50

11

3.50

81.82

0.32

100.00

0.48

50.00

1.27

100.00

26

6.19

19.23

21

6.69

19.05

27

27

100.00

30

30

100.00

366

87.14

314

266

84.71

420

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

734
72.89%
*

309
267
214
1
28
38

73.57
63.57
50.95
0.24
6.67
9.05

226
194
145
1
27
31

71.97
61.78
46.18
0.32
8.60
9.87

- 103 -

535
461
359
1
1
55
69

72.89
62.81
48.91
0.24
0.32
7.49
9.40

ICD-O-FT T-192
ICD-O-3

C70C72

ICD-9
ICD-10

192
C70C72

99
0.06%
0.06%3534
343499
55(ICD-O-3 C71 C72)
6.97%24

()

(10)
2

(10)
3

(10)
()

25

30

49

52

0.21

0.26

0.18
0.19
0.83

0.22
0.23
1

()

11

13

36

59

0.09

0.11

0.09

0.08

(10)

0.10

0.09

()

1.11

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 104 -


55
4480.00%72.00%86.67%

40.00%36.67%

6.67

100.00

12.00

100.00

10.00

100.00

16.00

100.00

23.33

100.00

10

40.00

70.00

11

36.67

81.82

3.33

100.00

4.00

100.00

20.00

40.00

16.67

80.00

4.00

100.00

4.00

3.33

100.00

66.67

18

72.00

30

26

86.67

25

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

55
72.73%

17

68.00

23

76.67

40

72.73

10

40.00

11

36.67

21

38.18

12.00

6.67

9.09

4.00

6.67

5.45

16.00

16.67

16.36

- 105 -

ICD-O-FT

T-193

ICD-O-3
ICD-9
ICD-10

C73
193
C73

99
2.66%0.33%
16526
22992,409
135

()

571

1,838

49

47

4.91

15.95

(10)
2

(10)
3

3.66

11.96

(10)

4.02

12.91

()

0.31

()

56

79

70

73

0.48

0.69

0.31

0.40

(10)

0.36

0.48

()

0.75

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 106 -


2,4092,390
99.21%99.30%99.18%

83.89%89.99%

479

83.89

476

99.37

1,654

89.99

1,653

99.94

47

8.23

47

100.00

107

5.82

105

98.13

11

1.93

11

100.00

22

1.20

22

100.00

0.70

100.00

0.16

100.00

0.11

100.00

10

1.75

10

100.00

16

0.87

15

93.75

0.88

100.00

0.27

100.00

10

1.75

10

100.00

14

0.76

13

92.86

0.18

100.00

0.70

75.00

15

0.82

33.33

100.00

15

15

100.00

567

99.30

1,838

1,823

99.18

571

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

2,409
93.03%

513

89.84

1,728

94.02

2,241

93.03

322

56.39

1,043

56.75

1,365

56.66

14

2.45

12

0.65

26

1.08

376

65.85

1,312

71.38

1,688

70.07

19

3.33

27

1.47

46

1.91

32

5.60

57

3.10

89

3.69

- 107 -

ICD-O-FT

T-194

ICD-O-3
ICD-9
ICD-10

C74 - C75
194
C74 - C75

99
0.06%0.10%
343230
309951
43

()

25

26

49

45

0.21

0.23

(10)
2

(10)
3

0.27

0.31

(10)

0.24

0.27

()

0.89

()

19

24

52

43

0.16

0.21

0.20

0.25

(10)

0.18

0.24

()

0.75

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 108 -


5143
84.31%88.00%80.77%

24.00%
34.62%

24.00

100.00

34.62

100.00

16.00

100.00

30.77

87.50

16.00

75.00

7.69

100.00

4.00

100.00

3.85

100.00

8.00

50.00

24.00

100.00

3.85

100.00

8.00

50.00

19.23

20.00

100.00

100.00

22

88.00

26

21

80.77

25

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

51
64.71%

19

76.00

14

53.85

33

64.71

20.00

11.54

15.69

28.00

10

38.46

17

33.33

4.00

3.85

3.92

8.00

7.69

7.84

12.00

26.92

10

19.61

- 109 -


ICD-O-FT

T-196

M-CODEp.497

ICD-O-3

C77

M-CODEp.497

991,312

()

779

533

61

61

6.70

4.62

4.92

3.25

(10)

5.45

3.59

()

1.52

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 110 -


1,312
1,29999.01%99.10%98.87%
151
151100.00%1,029
1,08099.91%
99.84%100.00%
1,312
81.64%83.30%

92

11.81

92

100.00

59

11.07

59

100.00

636

81.64

635

99.84

444

83.30

444

100.00

51

6.55

45

88.24

30

5.63

24

80.00

779

100.00

772

99.10

533

100.00

527

98.87

96ICD-O-3 M-CODEp.497

- 111 -


ICD-O-FT T-140 - T-199 (T-196) M-CODEp.497
ICD-O-3

C00 - C80 (C77) M-CODEp.497

991,603

()

880

723

66

63

7.56

6.27

5.56

4.32

(10)

6.13

4.78

()

1.28

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 112 -


1,603
1,573 98.13% 97.84%
98.48%21
21100.00%1,002
99999.70%
99.82%99.56%502
47895.22%93.99%
96.80%
1,603
61.70%63.49%

11

1.25

11

100.00

10

1.38

10

100.00

543

61.70

542

99.82

459

63.49

457

99.56

283

32.16

266

93.99

219

30.29

212

96.80

18

2.05

18

100.00

1.11

100.00

25

2.84

24

96.00

27

3.73

25

92.59

880

54.90

861

97.84

723

45.10

712

98.48

96ICD-O-3 M-CODEp.497

- 113 -

( ICD-O-3 M-CODEp.497 )

C00

C77

ICD-O-3

151

1,080

81

1,312

C44.0

C01-C02

21

22

C03

C05-C06

11

11

C09-C10

82

87

C12-C13

C14

C07-C08

22

23

C11

37

40

C16

193

204

C17

61

64

C18

30

31

C19-C21

C22

12

14

C23-C24

C25

C48

C26

C30-C31

47

52

C32

C33-C34

39

50

C38.4

- 114 -

( ICD-O-3 M-CODEp.497)

53

86

490

582

C40-C41

13

14

C47, C49

28

37

C44

74

75

C50

18

19

C53

C54

C55

C56

C61

C62

12

12

C63

C67

C64-C66, C68

C69

46

46

C71

52

57

C70, C72

10

C73

18

19

C74-C75

C76

C80

13

20

172

2,082

502

159

2,915

C37-C38.3, C38.8

C42

C00-C80

- 115 -


39

10

ICD-O-3

ICD-O-FT

p.497

ICD-O-3

p.497

ICD-9
ICD-10

201
C81

99
0.19%0.04%
262935
3799172
(ICD-O-3 M-CODEp.497)5.90%
18

()

103

69

36

29

0.89

0.60

(10)
2

(10)
3

0.84

0.54

(10)

0.85

0.57

()

1.49

()

10

56

44

0.09

0.07

0.06

0.06

(10)

0.07

0.06

()

1.17

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 116 -


172172
100.00%

51.46%57.97%

10

9.71

10

100.00

5.80

100.00

2.91

100.00

100.00

14

13.59

14

100.00

11

15.94

11

100.00

53

51.46

53

100.00

40

57.97

40

100.00

23

22.33

23

100.00

14

20.29

14

100.00

103

100.00

103

100.00

69

100.00

69

100.00

96ICD-O-3 M-CODEp.501

172
87.79%

17

16.50

13.04

26

15.12

36

34.95

29

42.03

65

37.79

87

84.47

64

92.75

151

87.79

18

17.48

12

17.39

30

17.44

2.91

2.91

6.80

4.35

10

5.81

5.83

4.35

5.23

- 117 -


p.497
p.497

ICD-O-FT
ICD-O-3
ICD-9

200202-203

ICD-10

C82 - C85

99
2.30%
2.41%1111
910992,082
(ICD-O-3 M-CODEp.497)71.42%
991

()

1,179

903

63

62

10.13

7.83

(10)
2

(10)
3

7.30

5.39

(10)

8.13

5.97

()

1.36

()

628

363

71

74

5.40

3.15

3.51

1.82

(10)

4.07

2.19

()

1.86

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 118 -


2,0822,078
99.81%99.83%99.78%
B
81.68%87.15%

963

81.68

961

99.79

787

87.15

786

99.87

T/NK

216

18.32

216

100.00

116

12.85

115

100.00

1,179

100.00

1,177

99.83

903

100.00

901

99.78

96ICD-O-3 M-CODEp.497

2,082
75.41%

208

17.64

176

19.49

384

18.44

164

13.91

137

15.17

301

14.46

906

76.84

664

73.53

1,570

75.41

732

62.09

555

61.46

1,287

61.82

0.68

0.22

10

0.48

19

1.61

14

1.55

33

1.59

117

9.92

75

8.31

192

9.22

125

10.60

100

11.07

225

10.81

- 119 -


ICD-O-FT
ICD-O-3
ICD-10

M-973
M-97313 M-97343
C90

990.55%
0.73%
21221619
99502(ICD-O3 M-CODEp.497)17.22%
300

()

283

219

69

69

2.43

1.90

(10)
2

(10)
3

1.66

1.21

(10)

1.88

1.36

()

1.38

()

192

108

73

72

1.65

0.94

1.03

0.57

(10)

1.24

0.66

()

1.88

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 120 -


502478
95.22%26693.99%212
96.80%

50269.92%

2.83

12

5.48

20

3.98

62

21.91

43

19.63

105

20.92

196

69.26

155

70.78

351

69.92

177

62.54

120

54.79

297

59.16

117

41.34

89

40.64

206

41.04

25

8.83

19

8.68

44

8.76

73

25.80

65

29.68

138

27.49

1.77

3.20

12

2.39

- 121 -

ICD-O-FT

T-199

ICD-O-3
ICD-9
ICD-10

C80
199
C80

99
1.02%1.04%
99929
428

()

538

391

69

73

4.62

3.39

(10)
2

(10)
3

3.06

2.00

(10)

3.52

2.36

()

1.49

()

271

157

69

74

2.33

1.36

1.53

0.78

(10)

1.75

0.94

()

1.86

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

- 122 -


929721
77.61%78.81%75.96%

27.88%38.87%

150

27.88

148

98.67

152

38.87

149

98.03

93

17.29

93

100.00

14

3.58

14

100.00

0.93

100.00

0.26

100.00

1.49

100.00

1.28

100.00

0.37

100.00

0.51

100.00

34

6.32

34

100.00

53

13.55

51

96.23

118

21.93

106

89.83

56

14.32

53

94.64

0.26

100.00

10

1.86

10

100.00

1.79

100.00

0.56

100.00

0.26

100.00

0.19

100.00

0.77

66.67

114

21.19

14

12.28

96

24.55

11

11.46

13

100.00

85.71

424

78.81

391

297

75.96

13
538

100.00

100.00

1. 96ICD-O-3 M-CODEp.497

2.

929
30.03%

39

7.25

65

16.62

104

11.19

127

23.61

28

7.16

155

16.68

164

30.48

115

29.41

279

30.03

0.19

0.51

0.32

0.26

0.26

181

33.64

135

34.53

316

34.02

206

38.29

139

35.55

345

37.14

- 123 -

- 124 -

99

- 125 -

99

ICD-O-3
1

C00-C14

C15

C16

C17

C18-C21

C22

C23-C24

C25

C48

C30

C32

C33-C34

1
|
4

5
|
9

10
|
14

15
|
19

41

PRIMARY ANATOMIC SITES

GENDER

TOTAL

Male

Female

Total

47

Male

22

Female

Total

22

Male

21

Female

13

Total

34

Male

Female

Total

Male

593

Female

342

Total

935

Male

Female

Total

Male

Female

Total

11

Male

Female

Total

Male

Female

Total

Male

Female

Total

Male

21

Female

Total

23

Male

Female

Total

11

1. C00-C14 C00-C06C09-C10C12-C14

- 126 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

10

- C00-C142
-

10

- C15
-

4 C16
-

- C17
-

11

31

79

93

110

112

61

41

26

20

61

57

51

57

24

33

13

15 C18-C21
10

18

51

140

150

161

169

85

74

39

25

- C22
-

- C23-C24
-

- C25
-

- C48
-

- C30
-

- C32
-

2 C33-C34
-

- 127 -

80
| 85+
84

ICD-O-3

99

ICD-O-3
C44

PRIMARY ANATOMIC SITES

GENDER

TOTAL

1
|
4

5
|
9

10
|
14

15
|
19

Male

158

Female

135

Total

293

1,579

C50

Female

C50

Male

C53

Female

3,337

C54

Female

C56

Female

C51-C52,

Female

77

Male

C57.7-C57.9

C61
C60,C63

Male

14

C67

Male

441

Female

168

Total

609

Male

Female

Total

Male

67

Female

84

Total

151

Male

10

Female

Total

14

Male

1,416

Female

5,771

Total

7,187

C64

C65-C66,

C68
C69

2. C67

- 128 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
| 85+
84

14

12

23

22

30

23

14

20

21

23

23

13 C44
21
34

ICD-O-3

13

28

17

43

43

53

46

13

28

72

166

399

304

226

157

93

62

35

16

2 C50

1 C50

53

177

470

444

461

430

341

280

207

178

134

94

42

24 C53

- C54

- C56

10

10

13

14

1 C51-C52,
C57.7-C57.9

- C60,C63

16

18

26

48

49

60

50

83

49

24

22

27

36

22

11

35 C67
6

19

27

32

72

71

87

86

105

60

41

- C64
-

12

12

12

10

12

23

14

3 C65-C66,
5 C68

20

16

24

31

26

10

2 C69
-

16

19

42

73

135

186

186

217

161

183

117

75

62

195

503

523

645

869

733

624

466

407

319

231

122

69

64

198

519

542

687

942

868

810

652

624

480

414

239

144

- 129 -

C61


ICD-O-FT

T-153T-154

ICD-O-3

C18 - C21

99
935104.0410 3
3.12593105.1010
3 4.1034210
2.971032.20

()

593

342

62

61

5.10

2.97

3.84

2.04

(10)

4.10

2.20

()

1.86

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000
4. 52

- 130 -


935
935100.00%

96.63%96.49%

573

96.63

573

100.00

330

96.49

330

100.00

1.01

100.00

1.17

100.00

14

2.36

14

100.00

2.34

100.00

593

100.00

593

100.00

342

100.00

342

100.00

96ICD-O-3 M-95903 - M-97293M-97503 - M-97583M-97643

935
90.16%

531

89.54

312

91.23

843

90.16

0.34

0.88

0.53

0.67

1.75

10

1.07

0.17

0.17

44

7.42

22

6.43

66

7.06

- 131 -

ICD-O-FT

T-174T-175

ICD-O-3

C50

991,5793
10 13.70 10 3
10.29100.03103
0.02

()

1,579

77

51

0.03

13.70

0.01

9.69

0.02

10.29

514.50

(10)
2

(10)
3

(10)
()

1. 96
2. 3.2 1976 3 2000
4. 52

- 132 -


1,5791,579
100.00%3
3100.00%
66.67%
87.78%

33.33

100.00

1,386

87.78

1,386

100.00

0.06

100.00

37

2.34

37

100.00

10

0.63

10

100.00

66.67

100.00

134

8.49

134

100.00

11

0.70

11

100.00

100.00

100.00

1,579

100.00

1,579

100.00

96ICD-O-3 M-95903 - M-97293M-97503 - M-97583M-97643

1,579
95.07%

100.00

1,501

95.06

1,504

95.07

510

32.30

510

32.30

14

0.89

14

0.89

33.33

913

57.82

914

57.77

0.06

0.06

42

2.66

42

2.66

- 133 -

ICD-O-FT

T-180

ICD-O-3

C53

993,33710
28.9510323.34

()

3,337

45

(10)

28.95

(10)
2

(10)

21.10
23.34

1. 96
2. 3.2 1976 3 2000
4. 52

- 134 -


3,3373,338
100.00%

90.74%

3,029

90.77

3,029

100.00

0.15

100.00

89

2.67

89

100.00

214

6.41

213

99.53

3,337

100.00

3,337

100.00

1. 96ICD-O-3 M-95903 - M-97293M-97503 - M-97583M97643


2. M-80102Intraepithelial carcinoma, NOS214

3,337
88.97%

2,969

88.97

0.27

0.09

0.09

297

8.90

- 135 -

ICD-O-FT

T-188

ICD-O-3

C67

9960910
2.6310 3 1.97441
103.791032.92
168101.46103
1.07

()

441

168

69

68

3.79

1.46

2.54

0.97

(10)

2.92

1.07

()

2.73

(10)
2

(10)
3

1. 96
2. 3.2 1976 3 2000

4. 52

- 136 -


609607
99.67%

99.32%98.81%

438

99.32

438

100.00

166

98.81

164

98.80

0.60

100.00

0.45

100.00

0.23

100.00

0.60

100.00

441

100.00

441

100.00

168

100.00

166

98.81

96ICD-O-3 M-95903 - M-97293M-97503 - M-97583M-97643

60993.92%

420

95.24

152

90.48

572

93.92

0.91

1.19

0.99

**

265

60.09

98

58.33

363

59.61

94

21.32

36

21.43

130

21.35

0.91

0.60

0.82

12

2.72

12

7.14

24

3.94

*
**

- 137 -

- 138 -

99

- 139 -

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010

ICD-O-3

PRIMARY ANATOMIC SITES

C00-C80

C00-C14

C00-C14

15
|
19

30

68

63

91

156

Female

39,757

24

59

42

85

99

Total

90,649

54

127

105

176

255

Male

7,353

14

LIP, ORAL CAVITY AND PHARYNX

Female

1,014

Total

8,367

20

Male

6,028

ORAL CAVITY, OROPHARYNX AND

Female

532

Total

6,560

Male

3,967

Female

425

Total

4,392

Male

1,086

Female

83

Total

1,169

Male

975

Female

24

Total

999

C44.0

Male

210

LIPexcludes skin of lip C44.0

Female

18

Total

228

Male

1,583

TONGUE

Female

222

Total

1,805

Male

384

GUM

Female

61

Total

445

Male

151

FLOOR OF MOUTH

Female

13

Total

164

Male

2,125

OTHER AND UNSPECIFIED PARTS OF

Female

144

Total

2,269

Male

586

OROPHARYNX

Female

49

Total

635

HYPOPRAYNX

MOUTH

C09-C10

10
|
14

50,892

OROPHARYNX

C05-C06

5
|
9

Male

C04

TOTAL

1
|
4

ORAL CAVITY

C03

GENDER

ALL SITES

C01-C02

HYPOPHARYNX

C00

1. 96 ICD-O-3 M-CODE
p.497
2. ICD-O-3

C00-C06C09-C10C12-C14

3. Head and Neck Surgery and Oncology, 3rd ed. 18

- 140 -

20
|
24

25
|
29

30
|
34

191

342

741 1,275 2,316 3,714 5,056

6,094 5,350 5,629 5,789 5,920 5,009 3,058 C00-C80

206

487

917 1,469 2,590 4,018 4,636

4,937 3,873 3,847 3,938 3,564 2,757 2,209

397

829 1,658 2,744 4,906 7,732 9,692 11,031 9,223 9,476 9,727 9,484 7,766 5,267
212

35
|
39

462

40
|
44

11

48

12

21

43

62

23

69

255

524

20

121

354

707

45
|
49

50
|
54

882 1,164 1,352

55
|
59

60
|
64

65
|
69

125

101

67

89

65

51

32

1,288

824

591

431

310

193

101

977

619

451

291

196

124

60

ICD-O-3

69 C00-C14

135

24

142

85+

959 1,290 1,487


979 1,127

245

80
|
84

723

126

342

75
|
79

1,163

77

524

70
|
74

2
58 C00-C14

10

18

70

66

59

48

58

43

36

26

27

131

372

731 1,039 1,197

1,043

678

499

349

239

160

84

20

110

269

502

639

736

618

383

286

182

109

75

34

16

19

40

50

50

50

39

52

34

31

23

27

118

285

521

679

786

668

433

325

234

143

106

57

60

117

190

207

185

125

83

47

36

24

17

17

10

62

122

207

224

195

132

90

51

44

27

25

88

150

184

174

111

82

62

51

25

18

25

88

153

187

180

113

84

64

52

27

20

19

21

36

38

27

30

20

- C00

19

22

36

39

30

33

23

57

124

215

252

287

251

144

97

73

43

21

9 C01-C02

14

13

30

36

27

27

23

13

12

10

14

60

138

228

282

323

278

171

120

86

55

31

16

15

41

43

79

65

38

35

19

19

14

11

16

44

47

83

73

46

39

30

25

20

13

10

14

29

32

33

17

- C04

11

14

31

35

35

17

10

45

141

264

370

392

318

218

160

83

56

46

11

14

16

14

12

24

13

13

10

50

143

269

381

406

334

232

172

107

69

59

29

33

65

111

112

96

63

43

26

20

11

10

33

68

120

122

102

68

46

28

26

14

- 141 -

8 C03

20 C05-C06

3 C09-C10

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C12-C13

C14

GENDER

Male

HYPOPHARYNX

Female

C11

1
|
4

5
|
9

10
|
14

15
|
19

921

21

TOTAL

Total

942

Male

68

PHARYNX AND ILL-DEFINED SITES IN LIP,

Female

Total

72

Male

131

MAJOR SALIVARY GLANDS

Female

105

Total

236

Male

1,194

10

NASOPHARYNX

Female

377

Total

1,571

12

ORAL CAVITY AND PHARYNX

C07-C08

C15-C26,

Male

22,112

C48

DIGESTIVE ORGANS AND PERITONEUM

Female

12,143

11

Total

34,255

18

Male

2,091

ESOPHAGUS

Female

147

C15

C16

C17

C18-C21

Total

2,238

Male

2,415

STOMACH

Female

1,439

Total

3,854

Male

190

SMALL INTESTINE

Female

135

Total

325

Male

8,143

COLON, RECTUM, RECTOSIGMOID JUNCTION

Female

5,897

Total

14,040

Male

4,871

COLON

Female

3,764

Total

8,635

Male

3,272

RECTUM, RECTOSIGMOID JUNCTION AND

Female

2,133

Total

5,405

AND ANUS

C18

C19-C21

ANUS

1. 96 ICD-O-3 M-CODE
p.497

- 142 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

24

87

144

168

165

104

76

60

45

25

24

87

146

171

170

106

78

62

46

27

19

21

11

- C14

10

21

12

11

14

14

20

19

10

11

1 C07-C08

15

12

10

11

10

10

26

26

24

27

27

19

14

14

16

14

24

87

97

161

171

205

167

96

63

47

38

10

12

27

29

41

56

58

51

31

15

21

17

12

36

114

126

202

227

263

218

127

78

68

55

19

13

25

77

197

435

889 1,614 2,347 3,046 2,671 2,651 2,504 2,396 1,998 1,237 C15-C26,

46

120

192

310

34

123

317

627 1,199 2,192 3,313 4,359 3,973 4,227 4,230 4,070 3,275 2,268

54

192

316

385

361

239

165

126

98

86

58 C15

13

14

13

22

11

21

22

17

55

199

321

398

375

252

187

137

119

108

75

11

36

60

104

202

246

219

227

283

372

391

258 C16

21

33

54

95

112

137

130

139

176

188

184

160

12

32

69

114

199

314

383

349

366

459

560

575

418

17

21

19

23

21

24

20

19

10

11

15

24

21

10

11

14

11

24

31

30

38

45

45

30

30

23

10

32

82

135

221

414

753 1,072 1,054 1,134

969

933

818

514 C18-C21

24

72

109

169

341

579

717

699

554

503

13

56

154

244

390

755 1,332 1,789 1,711 1,883 1,686 1,632 1,372 1,017

21

52

74

129

218

443

624

625

662

569

561

546

341 C18

16

53

70

108

203

351

439

409

483

461

464

357

346

37

105

144

237

421

794 1,063 1,034 1,145 1,030 1,025

903

687

11

30

61

92

196

310

448

429

472

400

372

272

173 C19-C21

19

39

61

138

228

278

248

266

256

235

197

157

19

49

100

153

334

538

726

677

738

656

607

469

330

578

85+

ICD-O-3

18 C12-C13

10 C11

966 1,313 1,302 1,576 1,726 1,674 1,277 1,031 C48

717

- 143 -

657

749

9 C17

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C22

C23-C24


GENDER

C48

C26

C33-C34

C38.4

15
|
19

TOTAL

Male

7,751

Female

3,272

Total

11,023

Male

486

GALLBLADDER AND EXTRAHEPATIC BILE

Female

438

Total

924

Male

937

PANCREAS

Female

706

Total

1,643

Male

80

RETROPERITONEUM AND PERITONEUM

Female

77

Total

157

Male

19

Female

32

Total

51

Male

7,630

RESPIRATORY SYSTEM AND INTRATHORACIC

Female

4,131

Total

11,761

Male

119

NASAL CAVITIES, ACCESSORY SINUSES,

Female

53

Total

172

Male

602

LARYNX

Female

33

Total

635

Male

6,697

TRACHEA, BRONCHUS AND LUNG

Female

3,918

Total

10,615

Male

43

PLEURA

Female

19

Total

62

MIDDLE EAR AND INNER EAR

C32

10
|
14

LIVER AND INTRAHEPATIC BILE DUCTS

ORGANS

C30-C31

5
|
9

OTHER AND ILL-DEFINED SITES WITHIN


DIGESTIVE ORGANS AND PERITONEUM

C30-C39

1
|
4

DUCTS

C25

C37-C38.3,

Male

168

C38.8

THYMUS, HEART AND MEDIASTINUM

Female

108

Total

276

1. 96 ICD-O-3 M-CODE
p.497

- 144 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

32

83

185

376

668

865 1,172

970

936

914

769

500

259 C22

16

33

43

79

172

370

500

605

541

361

218

12

40

99

218

419

747 1,037 1,488 1,340 1,436 1,519 1,310

861

477

32

23

60

47

51

65

75

70

47 C23-C24

10

27

40

38

51

81

87

48

43

10

16

42

50

100

85

102

146

162

118

90

11

26

54

87

104

108

108

118

118

111

87 C25

10

18

27

46

58

70

74

106

121

88

76

21

44

81

133

162

178

182

224

239

199

163

2 C48

11

12

12

19

14

20

13

19

12

15

3 C26

12

10

13

53

71

175

337

540

774

777

912 1,052 1,242 1,055

610 C30-C39

11

32

51

158

255

367

506

453

479

416

347

12

24

85

122

333

592

907 1,280 1,230 1,391 1,591 1,751 1,471

957

11

16

17

12

12

16

3 C30-C31

12

18

22

23

15

19

20

10

20

50

79

100

77

72

59

61

38

22

52

83

104

80

76

64

62

42

37

31

55

130

262

421

635

669

811

954 1,156

995

567 C33-C34

25

44

140

234

344

477

433

455

516

405

338

11

56

99

270

496

765 1,112 1,102 1,266 1,470 1,655 1,400

905

- C38.4

12

14

17

20

15

16

12

14

13

11

11

12

12

17

10

11

18

28

21

32

32

26

21

25

18

15

316

- 145 -

539

509

499

85+

ICD-O-3

34 C32

6 C37-C38.3,
1 C38.8
7

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES


4

C42

C40-C41

C47, C49

GENDER

C44

C44

5
|
9

10
|
14

15
|
19

1,087

21

14

24

29

736

36

15

TOTAL

Male

LEUKEMIA

Female

Total

1,823

10

57

22

39

36

Male

89

12

13

BONES, JOINTS AND ARTICULAR CARTILAGE

Female

74

11

Total

163

23

22

Male

276

12

CONNECTIVE, SUBCUTANEOUS AND OTHER

Female

232

Total

508

21

Male

1,575

SKIN

Female

1,403

Total

2,978

Male

125

SKIN, MALIGNANT MELANOMA

Female

87

Total

212

Male

1,450

SKIN (excludes MALIGNANT MELANOMA)

Female

1,316

Total

2,766

Female

9,655

Male

39

Female

4,822

13

11

Female

C50

1
|
4

SOFT TISSUES

C44

FEMALE BREAST

C50

MALE BREAST

C51-C58

FEMALE GENITAL ORGANS

C55

UTERUS, NOS

1. 96 ICD-O-3 M-CODE
p.497
4. ICD-O-3 M-CODE p.497
5. ICD-O-3 C44 M-87203 - M-87903

- 146 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

22

34

49

41

41

70

91

79

72

83

118

110

113

12

27

36

40

30

50

49

73

56

56

68

70

54

45

34

61

85

81

71

120

140

152

128

139

186

180

167

115

- C40-C41

11

10

12

10

10

10

10

11

10

15

35

25

34

21

12

22

26

20

12 C47, C49

14

11

19

21

21

21

18

13

28

16

10

10

13

14

25

21

34

56

46

55

39

25

50

42

30

22

10

16

29

34

51

55

81

102

122

153

196

261

262

197 C44

21

16

21

38

57

77

103

95

107

197

212

211

237

14

37

45

55

89

112

158

205

217

260

393

473

473

434

11

14

15

10

21

11

13

14

11

10

18

24

16

22

24

32

19

18

14

27

28

46

51

72

91

108

138

186

240

251

185 C44

18

14

19

33

52

68

90

93

100

183

201

203

231

13

32

41

47

79

103

140

181

201

238

369

441

454

416

14

91

281

551 1,166 1,783 1,675 1,467

890

701

479

282

159

116 C50

5 C50

39

71

169

254

411

686

815

766

453

360

269

217

177

- 147 -

85+

ICD-O-3

4
70 C42

5
12 C44

107 C51-C58

1 C55

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C53


GENDER

1
|
4

5
|
9

10
|
14

15
|
19

TOTAL

Female

1,680

Female

1,737

Female

1,245

11

11


C57.7-C57.9

Female

152

CERVIX UTERI

C54

CORPUS UTERI

C56,

C57.0-C57.4 OVARY, FALLOPIAN TUBE AND BROAD


LIGAMENT

C51-C52,

VAGINA, VULVA, OTHER AND UNSPECIFIED


FEMALE GENITAL ORGANS

C60-C63

Male

4,661

17

Male

4,392

Male

178

17

Male

91

Male

2,780

URINARY TRACT

Female

1,661

Total

4,441

Male

1,427

BLADDER

Female

537

MALE GENITAL ORGANS

C61

PROSTATE GLAND

C62

TESTIS

C60,C63

PENIS AND OTHER MALE GENITAL ORGANS

C64-C68

C67

C64

Total

1,964

Male

678

KIDNEY

Female

350

Total

1,028

1. 96 ICD-O-3 M-CODE
p.497

- 148 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

13

61

92

149

211

236

228

148

144

116

103

110

66

C53

23

55

65

140

269

381

338

180

127

73

50

21

12

C54

31

34

50

95

116

190

183

182

106

78

68

44

30

14

C56,

ICD-O-3

C57.0-C57.4

14

13

18

19

10

11

20

15

14

C51-C52,
C57.7-C57.9

37

41

30

22

17

33

95

236

405

657

888

917

825

435

C60-C63

19

79

222

396

647

874

911

813

427

C61

37

40

29

20

C62

10

10

10

14

12

C60,C63

23

48

76

154

216

307

276

325

364

423

318

228

C64-C68

11

22

34

55

98

160

192

213

258

253

205

147

11

34

70

110

209

314

467

468

538

622

676

523

375

14

32

64

87

138

118

156

200

247

207

150

18

41

50

49

66

85

89

76

49

10

20

38

82

128

188

167

222

285

336

283

199

13

27

24

60

78

102

79

61

71

57

52

39

11

26

21

30

40

42

36

38

36

33

21

20

38

50

81

108

142

121

97

109

93

85

60

- 149 -

C67

C64

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C65

C66

C68.0-C68.1

C68.8

C68.9

C69

C70-C72

C70, C72

C74-C75

1
|
4

5
|
9

10
|
14

15
|
19

TOTAL

Male

348

RENAL PELVIS

Female

396

Total

744

Male

200

URETER

Female

251

Total

451

Male

16

URETHRA AND PARAURETHRAL GLAND

Female

Total

24

Male

OVERLAPPING LESION OF URINARY ORGANS

Female

Total

11

Male

107

URINARY SYSTEM, NOS

Female

112

Total

219

Male

39

EYE AND LACRIMAL GLAND

Female

22

Total

61

13

Male

445

12

18

18

15

BRAIN AND OTHER PARTS OF CENTRAL

Female

344

12

13

Total

789

11

18

30

31

24

Male

420

12

17

18

12

BRAIN

Female

314

11

12

Total

734

10

18

28

30

21

Male

25

OTHER AND UNSPECIFIED PARTS OF

Female

30

Total

55

Male

571

THYROID GLAND

Female

1,838

12

14

NERVOUS SYSTEM

C73

GENDER

NERVOUS SYSTEM

C71

Total

2,409

12

19

Male

25

OTHER ENDOCRINE GLANDS

Female

26

Total

51

1. 96 ICD-O-3 M-CODE
p.497

- 150 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

12

15

27

41

39

53

43

62

30

17

10

16

36

55

58

60

64

49

39

14

25

43

77

94

111

103

126

79

56

17

17

24

36

25

34

16

16

20

33

35

53

42

29

30

13

20

37

57

71

78

76

45

46

12

17

20

21

13

13

12

17

21

20

15

10

19

24

34

41

41

28

10

11

18

20

20

32

39

38

38

34

43

32

20

20

13

10

17

26

26

23

26

38

26

26

27

26

10

21

26

37

46

58

62

64

76

60

69

59

46

30

21

11

16

19

18

30

37

36

37

32

41

31

20

18

11

10

15

24

23

22

21

37

22

24

25

25

21

23

34

42

53

59

57

74

54

65

56

45

27

17

11

28

59

64

59

66

77

71

43

27

26

14

14

72

119

129

186

240

277

268

202

109

89

57

35

17

12

83

147

188

250

299

343

345

273

152

116

83

49

31

18

- 151 -

ICD-O-3

C65

C66

C68.0-C68.1

C68.8

C68.9

C69

C70-C72

C71

C70, C72

C73

C74-C75

99
PRIMARY ANATOMIC SITES, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C76

C80


GENDER

1
|
4

5
|
9

10
|
14

15
|
19

TOTAL

Male

OTHER AND ILL-DEFINED SITES

Female

Total

15

Male

538

UNKNOWN PRIMARY SITES

Female

391

Total

929

Male

1,659

15

23

31

Female

1,256

13

Total

2,915

12

24

27

44

MALIGNANT LYMPHOMA

1. 96 ICD-O-3 M-CODE
p.497

- 152 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

- C76

19

31

46

57

41

56

59

71

64

64 C80

13

19

25

25

35

34

52

50

74

51

11

13

32

50

71

82

76

90

111

121

138

115

25

45

44

53

50

105

127

169

154

178

169

180

171

110

21

48

41

39

58

80

107

131

136

121

145

151

90

59

46

93

85

92

108

185

234

300

290

299

314

331

261

169

- 153 -

85+

ICD-O-3

99
WHO 2008 1
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010

1
|
4

5
|
9

10
|
14

15
|
19

1,087

21

14

24

29

736

36

15

HEMATOPOIETIC AND LYMPHOID TUMORS

GENDER

TOTAL

Male

LEUKEMIA AND MYELOID NEOPLSAM, TOTAL

Female

Total

1,823

10

57

22

39

36

Male

425

ACUTE MYELOID LEUKEMIA

Female

309

Total

734

13

Male

60

AML with recurrent genetic abnormalities

Female

41

Total

101

Male

38

AML with myelodysplasia-related changes

Female

21

Total

59

Male

Therapy-related myeloid neoplasms

Female

Total

Male

132

Acute myeloid leukemia, NOS

Female

93

Total

225

Male

183

Other acute myeloid leukemia

Female

145

Total

328

Male

Myeloid sarcoma

Female

Total

Male

Blastic plasmacytoid dendritic cell neoplasm

Female

Total

Male

131

17

10

14

14

ACUTE LYMPHOBLASTIC LEUKEMIA

Female

104

30

Total

235

47

17

19

16

B /

Male

116

16

12

13

B lymphoblastic leukemia / lymphoma

Female

101

30

Total

217

46

15

17

15

1. WHO 2008 p.497

- 154 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

22

34

49

41

41

70

91

79

72

83

118

110

113

70

12

27

36

40

30

50

49

73

56

56

68

70

54

45

34

61

85

81

71

120

140

152

128

139

186

180

167

115

18

17

18

17

27

36

36

33

30

50

46

41

28

13

14

25

13

26

18

34

22

14

36

28

24

22

12

31

31

43

30

53

54

70

55

44

86

74

65

50

10

11

10

11

10

13

12

20

22

18

12

10

16

12

10

16

10

17

18

30

38

30

21

15

11

25

18

11

20

17

13

11

14

14

10

15

10

19

10

10

10

13

13

21

14

29

21

40

28

16

39

27

23

21

10

10

12

14

18

13

15

12

10

11

17

13

15

11

- 155 -

99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

1
|
4

5
|
9

10
|
14

15
|
19

15

HEMATOPOIETIC AND LYMPHOID TUMORS

GENDER

T /

Male

T lymphoblastic leukemia / lymphoma

Female

TOTAL

Total

18

Male

148

CHRONIC MYELOID LEUKEMIA

Female

77

Total

225

Male

89

CHRONIC LYMPHOCYTIC LEUKEMIA

Female

46

Total

135

Male

19

ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE

Female

16

Total

35

Male

135

MYELOPROLIFERATIVE NEOPLASMS

Female

95

Total

230

Male

124

MYELODYSPLASTIC SYNDROMES

Female

76

Total

200

Male

ACUTE BIPHENOTYPIC LEUKEMIA

Female

Total

Male

OTHER LEUKEMIA

Female

Total

13

Male

LEUKEMIA, NOS

Female

Total

12

1. WHO 2008 p.497

- 156 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

16

13

13

17

14

10

10

26

17

16

19

25

18

13

12

18

11

15

10

11

14

15

10

13

13

12

19

21

22

14

17

11

17

11

16

20

16

10

12

11

16

14

12

17

22

20

15

27

20

34

21

16

13

14

15

16

28

13

13

15

11

14

17

22

28

31

39

19

- 157 -

99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

HEMATOPOIETIC AND LYMPHOID TUMORS

GENDER

1
|
4

5
|
9

10
|
14

15
|
19

TOTAL

Male

1,659

15

23

31

MALIGNANT LYMPHOMA

Female

1,256

13

Total

2,915

12

24

27

44

Male

103

13

HODGKIN LYMPHOMA

Female

69

Total

172

19

Male

1,179

11

18

NON-HODGKIN LYMPHOMA

Female

903

Total

2,082

17

12

24

Male

963

10

B-cell lymphoid neoplasms

Female

787

Total

1,750

11

14

Male

116

Female

126

Total

242

Male

27

Female

41

Marginal zone lymphoma (splenic, nodal and MALT)

MALT lymphoma of stomach


ICD-O-3 C16 & M-96993

Total

68

Male

26

Lymphoplasmacytic lymphoma

Female

Total

31

Male

104

Follicular lymphoma

Female

122

Total

226

Male

41

Mantle cell lymphoma

Female

14

Total

55

Burkitt

Male

35

Burkitt lymphoma

Female

14

Total

49

B ()

Male

597

Diffuse large B-cell lymphoma (any subtype)

Female

480

Total

1,077

1. WHO 2008 p.497

- 158 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

25

45

44

53

50

105

127

169

154

178

169

180

171

110

21

48

41

39

58

80

107

131

136

121

145

151

90

59

46

93

85

92

108

185

234

300

290

299

314

331

261

169

11

12

12

10

20

10

21

32

13

12

10

11

13

13

31

37

40

41

78

92

123

109

116

123

131

122

80

11

28

31

33

50

64

83

94

99

93

94

102

61

45

24

59

68

73

91

142

175

217

208

209

217

233

183

125

19

27

34

31

57

78

108

87

100

101

106

107

75

10

25

24

24

42

52

76

81

88

83

84

94

53

44

17

44

51

58

73

109

154

189

175

183

185

200

160

119

14

15

13

15

15

13

16

14

13

12

13

12

10

12

17

30

21

28

25

28

27

20

11

11

19

13

13

10

10

25

18

18

16

10

13

21

36

37

31

29

14

11

10

12

14

10

14

22

20

35

42

70

51

60

61

62

76

59

17

16

13

20

31

32

42

48

54

58

68

37

35

27

30

35

40

66

74

112

99

114

119

130

113

94

- 159 -

99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

1
|
4

5
|
9

10
|
14

15
|
19

HEMATOPOIETIC AND LYMPHOID TUMORS

GENDER

TOTAL

Male

Primary mediastinal (thymic) large B-cell lymphoma

Female

Total

12

Male

37

Other B-cell lymphomas

Female

21

Total

58

T/NK

Male

216

T/NK-cell lymphoid neoplasms

Female

116

Total

332

10

NK/T

Male

31

Extranodal NK/T cell lymphoma, nasal or other type

Female

18

Total

49

T / Sezary

Male

23

Cutaneous T cell lymphoma (Including Mycosis


fungoides / Szary syndrome)

Female

17

Total

40

Male

Enteropathy-type T-cell lymphoma

Female

Total

Male

Hepatosplenic T-cell lymphoma

Female

Total

Male

Subcutaneous panniculitis-like T-cell Lymphoma

Female

Total

Male

83

Peripheral T-cell lymphoma, NOS

Female

32

Total

115

Male

26

Angioimmunoblastic T-cell lymphoma

Female

18

Total

44

Male

21

Anaplastic large cell lymphoma

Female

10

Total

31

1. WHO 2008 p.497

- 160 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

12

10

10

21

14

15

22

16

22

25

15

12

13

11

10

10

15

17

15

18

33

21

28

33

26

32

33

23

11

11

13

10

12

13

11

15

16

14

- 161 -

99
WHO 2008 1()
LEUKEMIA, LYMPHOMA, GENDER AND AGE DISTRIBUTION OF CANCERS, 2010
CONTINUED

1
|
4

5
|
9

10
|
14

15
|
19

HEMATOPOIETIC AND LYMPHOID TUMORS

GENDER

TOTAL

T /

Male

Adult T-cell lymphoma / leukemia

Female

Total

Male

23

Other T-cell lymphoma

Female

10

Total

33

Male

283

Plasma cell neoplasm

Female

219

Total

502

Male

18

Other LPD

Female

Total

26

Male

18

Histiocytic and dendritic cell neoplasms

Female

Total

26

Male

76

Female

57

Total

133

Malignant lymphoma, NOS and others

1. WHO 2008 p.497

- 162 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

16

21

26

32

47

36

36

40

20

13

15

28

27

25

42

35

19

10

29

36

54

59

72

78

71

59

30

11

12

10

12

15

18

12

13

24

16

12

- 163 -

10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010

ICD-O-3

PRIMARY ANATOMIC SITES

C00-C80

ALL SITES

C00-C14

LIP, ORAL CAVITY AND PHARYNX

C00-C14

ORAL CAVITY, OROPHARYNX AND HYPOPHARYNX

ORAL CAVITY

OROPHARYNX

HYPOPRAYNX

C44.0

C00

LIPexcludes skin of lip C44.0

C01-C02

TONGUE

C03

GUM

C04

FLOOR OF MOUTH

C05-C06

OTHER AND UNSPECIFIED PARTS OF MOUTH

C09-C10

OROPHARYNX

C12-C13

HYPOPHARYNX

C14

PHARYNX AND ILL-DEFINED SITES IN LIP, ORAL CAVITY AND PHARYNX

C07-C08

MAJOR SALIVARY GLANDS

C11

NASOPHARYNX

C15-C26, C48

DIGESTIVE ORGANS AND PERITONEUM

1. 96 ICD-O-3 M-CODE p.497

2. 2 1976
3. 3 2000
4. ICD-O-3

C00-C06C09-C10C12-C14

5. Head and Neck Surgery and Oncology, 3rd ed. 18

- 164 -

TOTAL

MALE

CRUDE
RATE

2
ASR2

3
ASR3

CASE
NUMBER

90,649

391.37

265.83

296.67

8,367

36.12

25.69

6,560

28.32

4,392

FEMALE

CRUDE
RATE

2
ASR2

3
ASR3

CASE
NUMBER

CRUDE
RATE

2
ASR2

3
ASR3

50,892

437.40

303.57

340.66

39,757

344.91

231.31

256.23

C00-C80

27.82

7,353

63.20

45.96

49.67

1,014

8.80

6.05

6.66

C00-C14

20.07

21.68

6,028

51.81

37.62

40.56

532

4.62

3.09

3.41

C00-C144

18.96

13.48

14.59

3,967

34.09

24.82

26.80

425

3.69

2.47

2.73

1,169

5.05

3.58

3.85

1,086

9.33

6.78

7.27

83

0.72

0.49

0.53

999

4.31

3.01

3.25

975

8.38

6.01

6.48

24

0.21

0.13

0.15

228

0.98

0.72

0.77

210

1.80

1.36

1.45

18

0.16

0.10

0.11

C00

1,805

7.79

5.56

6.02

1,583

13.61

9.90

10.72

222

1.93

1.34

1.46

C01-C02

445

1.92

1.33

1.45

384

3.30

2.35

2.56

61

0.53

0.34

0.38

C03

164

0.71

0.49

0.53

151

1.30

0.92

0.99

13

0.11

0.07

0.08

C04

2,269

9.80

6.98

7.53

2,125

18.26

13.33

14.34

144

1.25

0.83

0.92

C05-C06

635

2.74

1.94

2.09

586

5.04

3.66

3.92

49

0.43

0.28

0.31

C09-C10

942

4.07

2.84

3.07

921

7.92

5.68

6.12

21

0.18

0.12

0.13

C12-C13

72

0.31

0.21

0.23

68

0.58

0.42

0.45

0.03

0.02

0.02

C14

236

1.02

0.73

0.81

131

1.13

0.80

0.89

105

0.91

0.66

0.73

C07-C08

1,571

6.78

4.89

5.33

1,194

10.26

7.54

8.22

377

3.27

2.30

2.52

C11

34,255

147.89

98.39

110.57

22,112

190.04

131.93

147.25

12,143

105.34

66.58

75.74

CASE
NUMBER

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 165 -

ICD-O-3

C15-C26, C48

10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C15

ESOPHAGUS

C16

STOMACH

C17

SMALL INTESTINE

C18-C21

COLON, RECTUM, RECTOSIGMOID JUNCTION AND ANUS

C18

COLON

C19-C21

RECTUM, RECTOSIGMOID JUNCTION AND ANUS

C22

LIVER AND INTRAHEPATIC BILE DUCTS

C23-C24

GALLBLADDER AND EXTRAHEPATIC BILE DUCTS

C25

PANCREAS

C48

RETROPERITONEUM AND PERITONEUM

C26

OTHER AND ILL-DEFINED SITES WITHIN DIGESTIVE ORGANS AND PERITONEUM

C30-C39

RESPIRATORY SYSTEM AND INTRATHORACIC ORGANS

C30-C31

NASAL CAVITIES, ACCESSORY SINUSES, MIDDLE EAR AND INNER EAR

C32

LARYNX

C33-C34

TRACHEA, BRONCHUS AND LUNG

C38.4

PLEURA

C37-C38.3, C38.8

THYMUS, HEART AND MEDIASTINUM

1. 96 ICD-O-3 M-CODE p.497

2. 2 1976
3. 3 2000

- 166 -

TOTAL

CASE
NUMBER

MALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE

FEMALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE


CRUDE
RATE

2
2
ASR

3
3
ASR

ICD-O-3

2,238

9.66

6.66

7.23

2,091

17.97

12.77

13.81

147

1.28

0.77

0.90

C15

3,854

16.64

10.30

12.03

2,415

20.76

13.14

15.43

1,439

12.48

7.66

8.85

C16

325

1.40

0.96

1.06

190

1.63

1.14

1.27

135

1.17

0.78

0.86

C17

14,040

60.62

40.34

45.32

8,143

69.99

48.58

54.39

5,897

51.16

32.65

36.84

C18-C21

8,635

37.28

24.62

27.78

4,871

41.86

28.75

32.36

3,764

32.65

20.75

23.48

C18

5,405

23.34

15.72

17.54

3,272

28.12

19.83

22.04

2,133

18.50

11.90

13.35

C19-C21

11,023

47.59

32.41

36.07

7,751

66.62

47.52

52.34

3,272

28.39

18.00

20.54

C22

924

3.99

2.49

2.91

486

4.18

2.70

3.14

438

3.80

2.28

2.67

C23-C24

1,643

7.09

4.54

5.21

937

8.05

5.39

6.13

706

6.12

3.73

4.33

C25

157

0.68

0.54

0.57

80

0.69

0.58

0.60

77

0.67

0.51

0.54

C48

51

0.22

0.15

0.17

19

0.16

0.11

0.12

32

0.28

0.19

0.21

C26

11,761

50.78

32.56

37.40

7,630

65.58

43.20

49.98

4,131

35.84

22.71

25.69

C30-C39

172

0.74

0.53

0.58

119

1.02

0.73

0.80

53

0.46

0.34

0.36

C30-C31

635

2.74

1.85

2.05

602

5.17

3.62

4.00

33

0.29

0.18

0.21

C32

10,615

45.83

29.10

33.61

6,697

57.56

37.49

43.68

3,918

33.99

21.38

24.27

62

0.27

0.19

0.21

43

0.37

0.26

0.29

19

0.16

0.11

0.12

C38.4

276

1.19

0.89

0.96

168

1.44

1.09

1.20

108

0.94

0.68

0.73

C37-C38.3, C38.8

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 167 -

C33-C34

10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES


6

C42

LEUKEMIA

C40-C41

BONES, JOINTS AND ARTICULAR CARTILAGE

C47, C49

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

C44

SKIN
7

C44

SKIN, MALIGNANT MELANOMA

C44

SKIN (excludes MALIGNANT MELANOMA)

C50

FEMALE BREAST

C50

MALE BREAST

C51-C58

FEMALE GENITAL ORGANS

C55

UTERUS, NOS

C53

CERVIX UTERI

C54

CORPUS UTERI

C56, C57.0-C57.4

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

C51-C52, C57.7-C57.9

VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS

C60-C63

MALE GENITAL ORGANS

1. 96 ICD-O-3 M-CODE p.497

2. 2 1976
3. 3 2000
6. ICD-O-3

M-CODE p.497

7. ICD-O-3

C44M-87203 - M-87903

- 168 -

TOTAL

CASE
NUMBER

MALE

2
2
ASR

CASE
NUMBER

CRUDE
RATE

3
3
ASR

FEMALE

CRUDE
RATE

2
2
ASR

3
3
ASR

CASE
NUMBER


CRUDE
RATE

2
2
ASR

3
3
ASR

ICD-O-3

1,823

7.87

6.27

6.66

1,087

9.34

7.30

7.91

736

6.39

5.29

5.48

C426

163

0.70

0.70

0.71

89

0.76

0.77

0.77

74

0.64

0.63

0.65

C40-C41

508

2.19

1.63

1.78

276

2.37

1.75

1.93

232

2.01

1.51

1.63

C47, C49

2,978

12.86

7.85

9.29

1,575

13.54

8.62

10.20

1,403

12.17

7.13

8.44

C44

212

0.92

0.60

0.69

125

1.07

0.74

0.85

87

0.75

0.47

0.54

C447

2,766

11.94

7.24

8.60

1,450

12.46

7.88

9.35

1,316

11.42

6.66

7.90

C44

9,655

83.76

58.63

63.16

9,655

83.76

58.63

63.16

C50

39

0.34

0.21

0.24

39

0.34

0.21

0.24

C50

4,822

41.83

28.96

31.54

4,822

41.83

28.96

31.54

0.07

0.04

0.05

0.07

0.04

0.05

C55

1,680

14.57

9.74

10.81

1,680

14.57

9.74

10.81

C53

1,737

15.07

10.47

11.25

1,737

15.07

10.47

11.25

C54

1,245

10.80

7.83

8.46

1,245

10.80

7.83

8.46

C56, C57.0-C57.4

152

1.32

0.88

0.98

152

1.32

0.88

0.98

C51-C52, C57.7-C57.9

4,661

40.06

26.19

30.90

4,661

40.06

26.19

30.90

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 169 -

C51-C58

C60-C63

10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C61

PROSTATE GLAND

C62

TESTIS

C60,C63

PENIS AND OTHER MALE GENITAL ORGANS

C64-C68

URINARY TRACT

C67

BLADDER

C64

KIDNEY

C65

RENAL PELVIS

C66

URETER

C68.0-C68.1

URETHRA AND PARAURETHRAL GLAND

C68.8

OVERLAPPING LESION OF URINARY ORGANS

C68.9

URINARY SYSTEM, NOS

C69

EYE AND LACRIMAL GLAND

C70-C72

BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM

C71

BRAIN

C70, C72

OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM

C73

THYROID GLAND

C74-C75

OTHER ENDOCRINE GLANDS

1. 96 ICD-O-3 M-CODE p.497

2. 2 1976
3. 3 2000

- 170 -

TOTAL

CASE
NUMBER

MALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE

FEMALE

CRUDE
RATE

2
2
ASR

3
3
ASR

CASE
NUMBER


CRUDE
RATE

2
2
ASR

3
3
ASR

ICD-O-3

4,392

37.75

24.17

28.77

4,392

37.75

24.17

28.77

C61

178

1.53

1.49

1.54

178

1.53

1.49

1.54

C62

91

0.78

0.53

0.60

91

0.78

0.53

0.60

C60,C63

4,441

19.17

12.46

14.24

2,780

23.89

16.11

18.40

1,661

14.41

9.02

10.33

C64-C68

1,964

8.48

5.26

6.16

1,427

12.26

7.88

9.24

537

4.66

2.80

3.28

C67

1,028

4.44

3.10

3.41

678

5.83

4.20

4.60

350

3.04

2.05

2.27

C64

744

3.21

2.11

2.41

348

2.99

2.07

2.35

396

3.44

2.15

2.46

C65

451

1.95

1.28

1.45

200

1.72

1.20

1.35

251

2.18

1.34

1.54

C66

24

0.10

0.07

0.08

16

0.14

0.10

0.11

0.07

0.04

0.05

C68.0-C68.1

11

0.05

0.03

0.03

0.03

0.03

0.03

0.06

0.03

0.04

C68.8

219

0.95

0.62

0.71

107

0.92

0.63

0.72

112

0.97

0.60

0.70

C68.9

61

0.26

0.38

0.33

39

0.34

0.49

0.42

22

0.19

0.27

0.23

C69

789

3.41

3.05

3.11

445

3.82

3.47

3.54

344

2.98

2.63

2.70

C70-C72

734

3.17

2.85

2.91

420

3.61

3.29

3.35

314

2.72

2.41

2.47

C71

55

0.24

0.20

0.21

25

0.21

0.18

0.19

30

0.26

0.22

0.23

C70, C72

2,409

10.40

7.83

8.49

571

4.91

3.66

4.02

1,838

15.95

11.96

12.91

51

0.22

0.28

0.25

25

0.21

0.27

0.24

26

0.23

0.31

0.27

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 171 -

C73

C74-C75

10 99
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY PRIMARY
ANATOMIC SITES AND GENDER, 2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C76

OTHER AND ILL-DEFINED SITES

C80

UNKNOWN PRIMARY SITES

MALIGNANT LYMPHOMA

1. 96 ICD-O-3 M-CODE p.497

2. 2 1976
3. 3 2000

- 172 -

TOTAL

CASE
NUMBER

MALE

2
2
ASR

CASE
NUMBER

CRUDE
RATE

3
3
ASR

FEMALE

CRUDE
RATE

2
2
ASR

3
3
ASR

CASE
NUMBER


CRUDE
RATE

2
2
ASR

3
3
ASR

ICD-O-3

15

0.06

0.05

0.05

0.08

0.07

0.07

0.05

0.04

0.04

C76

929

4.01

2.51

2.92

538

4.62

3.06

3.52

391

3.39

2.00

2.36

C80

2,915

12.59

9.00

9.95

1,659

14.26

10.48

11.58

1,256

10.90

7.57

8.37

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 173 -

10 99 WHO 2008 1
CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010

HEMATOPOIETIC AND LYMPHOID TUMORS

LEUKEMIA AND MYELOID NEOPLSAM, TOTAL

ACUTE MYELOID LEUKEMIA

AML with recurrent genetic abnormalities

AML with myelodysplasia-related changes

Therapy-related myeloid neoplasms

Acute myeloid leukemia, NOS

Other acute myeloid leukemia

Myeloid sarcoma

Blastic plasmacytoid dendritic cell neoplasm

ACUTE LYMPHOBLASTIC LEUKEMIA

B /
B lymphoblastic leukemia / lymphoma

T /
T lymphoblastic leukemia / lymphoma

1. WHO 2008 p.497


2. 2 1976
3. 3 2000

- 174 -

TOTAL

MALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE

2
2
ASR

3
3
ASR

9.34

7.30

7.91

736

6.39

5.29

5.48

425

3.65

2.70

2.99

309

2.68

1.94

2.13

0.39

60

0.52

0.46

0.48

41

0.36

0.28

0.30

0.16

0.19

38

0.33

0.20

0.24

21

0.18

0.11

0.13

0.04

0.03

0.03

0.03

0.02

0.02

0.05

0.03

0.04

225

0.97

0.65

0.75

132

1.13

0.78

0.90

93

0.81

0.53

0.61

328

1.42

1.05

1.14

183

1.57

1.17

1.28

145

1.26

0.95

1.02

0.03

0.03

0.03

0.03

0.03

0.03

0.03

0.04

0.03

0.02

0.02

0.02

0.04

0.03

0.04

235

1.01

1.45

1.28

131

1.13

1.45

1.33

104

0.90

1.45

1.23

217

0.94

1.35

1.19

116

1.00

1.28

1.17

101

0.88

1.43

1.21

18

0.08

0.09

0.09

15

0.13

0.16

0.16

0.03

0.02

0.02

2
2
ASR

CASE
NUMBER

FEMALE

3
3
ASR

CASE
NUMBER

CRUDE
RATE

1,823

7.87

6.27

6.66

1,087

734

3.17

2.31

2.54

101

0.44

0.37

59

0.25

CRUDE
RATE

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 175 -

10 99 WHO 2008 1()


CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010 (CONTINUED)

HEMATOPOIETIC AND LYMPHOID TUMORS

CHRONIC MYELOID LEUKEMIA

CHRONIC LYMPHOCYTIC LEUKEMIA

ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE

MYELOPROLIFERATIVE NEOPLASMS

MYELODYSPLASTIC SYNDROMES

ACUTE BIPHENOTYPIC LEUKEMIA

OTHER LEUKEMIA

LEUKEMIA, NOS

1. WHO 2008 p.497


2. 2 1976
3. 3 2000

- 176 -

TOTAL

MALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE

2
2
ASR

3
3
ASR

1.27

0.95

1.05

77

0.67

0.49

0.54

89

0.76

0.53

0.60

46

0.40

0.27

0.29

0.12

19

0.16

0.11

0.13

16

0.14

0.09

0.11

0.67

0.76

135

1.16

0.77

0.90

95

0.82

0.58

0.63

0.86

0.53

0.63

124

1.07

0.68

0.80

76

0.66

0.40

0.47

0.02

0.02

0.02

0.02

0.02

0.02

0.02

0.01

0.01

13

0.06

0.04

0.04

0.04

0.03

0.03

0.07

0.05

0.05

12

0.05

0.04

0.04

0.08

0.07

0.07

0.03

0.01

0.02

2
2
ASR

CASE
NUMBER

FEMALE

3
3
ASR

CASE
NUMBER

CRUDE
RATE

225

0.97

0.72

0.79

148

135

0.58

0.39

0.44

35

0.15

0.10

230

0.99

200

CRUDE
RATE

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 177 -

10 99 WHO 2008 1()


CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010 (CONTINUED)

HEMATOPOIETIC AND LYMPHOID TUMORS

MALIGNANT LYMPHOMA

HODGKIN LYMPHOMA

NON-HODGKIN LYMPHOMA

B
B-cell lymphoid neoplasms

Marginal zone lymphoma (splenic, nodal and MALT)


MALT lymphoma of stomachICD-O-3 C16 & M-96993

Lymphoplasmacytic lymphoma

Follicular lymphoma

Mantle cell lymphoma

Burkitt
Burkitt lymphoma

B ()
Diffuse large B-cell lymphoma (any subtype)

B
Primary mediastinal (thymic) large B-cell lymphoma

1. WHO 2008 p.497


2. 2 1976
3. 3 2000

- 178 -

TOTAL

MALE

2
ASR2

CASE
NUMBER

9.95

0.69

8.99

1,750

FEMALE

CRUDE
RATE

2
ASR2

3
ASR3

CASE
NUMBER

1,659

14.26

10.48

11.58

1,256

0.71

103

0.89

0.84

0.85

6.32

7.03

1,179

10.13

7.30

7.56

5.22

5.83

963

8.28

242

1.04

0.73

0.81

116

68

0.29

0.19

0.22

31

0.13

0.09

226

0.98

55

3
ASR3

10.90

7.57

8.37

69

0.60

0.54

0.57

8.13

903

7.83

5.39

5.97

5.84

6.55

787

6.83

4.63

5.14

1.00

0.70

0.78

126

1.09

0.76

0.84

27

0.23

0.15

0.18

41

0.36

0.23

0.26

0.10

26

0.22

0.16

0.18

0.04

0.02

0.03

0.69

0.75

104

0.89

0.65

0.71

122

1.06

0.74

0.79

0.24

0.14

0.17

41

0.35

0.21

0.26

14

0.12

0.08

0.09

49

0.21

0.22

0.21

35

0.30

0.35

0.33

14

0.12

0.08

0.09

1,077

4.65

3.13

3.54

597

5.13

3.50

3.98

480

4.16

2.77

3.11

12

0.05

0.05

0.05

0.06

0.05

0.06

0.04

0.04

0.05

CRUDE
RATE

2,915

12.59

9.00

172

0.74

2,082

3
ASR3


2
ASR2

CASE
NUMBER

CRUDE
RATE

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 179 -

10 99 WHO 2008 1()


CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010 (CONTINUED)

HEMATOPOIETIC AND LYMPHOID TUMORS

B
Other B-cell lymphomas

T/NK
T/NK-cell lymphoid neoplasms

NK/T
Extranodal NK/T cell lymphoma, nasal or other type

T / Sezary
Cutaneous T cell lymphoma (Including Mycosis fungoides / Szary syndrome)

T
Enteropathy-type T-cell lymphoma

T
Hepatosplenic T-cell lymphoma

T
Subcutaneous panniculitis-like T-cell Lymphoma

T
Peripheral T-cell lymphoma, NOS

T
Angioimmunoblastic T-cell lymphoma

Anaplastic large cell lymphoma

T /
Adult T-cell lymphoma / leukemia

T
Other T-cell lymphoma / leukemia

1. WHO 2008 p.497


2. 2 1976
3. 3 2000

- 180 -

TOTAL

MALE

2
2
ASR

3
3
ASR

CASE
NUMBER

CRUDE
RATE

2
2
ASR

3
3
ASR

0.32

0.23

0.25

21

0.18

0.13

0.14

216

1.86

1.46

1.58

116

1.01

0.76

0.82

0.16

31

0.27

0.20

0.21

18

0.16

0.11

0.12

0.13

0.14

23

0.20

0.15

0.17

17

0.15

0.11

0.12

0.03

0.02

0.02

0.03

0.02

0.02

0.02

0.01

0.01

0.00

0.00

0.00

0.01

0.01

0.01

0.03

0.03

0.03

0.03

0.02

0.02

0.03

0.04

0.04

115

0.50

0.36

0.40

83

0.71

0.53

0.59

32

0.28

0.19

0.21

44

0.19

0.13

0.15

26

0.22

0.16

0.18

18

0.16

0.10

0.12

31

0.13

0.12

0.13

21

0.18

0.16

0.17

10

0.09

0.09

0.09

0.03

0.02

0.02

0.02

0.01

0.01

0.03

0.03

0.03

33

0.14

0.15

0.15

23

0.20

0.21

0.21

10

0.09

0.08

0.09

2
2
ASR

CASE
NUMBER

FEMALE

3
3
ASR

CASE
NUMBER

CRUDE
RATE

58

0.25

0.18

0.20

37

332

1.43

1.10

1.19

49

0.21

0.15

40

0.17

CRUDE
RATE

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 181 -

10 99 WHO 2008 1()


CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE BY GENDER IN
LEUKEMIA AND LYMPHOMA, 2010 (CONTINUED)

HEMATOPOIETIC AND LYMPHOID TUMORS

Plasma cell neoplasm

Other LPD

Histiocytic and dendritic cell neoplasms

Malignant lymphoma, NOS and others

1. WHO 2008 p.497


2. 2 1976
3. 3 2000

- 182 -

TOTAL

MALE

2
ASR2

CASE
NUMBER

FEMALE

2
ASR2

3
ASR3

CASE
NUMBER

CRUDE
RATE

2
ASR2

3
ASR3

2.43

1.66

1.88

219

1.90

1.21

1.36

18

0.15

0.23

0.20

0.07

0.13

0.11

0.16

18

0.15

0.23

0.20

0.07

0.13

0.11

0.43

76

0.65

0.45

0.51

57

0.49

0.31

0.36

3
ASR3

CASE
NUMBER

CRUDE
RATE

502

2.17

1.43

1.62

283

26

0.11

0.19

0.16

26

0.11

0.19

133

0.57

0.38

CRUDE
RATE

NOTE
ASR2Incidence rates are per 100,000 and are age-standardized to the 1976 world standard population.
ASR3Incidence rates are per 100,000 and are age-standardized to the 2000 world standard population.

- 183 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010

C00 - C80

10 10
10

2 3

10 10
10

2 3

5,765

1,262,554

456.61

269.07

303.85

5,351

1,356,218

394.55

236.56

262.64

3,322

754,586

440.24

309.20

345.45

2,778

775,361

358.28

240.68

267.50

811

193,573

418.96

282.12

314.91

642

190,561

336.90

218.50

242.34

776

206,243

376.26

294.31

328.59

705

209,101

337.16

249.15

275.79

2,028

525,788

385.71

305.24

346.54

1,878

556,511

337.46

255.89

283.51

1,646

381,903

431.00

315.82

354.00

1,460

390,370

374.00

259.02

287.00

673

134,036

502.10

353.96

396.62

565

138,354

408.37

274.30

303.33

8,062

1,935,668

416.50

323.71

364.52

6,762

1,961,699

344.70

247.83

276.82

3,818

1,009,274

378.29

299.75

337.76

2,883

992,786

290.39

226.30

252.46

896

264,014

339.38

242.88

272.41

722

249,001

289.96

208.92

230.33

1,194

234,682

508.77

318.61

361.27

832

225,804

368.46

233.32

256.95

1,244

291,177

427.23

268.54

303.41

912

269,791

338.04

212.63

234.93

3,122

793,368

393.51

307.15

345.00

2,393

772,752

309.67

232.15

257.20

3,029

670,812

451.54

312.15

349.63

2,020

636,474

317.37

207.96

229.96

1,202

271,053

443.46

277.75

310.61

830

255,438

324.93

206.50

225.86

1,948

374,746

519.82

322.29

359.18

1,162

342,907

338.87

200.24

219.16

1,573

283,284

555.27

327.36

366.00

1,005

259,964

386.59

218.21

240.55

2,838

562,141

504.86

319.60

357.99

2,110

539,380

391.19

239.94

265.26

2,990

636,341

469.87

327.25

364.44

2,171

607,195

357.55

239.60

265.88

2,105

449,267

468.54

300.67

336.25

1,469

424,242

346.26

218.60

241.22

238

49,769

478.21

287.11

320.00

145

47,149

307.54

183.94

203.02

881

174,584

504.63

318.27

357.66

528

164,221

321.52

201.08

224.29

586

120,747

485.31

317.65

351.06

358

109,926

325.67

195.43

217.91

123

49,871

246.64

153.05

174.00

64

47,493

134.76

85.96

95.63

16

5,744

278.55

208.04

218.86

4,200

190.48

110.32

124.02

22,566

5,397,185

418.11

294.89

332.00

18,809

5,454,961

344.81

235.18

261.39

11,329

2,635,767

429.82

306.44

343.77

8,283

2,564,082

323.04

221.89

244.53

15,385

3,251,327

473.19

316.76

354.08

11,703

3,182,015

367.79

237.49

262.76

1,467

295,331

496.73

317.69

354.63

886

274,147

323.18

198.87

221.79

139

55,615

249.93

158.58

178.80

72

51,693

139.28

88.02

98.00

9,087

2,017,140

450.49

283.48

318.83

8,129

2,131,579

381.36

237.59

263.84

5,934

1,441,543

411.64

308.14

346.38

5,250

1,484,897

353.56

252.18

279.39

13,855

3,364,779

411.77

318.11

358.12

11,399

3,404,840

334.79

243.71

272.46

7,672

1,724,239

444.95

300.03

336.34

5,520

1,655,235

333.49

218.06

240.81

13,826

2,980,563

463.87

302.66

338.51

9,135

2,756,345

331.42

212.32

233.69

368

106,961

344.05

270.88

302.44

239

94,002

254.25

185.94

205.83

50,892 11,635,225

437.40

303.57

340.66

39,757

11,526,898

344.91

231.31

256.23

1. 96 ICD-O-3 M-CODE p.497

2. * 5 4

- 184 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C00 - C06C09 - C10C12 - C14

10 10
10

2 3

10 10
10

2 3

361

1,262,554

28.59

18.64

20.26

54

1,356,218

3.98

2.34

2.58

397

754,586

52.61

36.92

39.95

25

775,361

3.22

2.14

2.42

76

193,573

39.26

27.18

29.01

190,561

2.62

1.38

1.70

66

206,243

32.00

25.66

27.94

11

209,101

5.26

3.96

4.34

233

525,788

44.31

34.46

37.29

23

556,511

4.13

3.01

3.42

164

381,903

42.94

31.33

33.52

16

390,370

4.10

2.85

3.24

97

134,036

72.37

56.19

59.58

138,354

5.78

4.24

4.47

933

1,935,668

48.20

36.15

38.82

94

1,961,699

4.79

3.52

3.87

427

1,009,274

42.31

33.53

36.46

45

992,786

4.53

3.55

3.96

109

264,014

41.29

31.70

34.33

13

249,001

5.22

3.69

4.10

89

234,682

37.92

27.79

29.75

225,804

1.77

0.68

0.96

115

291,177

39.49

28.23

31.03

10

269,791

3.71

2.40

2.67

408

793,368

51.43

40.15

43.42

31

772,752

4.01

3.01

3.32

487

670,812

72.60

53.32

57.43

34

636,474

5.34

3.36

3.73

181

271,053

66.78

45.92

49.72

255,438

3.52

2.36

2.61

322

374,746

85.92

58.04

62.45

15

342,907

4.37

2.90

3.21

249

283,284

87.90

59.26

63.40

11

259,964

4.23

2.23

2.59

300

562,141

53.37

36.11

39.27

27

539,380

5.01

3.28

3.55

441

636,341

69.30

49.65

53.30

18

607,195

2.96

1.96

2.12

305

449,267

67.89

47.08

50.76

46

424,242

10.84

6.64

7.30

15

49,769

30.14

21.83

22.70

47,149

139

174,584

79.62

56.01

60.82

12

164,221

7.31

4.85

5.01

105

120,747

86.96

63.30

66.38

20

109,926

18.19

11.82

12.46

49,871

10.03

6.95

7.36

47,493

2.11

1.96

1.81

5,744

69.64

54.48

58.50

4,200

2,176

5,397,185

40.32

29.55

31.93

236

5,454,961

4.33

2.95

3.27

1,631

2,635,767

61.88

46.00

49.64

112

2,564,082

4.37

2.96

3.28

1,968

3,251,327

60.53

42.60

45.85

151

3,182,015

4.75

3.07

3.40

244

295,331

82.62

59.04

63.14

32

274,147

11.67

7.67

8.04

55,615

16.18

11.02

11.77

51,693

1.93

1.78

1.64

758

2,017,140

37.58

25.32

27.46

79

2,131,579

3.71

2.28

2.54

636

1,441,543

44.12

33.46

35.96

63

1,484,897

4.24

2.99

3.36

1,679

3,364,779

49.90

38.43

41.43

151

3,404,840

4.43

3.19

3.59

922

1,724,239

53.47

38.73

41.82

84

1,655,235

5.07

3.33

3.64

1,951

2,980,563

65.46

45.98

49.51

136

2,756,345

4.93

3.36

3.60

52

106,961

48.62

37.27

40.00

16

94,002

17.02

11.25

13.05

6,028 11,635,225

51.81

37.62

40.56

532

11,526,898

4.62

3.09

3.41

1. 96 ICD-O-3 M-CODE p.497

- 185 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C44.0 C00

10 10
10

2 3

10 10
10

2 3

1,262,554

0.32

0.23

0.24

1,356,218

0.07

0.02

0.04

16

754,586

2.12

1.46

1.59

775,361

193,573

1.55

1.23

1.27

190,561

206,243

209,101

525,788

1.71

1.30

1.42

556,511

381,903

0.79

0.48

0.54

390,370

134,036

4.48

4.01

3.85

138,354

31

1,935,668

1.60

1.29

1.34

1,961,699

0.10

0.07

0.09

1,009,274

0.59

0.38

0.45

992,786

264,014

1.14

1.00

1.05

249,001

0.40

0.38

0.38

234,682

1.28

0.85

0.89

225,804

291,177

1.03

0.91

0.89

269,791

793,368

1.01

0.79

0.90

772,752

0.13

0.10

0.11

15

670,812

2.24

1.65

1.76

636,474

0.31

0.11

0.16

271,053

2.58

1.72

1.81

255,438

0.39

0.30

0.30

16

374,746

4.27

2.68

2.96

342,907

0.29

0.20

0.20

15

283,284

5.30

3.69

3.90

259,964

18

562,141

3.20

2.30

2.38

539,380

0.19

0.16

0.15

17

636,341

2.67

1.78

2.00

607,195

0.16

0.12

0.12

10

449,267

2.23

1.72

1.76

424,242

1.41

0.81

0.89

49,769

47,149

10

174,584

5.73

4.33

4.53

164,221

120,747

5.80

4.23

4.45

109,926

0.91

0.48

0.53

49,871

47,493

5,744

4,200

53

5,397,185

0.98

0.77

0.81

5,454,961

0.07

0.04

0.05

55

2,635,767

2.09

1.55

1.69

2,564,082

0.20

0.13

0.14

85

3,251,327

2.61

1.89

2.00

3,182,015

0.25

0.16

0.17

17

295,331

5.76

4.29

4.50

274,147

0.36

0.20

0.22

55,615

51,693

20

2,017,140

0.99

0.68

0.73

2,131,579

0.05

0.01

0.03

21

1,441,543

1.46

1.16

1.21

1,484,897

45

3,364,779

1.34

1.11

1.15

3,404,840

0.09

0.06

0.08

39

1,724,239

2.26

1.64

1.76

1,655,235

0.30

0.25

0.24

81

2,980,563

2.72

1.94

2.08

2,756,345

0.18

0.10

0.11

106,961

0.93

0.63

0.63

94,002

4.26

2.63

3.10

210 11,635,225

1.80

1.36

1.45

18

11,526,898

0.16

0.10

0.11

1. 96 ICD-O-3 M-CODE p.497

- 186 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C01 - C02

10 10
10

2 3

10 10
10

2 3

102

1,262,554

8.08

5.37

5.87

24

1,356,218

1.77

1.10

1.19

116

754,586

15.37

10.73

11.75

12

775,361

1.55

1.03

1.15

21

193,573

10.85

8.32

8.57

190,561

2.10

1.16

1.36

15

206,243

7.27

5.81

6.43

209,101

2.87

2.29

2.43

62

525,788

11.79

9.12

9.77

10

556,511

1.80

1.16

1.42

54

381,903

14.14

10.11

11.04

390,370

1.79

1.37

1.50

24

134,036

17.91

13.05

14.49

138,354

2.17

1.79

1.79

247

1,935,668

12.76

9.44

10.21

37

1,961,699

1.89

1.38

1.46

125

1,009,274

12.39

9.77

10.69

16

992,786

1.61

1.39

1.45

28

264,014

10.61

8.02

8.69

249,001

3.21

2.22

2.53

19

234,682

8.10

5.82

6.52

225,804

0.44

0.12

0.21

34

291,177

11.68

8.12

8.99

269,791

1.11

0.58

0.68

116

793,368

14.62

11.25

12.19

18

772,752

2.33

1.84

1.94

116

670,812

17.29

12.87

13.86

12

636,474

1.89

1.18

1.29

47

271,053

17.34

12.23

12.89

255,438

1.17

0.96

1.03

74

374,746

19.75

14.10

14.93

342,907

2.62

1.79

1.97

50

283,284

17.65

12.35

13.44

259,964

1.92

1.02

1.12

80

562,141

14.23

10.01

10.85

12

539,380

2.22

1.32

1.50

122

636,341

19.17

13.76

14.88

607,195

1.48

0.99

1.05

85

449,267

18.92

13.06

14.16

13

424,242

3.06

2.21

2.38

49,769

6.03

4.04

4.57

47,149

27

174,584

15.47

10.86

12.01

164,221

3.04

2.22

2.22

15

120,747

12.42

9.21

9.49

109,926

4.55

3.50

3.50

49,871

2.01

1.13

1.22

47,493

5,744

4,200

591

5,397,185

10.95

8.03

8.74

99

5,454,961

1.81

1.29

1.40

415

2,635,767

15.74

11.91

12.77

52

2,564,082

2.03

1.41

1.54

534

3,251,327

16.42

11.52

12.53

61

3,182,015

1.92

1.30

1.43

42

295,331

14.22

10.19

10.99

10

274,147

3.65

2.72

2.72

55,615

1.80

1.00

1.08

51,693

218

2,017,140

10.81

7.34

8.02

36

2,131,579

1.69

1.08

1.18

176

1,441,543

12.21

9.21

9.96

30

1,484,897

2.02

1.43

1.60

433

3,364,779

12.87

9.79

10.64

63

3,404,840

1.85

1.34

1.47

252

1,724,239

14.62

10.81

11.70

34

1,655,235

2.05

1.45

1.56

491

2,980,563

16.47

11.65

12.57

56

2,756,345

2.03

1.45

1.53

106,961

7.48

6.12

6.63

94,002

2.13

1.35

1.46

1,583 11,635,225

13.61

9.90

10.72

222

11,526,898

1.93

1.34

1.46

1. 96 ICD-O-3 M-CODE p.497

- 187 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C03

10 10
10

2 3

10 10
10

2 3

30

1,262,554

2.38

1.53

1.67

1,356,218

0.37

0.24

0.24

26

754,586

3.45

2.51

2.68

775,361

0.52

0.39

0.42

193,573

2.07

1.28

1.37

190,561

206,243

3.88

3.72

3.83

209,101

0.96

0.54

0.72

16

525,788

3.04

2.11

2.40

556,511

0.36

0.27

0.30

381,903

2.36

1.89

1.94

390,370

0.26

0.10

0.18

10

134,036

7.46

5.73

5.97

138,354

0.72

0.45

0.49

72

1,935,668

3.72

2.82

3.04

17

1,961,699

0.87

0.63

0.70

21

1,009,274

2.08

1.67

1.85

992,786

0.50

0.37

0.43

264,014

3.41

2.42

2.69

249,001

234,682

1.70

1.20

1.28

225,804

0.44

0.15

0.22

291,177

2.40

1.67

1.88

269,791

14

793,368

1.76

1.29

1.44

772,752

0.39

0.26

0.33

39

670,812

5.81

4.28

4.56

636,474

0.31

0.22

0.25

11

271,053

4.06

2.56

2.91

255,438

1.57

0.84

1.00

14

374,746

3.74

2.26

2.56

342,907

17

283,284

6.00

3.77

4.08

259,964

16

562,141

2.85

1.57

1.84

539,380

0.37

0.31

0.31

26

636,341

4.09

3.05

3.19

607,195

0.49

0.29

0.37

20

449,267

4.45

2.86

3.11

424,242

1.41

0.75

0.86

49,769

47,149

174,584

4.01

2.40

2.90

164,221

1.22

0.72

0.77

120,747

3.31

2.30

2.57

109,926

0.91

0.72

0.67

49,871

47,493

5,744

4,200

155

5,397,185

2.87

2.11

2.29

30

5,454,961

0.55

0.36

0.40

94

2,635,767

3.57

2.54

2.81

11

2,564,082

0.43

0.26

0.31

124

3,251,327

3.81

2.64

2.84

17

3,182,015

0.53

0.33

0.38

11

295,331

3.72

2.39

2.79

274,147

1.09

0.71

0.72

55,615

51,693

56

2,017,140

2.78

1.89

2.05

2,131,579

0.42

0.29

0.30

47

1,441,543

3.26

2.52

2.68

1,484,897

0.40

0.24

0.31

110

3,364,779

3.27

2.49

2.71

23

3,404,840

0.68

0.48

0.55

52

1,724,239

3.02

2.00

2.24

14

1,655,235

0.85

0.42

0.52

112

2,980,563

3.76

2.57

2.79

2,756,345

0.25

0.20

0.19

106,961

4.67

3.20

3.55

94,002

1.06

0.89

0.97

384 11,635,225

3.30

2.35

2.56

61

11,526,898

0.53

0.34

0.38

1. 96 ICD-O-3 M-CODE p.497

- 188 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C04

10 10
10

2 3

10 10
10

2 3

1,262,554

0.63

0.37

0.40

1,356,218

0.07

0.04

0.05

754,586

1.06

0.72

0.79

775,361

193,573

2.07

1.28

1.41

190,561

206,243

0.97

0.70

0.78

209,101

525,788

0.38

0.33

0.33

556,511

0.36

0.32

0.34

381,903

0.79

0.59

0.62

390,370

134,036

2.24

1.88

1.93

138,354

28

1,935,668

1.45

1.03

1.13

1,961,699

0.15

0.09

0.10

1,009,274

0.89

0.65

0.71

992,786

0.10

0.07

0.08

264,014

0.76

0.72

0.71

249,001

0.40

0.26

0.28

234,682

1.70

1.20

1.36

225,804

291,177

0.69

0.48

0.56

269,791

14

793,368

1.76

1.46

1.47

772,752

13

670,812

1.94

1.36

1.50

636,474

0.16

0.05

0.08

271,053

1.48

0.97

1.07

255,438

374,746

2.13

1.28

1.43

342,907

283,284

2.47

1.80

1.79

259,964

562,141

1.25

0.81

0.89

539,380

0.37

0.24

0.26

12

636,341

1.89

1.33

1.40

607,195

0.16

0.10

0.11

449,267

1.78

1.25

1.34

424,242

49,769

2.01

1.82

1.69

47,149

174,584

0.57

0.37

0.40

164,221

120,747

0.83

0.57

0.57

109,926

0.91

0.48

0.53

49,871

47,493

5,744

4,200

59

5,397,185

1.09

0.76

0.83

5,454,961

0.11

0.07

0.08

41

2,635,767

1.56

1.15

1.22

2,564,082

0.12

0.08

0.10

49

3,251,327

1.51

1.07

1.13

3,182,015

0.09

0.06

0.07

295,331

0.68

0.46

0.48

274,147

0.36

0.20

0.22

55,615

51,693

16

2,017,140

0.79

0.50

0.55

2,131,579

0.05

0.03

0.03

14

1,441,543

0.97

0.74

0.78

1,484,897

0.13

0.11

0.12

48

3,364,779

1.43

1.09

1.17

3,404,840

0.15

0.10

0.11

23

1,724,239

1.33

0.89

0.98

1,655,235

0.18

0.11

0.12

50

2,980,563

1.68

1.18

1.26

2,756,345

0.07

0.05

0.05

106,961

94,002

151 11,635,225

1.30

0.92

0.99

13

11,526,898

0.11

0.07

0.08

1. 96 ICD-O-3 M-CODE p.497

- 189 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C05 - C06

10 10
10

2 3

10 10
10

2 3

115

1,262,554

9.11

6.13

6.66

11

1,356,218

0.81

0.46

0.52

152

754,586

20.14

14.31

15.41

775,361

0.64

0.36

0.47

25

193,573

12.92

8.48

9.32

190,561

0.52

0.22

0.34

16

206,243

7.76

6.16

6.67

209,101

1.43

1.13

1.20

83

525,788

15.79

12.16

13.19

556,511

0.72

0.65

0.66

59

381,903

15.45

11.15

11.92

390,370

1.54

1.05

1.19

38

134,036

28.35

22.51

23.85

138,354

2.17

1.51

1.64

314

1,935,668

16.22

12.34

13.14

25

1,961,699

1.27

1.03

1.13

160

1,009,274

15.85

12.68

13.69

16

992,786

1.61

1.22

1.43

41

264,014

15.53

11.73

12.86

249,001

1.20

0.83

0.91

24

234,682

10.23

7.31

7.80

225,804

0.44

0.30

0.32

39

291,177

13.39

9.84

10.83

269,791

2.22

1.52

1.69

154

793,368

19.41

15.13

16.30

772,752

0.65

0.45

0.53

177

670,812

26.39

19.33

20.80

13

636,474

2.04

1.27

1.44

66

271,053

24.35

17.23

18.66

255,438

0.39

0.26

0.28

115

374,746

30.69

21.09

22.58

342,907

1.46

0.91

1.04

95

283,284

33.54

22.62

24.12

259,964

1.15

0.69

0.82

99

562,141

17.61

11.89

12.98

539,380

0.74

0.50

0.54

154

636,341

24.20

17.30

18.54

607,195

0.33

0.24

0.24

104

449,267

23.15

16.12

17.60

16

424,242

3.77

2.12

2.37

49,769

12.06

8.71

8.95

47,149

48

174,584

27.49

19.43

21.12

164,221

1.22

0.83

0.83

38

120,747

31.47

23.18

24.28

109,926

8.19

4.94

5.38

49,871

2.01

1.44

1.59

47,493

5,744

34.82

34.63

36.23

4,200

734

5,397,185

13.60

10.05

10.82

66

5,454,961

1.21

0.84

0.94

595

2,635,767

22.57

16.83

18.11

28

2,564,082

1.09

0.73

0.82

707

3,251,327

21.74

15.36

16.53

39

3,182,015

1.23

0.75

0.85

86

295,331

29.12

20.92

22.36

11

274,147

4.01

2.50

2.68

55,615

5.39

3.88

4.11

51,693

267

2,017,140

13.24

9.09

9.82

16

2,131,579

0.75

0.42

0.49

221

1,441,543

15.33

11.54

12.43

17

1,484,897

1.14

0.85

0.93

623

3,364,779

18.52

14.35

15.41

40

3,404,840

1.17

0.89

1.02

312

1,724,239

18.09

13.27

14.29

19

1,655,235

1.15

0.74

0.82

666

2,980,563

22.34

15.71

16.90

44

2,756,345

1.60

1.04

1.14

28

106,961

26.18

19.53

21.24

94,002

7.45

4.82

5.74

2,125 11,635,225

18.26

13.33

14.34

144

11,526,898

1.25

0.83

0.92

1. 96 ICD-O-3 M-CODE p.497

- 190 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C09 - C10

10 10
10

2 3

10 10
10

2 3

42

1,262,554

3.33

2.19

2.34

1,356,218

0.66

0.35

0.42

31

754,586

4.11

2.82

3.05

775,361

0.39

0.29

0.31

193,573

4.13

2.97

3.05

190,561

206,243

2.91

2.33

2.44

209,101

22

525,788

4.18

3.32

3.56

556,511

0.18

0.11

0.12

18

381,903

4.71

3.55

3.71

390,370

0.51

0.33

0.37

10

134,036

7.46

5.74

5.89

138,354

0.72

0.50

0.54

95

1,935,668

4.91

3.69

3.97

1,961,699

0.31

0.20

0.23

48

1,009,274

4.76

3.75

4.07

992,786

0.50

0.37

0.42

13

264,014

4.92

4.08

4.28

249,001

15

234,682

6.39

4.68

5.01

225,804

0.44

0.12

0.21

291,177

2.75

1.91

2.10

269,791

40

793,368

5.04

4.10

4.43

772,752

0.13

0.10

0.10

40

670,812

5.96

4.33

4.71

636,474

0.63

0.53

0.52

16

271,053

5.90

4.10

4.41

255,438

38

374,746

10.14

6.78

7.21

342,907

17

283,284

6.00

3.81

4.19

259,964

0.77

0.43

0.51

28

562,141

4.98

3.36

3.64

539,380

0.74

0.47

0.52

41

636,341

6.44

4.62

4.96

607,195

0.33

0.21

0.22

25

449,267

5.56

3.86

4.06

424,242

0.71

0.48

0.51

49,769

2.01

1.31

1.42

47,149

12

174,584

6.87

4.76

5.23

164,221

0.61

0.39

0.42

12

120,747

9.94

7.40

7.53

109,926

2.73

1.70

1.85

49,871

47,493

2.11

1.96

1.81

5,744

4,200

235

5,397,185

4.35

3.22

3.45

21

5,454,961

0.38

0.23

0.27

156

2,635,767

5.92

4.40

4.74

2,564,082

0.23

0.19

0.19

171

3,251,327

5.26

3.68

3.94

17

3,182,015

0.53

0.35

0.38

24

295,331

8.13

5.87

6.20

274,147

1.46

0.93

1.01

55,615

51,693

1.93

1.78

1.64

73

2,017,140

3.62

2.42

2.61

12

2,131,579

0.56

0.34

0.39

64

1,441,543

4.44

3.42

3.59

1,484,897

0.27

0.18

0.20

160

3,364,779

4.76

3.67

3.98

10

3,404,840

0.29

0.19

0.21

92

1,724,239

5.34

3.98

4.19

1,655,235

0.36

0.25

0.26

191

2,980,563

6.41

4.45

4.81

16

2,756,345

0.58

0.39

0.42

106,961

3.74

3.42

3.39

94,002

1.06

1.12

1.12

586 11,635,225

5.04

3.66

3.92

49

11,526,898

0.43

0.28

0.31

1. 96 ICD-O-3 M-CODE p.497

- 191 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C12 - C13

10 10
10

2 3

10 10
10

2 3

59

1,262,554

4.67

2.78

3.03

1,356,218

0.15

0.09

0.09

46

754,586

6.10

4.19

4.48

775,361

0.13

0.07

0.08

10

193,573

5.17

3.29

3.69

190,561

17

206,243

8.24

6.22

7.01

209,101

37

525,788

7.04

5.75

6.24

556,511

0.54

0.39

0.43

17

381,903

4.45

3.40

3.56

390,370

134,036

4.48

3.28

3.60

138,354

137

1,935,668

7.08

5.21

5.65

1,961,699

0.15

0.09

0.12

54

1,009,274

5.35

4.23

4.59

992,786

0.20

0.13

0.15

12

264,014

4.55

3.47

3.74

249,001

19

234,682

8.10

6.42

6.58

225,804

19

291,177

6.53

4.62

5.05

269,791

0.37

0.30

0.30

54

793,368

6.81

5.39

5.81

772,752

0.39

0.26

0.31

81

670,812

12.07

8.89

9.56

636,474

27

271,053

9.96

6.38

7.20

255,438

56

374,746

14.94

9.67

10.57

342,907

48

283,284

16.94

11.24

11.87

259,964

0.38

0.09

0.14

49

562,141

8.72

5.90

6.37

539,380

0.37

0.27

0.28

58

636,341

9.11

6.58

7.02

607,195

49

449,267

10.91

7.53

8.05

424,242

0.24

0.18

0.18

49,769

8.04

5.95

6.08

47,149

30

174,584

17.18

12.28

12.98

164,221

1.22

0.69

0.78

27

120,747

22.36

15.78

16.71

109,926

49,871

6.02

4.38

4.55

47,493

5,744

34.82

19.84

22.27

4,200

327

5,397,185

6.06

4.31

4.67

5,454,961

0.15

0.10

0.11

255

2,635,767

9.67

7.10

7.71

2,564,082

0.23

0.14

0.16

277

3,251,327

8.52

6.00

6.41

3,182,015

0.16

0.10

0.11

57

295,331

19.30

13.71

14.51

274,147

0.73

0.41

0.46

55,615

8.99

6.15

6.58

51,693

105

2,017,140

5.21

3.31

3.58

2,131,579

0.14

0.08

0.09

87

1,441,543

6.04

4.57

4.99

1,484,897

0.20

0.13

0.15

241

3,364,779

7.16

5.52

5.94

3,404,840

0.18

0.10

0.13

137

1,724,239

7.95

5.57

6.02

1,655,235

0.18

0.12

0.13

336

2,980,563

11.27

7.90

8.49

2,756,345

0.22

0.14

0.15

106,961

5.61

4.37

4.57

94,002

921 11,635,225

7.92

5.68

6.12

21

11,526,898

0.18

0.12

0.13

1. 96 ICD-O-3 M-CODE p.497

- 192 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C14

10 10
10

2 3

10 10
10

2 3

1,262,554

0.08

0.05

0.05

1,356,218

0.07

0.04

0.04

754,586

0.27

0.19

0.19

775,361

193,573

0.52

0.31

0.34

190,561

206,243

0.97

0.72

0.78

209,101

525,788

0.38

0.37

0.38

556,511

0.18

0.12

0.14

381,903

0.26

0.17

0.18

390,370

134,036

138,354

1,935,668

0.46

0.33

0.34

1,961,699

0.05

0.03

0.03

1,009,274

0.40

0.40

0.39

992,786

264,014

0.38

0.28

0.30

249,001

234,682

0.43

0.31

0.31

225,804

291,177

1.03

0.67

0.74

269,791

793,368

1.01

0.75

0.88

772,752

670,812

0.89

0.60

0.67

636,474

271,053

1.11

0.72

0.77

255,438

374,746

0.27

0.18

0.19

342,907

283,284

259,964

562,141

0.53

0.28

0.33

539,380

11

636,341

1.73

1.22

1.31

607,195

449,267

0.89

0.68

0.68

424,242

0.24

0.08

0.12

49,769

47,149

174,584

2.29

1.58

1.65

164,221

120,747

0.83

0.64

0.77

109,926

49,871

47,493

5,744

4,200

22

5,397,185

0.41

0.30

0.32

5,454,961

0.04

0.02

0.02

20

2,635,767

0.76

0.53

0.60

2,564,082

0.04

0.02

0.02

21

3,251,327

0.65

0.45

0.47

3,182,015

0.03

0.01

0.02

295,331

1.69

1.22

1.31

274,147

55,615

51,693

2,017,140

0.15

0.10

0.10

2,131,579

0.05

0.02

0.03

1,441,543

0.42

0.31

0.33

1,484,897

0.07

0.04

0.04

19

3,364,779

0.56

0.40

0.44

3,404,840

0.03

0.02

0.02

15

1,724,239

0.87

0.57

0.64

1,655,235

24

2,980,563

0.81

0.58

0.61

2,756,345

106,961

94,002

1.06

0.44

0.67

68 11,635,225

0.58

0.42

0.45

11,526,898

0.03

0.02

0.02

1. 96 ICD-O-3 M-CODE p.497

- 193 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C07 - C08

10 10
10

2 3

10 10
10

2 3

12

1,262,554

0.95

0.80

0.85

14

1,356,218

1.03

0.65

0.72

754,586

0.80

0.58

0.67

775,361

0.39

0.38

0.38

193,573

1.03

0.78

0.89

190,561

1.05

0.50

0.66

206,243

0.97

0.72

0.78

209,101

525,788

0.76

0.58

0.63

556,511

0.72

0.57

0.61

381,903

1.05

0.70

0.74

390,370

1.02

0.74

0.85

134,036

0.75

0.57

0.57

138,354

0.72

0.91

0.93

28

1,935,668

1.45

1.15

1.29

15

1,961,699

0.76

0.54

0.60

13

1,009,274

1.29

0.97

1.12

992,786

0.91

0.65

0.77

264,014

2.27

1.81

1.99

249,001

1.61

1.29

1.37

234,682

0.85

0.43

0.52

225,804

0.89

0.39

0.44

291,177

2.06

1.55

1.63

269,791

0.37

0.30

0.30

793,368

0.50

0.40

0.41

772,752

0.91

0.72

0.82

670,812

1.34

0.95

1.08

636,474

1.26

0.94

1.05

271,053

0.74

0.20

0.37

255,438

0.78

0.44

0.54

374,746

342,907

0.29

0.26

0.31

283,284

1.06

0.55

0.64

259,964

0.77

0.64

0.60

562,141

1.25

0.67

0.80

539,380

1.48

1.03

1.16

636,341

1.41

1.05

1.11

607,195

0.99

0.66

0.76

449,267

1.11

0.81

0.89

424,242

1.65

1.19

1.33

49,769

47,149

174,584

1.72

1.12

1.24

164,221

1.83

1.44

1.51

120,747

2.48

1.39

1.73

109,926

0.91

0.35

0.42

49,871

47,493

2.11

1.68

1.85

5,744

4,200

71

5,397,185

1.32

0.98

1.09

47

5,454,961

0.86

0.60

0.67

19

2,635,767

0.72

0.50

0.56

22

2,564,082

0.86

0.64

0.72

35

3,251,327

1.08

0.73

0.81

31

3,182,015

0.97

0.72

0.79

295,331

2.03

1.22

1.42

274,147

1.46

1.02

1.09

55,615

51,693

1.93

1.56

1.72

18

2,017,140

0.89

0.72

0.78

17

2,131,579

0.80

0.56

0.60

13

1,441,543

0.90

0.65

0.70

11

1,484,897

0.74

0.56

0.63

45

3,364,779

1.34

1.00

1.17

30

3,404,840

0.88

0.66

0.74

25

1,724,239

1.45

1.06

1.15

13

1,655,235

0.79

0.61

0.66

26

2,980,563

0.87

0.58

0.65

31

2,756,345

1.12

0.75

0.85

106,961

3.74

2.77

3.18

94,002

1.06

0.89

0.97

131 11,635,225

1.13

0.80

0.89

105

11,526,898

0.91

0.66

0.73

1. 96 ICD-O-3 M-CODE p.497

- 194 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C11

10 10
10

2 3

10 10
10

2 3

124

1,262,554

9.82

6.93

7.59

41

1,356,218

3.02

1.95

2.13

94

754,586

12.46

8.97

9.81

24

775,361

3.10

2.10

2.35

16

193,573

8.27

5.64

6.19

190,561

2.62

1.45

1.71

19

206,243

9.21

8.03

8.62

209,101

2.87

2.08

2.28

46

525,788

8.75

6.89

7.57

20

556,511

3.59

2.41

2.81

34

381,903

8.90

6.52

6.94

14

390,370

3.59

2.58

2.87

134,036

5.22

3.81

3.98

138,354

5.78

4.18

4.32

201

1,935,668

10.38

7.61

8.28

69

1,961,699

3.52

2.41

2.73

108

1,009,274

10.70

8.50

9.16

21

992,786

2.12

1.70

1.84

26

264,014

9.85

7.13

8.10

10

249,001

4.02

3.16

3.44

35

234,682

14.91

10.99

11.86

225,804

3.10

2.04

2.37

36

291,177

12.36

9.13

9.99

269,791

2.59

2.18

2.25

64

793,368

8.07

6.17

6.75

22

772,752

2.85

2.18

2.35

69

670,812

10.29

7.97

8.66

16

636,474

2.51

1.72

1.87

25

271,053

9.22

6.14

7.08

10

255,438

3.91

3.12

3.22

35

374,746

9.34

6.53

7.19

342,907

2.04

1.19

1.33

24

283,284

8.47

5.73

6.20

16

259,964

6.15

4.01

4.36

53

562,141

9.43

6.61

6.91

16

539,380

2.97

2.18

2.34

74

636,341

11.63

8.18

8.97

19

607,195

3.13

2.26

2.41

52

449,267

11.57

8.10

8.82

22

424,242

5.19

3.72

4.05

49,769

18.08

13.00

13.65

47,149

4.24

3.56

3.66

18

174,584

10.31

7.30

7.90

164,221

4.26

2.65

3.03

21

120,747

17.39

12.63

13.94

109,926

7.28

5.47

5.51

49,871

6.02

4.13

4.76

47,493

5,744

17.41

11.13

11.13

4,200

565

5,397,185

10.47

7.77

8.47

166

5,454,961

3.04

2.10

2.32

239

2,635,767

9.07

6.79

7.47

75

2,564,082

2.93

2.12

2.32

347

3,251,327

10.67

7.61

8.22

121

3,182,015

3.80

2.69

2.92

39

295,331

13.21

9.43

10.32

15

274,147

5.47

3.75

3.99

55,615

7.19

4.87

5.42

51,693

218

2,017,140

10.81

7.65

8.37

65

2,131,579

3.05

2.00

2.21

122

1,441,543

8.46

6.43

6.96

53

1,484,897

3.57

2.46

2.76

352

3,364,779

10.46

8.01

8.72

110

3,404,840

3.23

2.29

2.54

176

1,724,239

10.21

7.63

8.27

60

1,655,235

3.62

2.73

2.93

302

2,980,563

10.13

7.11

7.77

82

2,756,345

2.97

2.13

2.30

24

106,961

22.44

18.41

19.38

94,002

7.45

5.80

6.32

1,194 11,635,225

10.26

7.54

8.22

377

11,526,898

3.27

2.30

2.52

1. 96 ICD-O-3 M-CODE p.497

- 195 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C15

10 10
10

2 3

10 10
10

2 3

159

1,262,554

12.59

7.60

8.33

19

1,356,218

1.40

0.73

0.86

125

754,586

16.57

11.21

12.25

10

775,361

1.29

0.90

0.93

42

193,573

21.70

14.80

16.01

190,561

2.10

1.39

1.51

36

206,243

17.46

13.16

14.52

209,101

0.96

0.67

0.77

83

525,788

15.79

12.77

13.79

556,511

1.26

0.97

1.10

50

381,903

13.09

9.57

10.45

390,370

26

134,036

19.40

14.39

15.21

138,354

1.45

0.53

0.86

342

1,935,668

17.67

13.25

14.51

32

1,961,699

1.63

1.11

1.37

143

1,009,274

14.17

11.59

12.51

15

992,786

1.51

1.09

1.37

27

264,014

10.23

7.66

8.18

249,001

1.20

0.84

0.92

53

234,682

22.58

15.67

16.81

225,804

56

291,177

19.23

13.52

14.57

269,791

1.85

0.70

0.93

148

793,368

18.65

14.33

15.81

10

772,752

1.29

0.93

1.08

138

670,812

20.57

15.07

16.16

636,474

1.41

0.99

1.06

71

271,053

26.19

17.93

19.19

255,438

1.96

1.45

1.48

75

374,746

20.01

13.47

14.45

342,907

0.29

0.26

0.29

72

283,284

25.42

16.58

17.87

259,964

0.77

0.33

0.42

105

562,141

18.68

12.19

13.31

539,380

1.11

0.46

0.58

130

636,341

20.43

14.65

15.55

607,195

0.33

0.20

0.25

96

449,267

21.37

14.75

15.62

424,242

0.94

0.53

0.60

12

49,769

24.11

15.49

16.81

47,149

55

174,584

31.50

21.49

23.32

164,221

2.44

1.80

1.82

39

120,747

32.30

23.36

24.29

109,926

3.64

1.63

2.05

49,871

16.04

9.70

11.32

47,493

2.11

0.57

1.02

5,744

4,200

858

5,397,185

15.90

11.37

12.36

80

5,454,961

1.47

0.89

1.07

515

2,635,767

19.54

14.37

15.54

32

2,564,082

1.25

0.86

0.94

616

3,251,327

18.95

13.04

14.04

26

3,182,015

0.82

0.47

0.54

94

295,331

31.83

22.21

23.67

274,147

2.92

1.76

1.96

55,615

14.38

8.80

10.30

51,693

1.93

0.52

0.94

284

2,017,140

14.08

8.91

9.75

29

2,131,579

1.36

0.80

0.90

237

1,441,543

16.44

12.39

13.44

15

1,484,897

1.01

0.68

0.80

554

3,364,779

16.46

12.58

13.60

44

3,404,840

1.29

0.89

1.05

347

1,724,239

20.12

14.12

15.40

26

1,655,235

1.57

0.89

1.06

647

2,980,563

21.71

15.03

16.12

27

2,756,345

0.98

0.49

0.57

14

106,961

13.09

9.01

9.84

94,002

5.32

3.96

4.40

2,091 11,635,225

17.97

12.77

13.81

147

11,526,898

1.28

0.77

0.90

1. 96 ICD-O-3 M-CODE p.497

- 196 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C16

10 10
10

2 3

10 10
10

2 3

336

1,262,554

26.61

12.94

15.61

183

1,356,218

13.49

7.04

8.15

117

754,586

15.51

9.78

11.64

81

775,361

10.45

6.94

7.76

50

193,573

25.83

16.41

18.53

31

190,561

16.27

9.88

11.17

41

206,243

19.88

13.56

16.38

27

209,101

12.91

8.70

10.39

111

525,788

21.11

16.47

18.98

61

556,511

10.96

8.28

9.30

66

381,903

17.28

11.32

13.79

50

390,370

12.81

8.18

9.56

28

134,036

20.89

13.26

15.75

19

138,354

13.73

8.89

9.90

421

1,935,668

21.75

16.26

18.98

236

1,961,699

12.03

8.66

10.07

208

1,009,274

20.61

15.25

17.66

118

992,786

11.89

9.00

10.44

46

264,014

17.42

10.87

12.89

33

249,001

13.25

9.08

10.27

87

234,682

37.07

20.74

24.55

35

225,804

15.50

7.69

9.36

59

291,177

20.26

12.63

14.28

31

269,791

11.49

6.47

7.15

157

793,368

19.79

14.69

17.35

79

772,752

10.22

7.35

8.49

112

670,812

16.70

10.65

12.36

87

636,474

13.67

7.58

8.82

48

271,053

17.71

9.75

11.52

23

255,438

9.00

6.01

6.55

72

374,746

19.21

11.20

12.73

41

342,907

11.96

5.93

6.51

42

283,284

14.83

7.68

9.07

34

259,964

13.08

5.67

6.62

106

562,141

18.86

11.03

12.69

81

539,380

15.02

7.49

8.86

117

636,341

18.39

11.49

13.57

74

607,195

12.19

7.86

8.87

82

449,267

18.25

10.81

12.47

52

424,242

12.26

6.48

7.63

10

49,769

20.09

9.65

11.90

10

47,149

21.21

10.95

12.55

66

174,584

37.80

20.17

24.06

31

164,221

18.88

8.72

11.29

22

120,747

18.22

9.43

11.27

17

109,926

15.46

6.50

8.41

11

49,871

22.06

12.94

14.57

47,493

10.53

5.35

6.66

5,744

4,200

1,248

5,397,185

23.12

14.83

17.43

694

5,454,961

12.72

8.11

9.39

500

2,635,767

18.97

12.70

14.77

291

2,564,082

11.35

7.21

8.17

568

3,251,327

17.47

10.55

12.43

401

3,182,015

12.60

7.37

8.49

88

295,331

29.80

15.75

18.81

48

274,147

17.51

7.79

10.10

11

55,615

19.78

11.66

13.15

51,693

9.67

4.93

6.15

453

2,017,140

22.46

11.92

14.35

264

2,131,579

12.39

7.04

8.06

296

1,441,543

20.53

14.22

16.68

188

1,484,897

12.66

8.65

9.90

661

3,364,779

19.64

14.23

16.77

411

3,404,840

12.07

8.66

10.13

364

1,724,239

21.11

13.11

15.28

216

1,655,235

13.05

7.81

8.81

601

2,980,563

20.16

12.13

14.06

340

2,756,345

12.34

6.60

7.73

31

106,961

28.98

22.91

26.10

16

94,002

17.02

11.33

13.45

2,415 11,635,225

20.76

13.14

15.43

1,439

11,526,898

12.48

7.66

8.85

1. 96 ICD-O-3 M-CODE p.497

- 197 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C17

10 10
10

2 3

10 10
10

2 3

15

1,262,554

1.19

0.66

0.75

14

1,356,218

1.03

0.56

0.65

13

754,586

1.72

1.10

1.32

11

775,361

1.42

0.88

1.05

193,573

2.58

1.98

2.03

190,561

1.57

0.92

1.02

206,243

0.48

0.48

0.52

209,101

0.96

0.85

0.84

12

525,788

2.28

1.78

2.04

556,511

0.54

0.53

0.54

13

381,903

3.40

2.32

2.69

390,370

0.77

0.63

0.63

134,036

1.49

0.83

1.08

138,354

0.72

0.63

0.63

23

1,935,668

1.19

0.98

1.06

18

1,961,699

0.92

0.72

0.81

1,009,274

0.69

0.79

0.82

992,786

0.91

0.75

0.82

264,014

1.52

0.93

1.14

249,001

1.61

1.12

1.24

234,682

1.70

1.19

1.27

225,804

1.33

0.78

0.89

291,177

1.03

0.59

0.68

269,791

0.37

0.08

0.15

18

793,368

2.27

1.74

1.96

13

772,752

1.68

1.25

1.44

10

670,812

1.49

1.07

1.16

636,474

1.10

0.81

0.85

271,053

1.11

0.66

0.74

255,438

1.57

1.06

1.05

374,746

2.40

1.58

1.73

342,907

0.58

0.49

0.48

283,284

3.18

2.05

2.31

259,964

1.54

0.87

0.95

11

562,141

1.96

1.13

1.30

11

539,380

2.04

1.27

1.37

10

636,341

1.57

0.98

1.12

13

607,195

2.14

1.39

1.58

449,267

1.56

1.01

1.11

424,242

0.47

0.31

0.32

49,769

47,149

174,584

3.44

2.47

2.74

164,221

1.83

1.29

1.32

120,747

4.14

2.82

2.96

109,926

3.64

1.97

2.26

49,871

47,493

5,744

4,200

62

5,397,185

1.15

0.87

0.94

54

5,454,961

0.99

0.67

0.76

52

2,635,767

1.97

1.41

1.57

29

2,564,082

1.13

0.82

0.87

65

3,251,327

2.00

1.26

1.45

45

3,182,015

1.41

0.88

0.98

11

295,331

3.72

2.60

2.82

274,147

2.55

1.56

1.70

55,615

51,693

28

2,017,140

1.39

0.82

0.95

25

2,131,579

1.17

0.64

0.74

33

1,441,543

2.29

1.69

1.91

12

1,484,897

0.81

0.66

0.67

52

3,364,779

1.55

1.26

1.38

40

3,404,840

1.17

0.92

1.02

15

1,724,239

0.87

0.63

0.67

12

1,655,235

0.72

0.51

0.53

59

2,980,563

1.98

1.29

1.45

45

2,756,345

1.63

0.98

1.09

106,961

94,002

1.06

0.73

0.78

190 11,635,225

1.63

1.14

1.27

135

11,526,898

1.17

0.78

0.86

1. 96 ICD-O-3 M-CODE p.497

- 198 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C18 - C21

10 10
10

2 3

10 10
10

2 3

1,016

1,262,554

80.47

47.53

53.22

759

1,356,218

55.96

31.13

35.31

579

754,586

76.73

54.04

60.04

451

775,361

58.17

38.22

43.26

118

193,573

60.96

41.69

46.27

99

190,561

51.95

31.78

35.56

144

206,243

69.82

54.53

60.92

101

209,101

48.30

35.88

39.89

367

525,788

69.80

56.66

63.93

285

556,511

51.21

38.47

43.83

289

381,903

75.67

55.64

62.36

216

390,370

55.33

37.43

41.83

111

134,036

82.81

57.05

64.58

67

138,354

48.43

30.62

34.50

1,291

1,935,668

66.70

52.45

58.44

963

1,961,699

49.09

35.37

40.36

628

1,009,274

62.22

49.98

56.18

428

992,786

43.11

33.55

38.26

150

264,014

56.82

39.12

44.69

98

249,001

39.36

27.18

30.41

167

234,682

71.16

44.90

50.55

123

225,804

54.47

31.87

35.69

210

291,177

72.12

44.96

50.61

139

269,791

51.52

29.15

33.07

485

793,368

61.13

48.05

53.91

372

772,752

48.14

35.20

39.77

481

670,812

71.70

49.01

54.95

314

636,474

49.33

30.45

34.01

173

271,053

63.83

39.97

44.22

146

255,438

57.16

33.17

36.46

279

374,746

74.45

44.62

49.89

172

342,907

50.16

24.73

28.08

216

283,284

76.25

42.51

48.48

141

259,964

54.24

27.35

30.67

400

562,141

71.16

44.59

50.18

334

539,380

61.92

34.30

38.96

477

636,341

74.96

52.17

58.29

345

607,195

56.82

35.46

40.68

322

449,267

71.67

45.06

50.74

199

424,242

46.91

28.23

31.38

30

49,769

60.28

37.36

40.66

23

47,149

48.78

28.76

31.91

120

174,584

68.73

42.83

47.85

74

164,221

45.06

27.73

30.69

74

120,747

61.29

35.85

41.63

38

109,926

34.57

20.08

22.08

14

49,871

28.07

17.85

19.69

47,493

18.95

12.99

13.81

5,744

4,200

23.81

5.88

7.06

3,724

5,397,185

69.00

48.94

54.74

2,710

5,454,961

49.68

32.69

37.05

1,785

2,635,767

67.72

48.27

54.09

1,289

2,564,082

50.27

32.42

36.38

2,424

3,251,327

74.55

49.51

55.46

1,776

3,182,015

55.81

33.96

38.30

194

295,331

65.69

39.88

45.20

112

274,147

40.85

24.69

27.25

14

55,615

25.17

16.12

17.78

10

51,693

19.34

12.37

13.23

1,595

2,017,140

79.07

49.70

55.47

1,210

2,131,579

56.77

33.61

38.06

1,029

1,441,543

71.38

53.80

60.39

768

1,484,897

51.72

36.06

40.56

2,239

3,364,779

66.54

52.31

58.40

1,634

3,404,840

47.99

34.73

39.76

1,185

1,724,239

68.73

46.11

51.57

879

1,655,235

53.10

32.89

36.68

2,038

2,980,563

68.38

43.54

49.13

1,370

2,756,345

49.70

29.08

32.66

41

106,961

38.33

32.03

34.72

25

94,002

26.60

19.45

21.75

8,143 11,635,225

69.99

48.58

54.39

5,897

11,526,898

51.16

32.65

36.84

1. 96 ICD-O-3 M-CODE p.497

2. * 2

- 199 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C18

10 10
10

2 3

10 10
10

2 3

635

1,262,554

50.29

29.08

32.75

521

1,356,218

38.42

21.19

24.12

360

754,586

47.71

32.94

37.01

282

775,361

36.37

23.81

27.01

79

193,573

40.81

28.00

31.41

67

190,561

35.16

21.23

23.81

99

206,243

48.00

37.18

41.80

76

209,101

36.35

26.72

29.93

209

525,788

39.75

31.59

36.03

182

556,511

32.70

24.33

27.90

169

381,903

44.25

32.20

36.37

140

390,370

35.86

24.10

27.17

62

134,036

46.26

31.97

36.11

51

138,354

36.86

23.19

25.95

779

1,935,668

40.24

31.61

35.32

590

1,961,699

30.08

21.80

24.96

412

1,009,274

40.82

32.36

36.46

295

992,786

29.71

23.32

26.40

94

264,014

35.60

24.15

27.67

71

249,001

28.51

19.58

21.93

101

234,682

43.04

27.15

30.69

81

225,804

35.87

20.21

22.87

113

291,177

38.81

23.96

27.06

80

269,791

29.65

17.46

19.60

274

793,368

34.54

26.87

30.25

223

772,752

28.86

21.26

24.01

297

670,812

44.27

30.62

34.07

210

636,474

32.99

20.53

22.93

95

271,053

35.05

21.70

24.17

98

255,438

38.37

21.29

23.77

157

374,746

41.90

24.88

27.93

88

342,907

25.66

12.22

14.24

113

283,284

39.89

21.21

24.76

83

259,964

31.93

14.75

16.85

211

562,141

37.54

23.50

26.53

198

539,380

36.71

19.98

22.90

266

636,341

41.80

28.75

32.37

215

607,195

35.41

21.93

25.21

209

449,267

46.52

28.62

32.64

124

424,242

29.23

18.03

19.73

19

49,769

38.18

23.08

25.26

14

47,149

29.69

18.15

19.83

73

174,584

41.81

25.37

28.71

50

164,221

30.45

17.95

20.15

34

120,747

28.16

16.33

19.01

19

109,926

17.28

9.65

10.88

49,871

18.05

11.19

12.60

47,493

10.53

7.30

7.89

5,744

4,200

23.81

5.88

7.06

2,312

5,397,185

42.84

30.09

33.80

1,781

5,454,961

32.65

21.52

24.42

1,032

2,635,767

39.15

27.77

31.17

801

2,564,082

31.24

19.92

22.51

1,409

3,251,327

43.34

28.34

32.03

1,107

3,182,015

34.79

21.05

23.79

107

295,331

36.23

21.59

24.66

69

274,147

25.17

14.58

16.36

55,615

16.18

10.15

11.43

51,693

11.61

7.16

7.80

995

2,017,140

49.33

30.33

34.12

803

2,131,579

37.67

22.20

25.22

618

1,441,543

42.87

31.99

36.18

516

1,484,897

34.75

24.01

27.14

1,368

3,364,779

40.66

31.74

35.61

1,030

3,404,840

30.25

21.97

25.22

703

1,724,239

40.77

27.18

30.43

560

1,655,235

33.83

20.83

23.30

1,157

2,980,563

38.82

24.48

27.76

833

2,756,345

30.22

17.57

19.79

18

106,961

16.83

14.21

15.44

15

94,002

15.96

11.36

12.69

4,871 11,635,225

41.86

28.75

32.36

3,764

11,526,898

32.65

20.75

23.48

1. 96 ICD-O-3 M-CODE p.497

2. * 2

- 200 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C19 - C21

10 10
10

2 3

10 10
10

2 3

381

1,262,554

30.18

18.45

20.47

238

1,356,218

17.55

9.94

11.19

219

754,586

29.02

21.11

23.03

169

775,361

21.80

14.40

16.25

39

193,573

20.15

13.68

14.86

32

190,561

16.79

10.55

11.75

45

206,243

21.82

17.35

19.11

25

209,101

11.96

9.16

9.96

158

525,788

30.05

25.08

27.90

103

556,511

18.51

14.14

15.93

120

381,903

31.42

23.44

25.99

76

390,370

19.47

13.33

14.66

49

134,036

36.56

25.07

28.47

16

138,354

11.56

7.44

8.55

512

1,935,668

26.45

20.83

23.12

373

1,961,699

19.01

13.58

15.40

216

1,009,274

21.40

17.61

19.72

133

992,786

13.40

10.23

11.86

56

264,014

21.21

14.97

17.02

27

249,001

10.84

7.60

8.49

66

234,682

28.12

17.75

19.85

42

225,804

18.60

11.66

12.82

97

291,177

33.31

21.00

23.54

59

269,791

21.87

11.69

13.47

211

793,368

26.60

21.19

23.65

149

772,752

19.28

13.94

15.76

184

670,812

27.43

18.38

20.88

104

636,474

16.34

9.92

11.08

78

271,053

28.78

18.27

20.05

48

255,438

18.79

11.88

12.68

122

374,746

32.56

19.74

21.96

84

342,907

24.50

12.51

13.83

103

283,284

36.36

21.30

23.72

58

259,964

22.31

12.61

13.82

189

562,141

33.62

21.09

23.65

136

539,380

25.21

14.32

16.07

211

636,341

33.16

23.42

25.92

130

607,195

21.41

13.53

15.47

113

449,267

25.15

16.44

18.10

75

424,242

17.68

10.20

11.65

11

49,769

22.10

14.28

15.40

47,149

19.09

10.60

12.08

47

174,584

26.92

17.46

19.14

24

164,221

14.61

9.77

10.54

40

120,747

33.13

19.53

22.62

19

109,926

17.28

10.43

11.20

49,871

10.03

6.66

7.09

47,493

8.42

5.69

5.92

5,744

4,200

1,412

5,397,185

26.16

18.85

20.94

929

5,454,961

17.03

11.17

12.63

753

2,635,767

28.57

20.50

22.92

488

2,564,082

19.03

12.49

13.87

1,015

3,251,327

31.22

21.17

23.43

669

3,182,015

21.02

12.91

14.51

87

295,331

29.46

18.29

20.54

43

274,147

15.69

10.11

10.88

55,615

8.99

5.96

6.35

51,693

7.74

5.21

5.43

600

2,017,140

29.75

19.37

21.35

407

2,131,579

19.09

11.41

12.84

411

1,441,543

28.51

21.81

24.21

252

1,484,897

16.97

12.05

13.41

871

3,364,779

25.89

20.58

22.79

604

3,404,840

17.74

12.76

14.54

482

1,724,239

27.95

18.94

21.14

319

1,655,235

19.27

12.06

13.38

881

2,980,563

29.56

19.06

21.38

537

2,756,345

19.48

11.50

12.87

23

106,961

21.50

17.81

19.29

10

94,002

10.64

8.09

9.06

3,272 11,635,225

28.12

19.83

22.04

2,133

11,526,898

18.50

11.90

13.35

1. 96 ICD-O-3 M-CODE p.497

- 201 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C22

10 10
10

2 3

10 10
10

2 3

687

1,262,554

54.41

33.79

37.43

297

1,356,218

21.90

12.10

14.11

552

754,586

73.15

52.94

57.72

250

775,361

32.24

21.18

24.17

126

193,573

65.09

44.19

48.65

62

190,561

32.54

21.22

23.35

117

206,243

56.73

47.57

51.86

72

209,101

34.43

25.89

28.92

317

525,788

60.29

48.86

54.67

125

556,511

22.46

17.01

19.67

293

381,903

76.72

56.12

62.31

135

390,370

34.58

23.63

26.87

128

134,036

95.50

66.73

75.55

79

138,354

57.10

34.92

39.77

1,084

1,935,668

56.00

43.83

48.29

410

1,961,699

20.90

15.66

18.10

475

1,009,274

47.06

38.31

42.60

190

992,786

19.14

15.25

17.81

123

264,014

46.59

34.83

38.20

58

249,001

23.29

16.10

17.75

153

234,682

65.19

43.25

47.45

62

225,804

27.46

15.50

17.41

221

291,177

75.90

47.70

53.67

90

269,791

33.36

17.93

20.59

459

793,368

57.85

46.20

50.55

214

772,752

27.69

20.77

23.54

472

670,812

70.36

49.86

54.91

176

636,474

27.65

16.47

18.45

161

271,053

59.40

37.78

41.89

84

255,438

32.88

18.25

20.19

422

374,746

112.61

72.57

78.90

158

342,907

46.08

21.71

24.80

281

283,284

99.19

59.86

65.90

144

259,964

55.39

26.98

30.46

535

562,141

95.17

61.67

67.72

215

539,380

39.86

22.26

25.11

551

636,341

86.59

60.67

66.84

226

607,195

37.22

23.46

26.90

311

449,267

69.22

45.85

49.97

124

424,242

29.23

16.91

18.93

64

49,769

128.59

82.32

89.86

22

47,149

46.66

23.90

26.52

104

174,584

59.57

40.24

44.09

39

164,221

23.75

13.51

15.24

86

120,747

71.22

46.59

51.65

36

109,926

32.75

15.68

18.81

23

49,871

46.12

29.04

32.13

47,493

6.32

3.88

4.13

5,744

104.46

71.83

75.36

4,200

2,986

5,397,185

55.33

40.24

44.46

1,241

5,454,961

22.75

15.21

17.49

1,831

2,635,767

69.47

50.95

56.01

757

2,564,082

29.52

18.64

21.11

2,715

3,251,327

83.50

56.95

62.64

1,195

3,182,015

37.55

22.48

25.51

190

295,331

64.33

42.86

47.21

75

274,147

27.36

14.45

16.77

29

55,615

52.14

33.52

36.73

51,693

5.80

3.63

3.87

1,239

2,017,140

61.42

40.67

44.71

547

2,131,579

25.66

15.14

17.45

981

1,441,543

68.05

51.70

57.48

473

1,484,897

31.85

22.53

25.56

1,904

3,364,779

56.59

44.45

48.89

764

3,404,840

22.44

16.87

19.43

1,213

1,724,239

70.35

48.65

53.59

522

1,655,235

31.54

18.57

21.09

2,331

2,980,563

78.21

52.38

57.63

933

2,756,345

33.85

19.20

21.71

56

106,961

52.36

40.69

44.79

23

94,002

24.47

15.30

17.92

7,751 11,635,225

66.62

47.52

52.34

3,272

11,526,898

28.39

18.00

20.54

1. 96 ICD-O-3 M-CODE p.497

2. * 1

- 202 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C23 - C24

10 10
10

2 3

10 10
10

2 3

60

1,262,554

4.75

2.76

3.15

57

1,356,218

4.20

2.15

2.58

32

754,586

4.24

2.69

3.18

28

775,361

3.61

2.27

2.68

10

193,573

5.17

3.71

4.14

10

190,561

5.25

3.18

3.60

206,243

3.88

2.84

3.18

209,101

3.35

2.51

2.69

14

525,788

2.66

1.86

2.19

19

556,511

3.41

2.53

2.99

19

381,903

4.98

3.23

3.91

16

390,370

4.10

2.68

3.18

134,036

2.24

1.70

1.81

138,354

4.34

2.40

2.97

76

1,935,668

3.93

2.91

3.33

62

1,961,699

3.16

2.42

2.76

41

1,009,274

4.06

2.62

3.19

24

992,786

2.42

1.86

2.24

11

264,014

4.17

3.09

3.44

249,001

2.41

1.73

1.84

20

234,682

8.52

4.73

5.57

16

225,804

7.09

3.90

4.55

291,177

3.09

1.88

2.14

12

269,791

4.45

1.79

2.28

27

793,368

3.40

2.58

2.91

23

772,752

2.98

2.06

2.40

28

670,812

4.17

2.63

3.08

29

636,474

4.56

2.27

2.74

11

271,053

4.06

2.02

2.59

12

255,438

4.70

2.27

2.70

14

374,746

3.74

2.28

2.54

18

342,907

5.25

2.67

2.94

14

283,284

4.94

2.51

3.01

12

259,964

4.62

2.22

2.55

26

562,141

4.63

2.57

3.06

32

539,380

5.93

3.15

3.63

21

636,341

3.30

2.21

2.58

22

607,195

3.62

2.34

2.66

22

449,267

4.90

3.11

3.53

16

424,242

3.77

1.77

2.19

49,769

6.03

2.08

2.89

47,149

4.24

0.97

1.58

10

174,584

5.73

3.19

3.87

164,221

2.44

1.33

1.55

120,747

4.14

2.40

2.56

109,926

4.55

2.14

2.46

49,871

2.01

1.08

1.29

47,493

5,744

4,200

235

5,397,185

4.35

2.93

3.37

194

5,454,961

3.56

2.29

2.68

94

2,635,767

3.57

2.36

2.74

101

2,564,082

3.94

2.31

2.70

140

3,251,327

4.31

2.63

3.10

134

3,182,015

4.21

2.36

2.78

15

295,331

5.08

2.87

3.33

274,147

3.28

1.67

1.94

55,615

1.80

0.96

1.15

51,693

92

2,017,140

4.56

2.73

3.14

85

2,131,579

3.99

2.17

2.59

54

1,441,543

3.75

2.64

3.06

58

1,484,897

3.91

2.64

3.08

144

3,364,779

4.28

3.08

3.60

106

3,404,840

3.11

2.28

2.69

77

1,724,239

4.47

2.80

3.24

59

1,655,235

3.56

1.91

2.25

115

2,980,563

3.86

2.33

2.71

127

2,756,345

4.61

2.54

2.91

106,961

1.87

0.74

1.34

94,002

2.13

1.17

1.50

486 11,635,225

4.18

2.70

3.14

438

11,526,898

3.80

2.28

2.67

1. 96 ICD-O-3 M-CODE p.497

2. * 1

- 203 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C25

10 10
10

2 3

10 10
10

2 3

124

1,262,554

9.82

5.62

6.30

98

1,356,218

7.23

3.79

4.39

61

754,586

8.08

5.49

6.34

49

775,361

6.32

3.86

4.73

18

193,573

9.30

6.33

6.90

12

190,561

6.30

3.35

4.20

16

206,243

7.76

5.92

6.59

12

209,101

5.74

3.42

4.22

32

525,788

6.09

4.65

5.41

35

556,511

6.29

5.04

5.61

31

381,903

8.12

6.23

6.87

24

390,370

6.15

4.77

5.12

14

134,036

10.44

7.41

8.15

10

138,354

7.23

4.41

5.06

162

1,935,668

8.37

6.09

7.09

109

1,961,699

5.56

3.95

4.70

67

1,009,274

6.64

5.31

5.95

45

992,786

4.53

3.72

4.20

11

264,014

4.17

2.20

2.88

14

249,001

5.62

2.96

3.86

24

234,682

10.23

5.97

6.98

13

225,804

5.76

2.25

2.98

30

291,177

10.30

7.21

7.68

23

269,791

8.53

3.52

4.41

57

793,368

7.18

5.76

6.33

40

772,752

5.18

3.53

4.26

40

670,812

5.96

3.88

4.47

33

636,474

5.18

3.10

3.47

31

271,053

11.44

6.68

7.62

15

255,438

5.87

3.20

3.87

32

374,746

8.54

5.05

5.72

19

342,907

5.54

2.96

3.26

17

283,284

6.00

3.31

3.76

18

259,964

6.92

3.43

3.84

57

562,141

10.14

5.89

6.86

32

539,380

5.93

3.09

3.55

35

636,341

5.50

3.76

4.33

58

607,195

9.55

5.80

6.85

45

449,267

10.02

6.02

6.92

25

424,242

5.89

3.19

3.75

49,769

8.04

4.66

5.11

47,149

2.12

1.79

1.79

19

174,584

10.88

6.35

7.45

164,221

5.48

3.22

3.63

120,747

5.80

4.04

4.28

12

109,926

10.92

6.95

7.23

49,871

4.01

3.23

3.23

47,493

5,744

17.41

8.75

10.07

4,200

452

5,397,185

8.37

5.69

6.45

326

5,454,961

5.98

3.72

4.41

192

2,635,767

7.28

5.07

5.74

142

2,564,082

5.54

3.45

3.94

264

3,251,327

8.12

5.19

5.94

217

3,182,015

6.82

3.96

4.58

26

295,331

8.80

5.39

6.14

21

274,147

7.66

4.72

5.08

55,615

5.39

3.97

4.12

51,693

185

2,017,140

9.17

5.55

6.28

147

2,131,579

6.90

3.81

4.49

111

1,441,543

7.70

5.77

6.46

93

1,484,897

6.26

4.45

5.04

273

3,364,779

8.11

6.14

7.02

180

3,404,840

5.29

3.73

4.49

124

1,724,239

7.19

4.71

5.32

100

1,655,235

6.04

3.44

3.98

236

2,980,563

7.92

4.85

5.57

183

2,756,345

6.64

3.62

4.14

106,961

3.74

3.32

3.21

94,002

2.13

1.87

1.95

937 11,635,225

8.05

5.39

6.13

706

11,526,898

6.12

3.73

4.33

1. 96 ICD-O-3 M-CODE p.497

- 204 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C48

10 10
10

2 3

10 10
10

2 3

11

1,262,554

0.87

0.84

0.84

1,356,218

0.59

0.41

0.44

754,586

0.66

0.61

0.60

775,361

0.64

0.45

0.51

193,573

1.03

0.57

0.73

190,561

1.57

1.10

1.23

206,243

0.48

0.59

0.60

209,101

525,788

0.57

0.46

0.52

556,511

0.90

0.77

0.82

381,903

390,370

0.77

0.59

0.59

134,036

138,354

0.72

0.44

0.50

14

1,935,668

0.72

0.66

0.68

1,961,699

0.36

0.25

0.27

10

1,009,274

0.99

0.80

0.86

992,786

0.71

0.60

0.68

264,014

1.14

1.34

1.26

249,001

1.61

1.20

1.32

234,682

2.13

1.11

1.34

225,804

291,177

1.03

0.91

0.98

269,791

1.11

0.68

0.75

793,368

0.63

0.63

0.64

772,752

0.65

0.82

0.78

670,812

0.45

0.39

0.42

636,474

0.47

0.35

0.37

271,053

0.37

0.32

0.30

255,438

0.78

0.50

0.52

374,746

0.53

0.28

0.34

342,907

0.87

0.50

0.58

283,284

259,964

1.54

1.29

1.31

562,141

0.53

0.39

0.44

539,380

0.74

0.70

0.70

636,341

0.79

0.86

0.82

607,195

0.49

0.30

0.34

449,267

0.45

0.30

0.31

424,242

1.18

0.73

0.80

49,769

47,149

174,584

164,221

0.61

0.49

0.54

120,747

0.83

0.52

0.60

109,926

0.91

0.51

0.59

49,871

2.01

0.79

1.19

47,493

5,744

4,200

49

5,397,185

0.91

0.77

0.81

32

5,454,961

0.59

0.42

0.46

14

2,635,767

0.53

0.44

0.47

18

2,564,082

0.70

0.60

0.61

15

3,251,327

0.46

0.42

0.42

25

3,182,015

0.79

0.58

0.62

295,331

0.34

0.20

0.23

274,147

0.73

0.50

0.56

55,615

1.80

0.74

1.11

51,693

16

2,017,140

0.79

0.76

0.75

13

2,131,579

0.61

0.42

0.47

1,441,543

0.42

0.32

0.37

12

1,484,897

0.81

0.64

0.69

27

3,364,779

0.80

0.75

0.77

22

3,404,840

0.65

0.54

0.58

12

1,724,239

0.70

0.46

0.53

10

1,655,235

0.60

0.36

0.41

18

2,980,563

0.60

0.46

0.49

18

2,756,345

0.65

0.54

0.55

106,961

0.93

0.58

0.62

94,002

2.13

1.69

1.78

80 11,635,225

0.69

0.58

0.60

77

11,526,898

0.67

0.51

0.54

1. 96 ICD-O-3 M-CODE p.497

- 205 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C26

10 10
10

2 3

10 10
10

2 3

1,262,554

0.08

0.04

0.05

1,356,218

0.44

0.27

0.28

754,586

0.13

0.04

0.08

775,361

0.39

0.26

0.30

193,573

190,561

206,243

0.48

0.34

0.39

209,101

0.48

0.34

0.38

525,788

556,511

0.18

0.08

0.15

381,903

390,370

134,036

138,354

1,935,668

0.05

0.06

0.06

1,961,699

0.31

0.25

0.26

1,009,274

0.10

0.07

0.08

992,786

0.10

0.07

0.08

264,014

249,001

234,682

0.43

0.32

0.41

225,804

0.44

0.12

0.21

291,177

269,791

793,368

0.50

0.38

0.44

772,752

0.26

0.18

0.19

670,812

0.15

0.10

0.12

636,474

0.47

0.42

0.43

271,053

0.37

0.31

0.31

255,438

0.39

0.24

0.27

374,746

342,907

283,284

0.71

0.44

0.47

259,964

562,141

539,380

0.37

0.26

0.28

636,341

0.16

0.09

0.11

607,195

0.49

0.39

0.39

449,267

0.67

0.43

0.47

424,242

0.24

0.19

0.18

49,769

47,149

174,584

0.57

0.42

0.53

164,221

0.61

0.34

0.39

120,747

109,926

49,871

47,493

5,744

4,200

5,397,185

0.09

0.07

0.07

15

5,454,961

0.27

0.19

0.21

2,635,767

0.23

0.16

0.18

2,564,082

0.27

0.19

0.21

3,251,327

0.22

0.13

0.15

3,182,015

0.28

0.21

0.22

295,331

0.34

0.25

0.32

274,147

0.36

0.21

0.24

55,615

51,693

2,017,140

0.10

0.04

0.05

2,131,579

0.42

0.27

0.29

1,441,543

0.07

0.04

0.05

1,484,897

0.13

0.07

0.10

3,364,779

0.09

0.07

0.08

3,404,840

0.18

0.11

0.13

1,724,239

0.06

0.04

0.04

1,655,235

0.18

0.13

0.13

12

2,980,563

0.40

0.26

0.29

11

2,756,345

0.40

0.30

0.31

106,961

94,002

1.06

0.75

0.82

19 11,635,225

0.16

0.11

0.12

32

11,526,898

0.28

0.19

0.21

1. 96 ICD-O-3 M-CODE p.497

- 206 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C30 - C31

10 10
10

2 3

10 10
10

2 3

1,262,554

0.63

0.38

0.46

1,356,218

0.66

0.44

0.47

11

754,586

1.46

1.07

1.14

775,361

0.26

0.16

0.18

193,573

190,561

0.52

0.22

0.34

206,243

1.45

1.33

1.35

209,101

0.48

0.49

0.46

525,788

0.57

0.53

0.52

556,511

0.90

0.61

0.71

381,903

1.05

0.83

0.82

390,370

0.51

0.32

0.35

134,036

2.24

1.80

1.78

138,354

1.45

1.31

1.30

28

1,935,668

1.45

1.14

1.30

1,961,699

0.46

0.33

0.40

11

1,009,274

1.09

0.85

1.01

992,786

0.60

0.50

0.53

264,014

1.89

1.75

1.76

249,001

0.80

0.70

0.72

234,682

1.28

0.73

0.84

225,804

1.33

0.80

0.86

291,177

0.69

0.50

0.54

269,791

793,368

1.01

0.77

0.86

772,752

0.26

0.45

0.36

670,812

0.60

0.34

0.41

636,474

271,053

0.74

0.46

0.50

255,438

0.39

0.32

0.35

374,746

0.80

0.50

0.51

342,907

0.87

0.58

0.59

283,284

0.71

0.41

0.47

259,964

562,141

0.71

0.48

0.52

539,380

0.19

0.10

0.11

636,341

0.79

0.56

0.60

607,195

0.33

0.25

0.25

449,267

1.11

0.82

0.83

424,242

0.47

0.28

0.31

49,769

47,149

174,584

1.15

0.47

0.63

164,221

120,747

0.83

0.52

0.60

109,926

49,871

4.01

2.78

3.41

47,493

5,744

4,200

60

5,397,185

1.11

0.80

0.91

31

5,454,961

0.57

0.40

0.44

20

2,635,767

0.76

0.55

0.61

11

2,564,082

0.43

0.40

0.40

34

3,251,327

1.05

0.76

0.79

11

3,182,015

0.35

0.24

0.25

295,331

1.02

0.49

0.61

274,147

55,615

3.60

2.48

3.05

51,693

19

2,017,140

0.94

0.62

0.70

11

2,131,579

0.52

0.33

0.36

13

1,441,543

0.90

0.76

0.75

11

1,484,897

0.74

0.53

0.59

34

3,364,779

1.01

0.71

0.85

11

3,404,840

0.32

0.23

0.25

17

1,724,239

0.99

0.73

0.78

1,655,235

0.36

0.24

0.27

36

2,980,563

1.21

0.85

0.92

13

2,756,345

0.47

0.41

0.40

106,961

94,002

119 11,635,225

1.02

0.73

0.80

53

11,526,898

0.46

0.34

0.36

1. 96 ICD-O-3 M-CODE p.497

- 207 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C32

10 10
10

2 3

10 10
10

2 3

70

1,262,554

5.54

3.02

3.49

1,356,218

0.52

0.29

0.32

39

754,586

5.17

3.55

3.92

775,361

0.39

0.30

0.29

13

193,573

6.72

4.65

5.03

190,561

0.52

0.31

0.34

12

206,243

5.82

4.87

5.23

209,101

13

525,788

2.47

1.68

2.14

556,511

0.36

0.20

0.27

11

381,903

2.88

2.26

2.38

390,370

134,036

5.22

3.58

3.92

138,354

1.45

1.00

1.08

89

1,935,668

4.60

3.40

3.75

1,961,699

0.15

0.10

0.12

51

1,009,274

5.05

4.12

4.60

992,786

0.20

0.16

0.17

264,014

2.65

1.72

2.00

249,001

12

234,682

5.11

3.52

3.79

225,804

291,177

2.75

1.91

2.05

269,791

1.11

0.58

0.67

43

793,368

5.42

4.63

4.95

772,752

0.39

0.32

0.36

37

670,812

5.52

4.21

4.43

636,474

0.31

0.19

0.21

17

271,053

6.27

4.00

4.38

255,438

0.39

0.24

0.27

15

374,746

4.00

2.71

2.93

342,907

17

283,284

6.00

3.02

3.55

259,964

26

562,141

4.63

3.15

3.43

539,380

0.19

0.06

0.09

42

636,341

6.60

4.48

4.97

607,195

0.33

0.22

0.24

40

449,267

8.90

5.91

6.49

424,242

0.24

0.10

0.12

49,769

10.05

6.17

6.70

47,149

10

174,584

5.73

4.03

4.37

164,221

16

120,747

13.25

9.34

9.92

109,926

49,871

4.01

2.25

2.50

47,493

5,744

4,200

262

5,397,185

4.85

3.38

3.77

16

5,454,961

0.29

0.19

0.22

125

2,635,767

4.74

3.56

3.86

2,564,082

0.31

0.20

0.23

187

3,251,327

5.75

3.84

4.24

3,182,015

0.28

0.18

0.19

26

295,331

8.80

6.15

6.59

274,147

55,615

3.60

1.99

2.22

51,693

109

2,017,140

5.40

3.22

3.66

10

2,131,579

0.47

0.29

0.31

56

1,441,543

3.88

2.87

3.20

1,484,897

0.34

0.21

0.24

170

3,364,779

5.05

4.04

4.38

3,404,840

0.26

0.20

0.23

87

1,724,239

5.05

3.55

3.88

1,655,235

0.24

0.16

0.17

169

2,980,563

5.67

3.78

4.15

2,756,345

0.18

0.10

0.12

106,961

8.41

6.73

7.84

94,002

602 11,635,225

5.17

3.62

4.00

33

11,526,898

0.29

0.18

0.21

1. 96 ICD-O-3 M-CODE p.497

- 208 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C33 - C34

10 10
10

2 3

10 10
10

2 3

771

1,262,554

61.07

33.68

38.75

584

1,356,218

43.06

23.38

26.78

392

754,586

51.95

34.59

40.17

280

775,361

36.11

23.42

26.58

119

193,573

61.48

39.70

46.04

64

190,561

33.59

19.57

22.62

94

206,243

45.58

34.16

39.75

65

209,101

31.09

22.10

24.90

231

525,788

43.93

32.80

39.19

168

556,511

30.19

22.47

25.59

221

381,903

57.87

41.67

47.85

129

390,370

33.05

22.21

24.93

71

134,036

52.97

36.49

41.65

52

138,354

37.58

22.52

26.17

1,104

1,935,668

57.03

43.29

50.93

617

1,961,699

31.45

22.60

26.12

530

1,009,274

52.51

38.75

45.67

242

992,786

24.38

18.60

21.49

134

264,014

50.75

33.93

39.32

76

249,001

30.52

18.03

21.27

231

234,682

98.43

55.89

66.13

109

225,804

48.27

27.71

30.80

156

291,177

53.58

29.83

35.38

98

269,791

36.32

21.00

23.40

400

793,368

50.42

37.06

43.78

213

772,752

27.56

20.04

22.84

420

670,812

62.61

39.33

46.38

239

636,474

37.55

22.79

25.72

153

271,053

56.45

31.58

36.93

69

255,438

27.01

16.31

17.75

250

374,746

66.71

36.64

42.90

125

342,907

36.45

18.90

21.01

241

283,284

85.07

46.10

52.59

116

259,964

44.62

22.10

24.53

374

562,141

66.53

39.84

45.60

227

539,380

42.09

24.33

26.85

331

636,341

52.02

34.88

39.93

197

607,195

32.44

20.69

23.39

236

449,267

52.53

30.63

35.96

120

424,242

28.29

15.57

17.86

31

49,769

62.29

33.09

38.42

20

47,149

42.42

22.86

25.26

100

174,584

57.28

33.71

38.94

48

164,221

29.23

15.97

18.84

81

120,747

67.08

39.53

45.72

49

109,926

44.58

24.61

27.56

24

49,871

48.12

30.25

34.46

47,493

18.95

12.06

13.17

5,744

34.82

24.93

28.31

4,200

47.62

20.32

27.65

3,139

5,397,185

58.16

38.67

45.20

1,855

5,454,961

34.01

21.95

25.14

1,454

2,635,767

55.16

36.29

42.78

814

2,564,082

31.75

20.47

23.06

1,897

3,251,327

58.35

36.92

42.52

1,141

3,182,015

35.86

21.62

24.33

181

295,331

61.29

36.01

41.62

97

274,147

35.38

19.53

22.45

26

55,615

46.75

29.61

33.78

11

51,693

21.28

12.78

14.38

1,163

2,017,140

57.66

33.96

39.19

864

2,131,579

40.53

23.38

26.71

736

1,441,543

51.06

36.80

42.88

478

1,484,897

32.19

21.94

24.97

1,858

3,364,779

55.22

40.62

47.89

1,010

3,404,840

29.66

21.39

24.57

1,050

1,724,239

60.90

37.79

44.05

579

1,655,235

34.98

21.33

23.89

1,829

2,980,563

61.36

36.97

42.89

951

2,756,345

34.50

19.83

22.35

45

106,961

42.07

32.27

37.73

27

94,002

28.72

20.16

22.43

6,697 11,635,225

57.56

37.49

43.68

3,918

11,526,898

33.99

21.38

24.27

1. 96 ICD-O-3 M-CODE p.497

- 209 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C38.4

10 10
10

2 3

10 10
10

2 3

1,262,554

0.24

0.15

0.16

1,356,218

0.29

0.21

0.22

754,586

0.93

0.72

0.79

775,361

193,573

190,561

206,243

209,101

0.48

0.49

0.46

525,788

0.19

0.13

0.14

556,511

381,903

390,370

134,036

1.49

0.81

1.00

138,354

1,935,668

0.21

0.17

0.17

1,961,699

0.10

0.09

0.08

1,009,274

0.50

0.46

0.49

992,786

0.10

0.09

0.10

264,014

0.76

0.53

0.61

249,001

234,682

0.85

0.50

0.55

225,804

291,177

269,791

0.37

0.34

0.31

793,368

0.25

0.16

0.21

772,752

0.26

0.14

0.20

670,812

0.60

0.31

0.41

636,474

0.16

0.09

0.10

271,053

255,438

374,746

342,907

0.29

0.08

0.10

283,284

0.35

0.12

0.17

259,964

0.38

0.28

0.30

562,141

0.53

0.38

0.39

539,380

0.19

0.04

0.08

636,341

0.31

0.24

0.24

607,195

0.16

0.08

0.11

449,267

0.22

0.13

0.15

424,242

0.47

0.31

0.32

49,769

2.01

0.64

0.96

47,149

174,584

1.15

0.93

0.97

164,221

120,747

0.83

0.57

0.57

109,926

49,871

47,493

5,744

4,200

16

5,397,185

0.30

0.24

0.25

5,454,961

0.16

0.14

0.14

2,635,767

0.27

0.15

0.19

2,564,082

0.16

0.08

0.10

17

3,251,327

0.52

0.35

0.39

3,182,015

0.16

0.09

0.10

295,331

1.02

0.78

0.81

274,147

55,615

51,693

10

2,017,140

0.50

0.35

0.38

2,131,579

0.19

0.14

0.14

1,441,543

0.21

0.12

0.14

1,484,897

0.07

0.06

0.06

11

3,364,779

0.33

0.29

0.31

3,404,840

0.18

0.14

0.15

1,724,239

0.46

0.29

0.34

1,655,235

0.12

0.03

0.06

2,980,563

0.30

0.19

0.21

2,756,345

0.18

0.11

0.12

106,961

1.87

1.25

1.34

94,002

43 11,635,225

0.37

0.26

0.29

19

11,526,898

0.16

0.11

0.12

1. 96 ICD-O-3 M-CODE p.497

2. * 1

- 210 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C37 - C38.3C38.8

10 10
10

2 3

10 10
10

2 3

15

1,262,554

1.19

0.96

0.98

1,356,218

0.66

0.46

0.49

12

754,586

1.59

0.99

1.20

11

775,361

1.42

0.98

1.06

193,573

0.52

0.29

0.33

190,561

0.52

0.28

0.32

206,243

1.94

1.41

1.53

209,101

0.96

0.75

0.75

525,788

1.71

1.26

1.45

556,511

0.72

1.00

0.86

381,903

1.05

1.01

1.00

10

390,370

2.56

1.99

2.12

134,036

2.24

1.57

1.85

138,354

0.72

0.45

0.49

26

1,935,668

1.34

1.12

1.22

18

1,961,699

0.92

0.63

0.68

16

1,009,274

1.59

1.17

1.34

992,786

0.50

0.37

0.44

264,014

1.14

0.83

0.93

249,001

0.80

0.55

0.67

234,682

1.70

1.10

1.24

225,804

0.44

0.30

0.32

291,177

1.03

0.87

0.85

269,791

1.11

0.86

0.96

793,368

1.13

0.97

1.04

772,752

0.65

0.51

0.54

670,812

1.04

0.81

0.88

636,474

0.31

0.24

0.26

271,053

1.84

1.78

1.80

255,438

1.17

0.83

0.82

374,746

1.33

1.09

1.13

342,907

0.29

0.25

0.25

283,284

2.12

1.20

1.37

259,964

2.31

1.46

1.57

562,141

1.60

0.95

1.14

11

539,380

2.04

1.39

1.48

13

636,341

2.04

1.35

1.55

607,195

0.82

0.54

0.60

449,267

0.89

1.16

1.01

424,242

1.41

0.82

0.96

49,769

2.01

1.82

1.69

47,149

174,584

3.44

2.28

2.49

164,221

120,747

0.83

0.58

0.63

109,926

1.82

1.03

1.18

49,871

4.01

2.15

3.04

47,493

5,744

4,200

72

5,397,185

1.33

1.05

1.14

41

5,454,961

0.75

0.52

0.57

35

2,635,767

1.33

1.07

1.15

15

2,564,082

0.59

0.54

0.52

52

3,251,327

1.60

1.12

1.24

50

3,182,015

1.57

1.08

1.18

295,331

2.37

1.59

1.73

274,147

0.73

0.41

0.47

55,615

3.60

1.98

2.78

51,693

27

2,017,140

1.34

0.96

1.04

20

2,131,579

0.94

0.64

0.69

21

1,441,543

1.46

1.12

1.24

18

1,484,897

1.21

1.08

1.07

47

3,364,779

1.40

1.18

1.27

27

3,404,840

0.79

0.57

0.62

35

1,724,239

2.03

1.43

1.61

14

1,655,235

0.85

0.65

0.69

35

2,980,563

1.17

0.83

0.91

28

2,756,345

1.02

0.63

0.71

106,961

2.80

2.88

2.87

94,002

168 11,635,225

1.44

1.09

1.20

108

11,526,898

0.94

0.68

0.73

1. 96 ICD-O-3 M-CODE p.497

- 211 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

162

1,262,554

12.83

8.59

9.34

84

1,356,218

6.19

4.36

4.66

66

754,586

8.75

7.19

7.63

30

775,361

3.87

3.10

3.28

17

193,573

8.78

8.05

8.24

16

190,561

8.40

6.78

6.95

17

206,243

8.24

6.15

6.65

12

209,101

5.74

4.64

5.13

43

525,788

8.18

7.40

7.94

45

556,511

8.09

8.32

8.23

25

381,903

6.55

4.84

5.46

23

390,370

5.89

5.84

5.82

14

134,036

10.44

6.16

7.46

10

138,354

7.23

4.99

5.46

164

1,935,668

8.47

7.26

7.83

128

1,961,699

6.52

6.04

6.16

96

1,009,274

9.51

8.42

9.04

80

992,786

8.06

7.05

7.53

25

264,014

9.47

7.39

8.04

18

249,001

7.23

5.83

6.10

41

234,682

17.47

12.09

13.53

22

225,804

9.74

9.67

9.37

16

291,177

5.49

3.92

4.29

269,791

3.34

2.83

2.81

72

793,368

9.08

7.63

8.37

47

772,752

6.08

5.17

5.55

44

670,812

6.56

5.32

5.62

35

636,474

5.50

3.50

3.99

26

271,053

9.59

7.31

7.70

16

255,438

6.26

3.71

4.15

27

374,746

7.20

4.71

5.25

17

342,907

4.96

2.63

2.92

32

283,284

11.30

6.63

7.67

19

259,964

7.31

5.75

5.83

71

562,141

12.63

10.36

10.70

36

539,380

6.67

5.58

5.51

52

636,341

8.17

6.94

7.30

40

607,195

6.59

6.30

6.22

46

449,267

10.24

7.61

8.43

30

424,242

7.07

6.52

6.34

49,769

2.01

1.20

1.32

47,149

2.12

1.80

1.80

23

174,584

13.17

8.79

9.90

10

164,221

6.09

4.87

5.04

120,747

5.80

3.81

4.39

109,926

4.55

2.46

3.01

49,871

47,493

6.32

4.50

4.79

5,744

4,200

538

5,397,185

9.97

7.83

8.49

369

5,454,961

6.76

5.68

5.92

212

2,635,767

8.04

6.49

6.98

160

2,564,082

6.24

4.87

5.17

307

3,251,327

9.44

7.30

7.87

189

3,182,015

5.94

5.19

5.21

30

295,331

10.16

6.76

7.66

15

274,147

5.47

3.88

4.20

55,615

51,693

5.80

4.17

4.44

228

2,017,140

11.30

8.11

8.77

114

2,131,579

5.35

3.91

4.17

116

1,441,543

8.05

6.50

7.06

106

1,484,897

7.14

6.54

6.67

297

3,364,779

8.83

7.34

8.07

229

3,404,840

6.73

5.79

6.18

148

1,724,239

8.58

6.82

7.29

101

1,655,235

6.10

4.61

4.87

293

2,980,563

9.83

7.54

8.09

181

2,756,345

6.57

5.82

5.79

106,961

2.80

2.87

2.76

94,002

4.26

2.67

3.25

1,087 11,635,225

9.34

7.30

7.91

736

11,526,898

6.39

5.29

5.48

1. 96 ICD-O-3 M-CODE p.497

- 212 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

66

1,262,554

5.23

3.28

3.62

40

1,356,218

2.95

1.83

2.08

21

754,586

2.78

1.91

2.17

11

775,361

1.42

0.86

1.09

193,573

2.58

2.45

2.46

190,561

2.10

1.22

1.43

206,243

1.94

1.33

1.60

209,101

1.43

1.24

1.40

17

525,788

3.23

2.55

2.91

24

556,511

4.31

4.33

4.32

381,903

1.83

1.46

1.58

390,370

2.05

1.70

1.76

134,036

2.24

1.39

1.70

138,354

2.17

1.75

1.78

61

1,935,668

3.15

2.68

2.87

48

1,961,699

2.45

2.09

2.20

34

1,009,274

3.37

2.92

3.13

28

992,786

2.82

2.01

2.39

10

264,014

3.79

2.79

3.14

11

249,001

4.42

2.93

3.29

17

234,682

7.24

5.23

5.75

225,804

2.66

1.90

2.02

291,177

3.09

2.10

2.33

269,791

1.48

0.84

0.95

28

793,368

3.53

2.80

3.20

23

772,752

2.98

2.19

2.52

19

670,812

2.83

1.80

2.14

13

636,474

2.04

1.16

1.38

12

271,053

4.43

3.75

3.69

10

255,438

3.91

2.28

2.56

13

374,746

3.47

2.29

2.52

342,907

2.33

1.30

1.46

15

283,284

5.30

3.30

3.83

259,964

1.92

0.91

1.13

25

562,141

4.45

3.13

3.39

18

539,380

3.34

3.07

2.90

23

636,341

3.61

2.84

3.07

17

607,195

2.80

2.06

2.26

22

449,267

4.90

2.89

3.53

13

424,242

3.06

2.34

2.51

49,769

2.01

1.20

1.32

47,149

2.12

1.80

1.80

174,584

4.58

3.66

3.87

164,221

3.65

2.11

2.42

120,747

4.14

2.43

2.88

109,926

3.64

2.23

2.59

49,871

47,493

2.11

1.44

1.59

5,744

4,200

206

5,397,185

3.82

2.91

3.17

144

5,454,961

2.64

1.91

2.12

89

2,635,767

3.38

2.51

2.81

78

2,564,082

3.04

2.23

2.42

117

3,251,327

3.60

2.49

2.81

76

3,182,015

2.39

1.80

1.91

13

295,331

4.40

3.17

3.48

10

274,147

3.65

2.14

2.47

55,615

51,693

1.93

1.34

1.48

87

2,017,140

4.31

2.82

3.14

51

2,131,579

2.39

1.47

1.71

36

1,441,543

2.50

1.94

2.17

42

1,484,897

2.83

2.54

2.60

116

3,364,779

3.45

2.79

3.07

88

3,404,840

2.58

1.94

2.19

65

1,724,239

3.77

2.96

3.17

41

1,655,235

2.48

1.65

1.84

118

2,980,563

3.96

2.76

3.09

84

2,756,345

3.05

2.23

2.36

106,961

0.93

0.62

0.71

94,002

2.13

1.87

1.95

425 11,635,225

3.65

2.70

2.99

309

11,526,898

2.68

1.94

2.13

1. 96 ICD-O-3 M-CODE p.497

- 213 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

16

1,262,554

1.27

1.50

1.39

1,356,218

0.59

1.05

0.87

754,586

0.93

1.66

1.38

775,361

0.39

0.81

0.65

193,573

1.03

1.83

1.65

190,561

3.15

3.67

3.33

206,243

0.48

0.62

0.58

209,101

0.48

0.28

0.36

525,788

0.76

1.43

1.14

556,511

0.72

1.43

1.17

381,903

0.26

0.17

0.18

390,370

0.51

1.36

1.07

134,036

0.75

0.56

0.62

138,354

0.72

0.54

0.54

23

1,935,668

1.19

1.38

1.31

21

1,961,699

1.07

1.72

1.47

16

1,009,274

1.59

2.04

1.89

11

992,786

1.11

1.53

1.33

264,014

1.14

1.02

1.04

249,001

1.61

2.05

1.84

234,682

0.43

0.47

0.48

225,804

2.21

4.81

3.82

291,177

1.03

1.04

1.03

269,791

0.37

1.06

0.78

14

793,368

1.76

1.94

1.86

772,752

1.04

1.28

1.14

670,812

1.04

1.58

1.35

636,474

0.63

0.69

0.67

271,053

0.74

0.74

0.79

255,438

0.39

0.38

0.38

374,746

0.80

0.64

0.70

342,907

0.29

0.13

0.14

283,284

1.06

1.10

1.07

259,964

1.15

2.10

1.77

10

562,141

1.78

3.04

2.66

539,380

0.56

1.09

0.94

636,341

1.10

1.94

1.67

10

607,195

1.65

2.97

2.46

449,267

1.11

1.62

1.44

424,242

0.71

2.44

1.79

49,769

47,149

174,584

1.15

0.71

0.93

164,221

1.22

2.06

1.85

120,747

109,926

0.91

0.23

0.42

49,871

47,493

2.11

1.61

1.61

5,744

4,200

65

5,397,185

1.20

1.44

1.35

57

5,454,961

1.04

1.62

1.38

30

2,635,767

1.14

1.45

1.32

18

2,564,082

0.70

0.91

0.81

34

3,251,327

1.05

1.63

1.43

25

3,182,015

0.79

1.63

1.32

295,331

0.68

0.42

0.54

274,147

1.09

1.33

1.29

55,615

51,693

1.93

1.48

1.48

23

2,017,140

1.14

1.55

1.39

11

2,131,579

0.52

0.97

0.80

1,441,543

0.62

0.92

0.80

14

1,484,897

0.94

1.39

1.21

41

3,364,779

1.22

1.45

1.37

32

3,404,840

0.94

1.43

1.23

18

1,724,239

1.04

1.23

1.18

15

1,655,235

0.91

1.27

1.11

40

2,980,563

1.34

1.86

1.67

31

2,756,345

1.12

2.01

1.66

106,961

94,002

1.06

0.35

0.63

131 11,635,225

1.13

1.45

1.33

104

11,526,898

0.90

1.45

1.23

1. 96 ICD-O-3 M-CODE p.497

- 214 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

26

1,262,554

2.06

1.46

1.62

1,356,218

0.37

0.22

0.23

14

754,586

1.86

1.36

1.56

775,361

0.90

0.59

0.62

193,573

0.52

0.35

0.35

190,561

1.57

1.09

1.14

206,243

0.48

0.21

0.25

209,101

0.48

0.48

0.48

525,788

1.33

1.14

1.28

556,511

0.72

0.78

0.79

381,903

1.57

1.13

1.23

390,370

1.02

0.73

0.87

134,036

2.98

1.76

2.08

138,354

1.45

1.18

1.24

25

1,935,668

1.29

1.02

1.11

19

1,961,699

0.97

0.69

0.78

1,009,274

0.89

0.68

0.74

992,786

0.71

0.63

0.67

264,014

0.76

0.37

0.50

249,001

234,682

2.13

2.41

2.28

225,804

1.33

1.12

1.26

291,177

0.34

0.23

0.25

269,791

793,368

0.50

0.35

0.42

772,752

0.13

0.10

0.12

670,812

1.04

0.81

0.89

636,474

0.47

0.33

0.40

271,053

1.48

1.05

1.23

255,438

0.39

0.09

0.16

374,746

1.07

0.73

0.76

342,907

0.87

0.28

0.35

283,284

1.41

0.70

0.81

259,964

1.15

0.79

0.90

562,141

1.42

0.94

1.04

539,380

0.56

0.20

0.28

636,341

1.10

0.85

0.92

607,195

0.66

0.41

0.49

449,267

1.78

1.52

1.64

424,242

0.94

0.67

0.69

49,769

47,149

174,584

0.57

0.13

0.24

164,221

120,747

109,926

49,871

47,493

5,744

4,200

70

5,397,185

1.30

1.00

1.08

38

5,454,961

0.70

0.53

0.58

26

2,635,767

0.99

0.74

0.83

12

2,564,082

0.47

0.34

0.39

51

3,251,327

1.57

1.13

1.26

27

3,182,015

0.85

0.56

0.63

295,331

0.34

0.08

0.14

274,147

55,615

51,693

40

2,017,140

1.98

1.42

1.60

12

2,131,579

0.56

0.35

0.37

19

1,441,543

1.32

0.94

1.06

14

1,484,897

0.94

0.81

0.86

36

3,364,779

1.07

0.81

0.90

24

3,404,840

0.70

0.54

0.60

22

1,724,239

1.28

0.99

1.08

10

1,655,235

0.60

0.43

0.49

29

2,980,563

0.97

0.70

0.77

17

2,756,345

0.62

0.39

0.47

106,961

1.87

2.25

2.05

94,002

148 11,635,225

1.27

0.95

1.05

77

11,526,898

0.67

0.49

0.54

1. 96 ICD-O-3 M-CODE p.497

- 215 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

19

1,262,554

1.50

0.84

0.95

1,356,218

0.66

0.37

0.42

754,586

0.93

0.66

0.70

775,361

0.39

0.29

0.30

193,573

1.55

1.27

1.35

190,561

1.05

0.33

0.59

206,243

0.97

0.90

0.89

209,101

525,788

0.19

0.14

0.14

556,511

0.72

0.57

0.60

381,903

0.26

0.23

0.25

390,370

0.26

0.16

0.17

134,036

0.75

0.47

0.54

138,354

14

1,935,668

0.72

0.57

0.69

1,961,699

0.36

0.28

0.31

1,009,274

0.40

0.34

0.40

992,786

0.50

0.46

0.47

264,014

1.14

0.82

0.96

249,001

234,682

0.43

0.29

0.31

225,804

291,177

0.34

0.29

0.29

269,791

0.37

0.12

0.18

793,368

0.50

0.35

0.41

772,752

0.39

0.24

0.29

670,812

0.30

0.20

0.22

636,474

0.31

0.19

0.22

271,053

1.48

0.85

0.99

255,438

0.39

0.30

0.30

374,746

342,907

0.29

0.24

0.22

283,284

0.71

0.20

0.33

259,964

562,141

1.25

0.97

1.01

539,380

0.56

0.44

0.43

636,341

0.94

0.48

0.62

607,195

0.66

0.42

0.46

449,267

0.45

0.32

0.34

424,242

49,769

47,149

174,584

2.86

2.35

2.42

164,221

120,747

109,926

49,871

47,493

5,744

4,200

47

5,397,185

0.87

0.61

0.70

24

5,454,961

0.44

0.29

0.33

11

2,635,767

0.42

0.28

0.32

11

2,564,082

0.43

0.31

0.33

26

3,251,327

0.80

0.53

0.59

11

3,182,015

0.35

0.24

0.24

295,331

1.69

1.37

1.42

274,147

55,615

51,693

26

2,017,140

1.29

0.77

0.86

12

2,131,579

0.56

0.34

0.37

1,441,543

0.55

0.46

0.48

1,484,897

0.47

0.29

0.35

23

3,364,779

0.68

0.54

0.62

11

3,404,840

0.32

0.27

0.29

12

1,724,239

0.70

0.40

0.48

1,655,235

0.24

0.14

0.16

20

2,980,563

0.67

0.45

0.50

12

2,756,345

0.44

0.30

0.31

106,961

94,002

89 11,635,225

0.76

0.53

0.60

46

11,526,898

0.40

0.27

0.29

1. 96 ICD-O-3 M-CODE p.497

- 216 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

16

1,262,554

1.27

0.76

0.88

14

1,356,218

1.03

0.61

0.70

754,586

0.53

0.39

0.43

775,361

0.39

0.27

0.31

193,573

1.55

1.20

1.28

190,561

0.52

0.47

0.47

206,243

1.94

1.23

1.45

209,101

0.48

0.49

0.46

525,788

1.71

1.37

1.53

556,511

0.54

0.45

0.49

381,903

0.52

0.60

0.58

390,370

0.51

0.98

0.81

134,036

2.98

1.74

2.09

138,354

1.45

0.53

0.86

24

1,935,668

1.24

0.92

1.08

17

1,961,699

0.87

0.66

0.72

18

1,009,274

1.78

1.36

1.58

19

992,786

1.91

1.48

1.67

264,014

0.76

0.66

0.68

249,001

0.80

0.55

0.63

234,682

2.13

1.30

1.55

225,804

1.77

0.88

1.10

291,177

0.69

0.26

0.39

269,791

1.11

0.82

0.90

14

793,368

1.76

1.37

1.55

772,752

0.91

0.84

0.89

670,812

0.45

0.26

0.32

636,474

0.47

0.28

0.32

271,053

0.74

0.45

0.49

255,438

374,746

0.80

0.39

0.55

342,907

283,284

2.12

1.14

1.31

259,964

2.31

1.61

1.60

562,141

0.89

0.50

0.60

539,380

0.37

0.31

0.31

636,341

0.47

0.27

0.33

607,195

0.33

0.16

0.22

449,267

0.89

0.48

0.58

424,242

0.94

0.48

0.58

49,769

47,149

174,584

0.57

0.13

0.24

164,221

120,747

0.83

0.64

0.77

109,926

49,871

47,493

5,744

4,200

74

5,397,185

1.37

0.93

1.09

61

5,454,961

1.12

0.76

0.86

31

2,635,767

1.18

0.81

0.93

13

2,564,082

0.51

0.39

0.42

28

3,251,327

0.86

0.55

0.64

21

3,182,015

0.66

0.50

0.52

295,331

0.68

0.35

0.47

274,147

55,615

51,693

20

2,017,140

0.99

0.63

0.72

17

2,131,579

0.80

0.49

0.56

22

1,441,543

1.53

1.14

1.27

1,484,897

0.61

0.59

0.59

44

3,364,779

1.31

0.94

1.13

40

3,404,840

1.17

0.89

0.99

10

1,724,239

0.58

0.41

0.46

12

1,655,235

0.72

0.48

0.53

39

2,980,563

1.31

0.79

0.93

16

2,756,345

0.58

0.41

0.44

106,961

94,002

1.06

0.44

0.67

135 11,635,225

1.16

0.77

0.90

95

11,526,898

0.82

0.58

0.63

1. 96 ICD-O-3 M-CODE p.497

- 217 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

15

1,262,554

1.19

0.58

0.70

1,356,218

0.37

0.15

0.22

754,586

1.06

0.72

0.86

775,361

0.13

0.08

0.09

193,573

1.03

0.55

0.72

190,561

206,243

1.45

0.62

0.74

209,101

2.39

1.66

1.96

525,788

0.95

0.77

0.94

556,511

0.54

0.39

0.44

381,903

1.83

1.09

1.44

390,370

1.28

0.73

0.91

134,036

0.75

0.24

0.43

138,354

1.45

0.99

1.03

13

1,935,668

0.67

0.51

0.59

12

1,961,699

0.61

0.43

0.52

11

1,009,274

1.09

0.77

0.93

992,786

0.91

0.88

0.93

264,014

1.52

1.36

1.35

249,001

12

234,682

5.11

2.39

3.16

225,804

1.77

0.96

1.16

291,177

269,791

793,368

0.88

0.68

0.79

772,752

0.65

0.52

0.59

670,812

0.45

0.34

0.35

636,474

0.47

0.20

0.27

271,053

0.37

0.32

0.30

255,438

1.17

0.65

0.75

374,746

0.80

0.46

0.53

342,907

0.87

0.26

0.35

283,284

0.35

0.09

0.16

259,964

0.38

0.28

0.30

14

562,141

2.49

1.51

1.69

539,380

0.93

0.37

0.49

636,341

0.79

0.48

0.58

607,195

0.49

0.27

0.34

449,267

0.67

0.41

0.50

424,242

0.94

0.46

0.54

49,769

47,149

174,584

2.86

1.55

1.83

164,221

1.22

0.69

0.76

120,747

0.83

0.74

0.74

109,926

49,871

47,493

2.11

1.44

1.59

5,744

4,200

60

5,397,185

1.11

0.70

0.84

35

5,454,961

0.64

0.43

0.51

19

2,635,767

0.72

0.52

0.59

17

2,564,082

0.66

0.40

0.47

39

3,251,327

1.20

0.71

0.85

21

3,182,015

0.66

0.34

0.41

295,331

2.03

1.23

1.39

274,147

0.73

0.40

0.44

55,615

51,693

1.93

1.34

1.48

23

2,017,140

1.14

0.64

0.76

2,131,579

0.28

0.13

0.17

18

1,441,543

1.25

0.77

0.97

15

1,484,897

1.01

0.66

0.78

29

3,364,779

0.86

0.64

0.76

28

3,404,840

0.82

0.60

0.73

16

1,724,239

0.93

0.61

0.68

14

1,655,235

0.85

0.49

0.55

38

2,980,563

1.27

0.77

0.90

13

2,756,345

0.47

0.27

0.31

106,961

94,002

124 11,635,225

1.07

0.68

0.80

76

11,526,898

0.66

0.40

0.47

1. 96 ICD-O-3 M-CODE p.497

- 218 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C40 - C41

10 10
10

2 3

10 10
10

2 3

10

1,262,554

0.79

0.68

0.72

1,356,218

0.52

0.48

0.49

754,586

0.40

0.38

0.39

775,361

0.90

1.06

1.04

193,573

1.55

1.56

1.53

190,561

1.05

1.39

1.37

206,243

0.97

0.86

0.89

209,101

0.48

0.63

0.61

525,788

0.95

0.88

0.92

556,511

0.72

0.69

0.70

381,903

0.26

0.29

0.30

390,370

0.51

0.54

0.53

134,036

1.49

1.17

1.32

138,354

0.72

1.38

1.20

15

1,935,668

0.77

0.83

0.81

1,961,699

0.31

0.24

0.27

1,009,274

0.89

0.86

0.87

992,786

0.50

0.51

0.51

264,014

249,001

0.40

0.44

0.41

234,682

2.13

1.80

1.94

225,804

0.89

0.92

0.97

291,177

0.34

0.43

0.41

269,791

0.74

1.00

0.95

793,368

0.76

1.15

0.98

772,752

1.04

0.94

1.02

670,812

1.04

1.01

1.02

636,474

0.79

0.77

0.80

271,053

0.74

0.75

0.75

255,438

1.17

1.56

1.48

374,746

0.80

0.76

0.81

342,907

0.58

0.67

0.70

283,284

259,964

1.54

0.87

0.99

562,141

0.36

0.36

0.38

539,380

0.56

0.46

0.54

636,341

0.63

0.64

0.64

607,195

0.66

0.70

0.70

449,267

1.56

1.37

1.39

424,242

49,769

4.02

3.93

4.11

47,149

174,584

164,221

1.83

1.23

1.29

120,747

109,926

0.91

0.72

0.67

49,871

47,493

2.11

1.28

1.38

5,744

4,200

45

5,397,185

0.83

0.81

0.82

26

5,454,961

0.48

0.47

0.48

23

2,635,767

0.87

0.96

0.92

22

2,564,082

0.86

0.86

0.89

21

3,251,327

0.65

0.62

0.64

21

3,182,015

0.66

0.67

0.68

295,331

274,147

1.46

1.02

1.04

55,615

51,693

1.93

1.18

1.27

13

2,017,140

0.64

0.57

0.60

14

2,131,579

0.66

0.71

0.71

13

1,441,543

0.90

0.85

0.88

10

1,484,897

0.67

0.79

0.77

28

3,364,779

0.83

0.91

0.90

21

3,404,840

0.62

0.58

0.62

16

1,724,239

0.93

0.87

0.88

1,655,235

0.48

0.46

0.48

17

2,980,563

0.57

0.62

0.61

21

2,756,345

0.76

0.71

0.73

106,961

0.93

1.45

1.39

94,002

89 11,635,225

0.76

0.77

0.77

74

11,526,898

0.64

0.63

0.65

1. 96 ICD-O-3 M-CODE p.497

- 219 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C47C49

10 10
10

2 3

10 10
10

2 3

37

1,262,554

2.93

1.79

2.04

31

1,356,218

2.29

1.45

1.64

17

754,586

2.25

1.80

1.93

17

775,361

2.19

1.89

1.95

193,573

2.07

1.23

1.49

10

190,561

5.25

3.84

4.12

206,243

1.94

1.36

1.56

209,101

1.43

1.21

1.27

16

525,788

3.04

2.35

2.61

17

556,511

3.05

2.28

2.54

381,903

1.57

1.01

1.13

390,370

1.54

1.05

1.15

134,036

3.73

2.80

3.15

138,354

2.17

1.38

1.75

52

1,935,668

2.69

2.22

2.38

42

1,961,699

2.14

1.63

1.78

27

1,009,274

2.68

2.10

2.34

11

992,786

1.11

0.97

1.07

264,014

1.14

0.82

0.90

249,001

1.20

1.12

1.13

234,682

2.13

1.44

1.55

225,804

1.33

1.24

1.33

291,177

2.75

2.01

2.15

269,791

3.34

1.94

2.17

16

793,368

2.02

1.66

1.81

15

772,752

1.94

1.82

1.86

670,812

1.34

0.95

1.06

10

636,474

1.57

1.38

1.44

271,053

2.21

1.36

1.61

255,438

3.13

1.74

1.98

374,746

2.40

1.73

1.88

342,907

1.46

0.90

0.94

283,284

2.82

2.44

2.49

259,964

2.31

1.40

1.45

15

562,141

2.67

1.80

1.96

10

539,380

1.85

1.32

1.42

14

636,341

2.20

1.37

1.66

10

607,195

1.65

1.43

1.50

449,267

1.78

1.24

1.34

11

424,242

2.59

1.72

1.80

49,769

47,149

4.24

1.84

2.56

174,584

1.15

0.79

0.87

164,221

120,747

4.14

3.23

3.26

109,926

49,871

47,493

5,744

4,200

140

5,397,185

2.59

1.93

2.12

112

5,454,961

2.05

1.51

1.66

56

2,635,767

2.12

1.60

1.77

55

2,564,082

2.15

1.68

1.79

73

3,251,327

2.25

1.62

1.78

65

3,182,015

2.04

1.55

1.65

295,331

2.37

1.76

1.81

274,147

55,615

51,693

54

2,017,140

2.68

1.80

2.00

48

2,131,579

2.25

1.63

1.77

35

1,441,543

2.43

1.77

1.99

39

1,484,897

2.63

1.92

2.11

81

3,364,779

2.41

1.96

2.11

59

3,404,840

1.73

1.40

1.52

37

1,724,239

2.15

1.44

1.65

27

1,655,235

1.63

1.17

1.27

65

2,980,563

2.18

1.65

1.77

58

2,756,345

2.10

1.61

1.69

106,961

2.80

1.80

2.31

94,002

1.06

0.81

0.81

276 11,635,225

2.37

1.75

1.93

232

11,526,898

2.01

1.51

1.63

1. 96 ICD-O-3 M-CODE p.497

- 220 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C44

10 10
10

2 3

10 10
10

2 3

186

1,262,554

14.73

8.62

9.72

127

1,356,218

9.36

5.12

5.89

108

754,586

14.31

9.07

10.89

108

775,361

13.93

8.80

10.44

23

193,573

11.88

7.22

8.39

10

190,561

5.25

2.74

3.43

21

206,243

10.18

7.09

8.43

19

209,101

9.09

6.34

7.19

67

525,788

12.74

9.14

11.11

58

556,511

10.42

7.91

9.18

42

381,903

11.00

7.73

8.92

50

390,370

12.81

7.49

9.26

26

134,036

19.40

11.58

14.11

13

138,354

9.40

5.66

6.55

177

1,935,668

9.14

6.88

8.16

197

1,961,699

10.04

7.17

8.57

106

1,009,274

10.50

7.96

9.18

73

992,786

7.35

5.67

6.72

17

264,014

6.44

4.19

4.90

22

249,001

8.84

4.73

5.77

36

234,682

15.34

9.26

10.61

38

225,804

16.83

8.38

10.01

36

291,177

12.36

7.44

8.69

15

269,791

5.56

2.84

3.35

67

793,368

8.45

5.99

7.27

79

772,752

10.22

7.31

8.50

87

670,812

12.97

8.42

9.88

90

636,474

14.14

6.67

8.05

38

271,053

14.02

7.04

8.72

34

255,438

13.31

6.65

7.80

70

374,746

18.68

9.66

12.02

73

342,907

21.29

10.31

11.52

67

283,284

23.65

10.45

13.27

66

259,964

25.39

10.57

12.34

137

562,141

24.37

13.95

16.59

117

539,380

21.69

9.98

11.94

105

636,341

16.50

10.69

12.62

93

607,195

15.32

8.97

10.87

97

449,267

21.59

12.53

14.80

88

424,242

20.74

10.57

12.55

11

49,769

22.10

9.00

11.76

47,149

19.09

6.84

8.69

35

174,584

20.05

10.37

12.75

18

164,221

10.96

5.40

6.67

16

120,747

13.25

9.39

9.99

109,926

4.55

1.76

2.43

49,871

47,493

2.11

1.61

1.61

5,744

4,200

602

5,397,185

11.15

7.50

8.68

501

5,454,961

9.18

5.78

6.80

329

2,635,767

12.48

7.89

9.56

334

2,564,082

13.03

7.69

8.97

593

3,251,327

18.24

10.98

13.15

544

3,182,015

17.10

9.14

10.94

51

295,331

17.27

9.97

11.63

23

274,147

8.39

3.92

4.94

55,615

51,693

1.93

1.48

1.48

294

2,017,140

14.58

8.70

10.01

235

2,131,579

11.02

6.22

7.23

179

1,441,543

12.42

8.46

10.06

150

1,484,897

10.10

6.56

7.77

365

3,364,779

10.85

7.94

9.46

339

3,404,840

9.96

7.15

8.49

255

1,724,239

14.79

9.23

10.83

232

1,655,235

14.02

7.45

8.83

466

2,980,563

15.63

8.87

10.67

435

2,756,345

15.78

7.77

9.24

11

106,961

10.28

7.49

9.56

94,002

8.51

5.31

6.28

1,575 11,635,225

13.54

8.62

10.20

1,403

11,526,898

12.17

7.13

8.44

1. 96 ICD-O-3 M-CODE p.497

- 221 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C44 M-87203 - M-87903

10 10
10

2 3

10 10
10

2 3

15

1,262,554

1.19

0.71

0.81

1,356,218

0.59

0.31

0.35

754,586

0.93

0.68

0.76

775,361

0.52

0.34

0.41

193,573

0.52

0.26

0.39

190,561

206,243

0.97

0.50

0.69

209,101

0.48

0.37

0.40

525,788

0.38

0.26

0.34

556,511

0.72

0.63

0.63

381,903

0.52

0.40

0.40

390,370

1.79

1.10

1.31

134,036

138,354

0.72

0.23

0.42

14

1,935,668

0.72

0.58

0.66

1,961,699

0.41

0.33

0.38

1,009,274

0.89

0.73

0.80

992,786

0.91

0.64

0.77

264,014

0.38

0.43

0.40

249,001

234,682

0.85

0.29

0.46

225,804

0.44

0.30

0.32

291,177

1.37

0.94

1.10

269,791

0.37

0.30

0.30

793,368

1.01

0.89

0.95

772,752

1.04

0.84

0.90

670,812

0.89

0.59

0.68

636,474

1.10

0.45

0.56

271,053

1.84

1.06

1.22

255,438

1.17

0.63

0.74

374,746

1.33

1.03

1.08

342,907

2.33

1.04

1.23

283,284

1.06

0.62

0.69

259,964

0.38

0.24

0.28

11

562,141

1.96

1.22

1.43

539,380

1.30

0.71

0.81

12

636,341

1.89

1.21

1.44

607,195

0.33

0.18

0.23

10

449,267

2.23

1.50

1.60

424,242

1.41

0.78

0.90

49,769

2.01

0.64

0.96

47,149

174,584

1.72

0.89

1.08

164,221

0.61

0.35

0.38

120,747

1.66

1.26

1.34

109,926

49,871

47,493

5,744

4,200

48

5,397,185

0.89

0.61

0.70

28

5,454,961

0.51

0.34

0.38

26

2,635,767

0.99

0.74

0.82

30

2,564,082

1.17

0.74

0.84

46

3,251,327

1.41

0.93

1.06

28

3,182,015

0.88

0.50

0.59

295,331

1.69

1.04

1.19

274,147

0.36

0.20

0.22

55,615

51,693

22

2,017,140

1.09

0.69

0.79

12

2,131,579

0.56

0.32

0.37

1,441,543

0.49

0.32

0.40

13

1,484,897

0.88

0.60

0.68

32

3,364,779

0.95

0.73

0.83

18

3,404,840

0.53

0.41

0.47

30

1,724,239

1.74

1.25

1.39

15

1,655,235

0.91

0.57

0.65

31

2,980,563

1.04

0.67

0.76

28

2,756,345

1.02

0.52

0.61

106,961

0.93

0.57

0.86

94,002

125 11,635,225

1.07

0.74

0.85

87

11,526,898

0.75

0.47

0.54

1. 96 ICD-O-3 M-CODE p.497

- 222 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C44 M-87203 - M-87903

10 10
10

2 3

10 10
10

2 3

171

1,262,554

13.54

7.91

8.91

119

1,356,218

8.77

4.81

5.54

101

754,586

13.38

8.40

10.13

104

775,361

13.41

8.45

10.03

22

193,573

11.37

6.96

8.00

10

190,561

5.25

2.74

3.43

19

206,243

9.21

6.58

7.74

18

209,101

8.61

5.97

6.79

65

525,788

12.36

8.87

10.76

54

556,511

9.70

7.28

8.55

40

381,903

10.47

7.33

8.52

43

390,370

11.02

6.40

7.96

26

134,036

19.40

11.58

14.11

12

138,354

8.67

5.42

6.13

163

1,935,668

8.42

6.30

7.50

189

1,961,699

9.63

6.84

8.18

97

1,009,274

9.61

7.23

8.38

64

992,786

6.45

5.03

5.95

16

264,014

6.06

3.76

4.49

22

249,001

8.84

4.73

5.77

34

234,682

14.49

8.98

10.14

37

225,804

16.39

8.08

9.69

32

291,177

10.99

6.51

7.60

14

269,791

5.19

2.54

3.05

59

793,368

7.44

5.10

6.32

71

772,752

9.19

6.47

7.60

81

670,812

12.07

7.83

9.20

83

636,474

13.04

6.22

7.49

33

271,053

12.17

5.98

7.49

31

255,438

12.14

6.02

7.06

65

374,746

17.35

8.63

10.94

65

342,907

18.96

9.27

10.29

64

283,284

22.59

9.84

12.57

65

259,964

25.00

10.33

12.06

126

562,141

22.41

12.74

15.16

110

539,380

20.39

9.26

11.13

93

636,341

14.61

9.48

11.18

91

607,195

14.99

8.79

10.65

87

449,267

19.36

11.03

13.20

82

424,242

19.33

9.79

11.65

10

49,769

20.09

8.36

10.80

47,149

19.09

6.84

8.69

32

174,584

18.33

9.48

11.67

17

164,221

10.35

5.06

6.29

14

120,747

11.59

8.13

8.65

109,926

4.55

1.76

2.43

49,871

47,493

2.11

1.61

1.61

5,744

4,200

554

5,397,185

10.26

6.89

7.98

473

5,454,961

8.67

5.45

6.42

303

2,635,767

11.50

7.15

8.74

304

2,564,082

11.86

6.96

8.13

547

3,251,327

16.82

10.05

12.08

516

3,182,015

16.22

8.63

10.35

46

295,331

15.58

8.93

10.44

22

274,147

8.02

3.72

4.72

55,615

51,693

1.93

1.48

1.48

272

2,017,140

13.48

8.01

9.22

223

2,131,579

10.46

5.90

6.86

172

1,441,543

11.93

8.14

9.66

137

1,484,897

9.23

5.96

7.09

333

3,364,779

9.90

7.22

8.63

321

3,404,840

9.43

6.74

8.03

225

1,724,239

13.05

7.99

9.44

217

1,655,235

13.11

6.88

8.19

435

2,980,563

14.59

8.20

9.91

407

2,756,345

14.77

7.25

8.63

10

106,961

9.35

6.92

8.70

94,002

8.51

5.31

6.28

1,450 11,635,225

12.46

7.88

9.35

1,316

11,526,898

11.42

6.66

7.90

1. 96 ICD-O-3 M-CODE p.497

- 223 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C50 C50

10 10
10

2 3

10 10
10

2 3

1,500

1,356,218

110.60

69.70

75.15

1,262,554

0.55

0.31

0.36

728

775,361

93.89

63.88

68.49

754,586

0.27

0.18

0.23

140

190,561

73.47

49.96

53.76

193,573

167

209,101

79.87

59.53

64.83

206,243

513

556,511

92.18

66.72

72.44

525,788

0.57

0.37

0.47

334

390,370

85.56

59.13

63.92

381,903

0.26

0.15

0.18

121

138,354

87.46

62.07

66.88

134,036

0.75

0.57

0.57

1,880

1,961,699

95.84

66.42

71.97

12

1,935,668

0.62

0.45

0.51

748

992,786

75.34

57.54

62.09

1,009,274

0.10

0.07

0.08

157

249,001

63.05

48.58

52.47

264,014

179

225,804

79.27

55.49

59.74

234,682

206

269,791

76.36

55.52

59.94

291,177

563

772,752

72.86

54.27

58.44

793,368

0.25

0.19

0.24

435

636,474

68.35

51.24

54.98

670,812

0.30

0.16

0.22

168

255,438

65.77

47.82

51.27

271,053

0.37

0.19

0.23

194

342,907

56.58

42.09

44.77

374,746

183

259,964

70.39

49.52

53.44

283,284

0.35

0.17

0.21

415

539,380

76.94

53.60

57.52

562,141

0.18

0.14

0.15

478

607,195

78.72

55.09

59.05

636,341

0.31

0.18

0.23

291

424,242

68.59

47.68

51.17

449,267

0.45

0.24

0.29

27

47,149

57.27

43.97

46.41

49,769

137

164,221

83.42

56.87

62.15

174,584

0.57

0.19

0.23

74

109,926

67.32

47.11

51.51

120,747

11

47,493

23.16

15.97

17.24

49,871

4,200

95.24

62.38

65.40

5,744

4,977

5,454,961

91.24

63.25

68.34

20

5,397,185

0.37

0.24

0.28

1,873

2,564,082

73.05

53.58

57.59

2,635,767

0.30

0.18

0.23

2,577

3,182,015

80.99

56.05

60.15

10

3,251,327

0.31

0.18

0.22

211

274,147

76.97

52.93

57.83

295,331

0.34

0.12

0.14

15

51,693

29.02

19.87

21.26

55,615

2,228

2,131,579

104.52

67.71

72.88

2,017,140

0.45

0.26

0.31

1,275

1,484,897

85.86

60.82

65.87

1,441,543

0.35

0.22

0.26

3,079

3,404,840

90.43

64.04

69.27

3,364,779

0.24

0.18

0.20

1,152

1,655,235

69.60

50.40

54.17

1,724,239

0.17

0.11

0.13

1,874

2,756,345

67.99

49.10

52.70

13

2,980,563

0.44

0.23

0.28

32

94,002

34.04

27.62

29.03

106,961

0.93

0.58

0.62

9,655 11,526,898

83.76

58.63

63.16

39

11,635,225

0.34

0.21

0.24

1. 96 ICD-O-3 M-CODE p.497

2. * 2

- 224 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C55 C53

10 10
10

2 3

10 10
10

2 3

1,356,218

178

1,356,218

13.12

7.85

8.74

775,361

0.13

0.11

0.11

107

775,361

13.80

9.06

10.22

190,561

29

190,561

15.22

9.28

10.71

209,101

43

209,101

20.56

14.90

16.51

556,511

78

556,511

14.02

10.29

11.24

390,370

63

390,370

16.14

10.99

12.20

138,354

23

138,354

16.62

10.68

12.15

1,961,699

301

1,961,699

15.34

10.56

11.87

992,786

0.30

0.19

0.24

142

992,786

14.30

10.77

11.97

249,001

49

249,001

19.68

14.74

16.09

225,804

37

225,804

16.39

9.99

11.29

269,791

51

269,791

18.90

13.38

14.64

772,752

116

772,752

15.01

10.74

12.09

636,474

0.16

0.06

0.07

80

636,474

12.57

8.59

9.42

255,438

0.39

0.30

0.30

35

255,438

13.70

9.74

10.62

342,907

43

342,907

12.54

9.12

9.68

259,964

37

259,964

14.23

7.74

8.69

539,380

61

539,380

11.31

7.23

8.02

607,195

0.33

0.21

0.23

98

607,195

16.14

11.36

12.29

424,242

75

424,242

17.68

11.00

12.44

47,149

47,149

12.73

8.81

9.59

164,221

17

164,221

10.35

6.17

7.03

109,926

10

109,926

9.10

5.47

6.14

47,493

47,493

2.11

0.88

1.33

4,200

4,200

5,454,961

0.05

0.03

0.04

830

5,454,961

15.22

10.14

11.31

2,564,082

0.08

0.05

0.05

352

2,564,082

13.73

9.70

10.63

3,182,015

0.09

0.07

0.07

470

3,182,015

14.77

9.62

10.71

274,147

27

274,147

9.85

5.87

6.66

51,693

51,693

1.93

0.81

1.21

2,131,579

0.05

0.04

0.04

285

2,131,579

13.37

8.27

9.26

1,484,897

236

1,484,897

15.89

11.03

12.27

3,404,840

0.09

0.06

0.06

504

3,404,840

14.80

10.35

11.70

1,655,235

0.12

0.06

0.07

247

1,655,235

14.92

9.98

11.06

2,756,345

0.07

0.03

0.04

393

2,756,345

14.26

9.65

10.53

94,002

14

94,002

14.89

10.55

11.76

8 11,526,898

0.07

0.04

0.05

1,680

11,526,898

14.57

9.74

10.81

1. 96 ICD-O-3 M-CODE p.497

- 225 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C54 C56C57.0 - C57.4

10 10
10

2 3

10 10
10

2 3

268

1,356,218

19.76

12.52

13.57

187

1,356,218

13.79

9.19

9.96

116

775,361

14.96

10.04

10.81

76

775,361

9.80

6.64

7.31

33

190,561

17.32

11.74

12.96

25

190,561

13.12

9.77

10.36

37

209,101

17.69

13.38

14.56

33

209,101

15.78

12.26

12.94

90

556,511

16.17

12.07

12.80

69

556,511

12.40

8.90

9.90

57

390,370

14.60

9.85

10.81

59

390,370

15.11

11.35

12.13

28

138,354

20.24

14.56

15.51

24

138,354

17.35

13.80

14.44

342

1,961,699

17.43

11.83

12.73

224

1,961,699

11.42

8.21

8.85

141

992,786

14.20

10.59

11.31

101

992,786

10.17

7.91

8.62

28

249,001

11.24

8.97

9.51

17

249,001

6.83

5.13

5.56

19

225,804

8.41

5.73

6.25

19

225,804

8.41

5.73

6.33

37

269,791

13.71

10.07

10.72

25

269,791

9.27

6.30

6.91

105

772,752

13.59

10.33

10.99

75

772,752

9.71

7.57

8.11

77

636,474

12.10

9.08

9.70

51

636,474

8.01

6.48

6.95

33

255,438

12.92

8.85

9.54

14

255,438

5.48

3.22

3.64

35

342,907

10.21

7.42

7.91

33

342,907

9.62

7.24

7.68

29

259,964

11.16

7.51

8.14

14

259,964

5.39

4.22

4.46

83

539,380

15.39

10.31

11.04

50

539,380

9.27

6.77

7.26

64

607,195

10.54

7.37

7.88

70

607,195

11.53

8.34

9.00

67

424,242

15.79

11.10

11.99

52

424,242

12.26

8.53

9.29

47,149

8.48

5.23

5.84

47,149

8.48

4.92

5.47

25

164,221

15.22

10.73

11.24

14

164,221

8.53

6.76

7.13

17

109,926

15.46

10.55

11.21

109,926

8.19

5.18

5.74

47,493

4.21

2.61

2.93

47,493

4,200

4,200

905

5,454,961

16.59

11.38

12.27

631

5,454,961

11.57

8.31

8.98

340

2,564,082

13.26

9.79

10.43

242

2,564,082

9.44

7.06

7.64

448

3,182,015

14.08

9.58

10.31

349

3,182,015

10.97

7.89

8.51

42

274,147

15.32

10.64

11.21

23

274,147

8.39

6.12

6.58

51,693

3.87

2.42

2.72

51,693

384

2,131,579

18.01

11.63

12.58

263

2,131,579

12.34

8.27

9.01

245

1,484,897

16.50

11.78

12.72

210

1,484,897

14.14

10.58

11.38

554

3,404,840

16.27

11.41

12.28

395

3,404,840

11.60

8.64

9.36

215

1,655,235

12.99

9.51

10.12

144

1,655,235

8.70

6.24

6.78

331

2,756,345

12.01

8.55

9.17

224

2,756,345

8.13

6.00

6.43

94,002

7.45

6.20

6.55

94,002

8.51

7.58

7.91

1,737 11,526,898

15.07

10.47

11.25

1,245

11,526,898

10.80

7.83

8.46

1. 96 ICD-O-3 M-CODE p.497

- 226 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C51 - C52C57.7 - C57.9 C61

10 10
10

2 3

10 10
10

2 3

23

1,356,218

1.70

0.95

1.06

737

1,262,554

58.37

30.47

36.42

15

775,361

1.93

1.45

1.63

251

754,586

33.26

22.13

26.33

190,561

69

193,573

35.65

21.80

25.94

209,101

0.96

0.73

0.74

44

206,243

21.33

15.71

18.23

556,511

0.72

0.52

0.63

170

525,788

32.33

25.35

30.37

390,370

1.02

0.70

0.75

133

381,903

34.83

25.88

30.17

138,354

1.45

1.28

1.19

48

134,036

35.81

24.67

28.27

20

1,961,699

1.02

0.64

0.78

792

1,935,668

40.92

32.59

39.26

12

992,786

1.21

0.89

1.07

354

1,009,274

35.07

27.87

32.72

249,001

2.01

1.53

1.72

74

264,014

28.03

18.65

21.60

225,804

2.21

2.48

2.23

87

234,682

37.07

18.95

23.56

269,791

1.11

0.53

0.61

129

291,177

44.30

25.28

29.44

11

772,752

1.42

1.15

1.24

282

793,368

35.54

27.01

32.00

11

636,474

1.73

1.03

1.16

212

670,812

31.60

18.86

22.85

255,438

2.35

1.12

1.33

121

271,053

44.64

24.64

28.95

342,907

1.17

1.09

1.06

117

374,746

31.22

16.24

19.50

259,964

0.38

0.16

0.18

83

283,284

29.30

14.35

17.14

539,380

1.11

0.54

0.64

200

562,141

35.58

20.05

23.75

10

607,195

1.65

1.07

1.19

202

636,341

31.74

19.99

24.15

424,242

1.18

0.60

0.70

172

449,267

38.28

22.05

25.82

47,149

15

49,769

30.14

15.86

18.70

164,221

1.83

1.10

1.24

56

174,584

32.08

16.24

19.71

109,926

35

120,747

28.99

16.59

19.54

47,493

49,871

16.04

10.00

11.59

4,200

5,744

70

5,454,961

1.28

0.86

0.97

2,286

5,397,185

42.36

28.11

33.49

36

2,564,082

1.40

0.97

1.07

902

2,635,767

34.22

22.30

26.62

43

3,182,015

1.35

0.88

0.98

1,104

3,251,327

33.96

20.86

24.68

274,147

1.09

0.66

0.74

91

295,331

30.81

16.42

19.69

51,693

55,615

14.38

9.15

10.60

38

2,131,579

1.78

1.14

1.28

988

2,017,140

48.98

27.62

33.02

12

1,484,897

0.81

0.59

0.63

464

1,441,543

32.19

23.64

27.84

37

3,404,840

1.09

0.79

0.87

1,273

3,364,779

37.83

28.96

34.63

30

1,655,235

1.81

1.04

1.21

654

1,724,239

37.93

22.56

26.91

34

2,756,345

1.23

0.85

0.90

985

2,980,563

33.05

19.11

22.65

94,002

1.06

0.35

0.63

22

106,961

20.57

15.55

19.00

152 11,526,898

1.32

0.88

0.98

4,392

11,635,225

37.75

24.17

28.77

1. 96 ICD-O-3 M-CODE p.497

2. * 1

- 227 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C62 C60C63

10 10
10

2 3

10 10
10

2 3

25

1,262,554

1.98

1.89

2.01

15

1,262,554

1.19

0.68

0.76

16

754,586

2.12

2.10

2.16

754,586

1.06

0.76

0.83

193,573

2.07

2.32

2.31

193,573

0.52

0.26

0.39

206,243

1.45

1.42

1.51

206,243

1.45

1.42

1.50

525,788

1.52

1.29

1.45

525,788

0.57

0.51

0.55

381,903

1.57

1.52

1.59

381,903

0.79

0.68

0.68

134,036

0.75

0.77

0.76

134,036

34

1,935,668

1.76

1.70

1.74

1,935,668

0.46

0.30

0.36

16

1,009,274

1.59

1.51

1.55

1,009,274

0.79

0.64

0.68

264,014

1.14

1.34

1.20

264,014

234,682

0.85

0.74

0.73

234,682

1.28

0.97

1.07

291,177

1.37

1.52

1.54

291,177

0.69

0.29

0.39

13

793,368

1.64

1.55

1.58

793,368

0.63

0.52

0.55

10

670,812

1.49

1.49

1.51

670,812

0.75

0.45

0.52

271,053

1.11

1.19

1.16

271,053

0.37

0.32

0.30

374,746

0.53

0.52

0.58

374,746

1.07

0.60

0.66

283,284

0.71

0.80

0.83

283,284

0.71

0.38

0.44

562,141

1.07

1.07

1.11

562,141

0.89

0.43

0.58

11

636,341

1.73

1.49

1.60

636,341

0.94

0.65

0.70

449,267

0.89

0.81

0.86

449,267

0.89

0.49

0.57

49,769

49,769

2.01

0.44

0.80

174,584

2.29

2.14

2.10

174,584

0.57

0.37

0.40

120,747

0.83

0.99

1.02

120,747

0.83

0.29

0.35

49,871

49,871

2.01

1.13

1.22

5,744

5,744

91

5,397,185

1.69

1.66

1.71

41

5,397,185

0.76

0.51

0.58

36

2,635,767

1.37

1.30

1.35

18

2,635,767

0.68

0.51

0.55

46

3,251,327

1.41

1.37

1.43

29

3,251,327

0.89

0.57

0.65

295,331

1.69

1.67

1.65

295,331

0.68

0.33

0.38

55,615

55,615

1.80

1.00

1.08

41

2,017,140

2.03

1.96

2.05

23

2,017,140

1.14

0.70

0.78

22

1,441,543

1.53

1.44

1.53

10

1,441,543

0.69

0.60

0.65

60

3,364,779

1.78

1.72

1.75

11

3,364,779

0.33

0.21

0.25

21

1,724,239

1.22

1.13

1.21

20

1,724,239

1.16

0.79

0.88

33

2,980,563

1.11

1.16

1.16

23

2,980,563

0.77

0.48

0.55

106,961

0.93

0.63

0.63

106,961

3.74

2.82

3.30

178 11,635,225

1.53

1.49

1.54

91

11,635,225

0.78

0.53

0.60

1. 96 ICD-O-3 M-CODE p.497

- 228 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C67

10 10
10

2 3

10 10
10

2 3

166

1,262,554

13.15

6.86

8.02

63

1,356,218

4.65

2.38

2.88

89

754,586

11.79

7.80

9.12

36

775,361

4.64

2.86

3.41

17

193,573

8.78

4.82

5.95

13

190,561

6.82

3.84

4.61

15

206,243

7.27

5.53

6.40

209,101

1.43

1.21

1.29

54

525,788

10.27

7.28

8.90

21

556,511

3.77

3.26

3.58

56

381,903

14.66

10.82

12.23

26

390,370

6.66

4.16

4.94

12

134,036

8.95

5.65

6.63

138,354

5.06

3.10

3.51

188

1,935,668

9.71

7.39

8.63

78

1,961,699

3.98

2.86

3.43

96

1,009,274

9.51

7.01

8.34

34

992,786

3.42

2.47

3.09

17

264,014

6.44

3.68

4.61

249,001

1.61

1.13

1.26

38

234,682

16.19

9.47

11.10

16

225,804

7.09

4.07

4.52

38

291,177

13.05

7.32

8.59

13

269,791

4.82

2.72

3.00

96

793,368

12.10

9.39

10.76

34

772,752

4.40

3.03

3.59

74

670,812

11.03

6.76

8.10

32

636,474

5.03

3.09

3.40

35

271,053

12.91

7.57

8.63

16

255,438

6.26

3.15

3.67

57

374,746

15.21

8.73

10.18

17

342,907

4.96

2.03

2.46

53

283,284

18.71

9.94

11.62

16

259,964

6.15

2.62

3.03

118

562,141

20.99

11.58

13.84

39

539,380

7.23

4.18

4.63

85

636,341

13.36

8.78

10.17

31

607,195

5.11

3.05

3.60

78

449,267

17.36

10.33

11.88

24

424,242

5.66

3.00

3.53

49,769

8.04

4.47

5.12

47,149

24

174,584

13.75

7.37

8.66

10

164,221

6.09

3.48

3.93

14

120,747

11.59

5.72

7.07

109,926

2.73

1.72

1.79

49,871

4.01

2.75

2.84

47,493

2.11

1.68

2.02

5,744

4,200

575

5,397,185

10.65

6.92

8.14

224

5,454,961

4.11

2.57

3.06

316

2,635,767

11.99

8.00

9.39

120

2,564,082

4.68

2.87

3.29

495

3,251,327

15.22

9.43

11.00

179

3,182,015

5.63

3.20

3.70

38

295,331

12.87

6.73

8.03

13

274,147

4.74

2.76

3.05

55,615

3.60

2.49

2.57

51,693

1.93

1.53

1.84

255

2,017,140

12.64

7.21

8.42

99

2,131,579

4.64

2.54

3.06

154

1,441,543

10.68

7.52

8.85

70

1,484,897

4.71

3.29

3.78

373

3,364,779

11.09

8.29

9.72

153

3,404,840

4.49

3.18

3.82

228

1,724,239

13.22

7.97

9.43

77

1,655,235

4.65

2.64

3.03

402

2,980,563

13.49

8.03

9.37

137

2,756,345

4.97

2.75

3.14

10

106,961

9.35

7.11

8.48

94,002

1.06

0.44

0.67

1,427 11,635,225

12.26

7.88

9.24

537

11,526,898

4.66

2.80

3.28

1. 96 ICD-O-3 M-CODE p.497

2. * 1

- 229 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C64

10 10
10

2 3

10 10
10

2 3

119

1,262,554

9.43

5.92

6.48

52

1,356,218

3.83

2.09

2.44

43

754,586

5.70

4.20

4.57

30

775,361

3.87

2.81

3.11

11

193,573

5.68

3.86

4.19

190,561

1.05

0.73

0.73

17

206,243

8.24

6.79

7.31

209,101

3.83

2.57

3.04

28

525,788

5.33

4.46

4.78

14

556,511

2.52

2.48

2.50

23

381,903

6.02

4.12

4.70

19

390,370

4.87

3.46

3.89

134,036

6.71

4.72

5.32

138,354

5.06

5.39

5.03

121

1,935,668

6.25

5.08

5.44

53

1,961,699

2.70

1.98

2.28

66

1,009,274

6.54

5.08

5.65

29

992,786

2.92

2.24

2.56

264,014

3.41

2.57

2.79

249,001

1.61

0.97

1.20

14

234,682

5.97

4.70

4.86

225,804

3.54

2.41

2.63

291,177

2.75

1.53

1.79

269,791

2.97

2.08

2.13

35

793,368

4.41

3.40

3.77

21

772,752

2.72

2.02

2.23

29

670,812

4.32

3.10

3.48

18

636,474

2.83

1.69

1.90

14

271,053

5.17

3.52

3.66

255,438

3.52

1.87

2.09

19

374,746

5.07

3.03

3.30

342,907

1.46

0.81

0.91

11

283,284

3.88

2.53

2.79

259,964

1.15

0.44

0.52

32

562,141

5.69

3.65

4.15

14

539,380

2.60

1.81

1.89

32

636,341

5.03

3.46

3.85

24

607,195

3.95

2.55

2.79

18

449,267

4.01

2.37

2.77

16

424,242

3.77

2.48

2.69

49,769

4.02

2.56

2.95

47,149

2.12

1.35

1.55

174,584

5.16

3.41

3.84

164,221

1.22

0.94

0.91

120,747

4.14

2.99

3.09

109,926

2.73

1.26

1.54

49,871

6.02

3.61

3.79

47,493

5,744

17.41

11.13

11.13

4,200

365

5,397,185

6.76

5.00

5.44

164

5,454,961

3.01

1.98

2.26

125

2,635,767

4.74

3.50

3.83

67

2,564,082

2.61

1.83

1.99

170

3,251,327

5.23

3.52

3.93

114

3,182,015

3.58

2.48

2.67

14

295,331

4.74

3.22

3.52

274,147

1.82

1.09

1.19

55,615

7.19

4.42

4.58

51,693

162

2,017,140

8.03

5.32

5.81

82

2,131,579

3.85

2.36

2.69

88

1,441,543

6.10

4.71

5.15

50

1,484,897

3.37

2.76

2.92

202

3,364,779

6.00

4.71

5.19

87

3,404,840

2.56

1.88

2.12

76

1,724,239

4.41

3.35

3.59

53

1,655,235

3.20

2.00

2.22

149

2,980,563

5.00

3.25

3.59

74

2,756,345

2.68

1.67

1.83

106,961

94,002

1.06

1.12

1.04

678 11,635,225

5.83

4.20

4.60

350

11,526,898

3.04

2.05

2.27

1. 96 ICD-O-3 M-CODE p.497

- 230 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C65

10 10
10

2 3

10 10
10

2 3

44

1,262,554

3.48

2.11

2.37

44

1,356,218

3.24

1.87

2.07

24

754,586

3.18

2.15

2.47

16

775,361

2.06

1.26

1.53

193,573

3.62

2.11

2.36

190,561

3.67

2.43

2.58

206,243

0.97

1.07

1.12

209,101

1.91

1.17

1.47

12

525,788

2.28

2.13

2.30

22

556,511

3.95

2.94

3.50

17

381,903

4.45

2.63

3.52

23

390,370

5.89

3.97

4.67

134,036

4.48

2.94

3.61

12

138,354

8.67

4.66

5.78

45

1,935,668

2.32

1.69

2.02

37

1,961,699

1.89

1.49

1.68

24

1,009,274

2.38

2.32

2.53

18

992,786

1.81

1.37

1.65

264,014

1.89

1.29

1.51

10

249,001

4.02

3.23

3.42

234,682

2.13

1.04

1.35

225,804

3.99

2.35

2.67

291,177

2.40

1.65

1.75

11

269,791

4.08

1.80

2.14

19

793,368

2.39

1.95

2.18

38

772,752

4.92

3.40

3.99

21

670,812

3.13

2.13

2.41

21

636,474

3.30

1.89

2.10

10

271,053

3.69

2.55

2.74

12

255,438

4.70

2.91

3.19

10

374,746

2.67

1.60

1.80

15

342,907

4.37

2.06

2.37

15

283,284

5.30

3.19

3.47

17

259,964

6.54

3.30

3.60

24

562,141

4.27

2.92

3.14

30

539,380

5.56

2.89

3.34

25

636,341

3.93

2.77

3.07

25

607,195

4.12

2.75

3.03

16

449,267

3.56

2.18

2.54

17

424,242

4.01

2.25

2.51

49,769

4.02

3.68

3.68

47,149

174,584

2.86

1.61

1.92

164,221

3.65

1.77

2.18

120,747

2.48

0.91

1.42

109,926

1.82

1.06

1.29

49,871

47,493

5,744

4,200

139

5,397,185

2.58

1.84

2.10

140

5,454,961

2.57

1.74

1.96

72

2,635,767

2.73

2.00

2.22

108

2,564,082

4.21

2.58

2.95

129

3,251,327

3.97

2.59

2.95

140

3,182,015

4.40

2.56

2.95

295,331

2.71

1.33

1.72

274,147

2.92

1.46

1.79

55,615

51,693

68

2,017,140

3.37

2.11

2.39

60

2,131,579

2.81

1.66

1.88

44

1,441,543

3.05

2.18

2.58

68

1,484,897

4.58

3.09

3.65

83

3,364,779

2.47

1.95

2.19

100

3,404,840

2.94

2.21

2.55

54

1,724,239

3.13

2.09

2.34

65

1,655,235

3.93

2.39

2.67

96

2,980,563

3.22

2.06

2.34

102

2,756,345

3.70

2.06

2.34

106,961

1.87

0.94

1.53

94,002

1.06

0.54

0.65

348 11,635,225

2.99

2.07

2.35

396

11,526,898

3.44

2.15

2.46

1. 96 ICD-O-3 M-CODE p.497

- 231 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C66

10 10
10

2 3

10 10
10

2 3

19

1,262,554

1.50

0.76

0.89

23

1,356,218

1.70

0.83

0.98

22

754,586

2.92

2.19

2.39

16

775,361

2.06

1.41

1.60

193,573

3.10

2.05

2.42

190,561

2.10

1.36

1.55

206,243

0.48

0.59

0.59

209,101

0.48

0.37

0.40

525,788

1.33

1.03

1.29

556,511

1.62

1.29

1.52

381,903

2.36

1.80

1.99

15

390,370

3.84

2.90

3.09

134,036

1.49

0.81

1.06

138,354

5.78

3.68

4.10

28

1,935,668

1.45

1.19

1.39

26

1,961,699

1.33

1.01

1.12

10

1,009,274

0.99

0.69

0.81

992,786

0.91

0.71

0.83

264,014

249,001

0.80

0.63

0.66

234,682

1.28

0.86

0.91

225,804

3.54

1.86

2.16

291,177

1.03

0.64

0.74

269,791

2.22

1.29

1.38

11

793,368

1.39

1.09

1.20

18

772,752

2.33

1.57

1.88

12

670,812

1.79

1.28

1.40

11

636,474

1.73

0.85

1.01

271,053

1.11

0.66

0.72

255,438

1.17

0.52

0.62

374,746

1.60

1.01

1.11

20

342,907

5.83

2.75

3.14

12

283,284

4.24

2.41

2.69

15

259,964

5.77

2.36

2.72

21

562,141

3.74

2.34

2.61

20

539,380

3.71

1.71

2.05

14

636,341

2.20

1.65

1.75

20

607,195

3.29

1.95

2.32

449,267

1.56

0.85

1.01

13

424,242

3.06

1.72

1.91

49,769

47,149

2.12

1.13

1.25

174,584

1.15

1.03

1.00

164,221

1.83

0.85

1.01

120,747

1.66

1.50

1.44

109,926

49,871

47,493

5,744

4,200

70

5,397,185

1.30

0.89

1.03

79

5,454,961

1.45

0.96

1.09

39

2,635,767

1.48

1.06

1.19

61

2,564,082

2.38

1.38

1.63

87

3,251,327

2.68

1.82

2.02

108

3,182,015

3.39

1.98

2.26

295,331

1.35

1.22

1.18

274,147

1.09

0.50

0.59

55,615

51,693

41

2,017,140

2.03

1.24

1.39

39

2,131,579

1.83

1.03

1.19

25

1,441,543

1.73

1.31

1.53

37

1,484,897

2.49

1.85

2.05

46

3,364,779

1.37

1.03

1.19

59

3,404,840

1.73

1.27

1.50

35

1,724,239

2.03

1.42

1.54

43

1,655,235

2.60

1.40

1.63

52

2,980,563

1.74

1.16

1.29

69

2,756,345

2.50

1.35

1.53

106,961

94,002

1.06

0.73

0.84

200 11,635,225

1.72

1.20

1.35

251

11,526,898

2.18

1.34

1.54

1. 96 ICD-O-3 M-CODE p.497

- 232 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C68.0 - C68.1

10 10
10

2 3

10 10
10

2 3

1,262,554

0.08

0.06

0.06

1,356,218

754,586

0.53

0.46

0.45

775,361

0.13

0.07

0.08

193,573

190,561

206,243

209,101

525,788

0.38

0.24

0.33

556,511

0.36

0.20

0.30

381,903

0.26

0.23

0.25

390,370

134,036

138,354

0.72

0.50

0.54

1,935,668

0.05

0.03

0.03

1,961,699

0.05

0.05

0.04

1,009,274

992,786

264,014

249,001

234,682

0.43

0.29

0.31

225,804

291,177

269,791

793,368

0.13

0.11

0.12

772,752

0.13

0.09

0.09

670,812

636,474

0.16

0.06

0.07

271,053

255,438

374,746

342,907

0.29

0.06

0.10

283,284

0.35

0.17

0.21

259,964

562,141

0.18

0.16

0.16

539,380

636,341

0.16

0.12

0.14

607,195

449,267

0.22

0.09

0.14

424,242

49,769

47,149

174,584

0.57

0.37

0.40

164,221

120,747

109,926

49,871

47,493

5,744

4,200

5,397,185

0.06

0.04

0.04

5,454,961

0.02

0.02

0.01

2,635,767

0.11

0.07

0.09

2,564,082

0.20

0.10

0.13

3,251,327

0.28

0.21

0.22

3,182,015

0.06

0.04

0.04

295,331

0.34

0.22

0.24

274,147

55,615

51,693

2,017,140

0.25

0.20

0.20

2,131,579

0.05

0.02

0.03

1,441,543

0.21

0.14

0.17

1,484,897

0.20

0.12

0.15

3,364,779

0.03

0.02

0.02

3,404,840

0.06

0.04

0.04

1,724,239

0.17

0.12

0.13

1,655,235

2,980,563

0.13

0.08

0.09

2,756,345

0.07

0.02

0.03

106,961

94,002

16 11,635,225

0.14

0.10

0.11

11,526,898

0.07

0.04

0.05

1. 96 ICD-O-3 M-CODE p.497

- 233 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C68.8

10 10
10

2 3

10 10
10

2 3

1,262,554

1,356,218

754,586

0.13

0.07

0.09

775,361

193,573

190,561

0.52

0.22

0.34

206,243

209,101

525,788

556,511

381,903

390,370

134,036

138,354

1,935,668

0.05

0.03

0.03

1,961,699

1,009,274

992,786

264,014

249,001

234,682

0.43

0.42

0.39

225,804

291,177

269,791

793,368

772,752

0.13

0.10

0.11

670,812

0.15

0.14

0.13

636,474

271,053

255,438

0.39

0.26

0.28

374,746

342,907

0.29

0.07

0.11

283,284

259,964

562,141

539,380

636,341

607,195

0.16

0.06

0.11

449,267

424,242

0.24

0.18

0.18

49,769

47,149

174,584

164,221

0.61

0.25

0.31

120,747

109,926

49,871

47,493

5,744

4,200

5,397,185

0.04

0.03

0.03

5,454,961

0.02

0.01

0.01

2,635,767

0.04

0.04

0.03

2,564,082

0.12

0.07

0.08

3,251,327

0.03

0.02

0.02

3,182,015

0.06

0.04

0.04

295,331

274,147

0.36

0.15

0.18

55,615

51,693

2,017,140

0.05

0.03

0.03

2,131,579

1,441,543

1,484,897

0.07

0.03

0.05

3,364,779

0.06

0.05

0.05

3,404,840

0.06

0.04

0.05

1,724,239

1,655,235

0.06

0.02

0.03

2,980,563

0.03

0.03

0.03

2,756,345

0.11

0.05

0.06

106,961

94,002

4 11,635,225

0.03

0.03

0.03

11,526,898

0.06

0.03

0.04

1. 96 ICD-O-3 M-CODE p.497

- 234 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C68.9

10 10
10

2 3

10 10
10

2 3

15

1,262,554

1.19

0.69

0.78

18

1,356,218

1.33

0.74

0.86

11

754,586

1.46

1.15

1.23

10

775,361

1.29

0.87

0.99

193,573

190,561

206,243

1.94

1.53

1.72

209,101

525,788

0.19

0.20

0.22

556,511

0.18

0.20

0.20

381,903

0.79

0.62

0.69

390,370

0.51

0.35

0.40

134,036

138,354

0.72

0.44

0.50

13

1,935,668

0.67

0.56

0.62

14

1,961,699

0.71

0.58

0.64

10

1,009,274

0.99

0.58

0.79

992,786

0.50

0.48

0.53

264,014

249,001

1.20

0.80

0.91

234,682

1.70

0.80

1.05

225,804

0.44

0.35

0.35

291,177

0.69

0.40

0.44

269,791

1.85

0.85

1.05

793,368

0.25

0.27

0.26

772,752

1.04

0.57

0.77

670,812

0.45

0.31

0.35

636,474

0.16

0.09

0.10

271,053

0.37

0.21

0.23

255,438

0.39

0.24

0.27

374,746

1.33

0.80

0.92

342,907

0.87

0.48

0.56

283,284

2.47

1.24

1.46

259,964

1.54

0.83

0.90

562,141

1.60

0.88

1.05

539,380

1.67

0.88

1.00

10

636,341

1.57

1.18

1.28

14

607,195

2.31

1.35

1.62

449,267

0.67

0.42

0.48

10

424,242

2.36

1.25

1.46

49,769

2.01

0.64

0.96

47,149

174,584

0.57

0.41

0.45

164,221

120,747

1.66

0.91

1.14

109,926

1.82

0.99

1.14

49,871

47,493

5,744

4,200

48

5,397,185

0.89

0.61

0.71

46

5,454,961

0.84

0.57

0.66

12

2,635,767

0.46

0.34

0.37

14

2,564,082

0.55

0.30

0.37

44

3,251,327

1.35

0.91

1.02

50

3,182,015

1.57

0.91

1.05

295,331

1.02

0.61

0.73

274,147

0.73

0.41

0.47

55,615

51,693

26

2,017,140

1.29

0.86

0.95

28

2,131,579

1.31

0.78

0.89

1,441,543

0.55

0.44

0.49

1,484,897

0.27

0.21

0.22

27

3,364,779

0.80

0.56

0.69

22

3,404,840

0.65

0.49

0.57

22

1,724,239

1.28

0.85

0.95

18

1,655,235

1.09

0.65

0.73

24

2,980,563

0.81

0.52

0.58

38

2,756,345

1.38

0.74

0.86

106,961

94,002

1.06

0.44

0.67

107 11,635,225

0.92

0.63

0.72

112

11,526,898

0.97

0.60

0.70

1. 96 ICD-O-3 M-CODE p.497

- 235 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C69

10 10
10

2 3

10 10
10

2 3

10

1,262,554

0.79

0.97

0.87

1,356,218

0.22

0.29

0.25

754,586

1.06

1.67

1.41

775,361

0.13

0.09

0.10

193,573

190,561

206,243

209,101

0.96

1.37

1.13

525,788

0.57

0.84

0.72

556,511

381,903

390,370

134,036

138,354

1,935,668

0.31

0.37

0.36

1,961,699

0.10

0.08

0.08

1,009,274

0.10

0.24

0.18

992,786

0.71

1.26

1.02

264,014

249,001

0.40

0.87

0.64

234,682

225,804

291,177

269,791

0.37

0.12

0.14

793,368

0.13

0.33

0.24

772,752

670,812

0.30

0.19

0.23

636,474

271,053

255,438

0.39

0.32

0.35

374,746

342,907

283,284

0.71

0.62

0.65

259,964

562,141

0.36

0.23

0.25

539,380

0.37

0.37

0.37

636,341

0.47

1.45

1.06

607,195

0.16

0.10

0.11

449,267

424,242

49,769

47,149

174,584

164,221

120,747

0.83

1.69

1.47

109,926

49,871

47,493

2.11

0.57

1.02

5,744

4,200

17

5,397,185

0.31

0.41

0.37

16

5,454,961

0.29

0.48

0.40

2,635,767

0.23

0.32

0.28

2,564,082

0.04

0.03

0.03

15

3,251,327

0.46

0.78

0.65

3,182,015

0.13

0.11

0.11

295,331

0.34

0.70

0.61

274,147

55,615

51,693

1.93

0.52

0.94

18

2,017,140

0.89

1.21

1.05

2,131,579

0.19

0.22

0.20

1,441,543

0.21

0.31

0.27

1,484,897

0.13

0.25

0.20

10

3,364,779

0.30

0.51

0.42

3,404,840

0.15

0.17

0.16

1,724,239

0.12

0.11

0.11

1,655,235

0.42

0.55

0.48

2,980,563

0.17

0.20

0.18

2,756,345

0.15

0.28

0.23

106,961

0.93

1.74

1.52

94,002

39 11,635,225

0.34

0.49

0.42

22

11,526,898

0.19

0.27

0.23

1. 96 ICD-O-3 M-CODE p.497

- 236 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C71

10 10
10

2 3

10 10
10

2 3

58

1,262,554

4.59

3.25

3.50

34

1,356,218

2.51

2.04

2.17

27

754,586

3.58

3.15

3.29

17

775,361

2.19

2.12

2.21

193,573

4.13

3.30

3.54

190,561

1.57

1.32

1.43

206,243

4.36

5.28

4.91

209,101

3.35

2.33

2.68

16

525,788

3.04

2.75

2.90

14

556,511

2.52

2.45

2.41

13

381,903

3.40

3.43

3.38

13

390,370

3.33

2.81

2.90

134,036

2.24

3.30

2.89

138,354

2.17

1.69

1.83

72

1,935,668

3.72

3.53

3.54

53

1,961,699

2.70

2.47

2.59

34

1,009,274

3.37

3.32

3.28

25

992,786

2.52

2.30

2.45

11

264,014

4.17

3.76

3.86

249,001

3.61

3.40

3.45

234,682

2.13

1.41

1.58

225,804

2.66

4.43

3.63

291,177

2.06

1.57

1.64

269,791

2.97

2.40

2.39

25

793,368

3.15

3.29

3.26

16

772,752

2.07

2.45

2.29

29

670,812

4.32

4.03

4.12

24

636,474

3.77

2.95

3.11

11

271,053

4.06

2.94

3.15

11

255,438

4.31

2.59

2.84

17

374,746

4.54

4.19

4.30

13

342,907

3.79

3.49

3.34

13

283,284

4.59

5.57

5.16

259,964

1.54

1.30

1.42

19

562,141

3.38

3.40

3.39

16

539,380

2.97

2.60

2.64

20

636,341

3.14

2.63

2.79

17

607,195

2.80

2.80

2.76

449,267

1.78

1.50

1.60

13

424,242

3.06

2.08

2.28

49,769

47,149

10

174,584

5.73

3.99

4.40

164,221

2.44

1.58

1.65

120,747

3.31

3.44

3.45

109,926

2.73

2.18

2.51

49,871

2.01

1.55

1.96

47,493

5,744

17.41

25.79

24.36

4,200

23.81

21.74

23.91

203

5,397,185

3.76

3.33

3.39

145

5,454,961

2.66

2.37

2.46

98

2,635,767

3.72

3.46

3.53

78

2,564,082

3.04

2.76

2.76

103

3,251,327

3.17

3.03

3.04

83

3,182,015

2.61

2.27

2.33

14

295,331

4.74

3.76

4.01

274,147

2.55

1.82

1.99

55,615

3.60

3.89

4.12

51,693

1.93

1.56

1.72

85

2,017,140

4.21

3.21

3.42

51

2,131,579

2.39

2.05

2.15

49

1,441,543

3.40

3.44

3.42

40

1,484,897

2.69

2.28

2.36

115

3,364,779

3.42

3.25

3.30

102

3,404,840

3.00

2.79

2.88

63

1,724,239

3.65

3.47

3.50

42

1,655,235

2.54

2.16

2.21

103

2,980,563

3.46

3.24

3.26

72

2,756,345

2.61

2.35

2.36

106,961

2.80

2.97

3.14

94,002

5.32

3.51

3.98

420 11,635,225

3.61

3.29

3.35

314

11,526,898

2.72

2.41

2.47

1. 96 ICD-O-3 M-CODE p.497

- 237 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C70C72

10 10
10

2 3

10 10
10

2 3

1,262,554

1,356,218

0.15

0.08

0.10

754,586

0.13

0.09

0.11

775,361

193,573

0.52

0.23

0.27

190,561

206,243

209,101

525,788

556,511

0.36

0.24

0.27

381,903

0.52

0.48

0.50

390,370

0.51

0.41

0.41

134,036

138,354

1,935,668

0.41

0.34

0.36

1,961,699

0.05

0.03

0.04

1,009,274

0.20

0.16

0.18

992,786

0.40

0.27

0.31

264,014

0.76

0.72

0.71

249,001

234,682

225,804

0.44

0.12

0.21

291,177

269,791

1.11

0.87

1.01

793,368

0.25

0.19

0.22

772,752

0.39

0.62

0.51

670,812

0.15

0.19

0.18

636,474

0.16

0.09

0.10

271,053

0.37

0.32

0.30

255,438

374,746

0.27

0.27

0.27

342,907

0.87

0.76

0.72

283,284

0.35

0.09

0.16

259,964

562,141

0.18

0.40

0.35

539,380

0.56

0.57

0.56

636,341

0.31

0.27

0.28

607,195

0.16

0.37

0.32

449,267

424,242

0.94

0.61

0.69

49,769

47,149

174,584

164,221

120,747

109,926

49,871

47,493

5,744

4,200

13

5,397,185

0.24

0.18

0.19

11

5,454,961

0.20

0.12

0.14

2,635,767

0.19

0.18

0.18

2,564,082

0.35

0.38

0.35

3,251,327

0.22

0.20

0.21

10

3,182,015

0.31

0.29

0.30

295,331

274,147

55,615

51,693

2,017,140

0.05

0.04

0.05

2,131,579

0.09

0.05

0.07

1,441,543

0.21

0.17

0.18

1,484,897

0.27

0.20

0.21

11

3,364,779

0.33

0.27

0.28

3,404,840

0.26

0.21

0.22

1,724,239

0.35

0.30

0.31

1,655,235

0.30

0.24

0.26

2,980,563

0.13

0.13

0.13

2,756,345

0.25

0.32

0.29

106,961

94,002

2.13

1.08

1.42

25 11,635,225

0.21

0.18

0.19

30

11,526,898

0.26

0.22

0.23

1. 96 ICD-O-3 M-CODE p.497

- 238 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C73

10 10
10

2 3

10 10
10

2 3

88

1,262,554

6.97

4.89

5.39

287

1,356,218

21.16

15.20

16.34

40

754,586

5.30

3.85

4.26

102

775,361

13.16

9.02

9.78

17

193,573

8.78

6.19

6.94

16

190,561

8.40

5.86

6.42

12

206,243

5.82

4.59

5.18

31

209,101

14.83

10.90

12.20

24

525,788

4.56

3.48

3.85

75

556,511

13.48

10.18

11.12

20

381,903

5.24

3.80

4.14

84

390,370

21.52

15.65

16.98

134,036

5.22

4.02

4.47

19

138,354

13.73

11.19

11.82

109

1,935,668

5.63

4.29

4.67

377

1,961,699

19.22

14.15

15.30

43

1,009,274

4.26

3.56

3.88

138

992,786

13.90

10.97

11.85

16

264,014

6.06

4.58

5.15

26

249,001

10.44

8.32

9.07

234,682

2.98

2.26

2.41

45

225,804

19.93

14.98

16.16

291,177

2.06

1.33

1.57

29

269,791

10.75

8.15

8.76

30

793,368

3.78

2.87

3.16

88

772,752

11.39

8.71

9.52

28

670,812

4.17

3.15

3.43

79

636,474

12.41

9.77

10.55

271,053

2.58

2.09

2.27

34

255,438

13.31

10.06

11.24

11

374,746

2.94

2.18

2.52

62

342,907

18.08

14.95

15.79

13

283,284

4.59

2.87

3.26

39

259,964

15.00

11.65

12.25

31

562,141

5.51

3.94

4.24

100

539,380

18.54

13.78

15.05

31

636,341

4.87

3.52

3.76

103

607,195

16.96

12.65

13.57

20

449,267

4.45

3.38

3.74

58

424,242

13.67

11.20

11.73

49,769

2.01

1.45

1.45

47,149

12.73

9.91

10.71

174,584

1.72

1.26

1.32

22

164,221

13.40

9.68

10.67

120,747

2.48

2.24

2.35

15

109,926

13.65

10.36

11.23

49,871

6.02

3.73

4.16

47,493

6.32

4.10

4.95

5,744

4,200

298

5,397,185

5.52

4.16

4.57

949

5,454,961

17.40

12.97

14.00

100

2,635,767

3.79

2.87

3.17

338

2,564,082

13.18

10.14

10.98

163

3,251,327

5.01

3.63

3.96

511

3,182,015

16.06

11.94

12.83

295,331

2.03

1.67

1.75

37

274,147

13.50

9.93

10.86

55,615

5.39

3.35

3.74

51,693

5.80

3.76

4.55

128

2,017,140

6.35

4.50

4.96

389

2,131,579

18.25

12.90

13.90

80

1,441,543

5.55

4.16

4.62

225

1,484,897

15.15

11.28

12.29

164

3,364,779

4.87

3.76

4.11

598

3,404,840

17.56

13.02

14.18

79

1,724,239

4.58

3.53

3.87

221

1,655,235

13.35

10.45

11.20

112

2,980,563

3.76

2.77

3.02

389

2,756,345

14.11

11.02

11.82

106,961

4.67

3.31

4.08

11

94,002

11.70

10.21

10.58

571 11,635,225

4.91

3.66

4.02

1,838

11,526,898

15.95

11.96

12.91

1. 96 ICD-O-3 M-CODE p.497

- 239 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C74 - C75

10 10
10

2 3

10 10
10

2 3

1,262,554

0.32

0.37

0.33

1,356,218

0.15

0.41

0.32

754,586

0.13

0.11

0.10

775,361

0.13

0.42

0.31

193,573

190,561

0.52

0.23

0.27

206,243

209,101

525,788

556,511

0.18

0.12

0.14

381,903

0.26

0.19

0.19

390,370

0.26

0.18

0.18

134,036

0.75

0.57

0.57

138,354

1,935,668

0.26

0.37

0.32

1,961,699

1,009,274

0.20

0.31

0.26

992,786

0.20

0.33

0.27

264,014

0.38

0.78

0.58

249,001

0.40

0.49

0.51

234,682

225,804

0.89

0.56

0.59

291,177

0.34

0.23

0.25

269,791

0.37

0.30

0.30

793,368

0.13

0.09

0.09

772,752

0.52

0.82

0.72

670,812

0.45

0.64

0.54

636,474

0.16

0.14

0.15

271,053

255,438

0.39

1.28

0.94

374,746

342,907

283,284

0.71

0.50

0.60

259,964

0.77

0.56

0.66

562,141

0.36

0.50

0.46

539,380

0.56

0.38

0.39

636,341

607,195

0.16

0.06

0.11

449,267

0.22

0.14

0.15

424,242

0.47

0.99

0.77

49,769

47,149

174,584

164,221

120,747

109,926

49,871

47,493

5,744

4,200

13

5,397,185

0.24

0.34

0.29

5,454,961

0.16

0.23

0.20

2,635,767

0.15

0.19

0.17

2,564,082

0.27

0.43

0.37

3,251,327

0.25

0.21

0.22

10

3,182,015

0.31

0.37

0.33

295,331

274,147

55,615

51,693

2,017,140

0.25

0.28

0.25

2,131,579

0.14

0.41

0.31

1,441,543

0.14

0.10

0.10

1,484,897

0.20

0.13

0.15

10

3,364,779

0.30

0.43

0.37

3,404,840

0.12

0.23

0.19

1,724,239

0.23

0.29

0.26

1,655,235

0.18

0.17

0.17

2,980,563

0.13

0.14

0.14

13

2,756,345

0.47

0.52

0.48

106,961

94,002

25 11,635,225

0.21

0.27

0.24

26

11,526,898

0.23

0.31

0.27

1. 96 ICD-O-3 M-CODE p.497

- 240 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C76

10 10
10

2 3

10 10
10

2 3

1,262,554

0.08

0.02

0.03

1,356,218

0.07

0.04

0.05

754,586

0.53

0.33

0.38

775,361

193,573

190,561

0.52

0.17

0.30

206,243

0.48

0.59

0.59

209,101

525,788

556,511

381,903

0.26

0.75

0.55

390,370

134,036

138,354

1,935,668

1,961,699

1,009,274

0.10

0.13

0.13

992,786

264,014

249,001

234,682

225,804

291,177

269,791

793,368

772,752

0.26

0.21

0.21

670,812

636,474

271,053

255,438

374,746

342,907

0.29

0.25

0.25

283,284

0.35

0.18

0.20

259,964

562,141

539,380

636,341

607,195

0.16

0.14

0.14

449,267

424,242

49,769

47,149

174,584

164,221

120,747

109,926

49,871

47,493

5,744

4,200

5,397,185

0.06

0.04

0.05

5,454,961

0.04

0.02

0.02

2,635,767

2,564,082

0.12

0.09

0.09

3,251,327

0.18

0.19

0.18

3,182,015

0.03

0.03

0.03

295,331

274,147

55,615

51,693

2,017,140

0.25

0.13

0.16

2,131,579

0.05

0.03

0.03

1,441,543

0.14

0.26

0.21

1,484,897

0.07

0.03

0.05

3,364,779

0.03

0.03

0.03

3,404,840

0.03

0.03

0.03

1,724,239

0.06

0.04

0.04

1,655,235

0.12

0.10

0.10

2,980,563

2,756,345

0.04

0.02

0.03

106,961

94,002

9 11,635,225

0.08

0.07

0.07

11,526,898

0.05

0.04

0.04

1. 96 ICD-O-3 M-CODE p.497

- 241 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

C80

10 10
10

2 3

10 10
10

2 3

56

1,262,554

4.44

2.58

2.96

64

1,356,218

4.72

2.49

2.93

30

754,586

3.98

2.76

3.06

25

775,361

3.22

2.09

2.39

193,573

3.10

2.51

2.67

190,561

4.20

1.77

2.59

13

206,243

6.30

4.41

5.00

209,101

2.87

1.81

2.24

26

525,788

4.94

3.94

4.63

12

556,511

2.16

1.45

1.82

22

381,903

5.76

3.85

4.62

14

390,370

3.59

2.22

2.66

134,036

5.22

3.29

3.93

138,354

6.51

3.66

4.45

89

1,935,668

4.60

3.55

4.05

67

1,961,699

3.42

2.47

2.94

32

1,009,274

3.17

2.55

2.94

29

992,786

2.92

2.53

2.77

264,014

3.03

2.52

2.59

249,001

3.21

1.51

2.02

12

234,682

5.11

2.97

3.43

225,804

3.54

1.51

1.79

18

291,177

6.18

2.89

3.73

269,791

3.34

1.19

1.63

28

793,368

3.53

2.54

3.07

29

772,752

3.75

2.72

3.15

36

670,812

5.37

3.69

4.19

10

636,474

1.57

0.87

0.97

271,053

3.32

2.25

2.53

255,438

1.17

0.78

0.80

21

374,746

5.60

3.03

3.59

11

342,907

3.21

1.42

1.62

16

283,284

5.65

3.35

3.66

259,964

2.69

1.41

1.47

29

562,141

5.16

3.07

3.54

26

539,380

4.82

2.46

2.86

32

636,341

5.03

3.59

3.98

11

607,195

1.81

0.92

1.23

29

449,267

6.45

3.83

4.60

23

424,242

5.42

2.60

3.22

49,769

6.03

3.95

4.22

47,149

4.24

3.14

3.34

174,584

5.16

2.87

3.31

164,221

2.44

1.21

1.49

120,747

4.97

3.05

3.36

109,926

2.73

1.38

1.54

49,871

2.01

1.19

1.31

47,493

6.32

2.62

3.69

5,744

4,200

234

5,397,185

4.34

2.95

3.38

199

5,454,961

3.65

2.24

2.67

120

2,635,767

4.55

3.07

3.57

65

2,564,082

2.54

1.58

1.82

168

3,251,327

5.17

3.32

3.79

117

3,182,015

3.68

2.02

2.39

15

295,331

5.08

2.91

3.29

274,147

2.55

1.29

1.52

55,615

1.80

1.11

1.22

51,693

5.80

2.41

3.40

86

2,017,140

4.26

2.63

2.99

89

2,131,579

4.18

2.37

2.77

74

1,441,543

5.13

3.69

4.29

49

1,484,897

3.30

1.99

2.51

145

3,364,779

4.31

3.20

3.65

122

3,404,840

3.58

2.66

3.10

75

1,724,239

4.35

2.69

3.13

56

1,655,235

3.38

1.86

2.19

152

2,980,563

5.10

3.16

3.64

71

2,756,345

2.58

1.33

1.57

106,961

2.80

1.93

2.22

94,002

2.13

0.80

1.30

538 11,635,225

4.62

3.06

3.52

391

11,526,898

3.39

2.00

2.36

1. 96 ICD-O-3 M-CODE p.497

- 242 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

231

1,262,554

18.30

11.15

12.49

190

1,356,218

14.01

8.59

9.64

103

754,586

13.65

10.30

11.32

82

775,361

10.58

7.20

8.05

19

193,573

9.82

6.69

7.51

18

190,561

9.45

8.54

8.53

43

206,243

20.85

14.75

16.83

16

209,101

7.65

5.68

6.27

60

525,788

11.41

9.66

10.62

60

556,511

10.78

9.41

10.21

58

381,903

15.19

12.23

13.19

41

390,370

10.50

7.37

8.19

26

134,036

19.40

14.76

15.99

14

138,354

10.12

6.76

7.68

294

1,935,668

15.19

12.55

13.79

240

1,961,699

12.23

9.19

10.28

137

1,009,274

13.57

11.08

12.45

99

992,786

9.97

7.78

8.79

38

264,014

14.39

11.15

12.28

27

249,001

10.84

8.85

9.26

33

234,682

14.06

10.31

11.30

25

225,804

11.07

7.03

7.86

42

291,177

14.42

8.68

9.90

34

269,791

12.60

8.46

9.01

110

793,368

13.86

11.27

12.55

68

772,752

8.80

7.06

7.60

92

670,812

13.71

10.00

11.06

63

636,474

9.90

5.93

6.80

28

271,053

10.33

7.33

7.81

33

255,438

12.92

8.06

8.81

34

374,746

9.07

6.66

7.08

37

342,907

10.79

6.22

6.85

35

283,284

12.36

8.15

8.75

28

259,964

10.77

7.13

7.68

93

562,141

16.54

10.70

11.95

58

539,380

10.75

7.13

7.89

74

636,341

11.63

8.46

9.38

56

607,195

9.22

6.16

6.82

46

449,267

10.24

7.26

7.77

35

424,242

8.25

5.56

5.95

10

49,769

20.09

11.80

13.60

47,149

4.24

2.21

2.54

34

174,584

19.47

14.05

15.17

13

164,221

7.92

4.86

5.49

13

120,747

10.77

8.00

9.00

109,926

8.19

4.53

5.17

49,871

12.03

5.95

8.17

47,493

16.84

11.65

12.21

5,744

4,200

837

5,397,185

15.51

11.36

12.64

649

5,454,961

11.90

8.43

9.35

324

2,635,767

12.29

9.44

10.35

261

2,564,082

10.18

7.19

7.90

445

3,251,327

13.69

9.80

10.75

316

3,182,015

9.93

6.67

7.36

47

295,331

15.91

11.56

12.64

22

274,147

8.02

4.69

5.32

55,615

10.79

5.45

7.51

51,693

15.48

10.73

11.25

334

2,017,140

16.56

10.89

12.14

272

2,131,579

12.76

8.12

9.12

206

1,441,543

14.29

11.41

12.53

149

1,484,897

10.03

7.86

8.53

489

3,364,779

14.53

11.69

13.01

350

3,404,840

10.28

7.84

8.69

212

1,724,239

12.30

9.01

9.84

179

1,655,235

10.81

6.93

7.78

406

2,980,563

13.62

9.55

10.50

295

2,756,345

10.70

7.12

7.80

10

106,961

9.35

8.80

8.93

11

94,002

11.70

11.65

11.35

1,659 11,635,225

14.26

10.48

11.58

1,256

11,526,898

10.90

7.57

8.37

1. 96 ICD-O-3 M-CODE p.497

- 243 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

12

1,262,554

0.95

0.78

0.79

1,356,218

0.52

0.53

0.55

11

754,586

1.46

1.50

1.48

775,361

0.77

0.60

0.70

193,573

0.52

0.29

0.33

190,561

1.05

0.97

1.04

206,243

0.97

0.93

0.99

209,101

0.96

0.66

0.74

525,788

0.57

0.62

0.59

556,511

0.36

0.38

0.38

381,903

390,370

1.02

0.88

0.95

134,036

138,354

0.72

0.63

0.63

20

1,935,668

1.03

0.93

0.97

13

1,961,699

0.66

0.60

0.63

1,009,274

0.69

0.67

0.67

992,786

0.60

0.51

0.56

264,014

1.14

1.11

1.17

249,001

0.40

0.42

0.41

234,682

0.43

0.87

0.75

225,804

1.33

1.31

1.36

291,177

0.34

0.43

0.41

269,791

0.37

0.35

0.35

793,368

1.13

1.18

1.18

772,752

0.52

0.43

0.46

670,812

1.19

1.11

1.14

636,474

0.31

0.38

0.37

271,053

255,438

0.78

0.75

0.84

374,746

0.27

0.18

0.19

342,907

0.58

0.49

0.50

283,284

0.71

0.71

0.73

259,964

0.77

0.92

0.88

562,141

0.89

0.77

0.79

539,380

0.56

0.51

0.54

10

636,341

1.57

1.37

1.44

607,195

0.33

0.32

0.31

449,267

1.11

0.89

1.00

424,242

0.24

0.15

0.16

49,769

47,149

174,584

1.15

1.15

1.11

164,221

1.22

0.90

1.06

120,747

109,926

49,871

47,493

2.11

1.88

1.88

5,744

4,200

47

5,397,185

0.87

0.81

0.83

35

5,454,961

0.64

0.58

0.61

21

2,635,767

0.80

0.80

0.80

12

2,564,082

0.47

0.44

0.46

33

3,251,327

1.01

0.94

0.97

19

3,182,015

0.60

0.52

0.55

295,331

0.68

0.68

0.66

274,147

0.73

0.54

0.63

55,615

51,693

1.93

1.78

1.78

23

2,017,140

1.14

1.06

1.07

13

2,131,579

0.61

0.55

0.60

1,441,543

0.42

0.40

0.40

11

1,484,897

0.74

0.65

0.69

30

3,364,779

0.89

0.84

0.86

15

3,404,840

0.44

0.40

0.42

12

1,724,239

0.70

0.63

0.65

1,655,235

0.42

0.34

0.37

32

2,980,563

1.07

1.03

1.06

23

2,756,345

0.83

0.79

0.81

106,961

94,002

103 11,635,225

0.89

0.84

0.85

69

11,526,898

0.60

0.54

0.57

1. 96 ICD-O-3 M-CODE p.497

- 244 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

M-CODE

10 10
10

2 3

10 10
10

2 3

170

1,262,554

13.46

8.12

9.11

150

1,356,218

11.06

6.75

7.54

73

754,586

9.67

6.79

7.66

66

775,361

8.51

5.79

6.39

14

193,573

7.23

5.11

5.71

13

190,561

6.82

4.87

5.27

30

206,243

14.55

10.62

12.09

209,101

4.30

3.19

3.56

40

525,788

7.61

6.28

7.01

45

556,511

8.09

6.97

7.57

43

381,903

11.26

9.00

9.75

31

390,370

7.94

5.48

6.12

24

134,036

17.91

13.77

14.89

11

138,354

7.95

5.24

6.05

203

1,935,668

10.49

8.13

9.21

164

1,961,699

8.36

6.30

7.00

106

1,009,274

10.50

8.89

9.90

67

992,786

6.75

5.11

5.83

25

264,014

9.47

7.47

8.09

20

249,001

8.03

5.93

6.52

22

234,682

9.37

6.67

7.38

13

225,804

5.76

3.83

4.21

27

291,177

9.27

5.78

6.50

24

269,791

8.90

6.26

6.62

79

793,368

9.96

8.06

8.98

52

772,752

6.73

5.28

5.74

64

670,812

9.54

6.95

7.66

43

636,474

6.76

4.14

4.74

23

271,053

8.49

6.18

6.52

21

255,438

8.22

4.69

5.26

27

374,746

7.20

5.36

5.71

27

342,907

7.87

4.71

5.18

21

283,284

7.41

4.81

5.19

22

259,964

8.46

4.63

5.33

62

562,141

11.03

6.83

7.82

45

539,380

8.34

5.57

6.15

52

636,341

8.17

5.87

6.54

38

607,195

6.26

4.30

4.71

34

449,267

7.57

5.17

5.57

23

424,242

5.42

3.40

3.76

49,769

16.07

10.16

11.49

47,149

2.12

1.80

1.80

20

174,584

11.46

7.99

8.73

164,221

3.65

2.51

2.63

120,747

6.63

4.77

5.51

109,926

5.46

3.00

3.39

49,871

8.02

4.20

5.25

47,493

12.63

8.88

9.01

5,744

4,200

597

5,397,185

11.06

7.93

8.90

460

5,454,961

8.43

5.90

6.55

233

2,635,767

8.84

6.77

7.43

188

2,564,082

7.33

5.11

5.64

317

3,251,327

9.75

6.77

7.52

237

3,182,015

7.45

4.92

5.46

28

295,331

9.48

6.65

7.39

12

274,147

4.38

2.71

2.94

55,615

7.19

3.84

4.83

51,693

11.61

8.14

8.26

243

2,017,140

12.05

7.67

8.63

216

2,131,579

10.13

6.44

7.17

151

1,441,543

10.47

8.34

9.20

109

1,484,897

7.34

5.57

6.13

348

3,364,779

10.34

8.09

9.12

251

3,404,840

7.37

5.56

6.19

161

1,724,239

9.34

6.82

7.46

135

1,655,235

8.16

5.32

5.94

268

2,980,563

8.99

6.10

6.77

186

2,756,345

6.75

4.45

4.91

106,961

5.61

5.58

5.59

94,002

6.38

6.07

5.97

1,179 11,635,225

10.13

7.30

8.13

903

11,526,898

7.83

5.39

5.97

1. 96 ICD-O-3 M-CODE p.497

- 245 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)
M-CODE

10 10
10

2 3

10 10
10

2 3

37

1,262,554

2.93

1.45

1.76

28

1,356,218

2.06

1.12

1.31

15

754,586

1.99

1.37

1.60

775,361

1.16

0.72

0.87

193,573

2.07

1.29

1.46

190,561

1.05

0.78

0.81

206,243

4.36

2.06

2.82

209,101

1.91

1.34

1.52

13

525,788

2.47

2.09

2.29

556,511

1.62

1.34

1.50

13

381,903

3.40

2.82

3.03

390,370

1.28

0.86

0.94

134,036

0.75

0.47

0.54

138,354

1.45

0.88

0.99

52

1,935,668

2.69

2.27

2.46

47

1,961,699

2.40

1.74

1.99

19

1,009,274

1.88

1.27

1.54

19

992,786

1.91

1.54

1.77

264,014

2.27

1.68

1.87

249,001

1.61

1.38

1.41

234,682

1.70

1.00

1.16

225,804

2.66

1.42

1.62

10

291,177

3.43

1.76

2.12

269,791

2.59

1.47

1.62

17

793,368

2.14

1.62

1.90

772,752

1.04

0.61

0.77

13

670,812

1.94

1.21

1.43

13

636,474

2.04

1.06

1.24

271,053

0.74

0.41

0.49

255,438

3.52

2.49

2.56

374,746

1.07

0.74

0.79

342,907

1.75

0.71

0.83

10

283,284

3.53

2.17

2.32

259,964

1.15

0.75

0.74

24

562,141

4.27

2.86

3.08

539,380

1.67

1.00

1.11

636,341

1.41

0.93

1.06

12

607,195

1.98

1.23

1.37

449,267

1.56

1.19

1.20

10

424,242

2.36

1.50

1.57

49,769

2.01

1.20

1.32

47,149

174,584

5.16

3.52

3.99

164,221

2.44

1.21

1.46

120,747

1.66

1.09

1.27

109,926

1.82

0.92

1.12

49,871

4.01

1.75

2.91

47,493

2.11

0.88

1.33

5,744

4,200

141

5,397,185

2.61

1.76

2.02

117

5,454,961

2.14

1.43

1.63

49

2,635,767

1.86

1.28

1.47

45

2,564,082

1.76

1.10

1.25

80

3,251,327

2.46

1.72

1.88

50

3,182,015

1.57

0.97

1.07

11

295,331

3.72

2.52

2.88

274,147

2.19

1.07

1.30

55,615

3.60

1.61

2.68

51,693

1.93

0.81

1.21

52

2,017,140

2.58

1.43

1.71

37

2,131,579

1.74

0.98

1.15

40

1,441,543

2.77

2.05

2.33

22

1,484,897

1.48

1.06

1.18

84

3,364,779

2.50

2.04

2.26

62

3,404,840

1.82

1.34

1.49

29

1,724,239

1.68

1.07

1.23

29

1,655,235

1.75

1.00

1.15

76

2,980,563

2.55

1.63

1.83

65

2,756,345

2.36

1.34

1.51

106,961

1.87

2.03

2.01

94,002

4.26

3.72

3.77

283 11,635,225

2.43

1.66

1.88

219

11,526,898

1.90

1.21

1.36

1. 96 ICD-O-3 M-CODE p.497

- 246 -

99
GEOGRAPHIC VARIATION OF CRUDE AND AGE-STANDARDIZED CANCER INCIDENCE RATE
BY PRIMARY ANATOMIC SITES AND GENDER, 2010 (CONTINUED)

2. 10 2 1976
3. 10 3 2000
4.
5.
6.
7.
8.
9. 125

10. 50 125

11. 15 50
12.
13.
14.

- 247 -

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010

ICD-O-3

PRIMARY ANATOMIC SITES

C00-C80
C00-C14
3

C00-C14

LIP, ORAL CAVITY AND PHARYNX

ORAL CAVITY, OROPHARYNX AND HYPOPHARYNX

C44.0
LIPexcludes skin of lip C44.0

C01-C02

OTHER AND UNSPECIFIED PARTS OF MOUTH

C09-C10

C07-C08
C11
C15-C26, C48
C15
C16
C17

942

HYPOPHARYNX

C14

PHARYNX AND ILL-DEFINED SITES IN LIP, ORAL CAVITY AND PHARYNX

72
236

MAJOR SALIVARY GLANDS

1,571

NASOPHARYNX

DIGESTIVE ORGANS AND PERITONEUM

34,255
2,238

ESOPHAGUS

3,854

STOMACH

325

SMALL INTESTINE

1. 96
2. MV%Percentage of morphologically verified cases.
3. ICD-O-3

2,269
635

OROPHARYNX

C12-C13

228

164

FLOOR OF MOUTH

C05-C06

6,560

445

GUM

C04

8,367

1,805

TONGUE

C03

CASE
NUMBER

90,649

ALL SITES

C00

C00-C06C09-C10C12-C14

- 248 -

Morphological confirmation

Clinical confirmation

/
Histology

Unknown
Method

Cytology

MV%

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

ICD-O-3
Unknown

79,719

2,245

90.42

1,783

91

6,116

695

79,719 C00-C80

8,260

15

98.90

12

32

48

8,260 C00-C14

6,482

98.90

10

25

37

6,482 C00-C143

227

99.56

1,789

99.11

444

99.78

444 C03

164

100.00

164 C04

2,251

99.21

10

2,251 C05-C06

620

97.95

620 C09-C10

918

97.88

11

918 C12-C13

69

95.83

225

98.31

1,553

98.98

26,802

517

79.75

1,670

68

4,918

280

2,202

98.39

17

13

2,202 C15

3,777

98.18

11

37

20

3,777 C16

318

97.85

318 C17

- 249 -

227 C00
1,789 C01-C02

69 C14
225 C07-C08
1,553 C11
26,802 C15-C26, C48

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C18-C21

COLON, RECTUM, RECTOSIGMOID JUNCTION AND ANUS

C18

C22
C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
4

C42

C40-C41

RECTUM, RECTOSIGMOID JUNCTION AND ANUS

LIVER AND INTRAHEPATIC BILE DUCTS

GALLBLADDER AND EXTRAHEPATIC BILE DUCTS

14,040

5,405
11,023
924
1,643

PANCREAS

RETROPERITONEUM AND PERITONEUM

OTHER AND ILL-DEFINED SITES WITHIN DIGESTIVE ORGANS AND PERITONEUM

RESPIRATORY SYSTEM AND INTRATHORACIC ORGANS

NASAL CAVITIES, ACCESSORY SINUSES, MIDDLE EAR AND INNER EAR

157
51
11,761
172
635

LARYNX

TRACHEA, BRONCHUS AND LUNG

10,615
62

PLEURA

THYMUS, HEART AND MEDIASTINUM

276
1,823

LEUKEMIA

BONES, JOINTS AND ARTICULAR CARTILAGE

1. 96
2. MV%Percentage of morphologically verified cases.
4. ICD-O-3

CASE
NUMBER

8,635

COLON

C19-C21

M-CODE p.497

- 250 -

163

Morphological confirmation

Clinical confirmation

/
Histology

MV%2

Unknown
Method

Cytology

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

ICD-O-3
Unknown

13,673

17

97.51

23

27

198

102

8,338

15

96.73

18

19

160

85

- C18

5,335

98.74

38

17

- C19-C21

4,943

324

47.78

1,583

4,077

88

- C22

732

18

81.17

11

145

15

- C23-C24

977

142

68.11

50

13

422

39

- C25

138

89.81

14

- C48

42

94.12

- C26

9,646

1,348

93.48

30

602

134

- C30-C39

168

97.67

- C30-C31

624

98.43

- C32

8,541

1,343

93.11

29

584

117

55

95.16

- C38.4

258

93.48

12

- C37-C38.3, C38.8

1,794

98.85

17

155

95.09

- 251 -

- C18-C21

- C33-C34

- C424
- C40-C41

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C47, C49
C44
5

C44
C44
C50
C50

C51-C58
C55
C53
C54
C56, C57.0-C57.4

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

C61
C62
C60,C63
C64-C68

508

212

SKIN, MALIGNANT MELANOMA

SKIN (excludes MALIGNANT MELANOMA)

2,766
9,655

FEMALE BREAST

39

MALE BREAST

4,822

FEMALE GENITAL ORGANS

UTERUS, NOS

1,680

CERVIX UTERI

1,737

CORPUS UTERI

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

1,245
152
4,661

MALE GENITAL ORGANS

4,392

PROSTATE GLAND

178

TESTIS

PENIS AND OTHER MALE GENITAL ORGANS

91
4,441

URINARY TRACT

1. 96
2. MV%Percentage of morphologically verified cases.
5. ICD-O-3

CASE
NUMBER

2,978

SKIN

C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63

C44 M-87203 - M-87903

- 252 -

Morphological confirmation

Clinical confirmation

/
Histology

MV%2

Unknown
Method

Cytology

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

ICD-O-3
Unknown

496

97.83

2,956

99.33

15

- C44

207

98.11

- C445

2,749

99.42

12

- C44

9,593

15

99.51

29

17

- C50

39

100.00

- C50

4,680

55

98.20

41

37

75.00

- C55

1,649

21

99.40

- C53

1,730

99.65

- C54

1,146

33

94.70

30

27

149

98.03

4,568

98.05

45

26

20

- C60-C63

4,302

98.00

45

24

19

- C61

177

99.44

- C62

89

97.80

- C60,C63

4,162

88

95.70

152

32

- C64-C68

- 253 -

- C47, C49

- C51-C58

- C56, C57.0-C57.4
- C51-C52, C57.7-C57.9

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS IN PRIMARY ANATOMIC SITES, 2010
CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80

CASE
NUMBER

1,964

BLADDER

1,028

KIDNEY

744

RENAL PELVIS

451

URETER

URETHRA AND PARAURETHRAL GLAND

OVERLAPPING LESION OF URINARY ORGANS

24
11
219

URINARY SYSTEM, NOS

61

EYE AND LACRIMAL GLAND

BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM

789
734

BRAIN

OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM

55
2,409

THYROID GLAND

51

OTHER ENDOCRINE GLANDS

15

OTHER AND ILL-DEFINED SITES

929

UNKNOWN PRIMARY SITES

MALIGNANT LYMPHOMAM-CODE
1. 96
2. MV%Percentage of morphologically verified cases.

- 254 -

2,915

Morphological confirmation

Clinical confirmation

/
Histology

MV%2

Unknown
Method

Cytology

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

ICD-O-3
Unknown

1,911

19

98.27

14

18

- C67

908

89.11

99

10

- C64

688

31

96.64

23

- C65

427

13

97.56

- C66

24

100.00

- C68.0-C68.1

10

90.91

- C68.8

194

17

96.35

- C68.9

47

77.05

12

- C69

675

85.68

82

29

- C70-C72

631

86.10

76

24

- C71

44

80.00

- C70, C72

2,336

54

99.21

13

- C73

43

84.31

- C74-C75

10

73.33

- C76

612

109

77.61

169

32

- C80

2,843

29

98.52

18

14

11

- 255 -

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS OF LEUKEMIA AND LYMPHOMA, 2010

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

1,823

LEUKEMIA AND MYELOID NEOPLSAM, TOTAL

734

ACUTE MYELOID LEUKEMIA

235

ACUTE LYMPHOBLASTIC LEUKEMIA

225

CHRONIC MYELOID LEUKEMIA

135

CHRONIC LYMPHOCYTIC LEUKEMIA

35

ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE

230

MYELOPROLIFERATIVE NEOPLASMS

200

MYELODYSPLASTIC SYNDROMES

ACUTE BIPHENOTYPIC LEUKEMIA

13

OTHER LEUKEMIA

12

LEUKEMIA, NOS
1. 96
2. MV%Percentage of morphologically verified cases.

- 256 -

Morphological confirmation

Clinical confirmation

/
Histology

MV%2

Unknown
Method

Cytology

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

Unknown

1,794

98.85

17

731

99.86

235

100.00

222

99.11

134

99.26

33

97.14

223

97.83

190

96.00

100.00

12

92.31

10

83.33

- 257 -

99
METHODS OF ESTABLISHING CANCER DIAGNOSIS OF LEUKEMIA AND LYMPHOMA, 2010
CONTINUED

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

2,915

MALIGNANT LYMPHOMA

172

HODGKIN LYMPHOMA

2,082

NON-HODGKIN LYMPHOMA

1,750

B-cell lymphoid neoplasms

T/NK

332

T/NK-cell lymphoid neoplasms

502

Plasma cell neoplasm

26

Other LPD

133

Malignant lymphoma, NOS and others


1. 96
2. MV%Percentage of morphologically verified cases.

- 258 -

Morphological confirmation

Clinical confirmation

/
Histology

MV%2

Unknown
Method

Cytology

Laboratory
Test/Marker
Study

Surgical
Exploration/
Endoscopy

Imaging
Techniques

Clinical
diagnosis

Unknown

2,843

29

98.52

18

14

11

172

100.00

2,071

99.81

1,741

99.83

330

99.70

473

95.22

17

26

100.00

101

17

88.72

- 259 -

99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010

ICD-O-3

PRIMARY ANATOMIC SITES

C00-C80
C00-C14
3

C00-C14

LIP, ORAL CAVITY AND PHARYNX

ORAL CAVITY, OROPHARYNX AND HYPOPHARYNX

C44.0
LIPexcludes skin of lip C44.0

C01-C02

OTHER AND UNSPECIFIED PARTS OF MOUTH

C09-C10

C07-C08
C11
C15-C26, C48
C15
C16
C17

942

HYPOPHARYNX

C14

2,269
635

OROPHARYNX

C12-C13

228

164

FLOOR OF MOUTH

C05-C06

6,560

445

GUM

C04

8,367

1,805

TONGUE

C03

CASE NUMBER

90,649

ALL SITES

C00

PHARYNX AND ILL-DEFINED SITES IN LIP, ORAL CAVITY AND PHARYNX

72
236

MAJOR SALIVARY GLANDS

1,571

NASOPHARYNX

DIGESTIVE ORGANS AND PERITONEUM

34,255
2,238

ESOPHAGUS

3,854

STOMACH

325

SMALL INTESTINE

1. 96 ICD-O-3 M-CODE p.497

2.
3. ICD-O-3

C00-C06C09-C10C12-C14

- 260 -

Surgery

49,897

Radiotherapy Chemotherapy

METHODS OF CANCER TREATMENT

Immunotherapy Hematologic Palliative care


transplant/
Endocrine
procedure

Hormone/
Steroid
therapy

(55.04) 23,904 (26.37) 38,868 (42.88) 12,582 (13.88)

889

(0.98)

475

(0.52) 13,031 (14.38)

ICD-O-3
No therapy
record

9,117 (10.06) C00-C80

4,559

(54.49)

4,892 (58.47)

4,537 (54.22)

(0.01)

706

(8.44)

468

(5.59) C00-C14

4,358

(66.43)

3,354 (51.13)

3,176 (48.41)

(0.02)

575

(8.77)

367

(5.59) C00-C143

194

(85.09)

57 (25.00)

50 (21.93)

(3.07)

17

(7.46) C00

1,413

(78.28)

758 (41.99)

707 (39.17)

(0.06)

112

(6.20)

87

(4.82) C01-C02

352

(79.10)

252 (56.63)

226 (50.79)

39

(8.76)

18

(4.04) C03

130

(79.27)

77 (46.95)

63 (38.41)

15

(9.15)

11

(6.71) C04

1,761

(77.61)

945 (41.65)

889 (39.18)

170

(7.49)

138

(6.08) C05-C06

225

(35.43)

483 (76.06)

476 (74.96)

85 (13.39)

29

(4.57) C09-C10

256

(27.18)

737 (78.24)

714 (75.80)

137 (14.54)

60

(6.37) C12-C13

27

(37.50)

45 (62.50)

51 (70.83)

10 (13.89)

192

(81.36)

131 (55.51)

63 (26.69)

10

(4.24)

17

(7.20) C07-C08

(0.57)

1,407 (89.56)

1,298 (82.62)

121

(7.70)

84

(5.35) C11

17,892

(52.23)

4,978 (14.53) 12,753 (37.23)

168

(0.49)

6,224 (18.17)

693

(30.97)

1,540 (68.81)

1,497 (66.89)

(0.04)

668 (29.85)

208

2,351

(61.00)

359

(9.31)

1,620 (42.03)

(0.03)

784 (20.34)

542 (14.06) C16

222

(68.31)

16

(4.92)

106 (32.62)

59 (18.15)

42 (12.92) C17

- 261 -

(9.72) C14

4,509 (13.16) C15-C26, C48

(9.29) C15

99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010 CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C18-C21

COLON, RECTUM, RECTOSIGMOID JUNCTION AND ANUS

C18

C22

C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
5

C42

C40-C41

CASE NUMBER

14,040
8,635

COLON

C19-C21

RECTUM, RECTOSIGMOID JUNCTION AND ANUS

LIVER AND INTRAHEPATIC BILE DUCTS

GALLBLADDER AND EXTRAHEPATIC BILE DUCTS

5,405
11,023
924
1,643

PANCREAS

RETROPERITONEUM AND PERITONEUM

OTHER AND ILL-DEFINED SITES WITHIN DIGESTIVE ORGANS AND


PERITONEUM

RESPIRATORY SYSTEM AND INTRATHORACIC ORGANS

NASAL CAVITIES, ACCESSORY SINUSES, MIDDLE EAR AND INNER EAR

157
51

11,761
172
635

LARYNX

TRACHEA, BRONCHUS AND LUNG

10,615
62

PLEURA

THYMUS, HEART AND MEDIASTINUM

276
1,823

LEUKEMIA

BONES, JOINTS AND ARTICULAR CARTILAGE

163

1. 96 ICD-O-3 M-CODE p.497

2.
4. 43
5. ICD-O-3

M-CODE p.497

- 262 -

Surgery

Radiotherapy Chemotherapy

11,083

(78.94)

1,773 (12.63)

6,768

(78.38)

4,315

(79.83)

2,606

(23.64)

878

475

METHODS OF CANCER TREATMENT

Immunotherapy Hematologic Palliative care


transplant/
Endocrine
procedure

Hormone/
Steroid
therapy

ICD-O-3
No therapy
record

7,368 (52.48)

1,479 (10.53)

(2.63)

4,295 (49.74)

935 (10.83)

889 (10.30) C18

1,546 (28.60)

3,073 (56.85)

544 (10.06)

409

(7.97)

1,151 (10.44)

165

(1.50)

2,192 (19.89)

(51.41)

119 (12.88)

226 (24.46)

285 (30.84)

168 (18.18) C23-C24

328

(19.96)

251 (15.28)

712 (43.34)

730 (44.43)

322 (19.60) C25

110

(70.06)

39 (24.84)

46 (29.30)

(0.64)

16 (10.19)

18 (11.46) C48

24

(47.06)

(5.88)

27 (52.94)

11 (21.57)

6 (11.76) C26

2,630

(22.36)

3,486 (29.64)

6,928 (58.91)

17

(0.14)

3,685 (31.33)

109

(63.37)

95 (55.23)

69 (40.12)

(1.16)

14

(8.14)

20 (11.63) C30-C31

308

(48.50)

377 (59.37)

213 (33.54)

32

(5.04)

65 (10.24) C32

2,054

(19.35)

2,887 (27.20)

6,489 (61.13)

15

(0.14)

3,578 (33.71)

15

(24.19)

(9.68)

37 (59.68)

18 (29.03)

14 (22.58) C38.4

144

(52.17)

121 (43.84)

120 (43.48)

43 (15.58)

35 (12.68) C37-C38.3, C38.8

(0.05)

248 (13.60)

(0.44)

97

(5.32)

267 (14.65)

116

(71.17)

227

50

(2.74)

1,294 (70.98)

32 (19.63)

96 (58.90)

- 263 -

16

(9.82)

1,298

(9.25) C18-C21

(7.57) C19-C21
4

1,905 (17.28) C22

1,669 (14.19) C30-C39

1,534 (14.45) C33-C34

46

(2.52) C425

20 (12.27) C40-C41

99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C47, C49
C44
6

C44
C44
C50
C50

C51-C58
C55
C53
C54
C56, C57.0-C57.4

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

C61
C62
C60,C63
C64-C68

CASE NUMBER

508
2,978

SKIN

212

SKIN, MALIGNANT MELANOMA

SKIN (excludes MALIGNANT MELANOMA)

2,766
9,655

FEMALE BREAST

39

MALE BREAST

4,822

FEMALE GENITAL ORGANS

UTERUS, NOS

1,680

CERVIX UTERI

1,737

CORPUS UTERI

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63

1,245
152
4,661

MALE GENITAL ORGANS

4,392

PROSTATE GLAND

178

TESTIS

PENIS AND OTHER MALE GENITAL ORGANS

91
4,441

URINARY TRACT

1. 96 ICD-O-3 M-CODE p.497

2.
6. ICD-O-3

C44 M-87203 - M-87903

- 264 -

Surgery

Radiotherapy Chemotherapy

METHODS OF CANCER TREATMENT

Immunotherapy Hematologic Palliative care


transplant/
Endocrine
procedure

Hormone/
Steroid
therapy

ICD-O-3
No therapy
record

386

(75.98)

190 (37.40)

91 (17.91)

(0.20)

34

(6.69)

2,664

(89.46)

202

75

(2.52)

16

(0.54)

55

(1.85)

172

(81.13)

25 (11.79)

12

(5.66)

12

(5.66)

2,492

(90.09)

50

(0.14)

43

(1.55)

186

(6.72) C44

8,808

(91.23)

4,344 (44.99)

6,521 (67.54)

6,066 (62.83)

22

(0.23)

298

(3.09)

255

(2.64) C50

33

(84.62)

9 (23.08)

18 (46.15)

28 (71.79)

(5.13)

(7.69) C50

3,648

(75.65)

1,516 (31.44)

2,081 (43.16)

21

(0.44)

226

(4.69)

272

(50.00)

1 (12.50)

2 (25.00)

1 (12.50)

1 (12.50)

878

(52.26)

940 (55.95)

720 (42.86)

(0.18)

(0.18)

108

(6.43)

120

(7.14) C53

1,580

(90.96)

500 (28.79)

395 (22.74)

160

(9.21)

12

(0.69)

39

(2.25)

68

(3.91) C54

1,103

(88.59)

24

(1.93)

925 (74.30)

17

(1.37)

(0.40)

64

(5.14)

52

(4.18) C56, C57.0-C57.4

83

(54.61)

51 (33.55)

39 (25.66)

13

(8.55)

30 (19.74) C51-C52, C57.7-C57.9

2,113

(45.33)

1,324 (28.41)

119

(2.55)

2,700 (57.93)

(0.02)

272

(5.84)

380

(8.15)

348

(7.47) C60-C63

1,873

(42.65)

1,272 (28.96)

46

(1.05)

2,698 (61.43)

269

(6.12)

374

(8.52)

339

(7.72) C61

160

(89.89)

43 (24.16)

80

(87.91)

3,587

(80.77)

370

(6.78)

31 (14.62)

171

(6.18)

(1.81)

181

(3.75)

2 (25.00)

53 (10.43) C47, C49

209

(7.02) C44

23 (10.85) C446

(5.64) C51-C58

2 (25.00) C55

61 (34.27)

(1.12)

(1.69)

(1.69)

(2.25) C62

(9.89)

12 (13.19)

(1.10)

(3.30)

(5.49) C60,C63

(8.33)

1,501 (33.80)

(0.05)

434

(9.77)

349

(7.86)

438

(9.86) C64-C68

- 265 -

99
METHODS OF CANCER TREATMENT IN PRIMARY ANATOMIC SITES, 2010 CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80

CASE NUMBER

1,964

BLADDER

1,028

KIDNEY

744

RENAL PELVIS

451

URETER

URETHRA AND PARAURETHRAL GLAND

OVERLAPPING LESION OF URINARY ORGANS

24
11
219

URINARY SYSTEM, NOS

61

EYE AND LACRIMAL GLAND

BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM

789
734

BRAIN

OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM

55
2,409

THYROID GLAND

51

OTHER ENDOCRINE GLANDS

15

OTHER AND ILL-DEFINED SITES

929

UNKNOWN PRIMARY SITES

2,915

MALIGNANT LYMPHOMA

1. 96 ICD-O-3 M-CODE p.497

2.

- 266 -

Surgery

Radiotherapy Chemotherapy

METHODS OF CANCER TREATMENT

ICD-O-3

Immunotherapy Hematologic Palliative care


transplant/
Endocrine
procedure

Hormone/
Steroid
therapy

1,738

(88.49)

188

(9.57)

955 (48.63)

(0.05)

394 (20.06)

739

(71.89)

46

(4.47)

136 (13.23)

(0.10)

16

571

(76.75)

69

(9.27)

202 (27.15)

336

(74.50)

43

(9.53)

111 (24.61)

22

(91.67)

5 (20.83)

(8.33)

10

(90.91)

171

(78.08)

19

44

No therapy
record

120

(6.11)

109

(1.56)

92

(8.95)

150 (14.59) C64

(0.27)

70

(9.41)

84 (11.29) C65

(0.89)

43

(9.53)

62 (13.75) C66

(4.17)

(4.17) C68.0-C68.1

3 (27.27)

(9.09)

(9.09)

(9.09) C68.8

(8.68)

92 (42.01)

17

(7.76)

(72.13)

12 (19.67)

17 (27.87)

575

(72.88)

482 (61.09)

364 (46.13)

(0.13)

(0.13)

58

(7.35)

78

(9.89) C70-C72

535

(72.89)

461 (62.81)

359 (48.91)

(0.14)

(0.14)

55

(7.49)

69

(9.40) C71

40

(72.73)

21 (38.18)

(9.09)

(5.45)

2,241

(93.03)

1,365 (56.66)

26

(1.08)

1,688 (70.07)

46

(1.91)

89

33

(64.71)

8 (15.69)

(7.84)

10 (19.61) C74-C75

(33.33)

104

457

22 (10.05)

(5.55) C67

31 (14.16) C68.9

(4.92) C69

9 (16.36) C70, C72

(3.69) C73

17 (33.33)

(3.92)

4 (26.67)

4 (26.67)

7 (46.67) C76

(11.19)

155 (16.68)

279 (30.03)

(0.32)

(0.11)

316 (34.02)

345 (37.14) C80

(15.68)

488 (16.74)

2,147 (73.65)

1,666 (57.15)

220

(7.55)

81

(2.78)

360 (12.35)

292 (10.02)

- 267 -

99
METHODS OF CANCER TREATMENT OF LEUKEMIA AND LYMPHOMA, 2010

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

1,823

LEUKEMIA AND MYELOID NEOPLSAM, TOTAL

734

ACUTE MYELOID LEUKEMIA

235

ACUTE LYMPHOBLASTIC LEUKEMIA

225

CHRONIC MYELOID LEUKEMIA

135

CHRONIC LYMPHOCYTIC LEUKEMIA

35

ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE

230

MYELOPROLIFERATIVE NEOPLASMS

200

MYELODYSPLASTIC SYNDROMES

ACUTE BIPHENOTYPIC LEUKEMIA

13

OTHER LEUKEMIA

12

LEUKEMIA, NOS
1. 96 ICD-O-3 M-CODE p.497

2.

- 268 -

METHODS OF CANCER TREATMENT

Surgery

Radiotherapy

Chemotherapy

Steroid
therapy

Immunotherapy

Hematologic
transplant/
Endocrine
procedure

Palliative care

No therapy
record

(0.05)

50

(2.74)

1,294

(70.98)

248

(13.60)

(0.44)

97

(5.32)

267

(14.65)

46

(2.52)

(0.14)

15

(2.04)

578

(78.75)

46

(6.27)

(0.68)

59

(8.04)

151

(20.57)

11

(1.50)

26

(11.06)

219

(93.19)

156

(66.38)

29

(12.34)

18

(7.66)

(0.85)

(2.22)

206

(91.56)

(0.44)

(1.78)

15

(6.67)

(1.33)

79

(58.52)

32

(23.70)

(3.70)

(4.44)

17

(48.57)

(8.57)

12

(34.29)

(8.57)

(0.43)

145

(63.04)

(1.30)

12

(5.22)

(0.87)

(0.50)

35

(17.50)

(1.00)

(2.00)

48

(24.00)

16

(8.00)

(25.00)

4 (100.00)

(25.00)

(25.00)

(7.69)

(69.23)

(38.46)

(15.38)

(30.77)

(16.67)

(16.67)

(25.00)

- 269 -

99
METHODS OF CANCER TREATMENT OF LEUKEMIA AND LYMPHOMA, 2010
CONTINUED

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

2,915

MALIGNANT LYMPHOMA

172

HODGKIN LYMPHOMA

2,082

NON-HODGKIN LYMPHOMA

1,750

B-cell lymphoid neoplasms

T/NK

332

T/NK-cell lymphoid neoplasms

502

Plasma cell neoplasm

26

Other LPD

133

Malignant lymphoma, NOS and others


1. 96 ICD-O-3 M-95903 - M-97293
M-97503 - M-97583M-97643
2.

- 270 -

METHODS OF CANCER TREATMENT

Surgery

Radiotherapy

Chemotherapy

Steroid
therapy

Immunotherapy

Hematologic
transplant/
Endocrine
procedure

Palliative care

No therapy
record

457

(15.68)

488

(16.74)

2,147

(73.65)

1,666

(57.15)

220

(7.55)

81

(2.78)

360

(12.35)

292

(10.02)

26

(15.12)

65

(37.79)

151

(87.79)

30

(17.44)

(1.74)

10

(5.81)

(5.23)

384

(18.44)

301

(14.46)

1,570

(75.41)

1,287

(61.82)

10

(0.48)

33

(1.59)

192

(9.22)

225

(10.81)

338

(19.31)

254

(14.51)

1,322

(75.54)

1,091

(62.34)

(0.17)

25

(1.43)

161

(9.20)

181

(10.34)

46

(13.86)

47

(14.16)

248

(74.70)

196

(59.04)

(2.11)

(2.41)

31

(9.34)

44

(13.25)

20

(3.98)

105

(20.92)

351

(69.92)

297

(59.16)

206

(41.04)

44

(8.76)

138

(27.49)

12

(2.39)

15

(57.69)

(7.69)

19

(73.08)

11

(42.31)

(11.54)

(3.85)

12

(9.02)

15

(11.28)

56

(42.11)

41

(30.83)

(0.75)

(0.75)

20

(15.04)

45

(33.83)

- 271 -

10 99
RANKING OF CANCER INCIDENCE RATE BY PRIMARY ANATOMIC SITES IN VARIOUS
AGE GROUPS, 2010

0-9

10-19

20-29

(M-980-999)4

(M-980-999)4

(M-980-999)4

(C73)

(C62)

(C73)

41
3.70
26.28%

48
4.73
40.34%

53
3.27
22.18%

26
1.74
14.21%

77
4.34
14.53%

191
11.24
27.56%

(C70-C72)

(C70-C72)

(C70-C72)

(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4

(M-980-999)4

(C50)

34
3.07
21.79%

25
2.47
21.01%

33
2.04
13.81%

22
1.48
12.02%

56
3.16
10.57%

105
6.18
15.15%

(M-959-976)4

(C74-C75)

(M-959-976)4

(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4

(M-959-976)4

(C56, C57.0-C57.4)

16
1.44
10.26%

8
0.79
6.72%

27
1.67
11.30%

22
1.48
12.02%

44
2.48
8.30%

65
3.83
9.38%

(C69)

(C69)

(C40-C41)

(C56,C57.0-C57.4)
(C70-C72)(M-980-999)4

(C18-C21)

(M-959-976)4
(M-980-999)4

14
1.26
8.97%

7
0.69
5.88%

25
1.54
10.46%

22
1.48
12.02%

42
2.37
7.92%

39
2.30
5.63%

(C22)

(M-959-976)4

(C62)(M-965966)4

(C40-C41)

(C22)

(M-959-976)4
(M-980-999)4

10
0.90
6.41%

6
0.59
5.04%

18
1.11
7.53%

20
1.34
10.93%

41
2.31
7.74%

39
2.30
5.63%

1. 96
2. ICD-O-3
3. 10

- 272 -

30-39

40-49

50-59

60-69

70+

(C00-C14) 5

(C50)

(C00-C14) 5

(C50)

(C00-C14) 5

(C50)

(C18-C21)

(C50)

(C33-C34)

(C18-C21)

475
24.98
23.61%

832
43.35
34.88%

1,686
89.46
27.98%

2,949
156.64
44.65%

2,104
126.95
18.90%

3,142
185.31
32.86%

2,188
256.72
19.96%

1,591
174.48
20.64%

3,672
438.73
18.60%

2,473
270.54
19.88%

(C22)

(C73)

(C22)

(C73)

(C22)

(C18-C21)

(C22)

(C18-C21)

(C18-C21)

(C33-C34)

268
14.09
13.32%

315
16.41
13.21%

1,044
55.40
17.32%

517
27.46
7.83%

2,037
122.90
18.30%

1,296
76.44
13.55%

1,906
223.63
17.39%

1,406
154.19
18.24%

3,234
386.40
16.38%

1,758
192.32
14.14%

(C18-C21)

(C18-C21)

(C18-C21)

(C18-C21)

(C18-C21)

(C33-C34)

(C33-C34)

(C33-C34)

(C61)

(C22)

217
11.41
10.79%

181
9.43
7.59%

635
33.69
10.54%

510
27.09
7.72%

1,825
110.11
16.39%

821
48.42
8.59%

1,480
173.65
13.50%

888
97.39
11.52%

3,025
361.43
15.32%

1,725
188.71
13.87%

(C11)

(C53)

(C15)

(C54)

(C33-C34)

(C54)

(C00-C14) 5

(C22)

(C22)

(C50)

184
9.68
9.15%

153
7.97
6.42%

508
26.96
8.43%

409
21.72
6.19%

1,056
63.71
9.49%

719
42.41
7.52%

1,070
125.54
9.76%

870
95.41
11.29%

2,442
291.77
12.37%

1,036
113.34
8.33%

(C73)

(C56, C57.0C57.4)

(C33-C34)

(C33-C34)

(C15)

(C22)

(C61)

(C54)

(C16)

(C44)

123
6.47
6.11%

145
7.56
6.08%

392
20.80
6.51%

374
19.87
5.66%

746
45.01
6.70%

489
28.78
5.10%

1,043
122.38
9.52%

307
33.67
3.98%

1,304
155.80
6.61%

857
93.75
6.89%

4. ICD-O-3
5. ICD-O-3

M-CODE p.497

C00-C06C09-C10C12-C14

- 273 -

10 99
RANKING OF CANCER INCIDENCE RATE BY PRIMARY ANATOMIC SITES IN VARIOUS
AGE GROUPS, 2010CONTINUED

0-9

10-19

20-29

(C64.9)

(C22)

(C62)(M-965966)4

(C47, C49)

(C73)

(M-965-966)4

9
0.81
5.77%

5
0.49
4.20%

18
1.11
7.53%

16
1.07
8.74%

39
2.20
7.36%

30
1.77
4.33%

(C74-C75)

(C40-C41)(C47,
C49)(C64.9)

(C47, C49)

(M-959-976)4

(C11)

(C18-C21)

7
0.63
4.49%

3
0.30
2.52%

13
0.80
5.44%

9
0.60
4.92%

32
1.80
6.04%

27
1.59
3.90%

(C62)

(C40-C41)(C47,
C49)(C64.9)

(C11)

(M-965-966)4

(C70-C72)

(C54)

5
0.45
3.21%

3
0.30
2.52%

10
0.62
4.18%

7
0.47
3.83%

29
1.63
5.47%

26
1.53
3.75%

(C40-C41)(C47,
C49)(M-965-966)4

(C40-C41)(C47,
C49)(C64.9)

(C37-C38.3, C38.8)
(C48)

(C44)

(C44)

(C44)

4
0.36
2.56%

3
0.30
2.52%

6
0.37
2.51%

6
0.40
3.28%

26
1.47
4.91%

25
1.47
3.61%

(C40-C41)(C47,
C49)(M-965-966)4

(C48)(C51C52)(C56-C57)

(C37-C38.3, C38.8)
(C48)

(C18-C21)

(M-965-966)4

(C70-C72)

10

4
0.36
2.56%

2
0.20
1.68%

6
0.37
2.51%

4
0.27
2.19%

23
1.30
4.34%

18
1.06
2.60%

1. 96
2. ICD-O-3
3. 10

- 274 -

30-39

40-49

50-59

60-69

70+

(M-980-999)4

(C54)

(C11)

(C53)

(C16)

(C73)

(C16)

(C53)

(C44)

(C16)

90
4.73
4.47%

120
6.25
5.03%

332
17.62
5.51%

360
19.12
5.45%

448
27.03
4.02%

470
27.72
4.92%

446
52.33
4.07%

292
32.02
3.79%

916
109.44
4.64%

708
77.45
5.69%

(C33-C34)

(M-980-999)4

(C16)

(C56, C57.0C57.4)

(C11)

(C53)

(C15)

(C16)

(C67)

(C65-C66,
C68)

86
4.52
4.27%

76
3.96
3.19%

164
8.70
2.72%

306
16.25
4.63%

372
22.45
3.34%

464
27.37
4.85%

404
47.40
3.69%

269
29.50
3.49%

804
96.06
4.07%

436
47.70
3.51%

(M-959-976)4

(C33-C34)

(C73)

(C16)

(C61)

(C56, C57.0C57.4)

(C44)

(C65-C66,
C68)

(C00-C14) 5

(C53)

77
4.05
3.83%

69
3.60
2.89%

125
6.63
2.07%

149
7.91
2.26%

301
18.16
2.70%

365
21.53
3.82%

275
32.27
2.51%

212
23.25
2.75%

669
79.93
3.39%

395
43.21
3.18%

(C44)

(M-959-976)4

(M-959-976)4

(C22)

(C67)

(C16)

(C67)

(C44)

(M-959-976)4

(C25)

63
3.31
3.13%

64
3.33
2.68%

119
6.31
1.97%

122
6.48
1.85%

225
13.58
2.02%

249
14.69
2.60%

274
32.15
2.50%

202
22.15
2.62%

456
54.48
2.31%

391
42.78
3.14%

(C15)

(C11)

(M-980-999)4

(M-959-976)4

(M-959-976)4

(C44)

(M-959-976)4

(C73)

(C25)

(M-959-976)4

62
3.26
3.08%

56
2.92
2.35%

111
5.89
1.84%

114
6.06
1.73%

215
12.97
1.93%

180
10.62
1.88%

225
26.40
2.05%

198
21.71
2.57%

434
51.85
2.20%

302
33.04
2.43%

4. ICD-O-3
5. ICD-O-3

M-CODE p.497

C00-C06C09-C10C12-C14

- 275 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010

ORAL CAVITY, OROPHARYNX AND HYPOPHARYNX

ICD-O-3
80323
80703
80723
80743
80763

80523
80713
80733
80753
80833

MORPHOLOGY

GENDER

CASE
NUMBER

SQUAMOUS CELL CARCINOMA

80513

VERRUCOUS CARCINOMA

80203

CARCINOMA, UNDIFFERENTIATED

81403
82003
83103
84803
85503

81473
82603
84303
85253
85603

80303
80413
80823
85743

80333
80453
82463
89823

80103 80463

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

87203 87453

MALIGNANT MELANOMA

88013
88153
88513
91403
88003

88113
88503
88903
95403

SPECIFIED SARCOMA

SARCOMA, NOS

80003

C00 - C06C09 - C10C12 - C14

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

5,633
451

Male
Female

204
11

Male
Female

10
3

Male
Female

37
43

1
2

Male
Female

32
3

Male
Female

40
7

Male
Female

5
8

Male
Female

11
1

1
-

Male
Female

4
-

Male
Female

52
5

Male
Female

6,028
532

2
2

1. 96

- 276 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
2

16
6

112
8

334
16

669
19

925 1,064
53
61

907
54

578
54

415
40

273
49

178
33

110
34

51
22

5
-

14
-

23
-

29
1

40
1

40
1

19
-

18
1

8
3

4
3

1
-

3
1

3
-

2
-

1
2

1
-

2
-

1
1

1
2

4
1

2
1

1
5

2
4

4
3

3
8

5
5

5
3

4
4

2
3

2
-

1
-

1
-

4
-

5
1

5
-

7
1

4
-

2
-

3
-

1
-

1
-

5
-

3
-

4
2

6
-

5
-

4
1

5
2

5
1

2
1

1
-

1
1

1
2

1
-

1
1

1
1

1
-

3
-

2
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

5
-

8
-

4
1

11
-

6
-

4
2

2
-

4
2

5
-

1
-

2
4

20
7

121
10

354
18

707
24

979 1,127
60
70

977
66

619
59

451
48

291
58

196
43

124
36

58
26

- 277 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

C44.0
LIPExcludes Skin of Lip C44.0

ICD-O-3
80703 80713
80723 80743
80763

80513

MORPHOLOGY

GENDER

CASE
NUMBER

SQUAMOUS CELL CARCINOMA

VERRUCOUS CARCINOMA

81403 84303
85503

80103

CARCINOMA OF MINOR SALIVARY GLANDS

CARCINOMA, NOS

88003
80703 80713

C00

SARCOMA, NOS

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

189
13

Male
Female

14
3

Male
Female

4
1

Male
Female

2
1

Male
Female

1
-

Male
Female

210
18

1. 96

- 278 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

4
-

5
-

19
-

20
1

33
-

33
1

22
3

27
1

18
2

5
2

3
2

1
-

1
-

2
-

4
-

3
-

2
1

1
1

1
-

1
-

1
1

1
-

1
-

1
-

1
-

19

21

36

38

27

30

20

- 279 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

TONGUE

ICD-O-3
80323
80703
80723
80763

80523
80713
80743
80833

C01 - C02

80333
80453

80413
89823

80103

SQUAMOUS CELL CARCINOMA

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

87453

MALIGNANT MELANOMA

91403

SPECIFIED SARCOMA

88003

SARCOMA, NOS

80003

Male
Female

1,506
208

Male
Female

48
2

Male
Female

1
1

Male
Female

1
4

Male
Female

4
2

Male
Female

9
2

Male
Female

Male
Female

2
-

Male
Female

1
-

Male
Female

11
2

Male
Female

1,583
222

GENDER

CARCINOMA, UNDIFFERENTIATED

84303

15
|
19

MORPHOLOGY

82003
85603

10
|
14

VERRUCOUS CARCINOMA

80203

5
|
9

80513

CASE
NUMBER

0
|
4

OTHER MALIGNANCY

TOTAL

1. 96

- 280 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
2

9
5

52
3

120
14

205
11

240
27

275
33

236
25

139
26

90
22

70
12

42
11

18
10

9
7

3
-

3
-

7
-

7
1

11
1

7
-

3
-

5
-

2
-

1
1

1
-

1
-

2
1

1
-

3
-

1
-

1
-

1
-

1
1

1
-

1
-

1
-

1
-

1
-

1
-

3
-

4
-

1
-

2
-

57

124

215

252

287

251

144

97

73

43

21

14

13

30

36

27

27

23

13

12

10

- 281 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

GUM

80703
80723
80753

Male
Female

11
2

Male
Female

1
-

Male
Female

3
1

Male
Female

5
-

Male
Female

2
3

Male
Female

2
-

Male
Female

1
1

Male
Female

384
61

SQUAMOUS CELL CARCINOMA

Male
Female

82603
85603

80333

89823

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

MALIGNANT MELANOMA

SPECIFIED SARCOMA

80003

CASE
NUMBER

81403
85503

88903

359
54

GENDER

CARCINOMA, UNDIFFERENTIATED

88013

15
|
19

MORPHOLOGY

87203

10
|
14

VERRUCOUS CARCINOMA

80203

5
|
9

80513

0
|
4

ICD-O-3
80323
80713
80743
80763

C03

OTHER MALIGNANCY

TOTAL

1. 96

- 282 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

5
-

15
-

39
3

40
4

76
4

60
8

36
8

35
3

16
10

17
2

12
6

7
5

1
-

2
-

2
-

4
-

1
2

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
1

15

41

43

79

65

38

35

19

19

14

11

- 283 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

FLOOR OF MOUTH

ICD-O-3
80323
80703
80723

80523
80713
80763

Male
Female

147
8

Male
Female

1
-

Male
Female

Male
Female

2
4

Male
Female

1
-

Male
Female

151
13

GENDER

SQUAMOUS CELL CARCINOMA

CARCINOMA OF MINOR SALIVARY GLANDS

95403

15
|
19

MORPHOLOGY

84303

10
|
14

CARCINOMA, UNDIFFERENTIATED

82003

5
|
9

VERRUCOUS CARCINOMA

80203

CASE
NUMBER

0
|
4

80513

C04

SPECIFIED SARCOMA

TOTAL

1. 96

- 284 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

9
1

14
-

29
1

32
3

32
-

17
-

3
1

7
1

1
1

3
-

1
-

1
2

1
-

1
-

10

14

29

32

33

17

- 285 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OTHER AND UNSPECIFIED PARTS OF MOUTH

ICD-O-3
80323
80703
80723
80743
80763

80523
80713
80733
80753
80833

MORPHOLOGY

GENDER

CASE
NUMBER

SQUAMOUS CELL CARCINOMA

80513

VERRUCOUS CARCINOMA

81473
83103
84803
85503

80333 80823
82463

80103

81403
82003
84303
85253

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

5
|
9

10
|
14

15
|
19

1,930
100

Male
Female

129
4

Male
Female

22
33

1
2

Male
Female

9
0

11
2

3
4

4
1

1
-

Male
Female

MALIGNANT MELANOMA

0
|
4

Male
Female

Male
Female

CARCINOMA, NOS

87203

C05 - C06

88013 88113
88153 88513
91403

SPECIFIED SARCOMA

Male
Female

88003

Male
Female

1
0

Male
Female

16
0

Male
Female

2,125
144

2
2

SARCOMA, NOS

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 286 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

6
-

43
3

129
1

244
2

340
8

357
9

285
9

200
10

142
10

74
20

50
9

44
12

16
7

2
-

9
-

15
-

19
-

25
-

25
1

12
-

11
-

5
2

3
1

1
-

2
-

1
2

3
1

1
1

1
3

1
3

3
3

2
6

3
4

3
2

1
2

1
2

1
-

3
-

2
-

1
-

1
-

1
-

1
-

1
-

1
-

3
-

2
-

1
-

1
1

1
-

1
1

1
-

1
2

1
-

1
-

1
-

1
-

1
-

4
-

4
-

2
-

2
-

2
-

2
-

45

141

264

370

392

318

218

160

83

56

46

20

11

14

16

14

12

24

13

13

- 287 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OROPHARYNX

ICD-O-3
80323
80703
80723
80743
80833

80523
80713
80733
80753

80513

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88903

SPECIFIED SARCOMA

88003

SARCOMA, NOS

80003

Male
Female

552
46

Male
Female

1
-

Male
Female

6
1

Male
Female

2
-

Male
Female

7
-

Male
Female

6
2

Male
Female

1
-

Male
Female

1
-

Male
Female

10
-

Male
Female

586
49

GENDER

80103

15
|
19

MORPHOLOGY

SQUAMOUS CELL CARCINOMA

10
|
14

80303 80333
80453 80823
82463

5
|
9

CARCINOMA, UNDIFFERENTIATED

81403 85603

CASE
NUMBER

0
|
4

VERRUCOUS CARCINOMA

80203

C09 - C10

OTHER MALIGNANCY

TOTAL

1. 96

- 288 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

3
1

31
-

62
3

109
9

106
9

91
5

57
5

39
3

25
2

17
6

9
2

3
1

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
-

2
-

1
-

2
-

1
-

1
-

2
1

1
-

1
-

1
-

1
1

1
-

1
-

1
-

1
-

1
-

2
-

2
-

1
-

1
-

1
-

33

65

111

112

96

63

43

26

20

11

10

- 289 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

HYPOPHARYNX

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

SQUAMOUS CELL CARCINOMA

Male
Female

886
19

Male
Female

2
-

Male
Female

3
-

Male
Female

6
-

Male
Female

10
-

Male
Female

1
-

Male
Female

13
2

Male
Female

921
21

ICD-O-3
80323
80703
80723
80763

80523
80713
80743
80833

80203

CARCINOMA, UNDIFFERENTIATED

81403 81473
84303

80333 80453
80823 82463
85743

80103 80463

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88503

SPECIFIED SARCOMA

80003

C12 - C13

OTHER MALIGNANCY

TOTAL

1. 96

- 290 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

5
1

24
-

84
-

139
2

164
3

159
5

100
2

73
-

60
2

41
1

21
2

16
1

1
-

1
-

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

2
-

3
-

3
-

2
-

2
-

1
-

5
1

24
-

87
-

144
2

168
3

165
5

104
2

76
2

60
2

45
1

25
2

18
1

- 291 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

PHARYNX AND ILL-DEFINED SITES IN LIP, ORAL CAVITY AND PHARYNX

C14
5
|
9

10
|
14

15
|
19

ICD-O-3
80523 80703
80713 80723
80743 80763
80833

80333 80823

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

Male
Female

64
3

Male
Female

1
1

Male
Female

2
-

Male
Female

1
-

Male
Female

68
4

SQUAMOUS CELL CARCINOMA

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 292 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

2
-

8
1

21
-

11
1

7
-

6
-

3
-

5
1

1
-

2
-

1
-

1
-

2
-

9
1

21
-

11
1

8
-

6
-

3
-

7
1

- 293 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

MAJOR SALIVARY GLANDS

ICD-O-3
84303

81403 82553
84403 84803

82003

SQUAMOUS CELL CARCINOMA

ADENOCARCINOMA

MALIGNANT MIXED TUMOR

80203

Male
Female

21
19

2
1

Male
Female

12
1

Male
Female

21
4

Male
Female

23
32

Male
Female

11
21

Male
Female

8
8

Male
Female

12
4

Male
Female

2
-

Male
Female

17
13

Male
Female

2
1

Male
Female

2
2

Male
Female

131
105

2
2

GENDER

CARCINOMA, NOS

89403 89413

15
|
19

MORPHOLOGY

ACINAR CELL CARCINOMA

80103

10
|
14

ADENOID CYSTIC CARCINOMA

85503

5
|
9

MUCOEPIDERMOID CARCINOMA

CASE
NUMBER

0
|
4

80703 80713
80753

C07 - C08

CARCINOMA, UNDIFFERENTIATED

80413 80823
82903 85003
85623 89823

88303 88513
89803

80003

OTHER SPECIFIED CARCINOMA

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 294 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

2
2

2
3

2
1

1
2

2
1

1
-

1
1

3
1

2
-

2
2

1
-

2
-

1
-

2
-

2
-

1
-

1
1

2
-

2
1

4
-

4
2

2
-

1
-

1
-

5
-

2
-

1
-

1
2

3
6

3
3

6
1

4
2

1
6

1
2

1
3

1
1

1
2

2
-

1
1

1
-

1
4

1
3

2
5

1
1

1
-

1
-

2
1

1
-

2
2

1
1

1
1

1
-

1
2

2
1

3
-

1
-

2
-

2
1

1
-

1
-

1
-

1
-

1
3

4
1

3
2

2
-

3
1

1
-

1
3

1
1

1
-

1
-

1
-

1
-

1
4

4
2

4
6

11
15

14
12

14
10

20
7

19
8

8
11

10
4

4
10

11
5

8
6

1
3

- 295 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

NASOPHARYNX

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

19
11

Male
KERATINIZING SQUAMOUS CELL CARCINOMA Female

34
8

Male
Female

788
223

3
2

Male
Female

289
117

7
-

Male
Female

4
1

Male
Female

17
2

Male
Female

30
12

Male
Female

1
-

Male
Female

12
3

Male
Female

1,194
377

10
2

MORPHOLOGY

GENDER

SQUAMOUS CELL CARCINOMA

ICD-O-3

80703

C11

80713

80723 80843

NON-KERATINIZING SQUAMOUS CELL


CARCINOMA

80203 80413
80823

81403 82603
84303 85503

80303
80503
80733
82463
89823

80463
80523
81203
85743

80103

CARCINOMA, UNDIFFERENTIATED

CARCINOMA OF MINOR SALIVARY GLANDS

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88063

SPECIFIED SARCOMA

80003 87203

OTHER MALIGNANCY

TOTAL

1. 96

- 296 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

4
3

1
1

5
1

4
-

1
2

1
-

2
1

4
-

1
-

8
-

3
2

6
1

6
1

4
1

1
-

1
1

7
3

19
7

61
15

73
18

101
29

120
30

128
30

102
35

64
13

42
11

27
9

24
13

9
5

8
2

1
1

4
4

19
10

15
6

44
11

37
20

57
25

48
14

20
11

14
3

13
7

10
2

1
-

2
-

1
-

1
-

2
-

1
-

4
1

4
-

2
1

2
-

1
-

2
1

2
2

5
-

4
1

2
-

4
1

4
2

1
1

3
3

2
-

1
-

1
-

1
1

1
1

3
-

1
-

2
-

1
-

1
1

2
-

8
4

24
12

87
27

97
29

161
41

171
56

205
58

167
51

96
31

63
15

47
21

38
17

10
9

10
3

- 297 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

ESOPHAGUS

C15

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

1,913
119

76
16

5
-

Male
Female

31
5

Male
Female

26
3

Male
Female

4
-

Male
Female

2
-

Male
Female

1
1

Male
Female

33
3

Male
Female

2,091
147

MORPHOLOGY

GENDER

SQUAMOUS CELL CARCINOMA

ICD-O-3
80523 80703
80713 80723
80743 80763

81403 81453
82603 84803
84903

ADENOCARCINOMA

Male
Female

84303 85603

Male
Female

ADENOSQUAMOUS CARCINOMA

80203
80333
80453
80833

80323
80413
80463
82463

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88023 88903
89363

88003

SPECIFIED SARCOMA

SARCOMA, NOS

87203

MALIGNANT MELANOMA

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 298 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

1
-

7
1

52
1

181
6

299
4

362
12

333
12

223
12

152
19

107
7

86
18

67
16

42
11

1
-

1
-

2
-

3
-

7
1

8
-

8
1

4
1

6
1

9
4

6
2

10
4

11
2

1
-

2
-

1
-

1
-

3
-

1
-

8
-

8
1

4
-

3
-

2
-

1
-

1
3

2
-

5
-

4
-

2
-

3
-

3
-

2
-

3
2

2
-

1
-

1
-

2
-

1
-

1
-

1
-

4
-

2
1

5
-

4
-

4
1

4
-

3
-

5
-

2
1

1
-

2
-

8
1

54
1

192
7

316
5

385
13

361
14

239
13

165
22

126
11

98
21

86
22

58
17

- 299 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

STOMACH

ICD-O-3
81403
81423
81453
82113
82603
84803

81413
81443
82103
82553
82633
84903

85603 85703

80103

SQUAMOUS CELL CARCINOMA

OTHER SPECIFIED CARCINOMA

LEIOMYOSARCOMA

89363

Male
Female

2,140
1,226

Male
Female

5
2

Male
Female

32
3

Male
Female

47
16

Male
Female

31
17

Male
Female

2
2

Male
Female

127
151

1
-

Male
Female

2
1

Male
Female

29
21

Male
Female

2,415
1,439

1
-

GENDER

CARCINOMA, NOS

88903

15
|
19

MORPHOLOGY

ADENOSQUAMOUS CARCINOMA

80333
80453
82143
82443
85103
85763

10
|
14

80203
80413
80463
82403
82463
85743

5
|
9

ADENOCARCINOMA

CASE
NUMBER

0
|
4

80133 80703
80713 80723
80823

C16

GASTROINTESTINAL STROMAL SARCOMA

88023 91203
91403

80003 87203

OTHER SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 300 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

4
7

8
14

35
33

53
48

86
80

172
97

219
104

196
109

193
122

254
148

331
156

352
164

237
142

1
-

1
-

1
-

1
-

1
1

2
-

7
-

5
-

3
-

4
1

2
1

3
1

4
-

2
-

1
-

4
3

4
1

2
2

2
2

6
1

6
1

12
1

8
3

2
1

1
1

3
-

1
2

2
2

2
-

4
-

1
-

5
5

5
3

7
4

1
-

1
-

1
-

3
6

1
-

4
4

9
10

15
11

15
29

13
16

15
14

15
24

15
22

15
10

5
5

1
-

1
-

2
1

2
-

3
3

3
1

4
1

5
2

6
3

4
8

5
7

11
21

36
33

60
54

104
95

202
112

246
137

219
130

227
139

283
176

372
188

391
184

258
160

- 301 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

SMALL INTESTINE

ICD-O-3
81403 82613
84803 84903
85603

82403

80103

Male
Female

77
44

Male
Female

5
6

Male
Female

7
6

Male
Female

8
1

Male
Female

Male
Female

83
71

Male
Female

3
2

Male
Female

1
1

Male
Female

6
3

Male
Female

190
135

GENDER

OTHER SPECIFIED CARCINOMA

GASTROINTESTINAL STROMAL SARCOMA

88013 88063
88583 91203

88003

OTHER SPECIFIED SARCOMA

SARCOMA, NOS

80003 80043

15
|
19

MORPHOLOGY

LEIOMYOSARCOMA

89363

10
|
14

CARCINOMA, NOS

88903

5
|
9

CARCINOID TUMOR

CASE
NUMBER

0
|
4

ADENOCARCINOMA

80203 80333
80413 80703
82463 85003

C17

OTHER MALIGNANCY

TOTAL

1. 96

- 302 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

3
-

1
-

4
-

6
2

5
4

10
5

11
8

11
8

11
5

9
5

5
5

1
-

1
2

1
-

1
-

1
1

1
-

2
-

2
1

2
-

1
-

2
-

1
-

2
-

1
1

1
-

1
-

1
1

3
1

2
1

3
5

10
5

13
4

12
5

10
8

6
14

9
12

4
4

6
5

3
6

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

1
3

1
-

2
3

3
2

6
1

5
6

17
7

21
10

19
11

23
15

21
24

24
21

20
10

19
11

9
14

- 303 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

C18 - C21

COLON, RECTUM, RECTOSIGMOID JUNCTION AND ANUS

ICD-O-3
81403
82113
82213
82603
82623
84703
84813

82103
82203
82553
82613
82633
84803
84903

MORPHOLOGY

GENDER

CASE
NUMBER

ADENOCARCINOMA

82403 82433
82453 82493

80123
80143
80333
80513
80713
80833
81233
82443
85103
85743

80133
80203
80413
80703
80723
81203
81243
82463
85603

CARCINOID TUMOR

OTHER SPECIFIED CARCINOMA

80103 80213
80463

88523 89363

CARCINOMA, NOS

SPECIFIED SARCOMA

88003

SARCOMA, NOS

87203

MALIGNANT MELANOMA

80003

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

7,732
5,571

2
-

Male
Female

78
59

Male
Female

56
64

Male
Female

73
42

Male
Female

20
17

Male
Female

2
0

Male
Female

1
6

Male
Female

181
138

Male
Female

8,143
5,897

2
4

1. 96

- 304 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

65
|
69

70
|
74

75
|
79

80
|
84

85+

7
2

30
19

70
68

125
99

209
157

381
325

718 1,036 1,006 1,093


550
689
635
726

936
689

899
666

762
514

458
432

3
-

8
2

7
5

4
5

16
8

6
12

7
5

9
5

8
5

5
1

3
-

1
3

1
1

1
-

1
-

2
1

1
3

4
3

9
9

7
7

6
6

3
5

3
8

7
9

7
9

5
4

2
-

2
-

6
-

7
2

7
2

10
2

8
5

5
6

1
6

9
4

16
15

2
-

3
2

2
2

3
2

3
1

4
2

2
2

1
1

1
-

1
-

1
-

1
-

1
2

1
4

3
4

4
3

11
3

12
10

20
8

18
6

19
12

23
15

37
21

31
50

10
3

32
24

82
72

135
109

221
169

414
341

753 1,072 1,054 1,134


579
717
657
749

969
717

933
699

818
554

514
503

- 305 -

60
|
64

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

COLON

ICD-O-3
81403
82113
82213
82613
82633
84803
84903

82103
82203
82553
82623
84703
84813

80133
80203
80413
81233
82463
85603

80103

Male
Female

4,634
3,583

2
-

Male
Female

12
12

Male
Female

21
14

Male
Female

51
31

Male
Female

8
3

Male
Female

1
-

Male
Female

144
121

Male
Female

4,871
3,764

2
3

GENDER

CARCINOID TUMOR

OTHER SPECIFIED CARCINOMA

SARCOMA, NOS

80003

15
|
19

MORPHOLOGY

SPECIFIED SARCOMA

88003

10
|
14

CARCINOMA, NOS

88523 89363

5
|
9

ADENOCARCINOMA

CASE
NUMBER

0
|
4

82403 82433
82453
80143
80333
80703
82443
85103
85743

C18

OTHER MALIGNANCY

TOTAL

1. 96

- 306 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

4
1

21
13

48
51

73
65

126
103

204
201

423
345

600
430

599
400

640
472

546
442

542
440

504
329

302
291

1
-

2
-

1
2

1
-

2
-

1
-

2
1

1
-

1
2

1
-

1
-

3
1

6
-

2
-

3
1

2
5

3
2

1
-

5
-

6
1

6
-

5
1

6
4

3
5

8
4

11
11

2
-

1
-

1
-

2
-

1
1

1
-

1
-

1
2

1
4

3
4

4
2

9
2

10
9

15
8

12
6

17
10

16
14

29
19

27
41

4
1

21
16

52
53

74
70

129
108

218
203

443
351

624
439

625
409

662
483

569
461

561
464

546
357

341
346

- 307 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

RECTUM, RECTOSIGMOID JUNCTION AND ANUS

ICD-O-3
81403
82113
82213
82603
82623
84803
84903

82103
82203
82553
82613
82633
84813

80123
80333
80513
80713
80833
81233
82443
85103
85743

80203
80413
80703
80723
81203
81243
82463
85603

89363

CARCINOMA, NOS

SARCOMA, NOS

87203

MALIGNANT MELANOMA

80003

Male
Female

3,098
1,988

Male
Female

66
47

Male
Female

35
50

Male
Female

22
11

Male
Female

12
14

Male
Female

1
-

Male
Female

1
6

Male
Female

37
17

Male
Female

3,272
2,133

GENDER

SPECIFIED SARCOMA

88003

15
|
19

MORPHOLOGY

OTHER SPECIFIED CARCINOMA

10
|
14

CARCINOID TUMOR

80103 80213
80463

5
|
9

ADENOCARCINOMA

CASE
NUMBER

0
|
4

82403 82453
82493

C19 - C21

OTHER MALIGNANCY

TOTAL

1. 96

- 308 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

3
1

9
6

22
17

52
34

83
54

177
124

295
205

436
259

407
235

453
254

390
247

357
226

258
185

156
141

3
-

7
2

7
4

4
5

14
8

5
10

6
5

7
5

7
5

3
-

2
-

1
-

1
-

2
1

1
2

3
3

6
8

1
7

4
6

3
6

5
4

4
7

5
2

1
-

2
-

1
-

1
1

1
2

5
1

2
1

2
1

1
1

1
-

5
4

2
-

1
2

1
2

2
2

1
1

4
2

1
1

1
-

1
-

1
-

2
1

2
1

5
-

6
-

2
2

7
1

8
2

4
9

6
2

11
8

30
19

61
39

92
61

196
138

310
228

448
278

429
248

472
266

400
256

372
235

272
197

173
157

- 309 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

LIVER AND INTRAHEPATIC BILE DUCTS

ICD-O-3

C22

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

7,121
2,821

1
-

1
-

Male
Female

471
381

Male
Female

53
14

Male
Female

24
19

Male
Female

12
5

8
5

1
-

1
-

Male
Female

16
7

Male
Female

13
1

Male
Female

13
6

Male
Female

5
3

1
-

Male
Female

1
2

Male
Female

22
13

Male
Female

7,751
3,272

8
5

2
-

2
2

1
-

MORPHOLOGY

GENDER

81703 81713
81723 81733
81743 81753

81603 81623
84813

81803

HEPATOCELLULAR CARCINOMA

CHOLANGIOCARCINOMA

COMBINED HEPATOCELLULAR CARCINOMA


AND CHOLANGIOCARCINOMA

81403 81613
81903 84803

89703

ADENOCARCINOMA

HEPATOBLASTOMA

80323
80413
80713
84533
85743

80333
80463
82463
85603
89803

80103 80203

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

91203

ANGIOSARCOMA

88013 88033
88903 89333
89913 91333

88003

OTHER SPECIFIED SARCOMA

SARCOMA, NOS

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 310 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

8
3

31
6

80
16

178
30

354
33

617
66

811 1,084
143
274

894
320

866
429

847
534

684
464

440
314

225
187

1
-

2
-

4
3

17
8

39
13

36
23

62
36

52
42

61
62

52
58

66
65

47
44

32
25

3
-

4
1

2
-

12
3

8
1

9
1

5
1

3
2

4
3

3
2

1
-

1
-

3
-

3
1

3
1

5
4

2
5

1
3

4
3

1
-

1
-

1
-

3
-

3
1

3
-

1
3

4
1

2
2

1
-

1
1

6
-

1
-

1
-

3
-

1
-

2
-

1
-

3
-

2
3

3
3

1
-

1
-

1
1

1
-

1
-

1
-

2
-

3
1

3
2

1
-

2
4

4
1

5
1

2
4

9
3

32
8

83
16

185
33

376
43

668
79

865 1,172
172
316

970
370

936
500

914
605

769
541

500
361

259
218

- 311 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

GALLBLADDER AND EXTRAHEPATIC BILE DUCTS

ICD-O-3
81403
81623
82603
82633
84903

81603
82103
82613
84803
85743

80203
80413
80503
81443
82403
84533
85763

80103

15
|
19

Male
Female

397
372

Male
Female

11
6

Male
Female

25
18

Male
Female

16
13

Male
Female

Male
Female

37
28

Male
Female

486
438

MORPHOLOGY

GENDER

ADENOCARCINOMA

OTHER SPECIFIED CARCINOMA

SPECIFIED SARCOMA

80003 80013

10
|
14

CARCINOMA, NOS

89803

5
|
9

ADENOSQUAMOUS CARCINOMA

80133
80303
80453
80703
81563
82463
85003

CASE
NUMBER

0
|
4

85603

C23 - C24

OTHER MALIGNANCY

TOTAL

1. 96

- 312 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
2

5
3

4
8

25
5

16
25

56
34

39
34

45
47

52
69

62
73

58
40

34
32

1
-

2
1

2
1

1
1

3
1

2
1

1
-

2
-

4
3

4
1

4
-

2
2

5
6

1
1

2
-

2
-

2
-

1
-

1
1

2
1

1
-

3
1

3
3

1
4

1
1

3
-

2
2

1
1

4
4

9
9

7
5

10
6

1
2

7
3

8
8

32
10

23
27

60
40

47
38

51
51

65
81

75
87

70
48

47
43

- 313 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

PANCREAS

ICD-O-3
81403
82113
84403
84533
84803
85003

81443
82603
84413
84703
84903
85033

80213
80413
80703
81543
82463
85603

80103 80203

ADENOCARCINOMA

OTHER SPECIFIED CARCINOMA

SARCOMA, NOS

80003

Male
Female

566
418

Male
Female

3
4

Male
Female

1
5

Male
Female

47
36

Male
Female

90
53

Male
Female

2
2

Male
Female

2
1

Male
Female

226
187

Male
Female

937
706

GENDER

SPECIFIED SARCOMA

88003 88053

15
|
19

MORPHOLOGY

CARCINOMA, NOS

88013 89363

10
|
14

ISLET CELL CARCINOMA

80133
80333
80463
81413
82403
84523
85743

5
|
9

ACINAR CELL CARCINOMA

81503 81513

CASE
NUMBER

0
|
4

85503

C25

MALIGNANT NEOPLASM, NOS

TOTAL

1. 96

- 314 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
3

5
7

16
13

38
19

63
37

71
42

75
56

69
44

80
70

68
66

50
42

30
19

1
-

1
2

1
-

1
-

1
3

1
2

1
2

5
3

2
2

4
2

9
4

7
6

6
3

1
2

6
3

2
1

2
-

2
-

5
-

1
-

6
3

3
5

10
4

13
2

8
6

10
7

14
9

11
6

7
11

2
-

1
-

1
-

4
2

8
2

17
1

14
5

11
6

25
20

26
25

29
42

47
38

45
46

1
3

4
5

11
10

26
18

54
27

87
46

104
58

108
70

108
74

118
106

118
121

111
88

87
76

- 315 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

RETROPERITONEUM AND PERITONEUM

ICD-O-3
88503 88513
88523 88543
88553 88583

88903

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

29
20

Male
Female

4
15

Male
Female

5
2

Male
Female

2
4

1
-

Male
Female

18
3

2
-

2
-

4
1

Male
Female

7
12

Male
Female

5
10

Male
Female

2
6

Male
Female

8
5

Male
Female

80
77

1
1

2
1

2
1

4
2

MORPHOLOGY

GENDER

LIPOSARCOMA

LEIOMYOSARCOMA

88113 88303

C48

MALIGNANT FIBROHISTIOCYTOMA

80413 86803
93643 95003
95403

90643 90803
90853

PERIPHERAL PRIMITIVE
NEUROECTODERMAL TUMOR

GERM CELL TUMOR AND MALIGNANT


TERATOMA

90503 90513

MALIGNANT MESOTHELIOMA

88013
88603
89013
89303
92603

88023
89003
89103
89803
93703

88003

SPECIFIED SARCOMA

SARCOMA, NOS

80003 80333

OTHER MALIGNANCY

TOTAL

1. 96

- 316 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
2

4
4

4
2

4
3

5
1

5
4

2
3

1
1

2
-

1
-

1
-

1
2

2
1

2
-

1
-

1
-

1
-

1
-

3
1

3
-

2
-

1
-

1
-

2
2

1
1

1
-

1
2

1
2

1
1

1
1

2
3

1
2

1
1

1
1

1
-

1
-

1
1

1
-

1
1

1
-

2
2

1
-

11

12

12

- 317 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

C26

OTHER AND ILL-DEFINED SITES WITHIN DIGESTIVE ORGANS AND PERITONEUM

ICD-O-3
81403 81443
82603 84603
84803

80333 85003

MORPHOLOGY

GENDER

CASE
NUMBER

ADENOCARCINOMA

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

89363

SPECIFIED SARCOMA

80003

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

1
17

Male
Female

1
1

Male
Female

3
2

Male
Female

12
12

Male
Female

2
-

Male
Female

19
32

1. 96

- 318 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

1
-

1
-

1
-

1
-

1
-

1
2

1
1

3
3

2
-

1
3

1
-

1
1

1
-

1
-

1
-

2
1

1
3

2
2

4
8

2
5

2
5

2
1

1
3

3
-

- 319 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

NASAL CAVITIES, ACCESSORY SINUSES, MIDDLE EAR AND INNER EAR

ICD-O-3
80523 80703
80713 80723
80833

81403 81473
82003 82603

80413

MORPHOLOGY

GENDER

CASE
NUMBER

SQUAMOUS CELL CARCINOMA

ADENOCARCINOMA

SMALL CELL CARCINOMA

84303 85623

CARCINOMA OF MINOR SALIVARY GLANDS

80323
80823
82463
85743
90813

80333
81213
85603
89803

80103 80203

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

87203

MALIGNANT MELANOMA

88013
88113
88903
89203
91503

88103
88303
89003
91203
95003

80003 93713

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

C30 - C31
0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

69
20

Male
Female

8
7

Male
Female

3
1

Male
Female

3
3

Male
Female

11
8

Male
Female

13
6

Male
Female

3
3

Male
Female

7
4

Male
Female

2
1

Male
Female

119
53

1. 96

- 320 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

3
1

3
2

7
2

8
1

14
1

6
3

7
-

9
2

7
2

4
-

1
2

1
2

1
-

3
-

2
1

1
-

1
-

2
-

1
-

1
-

1
-

1
-

2
1

3
-

2
2

2
1

1
1

1
-

1
-

1
-

1
-

4
1

1
-

3
1

1
-

1
1

1
-

1
-

2
-

1
-

1
1

1
-

1
-

1
-

1
-

1
-

1
2

3
2

6
1

7
5

11
7

16
6

17
6

12
3

12
7

16
4

7
3

8
1

3
4

- 321 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

LARYNX

ICD-O-3
80513 80523
80703 80713
80723 80763

80413

MORPHOLOGY

GENDER

CASE
NUMBER

SQUAMOUS CELL CARCINOMA

SMALL CELL CARCINOMA

80323 80333
80833 82003
84303 85743

80103 82463

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88013

SPECIFIED SARCOMA

80003 87203

C32

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

580
28

Male
Female

3
-

Male
Female

5
2

Male
Female

6
1

Male
Female

Male
Female

8
1

Male
Female

602
33

1. 96

- 322 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

3
-

5
1

20
1

49
1

76
3

97
4

75
3

70
4

57
5

58
-

37
4

32
2

1
-

1
-

1
-

2
1

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
-

2
-

1
-

2
-

1
-

4
-

7
1

20
2

50
2

79
4

100
4

77
3

72
4

59
5

61
1

38
4

34
3

- 323 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

TRACHEA, BRONCHUS AND LUNG

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

1,660
234

Male
Female

2,954
2,933

1
-

Male
Female

49
41

43
21

784
91

64
20

Male
Female

45
46

Male
Female

15
26

Male
Female

472
211

Male
Female

182
81

MORPHOLOGY

GENDER

SQUAMOUS CELL CARCINOMA

ICD-O-3
80523
80713
80733
80823
80843

80703
80723
80743
80833

81403
82113
82513
82603
84803
84903

81413
82503
82553
83103
84813

ADENOCARCINOMA

85603

C33 - C34

ADENOSQUAMOUS CARCINOMA

80123 80143
80203 80213
80313

LARGE CELL CARCINOMA

Male
Female

80413 80443
80453

Male
Female

80133 82403
82463 82493

80223 82003
84303 85503

82523 82533
82543

80323
80463
81233
85743
88063

80333
80503
83333
85763

80103 82303

SMALL CELL CARCINOMA

Male
Female

NEUROENDOCRINE CARCINOMA

BRONCHIAL GLAND CARCINOMA

BRONCHIOLO-ALVEOLAR CARCINOMA

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

- 324 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

5
2

4
2

15
7

56
11

58
15

146
26

168
30

191
36

262
30

342
37

279
21

134
17

2
-

5
4

21
17

41
37

83
112

148
196

260
274

316
381

313
349

366
348

383
396

411
357

393
278

211
184

2
2

2
2

1
6

6
5

7
5

3
6

7
7

13
4

5
2

3
1

1
-

3
1

2
1

3
5

4
3

5
1

6
1

6
3

6
-

5
4

2
2

5
1

11
3

19
4

50
4

72
6

90
9

114
7

131
19

142
16

105
14

45
7

1
-

1
1

4
-

3
1

9
4

6
2

8
5

8
3

9
2

8
1

4
1

3
-

1
3

1
-

2
3

2
4

5
9

4
4

11
3

6
6

8
6

4
1

1
2

1
-

1
1

2
1

2
3

1
6

2
5

3
3

2
3

1
1

1
1

1
-

7
5

16
9

17
17

50
22

46
15

62
24

68
27

89
35

74
27

41
29

1
-

2
1

6
4

12
4

13
6

7
4

16
10

25
7

41
12

29
16

30
14

- 325 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

TRACHEA, BRONCHUS AND LUNG

ICD-O-3

MORPHOLOGY

GENDER

CASE
NUMBER

88153 88933
89803 91203

88003

SPECIFIED SARCOMA

SARCOMA, NOS

80003 80013
91333

C33 - C34CONTINUED

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

6
2

Male
Female

8
3

Male
Female

415
209

Male
Female

6,697
3,918

1
1

1. 96

- 326 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

1
1

1
-

1
-

1
-

1
-

1
2

1
-

1
-

3
-

1
-

1
-

2
-

2
3

6
2

6
6

15
11

17
6

30
13

54
18

92
28

95
39

96
82

4
1

6
5

31
25

55
44

130
140

262
234

421
344

635
477

669
433

811
455

954 1,156
516
499

995
405

567
338

- 327 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

PLEURA

ICD-O-3

C38.4

MORPHOLOGY

GENDER

CASE
NUMBER

90503 90513
90523 90533

80003 91203
91333

MALIGNANT MESOTHELIOMA

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

38
16

Male
Female

5
3

Male
Female

43
19

1. 96

- 328 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

1
-

1
-

4
-

4
1

5
2

3
2

5
4

9
2

3
1

2
2

1
-

2
-

2
-

1
1

1
-

1
-

5
-

4
1

7
2

3
4

5
4

9
3

5
1

2
2

- 329 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

THYMUS, HEART AND MEDIASTINUM

ICD-O-3
80703
85803
85823
85843
85863

80723
85813
85833
85853

MORPHOLOGY

GENDER

CASE
NUMBER

MALIGNANT THYMOMA AND THYMIC

80123
80333
80823
82403
82493
85603
85893

80103

GERM CELL TUMOR AND MALIGNANT

5
|
9

10
|
14

15
|
19

Male
Female

95
84

Male
Female

21
1

1
-

1
-

3
-

Male
Female

22
9

Male
Female

7
3

Male
Female

4
4

1
1

Male
Female

9
1

1
-

Male
Female

2
1

Male
Female

8
5

1
-

Male
Female

168
108

1
1

1
-

2
-

4
2

TERATOMA

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

80133 94903
95003 95403

88013 88513
88553 91203
93643

88003

NEUROGENIC MALIGNANCIES

SPECIFIED SARCOMA

SARCOMA, NOS

80003 90513

0
|
4

CARCINOMA

90613 90643
90703 90713
90853 91003
80203
80413
81403
82463
82603
85743
90813

C37 - C38.3C38.8

OTHER MALIGNANCY

TOTAL

1. 96

- 330 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

3
4

3
3

1
1

15
9

6
9

15
10

13
14

10
9

7
8

7
10

7
4

6
2

1
-

4
-

1
-

8
1

1
-

1
-

1
-

1
-

1
-

2
-

1
2

2
-

3
-

3
1

5
-

1
1

2
-

1
-

2
-

1
-

1
-

1
-

2
-

1
1

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
-

1
1

3
-

1
2

2
-

6
-

5
4

14
4

2
5

17
11

9
12

20
12

15
17

16
10

12
9

14
11

13
5

11
4

6
1

- 331 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

BONES, JOINTS AND ARTICULAR CARTILAGE

ICD-O-3

MORPHOLOGY

GENDER

CASE
NUMBER

91803 91813
91823 91863
91923

92203 92313
92403 92433

92503

OSTEOSARCOMA

CHONDROSARCOMA

MALIGNANT GIANT CELL TUMOR

Ewing

92603

EWING SARCOMA

93703

CHORDOMA

92703

MALIGNANT AMELOBLASTOMA

88013
88303
88903
90403
91333

88103
88503
89103
91203
95403

88003 88053

OTHER SPECIFIED SARCOMA

SARCOMA, NOS

80003 80203

C40 - C41

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

37
38

1
-

1
2

7
9

10
7

Male
Female

19
12

1
1

Male
Female

1
2

1
-

Male
Female

12
7

1
-

3
1

2
-

Male
Female

5
1

Male
Female

Male
Female

8
6

1
-

Male
Female

3
4

1
-

Male
Female

4
3

Male
Female

89
74

3
-

1
3

12
11

13
9

1. 96

- 332 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

5
3

1
1

2
-

1
2

2
2

1
2

3
2

1
2

1
1

1
-

1
-

3
-

1
4

1
2

3
1

3
-

1
1

2
-

1
-

2
1

2
1

1
1

1
-

1
-

1
-

1
-

2
-

1
-

1
-

1
1

1
-

2
1

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

7
4

4
6

7
2

3
9

5
5

6
3

5
3

6
4

6
4

2
2

3
2

5
2

1
1

- 333 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

ICD-O-3
88103 88113
88303 88323

MORPHOLOGY

GENDER

CASE
NUMBER

MALIGNANT FIBROHISTIOCYTOMA AND

C47C49
0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

50
38

1
1

Male
Female

84
46

1
2

2
-

Male
Female

17
18

Male
Female

9
12

4
4

Male
Female

20
19

2
-

FIBROSARCOMA

88503 88513
88523 88543
88553 88583

88903 88963

LIPOSARCOMA

LEIOMYOSARCOMA

89003 89013
89023 89103
89203 95813

91203 91333
91403 91503

90403 90413
90423 90433

SYNOVIAL SARCOMA

Male
Female

11
15

1
-

1
3

94903 95403

( Schwann )

Male
Female

12
8

Male
Female

9
4

1
1

1
1

Male
Female

37
49

1
-

RHABDOMYOSARCOMA

ANGIOSARCOMA

MALIGNANT NERVE SHEATH TUMOR


(INCLUDING MALIGNANT SCHWANNOMA)

93643 95003
95613

PERIPHERAL PRIMITIVE NEUROECTODERMAL


TUMOR

80043
88023
88043
88953
90443
92313
92433

88013
88033
88153
89823
91803
92403
92523

OTHER SPECIFIED SARCOMA

- 334 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
-

3
4

3
-

7
5

8
5

4
4

3
4

5
6

6
-

6
3

2
3

1
1

1
2

4
5

3
2

3
6

14
9

8
2

14
-

8
4

3
2

3
7

8
4

8
-

3
-

1
-

1
-

2
-

1
-

1
2

5
5

2
3

1
2

1
4

1
1

1
-

1
-

1
-

1
-

2
-

2
1

2
1

2
3

4
4

3
1

3
3

2
1

2
1

1
1

1
1

2
-

1
-

2
-

2
-

1
-

2
-

1
-

2
2

2
1

2
1

1
-

1
-

2
-

1
1

1
-

1
-

2
-

1
-

1
1

1
4

1
7

7
2

2
7

7
4

3
4

5
4

4
5

1
7

1
1

- 335 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

ICD-O-3

MORPHOLOGY

88003

SARCOMA, NOS

85623

SPECIFIED CARCINOMA

80003 90643

OTHER MALIGNANCY

TOTAL

C47C49CONTINUED

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

22
18

1
-

1
-

Male
Female

1
-

Male
Female

4
5

Male
Female

276
232

4
2

1
7

12
9

1. 96

- 336 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

3
1

3
1

1
3

2
3

2
-

3
1

3
3

3
3

1
-

1
-

1
1

2
-

10
3

6
8

11
14

10
11

15
19

35
21

25
21

34
21

21
18

12
13

22
28

26
16

20
10

12
10

- 337 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

SKIN

ICD-O-3
80903 80913
80923 80943
80973 80983
82003

80513
80713
80743
80823

80703
80723
80763
80933

81023
81403
83903
84013
84063
84093
84133
85003
89403

81103
83103
84003
84023
84073
84103
84803
85423

87203
87303
87423
87443
87713

87213
87403
87433
87453
87723

80303
80413
80753
81473
82463
82553
84903
85743

80323
80523
80833
82113
82473
84303
85603

80103

C44

MORPHOLOGY

GENDER

CASE
NUMBER

BASAL CELL CARCINOMA

SQUAMOUS CELL CARCINOMA

CARCINOMA OF SKIN APPENDAGES

MALIGNANT MELANOMA

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

- 338 -

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

674
740

Male
Female

504
391

Male
Female

77
51

1
-

Male
Female

125
87

1
-

1
-

Male
Female

23
25

Male
Female

10
3

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

2
2

4
6

11
8

17
13

21
32

38
45

45
62

61
64

82
71

107
126

110
123

107
106

68
81

8
3

5
3

8
2

17
6

17
10

28
16

27
19

31
18

55
39

102
67

106
72

100
135

1
-

3
1

4
5

2
2

5
4

6
-

9
6

6
5

5
9

14
3

14
8

7
7

1
-

2
3

2
2

6
2

5
5

4
5

9
9

11
13

14
2

15
7

10
14

21
11

11
8

12
6

1
-

1
2

2
-

1
1

2
-

2
2

3
1

4
5

4
8

3
3

1
-

2
-

1
-

2
1

1
-

1
1

2
-

- 339 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

SKIN

ICD-O-3
80803
88113
88323
88503
88903
89353
91403

88043
88303
88333
88553
89013
91203
91703

88003

C44CONTINUED

MORPHOLOGY

GENDER

CASE
NUMBER

SPECIFIED SARCOMA

SARCOMA, NOS

80003 81033

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

154
104

1
2

2
3

Male
Female

1
-

Male
Female

7
2

Male
Female

1,575
1,403

1
1

2
3

3
3

1. 96

- 340 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

7
3

12
15

14
5

9
6

15
11

10
10

8
9

11
11

8
4

15
3

15
7

7
3

17
7

3
4

1
-

1
-

1
-

1
-

2
1

2
1

10
4

16
21

29
16

34
21

51
38

55
57

81
77

102
103

122
95

153
107

196
197

261
212

262
211

197
237

- 341 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

FEMALE BREAST

ICD-O-3
80223
81403
84013
85013
85043
85223
85413
85733

80713
82113
85003
85033
85213
85233
85433
85753

84803 84813

C50

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

8,625

Female

242

Female

47

Female

364

Female

54

Female

16

Female

179

Female

64

MORPHOLOGY

GENDER

INVASIVE DUCTAL CARCINOMA

MUCINOUS ADENOCARCINOMA

85103 85123
85133

85203

MEDULLARY CARCINOMA

INVASIVE LOBULAR CARCINOMA

90203

MALIGNANT PHYLLODES TUMOR

Paget

85403

PAGET DISEASE, MAMMARY

80113
80323
80413
80703
82013
82463
82603
83143
84903
85073
85303
85603
85723
80103

80213
80333
80503
82003
82303
82553
83103
83153
85023
85243
85503
85703
85743

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

- 342 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

80

257

495 1,031 1,606 1,526 1,313

804

610

423

241

131

99

24

43

39

26

28

12

16

17

13

14

46

77

63

64

38

30

11

11

12

10

16

26

24

26

18

25

18

10

- 343 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

FEMALE BREAST

ICD-O-3
88023
88303
89353
89823
91803
80003

88153
88523
89803
91203
95403

C50CONTINUED

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

18

Female

46

Female

9,655

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 344 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

14

91

281

551 1,166 1,783 1,675 1,467

890

701

479

282

159

116

- 345 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

MALE BREAST

ICD-O-3
81403 85003
85233 85413

80503 84013
85033

80103

C50

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male

32

Male

Male

Male

Male

39

INVASIVE DUCTAL CARCINOMA

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88513

SPECIFIED SARCOMA

TOTAL

1. 96

- 346 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

- 347 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

UTERUS, NOS

ICD-O-3
83233

C55

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

Female

Female

Female

Female

Female

ADENOCARCINOMA

88113 88963
89803

80103

OTHER SPECIFIED SARCOMA

CARCINOMA, NOS

85603

OTHER SPECIFIED CARCINOMA

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 348 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

- 349 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

CERVIX UTERI

ICD-O-3
80513
80703
80723
80763

80523
80713
80743
80823

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

1,254

Female

50

Female

275

Female

Female

41

Female

40

Female

12

Female

1,680

MORPHOLOGY

GENDER

SQUAMOUS CELL CARCINOMA

85603

C53

ADENOSQUAMOUS CARCINOMA

81403
82603
82633
83803
84413
84823

81443
82623
83233
83843
84803
85703

ADENOCARCINOMA

83103

CLEAR CELL CARCINOMA

80133
80203
80413
80463
80983
85743

80153
80333
80453
80833
82463

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

80003

80043

OTHER MALIGNANCY

TOTAL

1. 96

- 350 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

10

39

59

94

156

163

167

118

120

95

89

83

58

16

22

42

32

54

41

20

15

13

11

13

61

92

149

211

236

228

148

144

116

103

110

66

- 351 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

CORPUS UTERI

ICD-O-3
80503 81403
82603 82623
83803 83823

85603 85703

C54

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

1,313

Female

34

Female

Female

163

Female

Female

58

Female

47

Female

95

Female

Female

Female

Female

1,737

MORPHOLOGY

GENDER

ADENOCARCINOMA

ADENOSQUAMOUS CARCINOMA

91003 91053

CHORIOCARCINOMA

80203
80333
80703
80723
82553
83203
84413
84803

80303
80413
80713
82463
83103
83233
84603
84903

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88903 88913
88963

89303 89313

LEIOMYOSARCOMA

ENDOMETRIAL STROMAL SARCOMA

89333 89503
89513 89803

Muller

88013 89633

MALIGNANT MULLERIAN MIXED TUMOR

OTHER SPECIFIED SARCOMA

88003 88053

SARCOMA, NOS

80003 89813

OTHER MALIGNANCY

TOTAL

1. 96

- 352 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

17

48

48

107

198

294

261

142

91

55

34

11

14

33

40

18

23

10

23

15

11

10

14

22

20

23

55

65

140

269

381

338

180

127

73

50

21

12

- 353 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

ICD-O-3

C56C57.0 - C57.4

MORPHOLOGY

GENDER

CASE
NUMBER

84703 84713
84723 84803
84823 90153

84413 84423
84603 84613

83803 83813

0
|
4

5
|
9

10
|
14

15
|
19

Female

159

Female

377

Female

159

Female

169

Female

51

Female

37

Female

Female

209

Female

27

Female

15

MUCINOUS ADENOCARCINOMA

SEROUS ADENOCARCINOMA

ENDOMETRIOID ADENOCARCINOMA

83103 83133

CLEAR CELL CARCINOMA

90603 90713
90803 90843
90853

85903 86203
86313

91003

GERM CELL TUMORS

SEX-CORD-STROMAL TUMOR

CHORIOCARCINOMA

80133
80213
80703
81403
82463
82603
84303
84903
86223
90003

80203
80523
81203
82403
82553
83233
84403
85603
89503
90143

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88103 89303
89313 89333
89353 89803
91203

SPECIFIED SARCOMA

- 354 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

11

10

14

13

19

19

20

17

10

10

20

29

54

56

80

49

28

25

20

14

16

36

38

19

18

22

39

29

27

17

16

14

15

29

30

29

17

18

21

10

15

- 355 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

ICD-O-3
88003 88053

C56C57.0 - C57.4CONTINUED

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

Female

38

Female

1,245

11

11

SARCOMA, NOS

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 356 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

31

34

50

95

116

190

183

182

106

78

68

44

30

14

- 357 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS

ICD-O-3
80513
80703
80723
80763

80523
80713
80743
80833

81403 82003

C51 - C52C57.7 - C57.9

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Female

86

Female

Female

Female

14

Female

Female

Female

12

Female

Female

Female

Female

152

SQUAMOUS CELL CARCINOMA

ADENOCARCINOMA

91003 91053

CHORIOCARCINOMA

85423

Paget
PAGET DISEASE OF EXTERNAL GENITALIA

80413 80903
81203 82463
83843 84133

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

87203 87213
87433

88043 88323
88903 89103
89363 90403

88003

MALIGNANT MELANOMA

OTHER SPECIFIED SARCOMA

SARCOMA, NOS

80003 90713
91043

OTHER MALIGNANCY

TOTAL

1. 96

- 358 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

10

12

15

10

14

13

18

19

10

11

20

15

14

- 359 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

PROSTATE GLAND

ICD-O-3
81403 81433
82553 83103
84903 85003

80123
80453
80903
85503

80413
80703
84803
85743

80103

C61

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male

4,268

Male

27

Male

19

Male

Male

76

Male

4,392

MORPHOLOGY

GENDER

ADENOCARCINOMA

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

89103 89353

SPECIFIED SARCOMA

80003

OTHER MALIGNANCY

TOTAL

1. 96

- 360 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

18

76

214

390

641

860

891

789

386

18

35

19

79

222

396

647

874

911

813

427

- 361 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

TESTIS

ICD-O-3
90613 90633
90643

90713

C62

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male

91

Male

Male

Male

54

Male

14

Male

Male

Male

Male

Male

178

17

SEMINOMA

ENDODERMAL SINUS TUMOR


(YOLK SAC TUMOR)

90703

EMBRYONAL CARCINOMA

90853 91013

MIXED GERM CELL TUMOR

90803 90813

MALIGNANT TERATOMA

91003

CHORIOCARCINOMA

82403 90653

SPECIFIED CARCINOMA

88583 89103
89123

80003

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 362 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

11

21

20

17

19

12

37

40

29

20

- 363 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

PENIS AND OTHER MALE GENITAL ORGANS

ICD-O-3
80513 80703
80713 80763

80903

C60C63

MORPHOLOGY

GENDER

CASE
NUMBER

0
|
4

5
|
9

10
|
14

15
|
19

Male

48

Male

Male

22

Male

Male

Male

Male

Male

91

SQUAMOUS CELL CARCINOMA

BASAL CELL CARCINOMA

85423

Paget
PAGET DISEASE

81403

ADENOCARCINOMA

80943

OTHER SPECIFIED CARCINOMA

88323 88513
88543 88583
88903 91203

80003 90503

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 364 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

10

10

10

14

12

- 365 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

BLADDER

ICD-O-3
80503 81203
81223 81303
81313

81403 82603
83103 84803

80703 80713

80133
80413
81443
83233
84903

80103

Male
Female

1,328
495

1
-

Male
Female

36
14

Male
Female

9
10

Male
Female

20
10

Male
Female

11
-

Male
Female

4
1

1
-

Male
Female

19
7

Male
Female

1,427
537

1
-

1
-

GENDER

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

15
|
19

MORPHOLOGY

80003 80033
95403

10
|
14

ADENOCARCINOMA

5
|
9

TRANSITIONAL CELL CARCINOMA

88903 88963
89203 89803
89903

CASE
NUMBER

0
|
4

SQUAMOUS CELL CARCINOMA

80123
80333
80453
82403
84703

C67

SPECIFIED SARCOMA

OTHER MALIGNANCY

TOTAL

1. 96

- 366 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

2
-

8
1

11
5

25
5

60
16

81
39

134
47

111
47

148
62

190
75

228
85

189
70

139
43

1
-

2
1

6
1

2
2

5
1

3
1

5
2

3
3

5
-

2
-

2
1

3
-

4
2

2
2

1
-

1
-

1
-

2
-

2
1

1
4

6
2

4
2

2
-

1
-

1
-

1
-

1
-

1
-

5
-

1
-

1
-

1
-

1
-

1
-

1
-

4
1

2
-

5
2

6
1

2
-

2
-

8
2

14
6

32
6

64
18

87
41

138
50

118
49

156
66

200
85

247
89

207
76

150
49

- 367 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

KIDNEY

ICD-O-3
83103 83123
83163 83173
83183 88013
89803

89603

MORPHOLOGY

GENDER

CASE
NUMBER

RENAL CELL CARCINOMA

NEPHROBLASTOMA (WILMS TUMOR)

80333 80413
81233 83193
83203 89593

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

88583 88603
91203

88053

SPECIFIED SARCOMA

SARCOMA, NOS

80003

C64

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

624
314

2
-

1
1

Male
Female

7
3

5
3

1
-

Male
Female

10
10

1
-

Male
Female

13
10

Male
Female

6
1

Male
Female

1
-

Male
Female

17
12

Male
Female

678
350

8
3

1
-

1
1

1. 96

- 368 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
-

3
4

13
6

27
11

21
26

56
21

73
30

101
38

69
39

59
30

64
36

48
31

51
27

34
14

1
-

1
-

3
-

1
-

1
1

1
1

2
1

1
-

2
-

2
-

1
3

2
1

4
3

1
2

1
-

2
-

3
-

1
-

1
-

4
2

3
-

4
1

1
4

4
4

2
-

3
5

13
7

27
11

24
26

60
21

78
30

102
40

79
42

61
36

71
38

57
36

52
33

39
21

- 369 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

RENAL PELVIS

ICD-O-3
81203 81223
81303 81313

80703 80713

MORPHOLOGY

GENDER

CASE
NUMBER

TRANSITIONAL CELL CARCINOMA

SQUAMOUS CELL CARCINOMA

81403 82553
82603 83103

80413 80523

ADENOCARCINOMA

OTHER SPECIFIED CARCINOMA

80103 82303

CARCINOMA, NOS

89003

SPECIFIED SARCOMA

80003

C65

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

271
349

Male
Female

14
6

Male
Female

59
31

Male
Female

2
-

Male
Female

2
2

Male
Female

Male
Female

Male
Female

348
396

1. 96

- 370 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

4
-

7
-

8
9

20
14

33
31

28
47

45
54

34
53

50
59

27
44

15
37

1
-

1
-

1
2

2
1

4
3

3
-

2
-

1
1

2
-

2
3

4
2

7
1

6
1

6
2

7
7

7
3

5
2

9
3

1
2

2
2

1
-

1
-

1
-

1
-

1
1

2
1

6
3

12
2

15
10

27
16

41
36

39
55

53
58

43
60

62
64

30
49

17
39

- 371 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

URETER

ICD-O-3
81203 81223
81303

80703 80713

MORPHOLOGY

GENDER

CASE
NUMBER

TRANSITIONAL CELL CARCINOMA

SQUAMOUS CELL CARCINOMA

81403

ADENOCARCINOMA

80823 82463

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

88903

SPECIFIED SARCOMA

80003

C66

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

188
241

Male
Female

1
1

Male
Female

Male
Female

2
-

Male
Female

4
5

Male
Female

1
-

Male
Female

4
2

Male
Female

200
251

1. 96

- 372 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

5
-

9
4

17
3

16
20

22
31

35
34

22
52

32
40

16
27

13
28

1
1

1
-

1
-

1
-

1
-

2
1

1
-

1
-

3
1

1
1

5
-

9
4

17
3

17
20

24
33

36
35

25
53

34
42

16
29

16
30

- 373 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

URETHRA AND PARAURETHRAL GLAND

ICD-O-3
81203 81303

MORPHOLOGY

GENDER

CASE
NUMBER

TRANSITIONAL CELL CARCINOMA

80703 80723

SQUAMOUS CELL CARCINOMA

81403

ADENOCARCINOMA

85603

OTHER SPECIFIED CARCINOMA

87203

C68.0 - C68.1

MALIGNANT MELANOMA

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

14
3

Male
Female

Male
Female

1
1

Male
Female

1
-

Male
Female

Male
Female

16
8

1. 96

- 374 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
-

1
-

1
1

2
-

4
-

2
-

2
1

1
-

1
-

2
2

1
1

2
1

2
-

5
-

2
-

2
1

- 375 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OVERLAPPING LESION OF URINARY ORGANS

ICD-O-3
81203 81303

C68.8

MORPHOLOGY

GENDER

CASE
NUMBER

TRANSITIONAL CELL CARCINOMA

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

4
7

Male
Female

4
7

1. 96

- 376 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
-

2
-

2
-

2
-

- 377 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

URINARY SYSTEM, NOS

ICD-O-3
81203 81223
81303

83103

MORPHOLOGY

GENDER

CASE
NUMBER

TRANSITIONAL CELL CARCINOMA

ADENOCARCINOMA

80413 80823

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

87203

MALIGNANT MELANOMA

80003

C68.9

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

98
108

Male
Female

Male
Female

2
-

Male
Female

4
2

Male
Female

Male
Female

3
-

Male
Female

107
112

1. 96

- 378 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

3
-

6
2

5
5

6
13

10
11

16
17

19
20

19
20

11
14

3
5

1
-

1
-

1
-

1
1

1
-

1
-

1
-

1
-

1
-

3
-

6
2

5
5

6
13

12
12

17
17

20
21

21
20

13
15

4
6

- 379 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

EYE AND LACRIMAL GLAND

ICD-O-3
95103 95113

MORPHOLOGY

GENDER

CASE
NUMBER

RETINOBLASTOMA

87203 87703

MALIGNANT MELANOMA

80703 80723

SQUAMOUS CELL CARCINOMA

81403 82003

LACRIMAL GLAND CARCINOMA

80823

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

88043 88153
92313

88003

SPECIFIED SARCOMA

SARCOMA, NOS

80003

C69

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

13
7

12
7

1
-

Male
Female

10
9

1
-

1
-

1
-

Male
Female

5
2

Male
Female

5
2

Male
Female

1
-

Male
Female

2
-

Male
Female

1
2

Male
Female

1
-

Male
Female

1
-

Male
Female

39
22

13
7

1
-

1
-

1
-

1. 96

- 380 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

1
1

1
-

1
1

2
-

1
1

4
-

1
1

1
-

1
-

2
-

1
-

1
-

1
-

1
-

1
1

1
-

1
-

2
1

1
-

1
4

1
1

3
1

1
1

1
-

1
1

5
1

3
-

2
2

2
1

- 381 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

BRAIN

ICD-O-3
94003 94013

C71

MORPHOLOGY

GENDER

CASE
NUMBER

MALIGNANT ASTROCYTOMA

94403 94413

GLIOBLASTOMA MULTIFORME

93813 93843
94113 94203
94213 94243

94503 94513
94603

93803 93823

OTHER SPECIFIED ASTROCYTOMA

OLIGODENDROGLIOMA

GLIOMA,NOS

94703 94713
94733 94743

95223

MEDULLOBLASTOMA

ESTHESIONEUROBLASTOMA

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

74
54

1
3

3
-

1
1

Male
Female

174
125

1
-

2
2

2
-

Male
Female

12
8

1
2

3
-

Male
Female

23
24

1
-

Male
Female

42
33

3
-

2
3

2
2

1
2

Male
Female

15
7

4
1

6
2

2
1

Male
Female

10
9

1
1

93913 93923
93943

EPENDYMOMA

Male
Female

11
8

2
2

2
2

90643 90803

Male

23

GERM CELL TUMOR AND MALIGNANT


TERATOMA

Female

Male
Female

8
11

Male
Female

90813 90853
91003 95083
88013
92203
93703
94423
95403
88003

91503
93623
93713
95063

SPECIFIED SARCOMA

SARCOMA, NOS

- 382 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
4

5
5

3
4

3
4

8
4

11
2

8
2

7
6

4
1

8
8

3
4

3
2

1
-

3
1

3
2

5
3

4
5

9
9

18
12

21
13

22
16

19
13

24
8

21
16

13
15

9
7

1
2

1
-

2
1

2
3

2
-

1
-

1
1

1
-

2
1

2
4

4
2

4
4

1
-

2
4

2
3

2
1

1
2

3
1

2
-

4
2

2
4

7
5

1
2

3
2

2
6

3
1

3
1

1
1

2
-

1
-

1
1

1
-

1
-

1
-

2
1

1
2

1
-

2
2

1
-

1
-

1
-

1
-

1
1

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
1

1
3

1
2

1
1

2
-

1
-

1
-

- 383 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

BRAIN

C71CONTINUED

ICD-O-3

CASE
GENDER NUMBER

MORPHOLOGY

95383

MALIGNANT MENINGIOMA

80003 87203
95013 95053
95373

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

2
4

Male
Female

26
21

1
-

2
-

Male
Female

420
314

16
12

17
11

18
12

12
9

1. 96

- 384 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

1
1

2
1

1
-

1
-

1
1

2
1

3
2

3
4

2
1

1
6

3
1

4
2

11
10

16
7

19
15

18
24

30
23

37
22

36
21

37
37

32
22

41
24

31
25

20
25

18
9

11
6

- 385 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

C70C72

OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM

ICD-O-3

CASE
GENDER NUMBER

MORPHOLOGY

93643 94733

PRIMITIVE NEUROECTODERMAL TUMOR

94003 94013
94203

93913

ASTROCYTOMA

EPENDYMOMA

95303

MALIGNANT MENINGIOMA

93703

CHORDOMA

90713

GERM CELL TUMOR

91503 91613
95393 95403

88003

SPECIFIED SARCOMA

SARCOMA, NOS

80003

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

Male
Female

3
3

1
-

Male
Female

4
7

Male
Female

10
11

1
-

Male
Female

Male
Female

1
-

1
-

Male
Female

5
5

1
-

Male
Female

1
-

Male
Female

1
1

Male
Female

25
30

1
1

3
-

1. 96

- 386 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

1
-

1
-

1
-

1
-

1
-

1
-

1
2

1
-

1
1

1
-

1
3

1
1

1
1

1
2

1
-

1
-

1
-

1
-

1
-

1
-

2
1

1
2

2
2

2
3

2
1

2
5

1
1

2
4

2
2

1
2

2
1

2
2

- 387 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

THYROID GLAND

ICD-O-3

82903 83303
83353

83453 83473
85103

80703

PAPILLARY CARCINOMA

FOLLICULAR ADENOCARCINOMA

MEDULLARY CARCINOMA

SQUAMOUS CELL CARCINOMA

81403

ADENOCARCINOMA, NOS

80203 80213

CARCINOMA, UNDIFFERENTIATED

80313 80413
82623 83373

80103

OTHER SPECIFIED CARCINOMA

CARCINOMA, NOS

91203

SPECIFIED SARCOMA

80003

CASE
GENDER NUMBER

MORPHOLOGY

82603 83403
83413 83433
83443 83503

C73

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

479
1,654

5
10

Male
Female

47
107

Male
Female

11
22

Male
Female

4
3

Male
Female

Male
Female

10
16

Male
Female

5
5

Male
Female

10
14

1
-

Male
Female

1
-

Male
Female

4
15

Male
Female

571
1,838

1
-

12

5
14

1. 96

- 388 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

8
62

26
112

52
121

60
169

55
225

60
259

67
245

61
186

32
97

17
75

16
44

9
28

6
9

5
3

2
10

5
8

3
15

4
11

6
8

6
13

5
9

3
6

7
3

3
3

1
3

2
3

1
-

1
-

1
4

2
4

3
2

2
2

1
-

1
-

1
-

1
1

1
-

1
1

1
1

2
3

2
3

3
2

1
3

1
-

1
-

1
-

2
-

1
-

1
-

2
2

1
2

1
-

1
2

2
1

1
-

1
2

2
1

1
1

11
72

28
119

59
129

64
186

59
240

66
277

77
268

71
202

43
109

27
89

26
57

14
35

14
17

6
12

- 389 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OTHER ENDOCRINE GLANDS

ICD-O-3
94903 95003

MORPHOLOGY

GENDER

CASE
NUMBER

NEUROBLASTOMA

83703

ADRENAL CORTICAL CARCINOMA

86803 87003

MALIGNANT PHEOCHROMOCYTOMA

81403

ADENOCARCINOMA, NOS

80703 82463

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

80003 93823
95083

C74 - C75

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

6
9

4
6

2
2

Male
Female

4
8

Male
Female

4
2

Male
Female

1
1

Male
Female

2
-

Male
Female

6
1

Male
Female

2
5

1
-

Male
Female

25
26

5
6

2
2

1. 96

- 390 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
1

1
-

1
2

1
-

1
1

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

2
-

1
-

1
-

2
1

2
1

2
3

4
1

4
1

2
2

1
1

1
1

- 391 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

OTHER AND ILL-DEFINED SITES

ICD-O-3
81403

MORPHOLOGY

GENDER

CASE
NUMBER

ADENOCARCINOMA, NOS

84803

OTHER SPECIFIED CARCINOMA

80103 80203

CARCINOMA, NOS

84303

CHONDROSARCOMA

88103 89363

SPECIFIED SARCOMA

80003 90803

C76

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

1
1

Male
Female

Male
Female

2
-

Male
Female

1
-

Male
Female

1
4

Male
Female

4
-

1
-

Male
Female

9
6

1
-

1. 96

- 392 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
-

1
1

1
1

2
1

2
-

2
1

- 393 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

UNKNOWN PRIMARY SITES

ICD-O-3

80703 80713
80723 80743

80203

ADENOCARCINOMA

SQUAMOUS CELL CARCINOMA

CARCINOMA, UNDIFFERENTIATED

80413

SMALL CELL CARCINOMA

91003

CHORIOCARCINOMA

80033
80333
80503
82403
82603
84303
84903
85743
91013

80323
80463
80823
82463
83103
84613
85603
85753

OTHER SPECIFIED CARCINOMA

80103

CARCINOMA, NOS

93643

MALIGNANT NEUROGENIC TUMORS

88013
88043
88303
89363
91203
95403

88023
88103
88903
89803
91403

CASE
GENDER NUMBER

MORPHOLOGY

81403 84413
84703 84803
84813

C80

SPECIFIED SARCOMA

- 394 -

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

150
152

Male
Female

93
14

Male
Female

5
1

Male
Female

8
5

Male
Female

2
2

1
-

Male
Female

34
53

1
-

Male
Female

118
56

1
-

Male
Female

Male
Female

10
7

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

1
2

1
2

2
1

5
3

7
7

11
8

16
12

12
15

17
8

20
24

22
27

19
25

17
18

1
-

3
-

10
2

10
-

16
1

18
2

11
1

8
1

7
2

6
3

2
1

1
1

1
-

1
-

2
-

1
-

1
-

1
-

3
-

1
1

2
-

1
-

1
1

2
2

3
7

4
7

2
5

1
7

4
9

5
5

3
2

4
5

4
1

4
-

1
-

1
-

2
-

2
4

8
2

8
5

10
4

9
9

15
7

12
7

15
3

20
11

10
4

1
-

1
2

1
-

1
-

1
-

2
-

2
1

1
-

- 395 -

99
AGE DISTRIBUTION OF CANCER MORPHOLOGY BY GENDER AND PRIMARY ANATOMIC SITES, 2010
(CONTINUED)

UNKNOWN PRIMARY SITES

ICD-O-3

MORPHOLOGY

GENDER

CASE
NUMBER

88003

SARCOMA, NOS

87203

MALIGNANT MELANOMA

80003
80043
90503
90713

80013
88063
90643
90853

C80CONTINUED

OTHER MALIGNANCY

TOTAL

0
|
4

5
|
9

10
|
14

15
|
19

Male
Female

3
1

Male
Female

1
3

Male
Female

114
96

Male
Female

538
391

1
1

2
-

1. 96

- 396 -

20
|
24

25
|
29

30
|
34

35
|
39

40
|
44

45
|
49

50
|
54

55
|
59

60
|
64

65
|
69

70
|
74

75
|
79

80
|
84

85+

2
-

1
-

1
-

1
1

3
1

1
-

1
1

1
-

5
4

5
2

6
1

10
8

10
12

24
9

15
29

32
27

5
1

7
4

6
3

9
4

19
13

31
19

46
25

57
25

41
35

56
34

59
52

71
50

64
74

64
51

- 397 -

99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010

ICD-O-3

PRIMARY ANATOMIC SITES

C00-C80
C00-C14
2

C00-C14

ORAL CAVITY, OROPHARYNX AND HYPOPHARYNX

C44.0

OTHER AND UNSPECIFIED PARTS OF MOUTH

C16
C17

942

HYPOPHARYNX

C14

2,269
635

OROPHARYNX

C12-C13

C15

164

FLOOR OF MOUTH

C09-C10

C15-C26, C48

445

GUM

C05-C06

C11

1,805

TONGUE

C04

6,560
228

LIPexcludes skin of lip C44.0

C03

C07-C08

8,367

LIP, ORAL CAVITY AND PHARYNX

C01-C02

CASE NUMBER

90,649

ALL SITES

C00

PHARYNX AND ILL-DEFINED SITES IN LIP, ORAL CAVITY AND PHARYNX

72
236

MAJOR SALIVARY GLANDS

1,571

NASOPHARYNX

DIGESTIVE ORGANS AND PERITONEUM

34,255
2,238

ESOPHAGUS

3,854

STOMACH

325

SMALL INTESTINE

1. 96 ICD-O-3 M-CODE p.497

2. ICD-O-3

C00-C06C09-C10C12-C14

- 398 -

Histologic grading and differentiation

Immunophenotype designation for lymphomas and


leukemias

Null

NK

ICD-O-3

Well
Moderately
Poorly
differentiated differentiated differentiated

Anaplastic

Not
determined

T-cell

B-cell

Null cell

NK cell

Not
determined

6,979

27,931

14,859

4,282

31,859

309

2,175

41

2,207

C00-C80

1,542

3,148

841

1,064

1,771

C00-C14

1,491

3,067

660

45

1,296

C00-C14

102

80

10

32

C00

447

935

152

263

C01-C02

134

209

34

66

C03

30

97

13

22

C04

722

1,004

149

385

C05-C06

21

275

132

14

193

C09-C10

29

431

160

315

C12-C13

36

10

20

C14

51

18

17

143

C07-C08

44

30

163

1,002

332

C11

1,866

14,171

4,811

362

13,045

C15-C26, C48

52

994

469

12

711

C15

162

955

1,802

56

879

C16

16

74

38

22

175

C17

- 399 -

99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C18-C21

COLON, RECTUM, RECTOSIGMOID JUNCTION AND ANUS

C18

C22
C23-C24
C25
C48
C26
C30-C39
C30-C31
C32
C33-C34
C38.4
C37-C38.3, C38.8
3

C42

C40-C41

CASE NUMBER

14,040
8,635

COLON

C19-C21

RECTUM, RECTOSIGMOID JUNCTION AND ANUS

LIVER AND INTRAHEPATIC BILE DUCTS

GALLBLADDER AND EXTRAHEPATIC BILE DUCTS

5,405
11,023
924
1,643

PANCREAS

RETROPERITONEUM AND PERITONEUM

OTHER AND ILL-DEFINED SITES WITHIN DIGESTIVE ORGANS AND PERITONEUM

RESPIRATORY SYSTEM AND INTRATHORACIC ORGANS

NASAL CAVITIES, ACCESSORY SINUSES, MIDDLE EAR AND INNER EAR

157
51
11,761
172
635

LARYNX

10,615

TRACHEA, BRONCHUS AND LUNG

62

PLEURA

THYMUS, HEART AND MEDIASTINUM

276
1,823

LEUKEMIA

BONES, JOINTS AND ARTICULAR CARTILAGE

163

1. 96 ICD-O-3 M-CODE P.497

3. ICD-O-3

M-98003 - M-99643M-99803 - M-99893

- 400 -

Histologic grading and differentiation

Immunophenotype designation for lymphomas and


leukemias

Null

NK

ICD-O-3

Well
Moderately
Poorly
Anaplastic
differentiated differentiated differentiated

Not
determined

T-cell

B-cell

Null cell

NK cell

Not
determined

1,025

9,275

1,177

136

2,427

C18-C21

650

5,698

786

90

1,411

C18

375

3,577

391

46

1,016

C19-C21

456

2,326

1,050

93

7,098

C22

73

293

131

418

C23-C24

59

244

121

15

1,204

C25

22

14

18

95

C48

38

C26

682

2,159

1,743

137

7,040

C30-C39

10

28

28

18

88

C30-C31

42

301

62

227

C32

614

1,821

1,624

107

6,449

C33-C34

59

C38.4

15

28

216

C37-C38.3, C38.8

39

279

1,501

17

19

117

- 401 -

C42

C40-C41

99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C47, C49
C44
4

C44
C44
C50
C50

C51-C58
C55
C53
C54
C56, C57.0-C57.4

CONNECTIVE, SUBCUTANEOUS AND OTHER SOFT TISSUES

C61
C62
C60,C63
C64-C68

CASE NUMBER

508
2,978

SKIN

212

SKIN, MALIGNANT MELANOMA

SKIN (excludes MALIGNANT MELANOMA)

2,766
9,655

FEMALE BREAST

39

MALE BREAST

4,822

FEMALE GENITAL ORGANS

UTERUS, NOS

1,680

CERVIX UTERI

1,737

CORPUS UTERI

OVARY, FALLOPIAN TUBE AND BROAD LIGAMENT

C51-C52, C57.7-C57.9 VAGINA, VULVA, OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS
C60-C63

1,245
152
4,661

MALE GENITAL ORGANS

4,392

PROSTATE GLAND

178

TESTIS

PENIS AND OTHER MALE GENITAL ORGANS

91
4,441

URINARY TRACT

1. 96 ICD-O-3 M-CODE P.497

4. ICD-O-3

C44 M-87203 - M-87903

- 402 -

Histologic grading and differentiation

Immunophenotype designation for lymphomas and


leukemias

Well
Moderately
Poorly
Anaplastic
differentiated differentiated differentiated

Not
determined

Null

NK

T-cell

B-cell

Null cell

NK cell

Not
determined

ICD-O-3

63

68

32

70

275

C47, C49

354

336

87

25

2,176

C44

203

C44

354

331

83

25

1,973

C44

1,384

4,367

2,874

1,028

C50

21

10

C50

546

1,525

894

361

1,496

C51-C58

C55

111

620

310

13

626

C53

331

634

327

169

276

C54

92

239

246

176

492

C56, C57.0-C57.4

12

32

11

95

C51-C52, C57.7-C57.9

170

1,068

3,007

21

395

C60-C63

156

1,036

3,000

17

183

C61

172

C62

13

30

40

C60,C63

139

932

456

1,973

941

C64-C68

- 403 -

99
HISTOLOGIC GRADING AND DIFFERENTIATION IN PRIMARY ANATOMIC SITES,
2010CONTINUED

ICD-O-3

PRIMARY ANATOMIC SITES

C67
C64
C65
C66
C68.0-C68.1
C68.8
C68.9
C69
C70-C72
C71
C70, C72
C73
C74-C75
C76
C80

CASE NUMBER

1,964

BLADDER

1,028

KIDNEY

744

RENAL PELVIS

451

URETER

URETHRA AND PARAURETHRAL GLAND

OVERLAPPING LESION OF URINARY ORGANS

24
11
219

URINARY SYSTEM, NOS

61

EYE AND LACRIMAL GLAND

BRAIN AND OTHER PARTS OF CENTRAL NERVOUS SYSTEM

789
734

BRAIN

OTHER AND UNSPECIFIED PARTS OF NERVOUS SYSTEM

55
2,409

THYROID GLAND

51

OTHER ENDOCRINE GLANDS

15

OTHER AND ILL-DEFINED SITES

929

UNKNOWN PRIMARY SITES

2,915

MALIGNANT LYMPHOMA
1. 96 ICD-O-3 M-CODE P.497

- 404 -

Histologic grading and differentiation

Well
Moderately
Poorly
differentiated differentiated differentiated

Immunophenotype designation for lymphomas and


leukemias

Null

NK

Anaplastic

Not
determined

T-cell

B-cell

Null cell

NK cell

Not
determined

ICD-O-3

50

383

144

1,094

293

C67

68

349

188

63

360

C64

19

94

77

404

150

C65

73

28

267

82

C66

C68.0-C68.1

C68.8

26

17

127

49

C68.9

48

C69

36

41

188

517

C70-C72

34

41

181

471

C71

46

C70, C72

212

71

46

34

2,046

C73

44

C74-C75

12

C76

19

897

C80

270

1,896

40

706

- 405 -

99
IMMUNOPHENOTYPE DESIGNATION OF LYMPHOMAS AND LEUKEMIAS, 2010

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

1,823

LEUKEMIA AND MYELOID NEOPLSAM, TOTAL

734

ACUTE MYELOID LEUKEMIA

235

ACUTE LYMPHOBLASTIC LEUKEMIA

225

CHRONIC MYELOID LEUKEMIA

135

CHRONIC LYMPHOCYTIC LEUKEMIA

35

ACUTE LEUKEMIAS OF AMBIGUOUS LINEAGE

230

MYELOPROLIFERATIVE NEOPLASMS

200

MYELODYSPLASTIC SYNDROMES

ACUTE BIPHENOTYPIC LEUKEMIA

13

OTHER LEUKEMIA

12

LEUKEMIA, NOS
1. 96 ICD-O-3 M-CODE P.497

- 406 -

Histologic grading and differentiation

Well
Moderately
Poorly
differentiated differentiated differentiated

Immunophenotype designation for lymphomas and


leukemias

Null

NK

Anaplastic

Not
determined

T-cell

B-cell

Null cell

NK cell

Not
determined

39

279

1,501

723

21

178

35

222

91

42

33

229

199

10

- 407 -

99
IMMUNOPHENOTYPE DESIGNATION OF LYMPHOMAS AND LEUKEMIAS, 2010
CONTINUED

HEMATOPOIETIC AND LYMPHOID TUMORS

CASE NUMBER

2,915

MALIGNANT LYMPHOMA

172

HODGKIN LYMPHOMA

2,082

NON-HODGKIN LYMPHOMA

1,750

B-cell lymphoid neoplasms

T/NK

332

T/NK-cell lymphoid neoplasms

502

Plasma cell neoplasm

26

Other LPD

133

Malignant lymphoma, NOS and others


1. 96 ICD-O-3 M-CODE P.497

- 408 -

Histologic grading and differentiation

Well
Moderately
Poorly
differentiated differentiated differentiated

Immunophenotype designation for lymphomas and


leukemias

Null

NK

Anaplastic

Not
determined

T-cell

B-cell

Null cell

NK cell

Not
determined

270

1,896

40

706

169

265

1,595

40

179

1,593

151

260

39

28

223

278

24

75

56

- 409 -

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010

C44.0


Total
0101

98
99

0102

98
99

0103

98
99

0104

98
99

0105

98
99

0106

98
99

0107

98
99

0108

98
99

0109

98
99

0111

98
99

0113

98
99

0114

98
99

0110

98
99

7,469
7,595
126
6,574
6,554
-20
2,375
2,366
-9
267
266
-1
936
965
29
247
291
44
77
56
-21
360
388
28
3,558
3,707
149
1,163
1,253
90
9,120
9,184
64
1,530
1,484
-46
17
13
-4

C00 C01-C02
35
23
-12
8
9
1
3
2
-1
1
-1
6
7
1
1
2
1
52
36
-16
1
3
2
-

186
177
-9
83
86
3
40
36
-4
2
-2
3
5
2
1
9
8
1
-1
2
-2
57
56
-1
19
18
-1
295
246
-49
22
24
2
-

C03
43
61
18
33
31
-2
17
14
-3
1
1
1
1
19
37
18
7
8
1
95
104
9
7
9
2
-

C04 C05-C06 C09-C10 C12-C13


13
22
9
9
12
3
3
2
-1
6
3
-3
1
1
27
24
-3
3
3
-

217
200
-17
107
96
-11
53
38
-15
2
4
2
6
1
-5
1
10
9
1
-1
74
83
9
15
24
9
351
321
-30
21
25
4
-

101 5 21 99 100 6 3 98

- 410 -

78
83
5
57
46
-11
21
13
-8
4
5
1
2
-2
1
1
1
-1
23
18
-5
5
9
4
99
75
-24
5
6
1
-

67
68
1
48
63
15
22
14
-8
2
4
2
31
35
4
4
8
4
128
110
-18
10
10
-

C14 C07-C08
2
3
1
1
1
1
1
2
2
-

42
32
-10
13
21
8
7
4
-3
2
2
2
-2
10
11
1
6
3
-3
43
30
-13
4
2
-2
-

967
867
-100
650
595
-55
227
237
10
16
32
16
125
108
-17
18
18
11
7
-4
9
13
4
328
302
-26
83
107
24
1,035
999
-36
115
133
18
-

59
57
-2
61
71
10
31
15
-16
3
2
-1
13
8
-5
1
3
2
2
1
-1
17
22
5
8
1
-7
100
115
15
7
17
10
-

172
171
-1
149
130
-19
50
40
-10
4
2
-2
26
20
-6
4
6
2
2
2
3
3
49
55
6
27
19
-8
139
134
-5
31
32
1
2
-2

20
19
-1
16
19
3
3
4
1
1
1
2
5
3
2
2
17
20
3
3
2
-1
-

- 411 -

C26 C30-C31
2
4
2
3
5
2
1
-1
1
1
1
-1
1
2
1
1
1
1
1
-

36
27
-9
26
18
-8
3
5
2
1
2
1
10
14
4
2
5
3
22
24
2
6
6
-

C32

C33-C34

43
48
5
60
66
6
18
14
-4
2
-2
2
2
1
-1
1
-1
26
29
3
5
14
9
65
82
17
3
9
6
-

874
898
24
1,011
1,006
-5
307
236
-71
33
40
7
75
83
8
29
30
1
1
6
5
10
15
5
370
354
-16
119
110
-9
919
846
-73
147
97
-50
1
3
2

C48

235
246
11
332
387
55
105
117
12
13
24
11
60
66
6
20
23
3
4
6
2
15
18
3
223
217
-6
76
90
14
467
473
6
114
68
-46
1
1

C25

417
458
41
563
501
-62
189
151
-38
35
32
-3
92
111
19
34
34
9
4
-5
15
28
13
279
339
60
96
123
27
699
796
97
148
127
-21
2
3
1

C23-C24

33
18
-15
17
16
-1
11
10
-1
1
1
4
1
-3
3
3
1
1
17
13
-4
7
5
-2
31
24
-7
7
1
-6
-

C22

318
297
-21
366
352
-14
99
107
8
21
15
-6
72
64
-8
21
21
7
2
-5
15
9
-6
161
178
17
57
45
-12
366
338
-28
74
64
-10
1
1
-

166
168
2
128
136
8
47
48
1
7
7
15
21
6
8
11
3
3
2
-1
68
78
10
14
15
1
209
213
4
17
9
-8
1
-1

202
190
-12
87
95
8
37
33
-4
7
1
-6
7
9
2
2
6
4
2
1
-1
8
4
-4
55
53
-2
22
26
4
194
197
3
20
15
-5
-

C18 C19-C21

C17

C16

C15

C11

0101

0102

0103

0104

0105

0106

0107

0108

0109

0110

0111

0113

0114

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0105

98
99

0106

98
99

0107

98
99

0108

98
99

0109

98
99

0110

98
99

0111

98
99

0113

98
99

0114

98
99

C50

C50

C55

C53

C54

185
204
19
122
90
-32
43
50
7
11
5
-6
17
22
5
14
13
-1
8
5
-3
105
121
16
30
27
-3
258
262
4
50
48
-2
2
-2

835
940
105
555
550
-5
373
417
44
39
38
-1
194
212
18
24
24
2
2
158
168
10
444
527
83
175
224
49
893
978
85
290
279
-11
1
2
1

1
1
2
3
1
2
-2
1
1
6
1
-5
2
1
-1
-

2
-2
1
1
1
1
1
1
-

282
284
2
164
196
32
72
83
11
32
24
-8
28
36
8
32
31
-1
11
5
-6
35
34
-1
433
390
-43
106
68
-38
416
429
13
90
94
4
3
-3

120
136
16
121
115
-6
40
56
16
4
6
2
9
12
3
2
2
1
6
5
7
14
7
91
130
39
45
58
13
207
222
15
27
34
7
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 412 -

0104

48
55
7
36
63
27
11
11
1
1
6
3
-3
1
2
1
2
1
-1
12
15
3
6
2
-4
60
46
-14
5
9
4
-

C44

98
99

24
21
-3
37
47
10
5
3
-2
1
2
1
8
3
-5
3
2
-1
16
22
6
2
2
-

0103

273
305
32
156
159
3
43
42
-1
1
-1
14
15
1
1
2
1
2
2
80
59
-21
14
10
-4
288
261
-27
12
24
12
1
-1

98
99

75
87
12
37
45
8
22
21
-1
2
1
-1
1
-1
1
-1
1
1
13
24
11
2
5
3
80
75
-5
6
6
-

0102

3
6
3
1
8
7
4
-4
1
-1
2
1
-1
1
1
2
6
4
1
1
-

C40-C41 C47, C49

98
99

C42

0101

C37-C38.3,
C38.8
41
36
-5
43
38
-5
7
7
1
1
17
6
-11
1
1
34
23
-11
2
3
1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
85
22
89
23
4
1
85
16
92
10
7
-6
24
6
39
5
15
-1
3
2
-1
10
1
11
3
1
2
1
2
1
1
-1
6
9
2
3
2
76
19
77
17
1
-2
25
2
30
3
5
1
129
18
154
29
25
11
17
4
23
5
6
1
-

13
25
12
7
9
2
4
4
31
35
4
1
1
-

68
76
8
94
122
28
19
33
14
4
4
1
-1
3
-3
12
14
2
10
10
93
99
6
21
12
-9
-

205
248
43
243
248
5
89
101
12
2
3
1
16
6
-10
1
3
2
16
11
-5
4
7
3
84
60
-24
10
16
6
193
206
13
72
90
18
-

- 413 -

5
6
1
8
5
-3
2
2
2
1
-1
9
12
3
1
1
-

14
6
-8
8
5
-3
1
1
1
1
4
2
-2
3
4
1
-

C76

C77

C80

1
1
1
-1
1
-1
1
-1
1
-1
-

157
149
-8
109
104
-5
26
48
22
3
3
12
17
5
1
6
5
30
46
16
18
21
3
168
188
20
21
28
7
1
1

76
67
-9
76
89
13
14
24
10
2
2
10
7
-3
9
7
-2
1
1
2
2
50
55
5
12
12
83
65
-18
11
14
3
-

95
79
-16
98
100
2
34
37
3
3
1
-2
6
13
7
4
4
1
-1
11
16
5
34
32
-2
14
20
6
140
134
-6
24
24
-

89
84
-5
97
118
21
31
24
-7
1
4
3
3
8
5
1
1
1
-1
2
4
2
38
27
-11
20
10
-10
96
119
23
21
18
-3
-

C73 C74-C75

162
114
-48
157
150
-7
76
69
-7
7
8
1
26
19
-7
10
7
-3
23
12
-11
65
66
1
33
27
-6
163
163
28
30
2
1
2
1

C71 C70, C72

C69

C65-C66,
C68

C64

C67

6
8
2
9
9
2
3
1
1
1
1
1
1
-1
4
2
-2
3
1
-2
12
11
-1
1
1
-

21
19
-2
18
17
-1
8
10
2
1
-1
2
2
1
-1
4
3
-1
4
7
3
24
19
-5
6
5
-1
1
-1

C62 C60, C63

337
392
55
445
397
-48
129
139
10
13
6
-7
60
55
-5
4
12
8
8
2
-6
12
16
4
96
114
18
54
61
7
342
411
69
53
68
15
1
-1

C61

0101

0102

0103

0104

0105

0106

0107

0108

0109

0110

0111

0113

0114

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0115

98
99

0119

98
99

0122

98
99

0124

98
99

0125

98
99

0126

98
99

0127

98
99

0128

98
99

0130

98
99

0140

98
99

0141

98
99

0142

98
99

0143

98
99

124
149
25
35
35
81
73
-8
27
27
58
70
12
1
-1
198
195
-3
151
166
15
74
67
-7
271
243
-28
4,145
5,105
960
1,638
1,864
226
983
1,073
90

C00 C01-C02
1
-1
4
6
2
1
8
7
1
1

1
1
1
1
2
2
3
1
-2
3
4
1
85
95
10
40
39
-1
18
10
-8

C03
1
1
1
1
4
1
-3
1
-1
1
-1
17
20
3
10
12
2
1
-1

C04 C05-C06 C09-C10 C12-C13


2
-2
4
8
4
5
6
1
1
3
2

1
1
2
4
2
1
1
2
2
1
1
2
2
84
85
1
39
43
4
22
16
-6

101 5 21 99 100 6 3 98

- 414 -

1
1
1
-1
1
-1
1
1
1
2
1
43
34
-9
13
27
14
5
6
1

1
-1
1
1
1
-1
27
38
11
11
15
4
6
3
-3

C14 C07-C08
1
-1
-

1
-1
28
20
-8
7
8
1
5
2
-3

C48

2
-2
1
1
2
-2
2
2
1
4
3
2
2
4
4
60
96
36
26
31
5
29
22
-7

1
-1
1
1
3
9
6
2
-2
-

- 415 -

C26 C30-C31
1
2
1
3
-3
1
1

1
2
1
1
-1
1
1
6
12
6
2
6
4
2
1
-1

C32

C33-C34

1
1
1
-1
1
1
2
2
1
-1
27
22
-5
10
22
12
11
9
-2

1
1
2
-2
4
5
1
1
-1
2
8
6
13
21
8
6
8
2
33
33
473
480
7
214
176
-38
100
125
25

C25

1
1
1
-1
2
-2
3
3
12
33
21
14
23
9
10
15
5

C23-C24

4
4
7
-7
4
1
-3
6
6
1
1
10
8
-2
4
2
-2
20
23
3
252
396
144
199
209
10
64
70
6

4
3
-1
3
3
2
2
1
2
1
3
2
-1
1
-1
2
2
6
7
1
11
6
-5
10
15
5
193
197
4
88
106
18
49
51
2

C22

8
13
5
6
-6
10
7
-3
2
2
7
5
-2
2
3
1
19
23
4
16
14
-2
25
22
-3
223
306
83
143
184
41
98
125
27

C18 C19-C21

1
1
8
10
2
7
6
-1
4
3
-1

C17

4
3
-1
5
5
7
2
-5
3
2
-1
2
3
1
13
7
-6
5
-5
16
13
-3
172
211
39
85
96
11
50
73
23

C16

1
1
1
1
1
1
1
-1
2
5
3
3
1
-2
5
3
-2
110
136
26
36
49
13
17
24
7

C15

2
-2
1
2
1
4
4
3
3
108
157
49
24
31
7
15
20
5

C11

0115

0119

0122

0124

0125

0126

0127

0128

0130

0140

0141

0142

0143

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0125

98
99

0126

98
99

0127

98
99

0128

98
99

0130

98
99

0140

98
99

0141

98
99

0142

98
99

0143

98
99

C50

C55

C53

C54

1
16
1
23
7
1
2
1
2
15
13
-2
1
3
1
6
3
2
6
2
4
-2
118
118
10
9
13
9
3
7
4
1
18
-6
14
8
20
1
14
-7
-6
43 1,096
50 1,346
7
250
37
171
22
244
-15
73
14
226
18
203
4
-23

6
3
-3
1
1
1
-1

1
-1

36
46
10
2
1
-1
3
9
6
5
5
8
11
3
55
51
-4
15
14
-1
5
1
-4
11
19
8
141
148
7
56
63
7
43
32
-11

1
8
7
1
5
4
1
1
2
1
-1
11
11
5
5
1
1
5
1
-4
54
88
34
31
28
-3
11
10
-1

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 416 -

0124

1
1
1
1
1
2
1
2
2
45
38
-7
11
9
-2
2
5
3

C50

98
99

1
1
5
10
5
5
3
-2
2
-2

0122

6
3
-3
2
5
3
32
47
15
24
26
2
10
13
3

98
99

3
1
-2
1
1
7
17
10
11
7
-4
4
11
7

C44

0119

2
3
1
1
-1
2
2

C40-C41 C47, C49

98
99

C42

0115

C37-C38.3,
C38.8
17
18
1
9
11
2
4
3
-1

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
4
6
1
2
1
4
4
1
1
1
1
6
1
2
-6
1
1
1
5
1
1
1
-4
49
10
57
7
8
-3
30
2
23
1
-7
-1
8
3
1
-5
1

5
5
3
1
-2
2
-2

- 417 -

1
1
1
-1
1
-1
1
3
2
11
26
15
9
10
1
2
6
4

1
-1
2
2
1
-1
1
-1

C73

C74-C75

C76

C77

C80

4
5
1
1
1
1
-1
1
1
1
1
1
-1
4
2
-2
160
179
19
62
66
4
28
51
23

2
4
2
2
-2
-

1
1
1
-1
1
1
1
1
2
3
1
3
3
89
113
24
12
23
11
10
14
4

1
-1
2
1
-1
1
-1
3
-3
1
-1
3
4
1
30
50
20
11
22
11
10
15
5

3
8
5
1
-1
1
1
1
4
3
1
2
1
10
5
-5
39
53
14
22
29
7
7
13
6

1
1
1
2
1
1
1
1
1
2
1
-1
5
5
40
51
11
12
21
9
8
11
3

18
12
-6
6
4
-2
7
4
-3
3
2
-1
2
2
9
7
-2
4
1
-3
27
15
-12
86
95
9
41
50
9
30
28
-2

C71 C70, C72

C69

C65-C66,
C68

C64

C67

2
1
-1
3
1
-2
2
-2

1
1
2
1
-1
1
2
1
1
-1
12
12
4
2
-2
1
2
1

C62 C60, C63

14
8
-6
5
12
7
3
7
4
6
5
-1
9
14
5
23
18
-5
3
4
1
40
33
-7
224
309
85
89
104
15
49
52
3

C61

0115

0119

0122

0124

0125

0126

0127

0128

0130

0140

0141

0142

0143

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0145

98
99

0146

98
99

0147

98
99

0148

98
99

0150

98
99

0201

98
99

0202

98
99

0203

98
99

0204

98
99

0207

98
99

0301

98
99

0302

98
99

0303

98
99

940
996
56
19
19
26
27
1
168
163
-5
10
8
-2
301
303
2
6
3
-3
39
24
-15
30
43
13
1,332
1,259
-73
279
245
-34
784
750
-34
12
12
-

C00 C01-C02
1
1
4
1
-3
2
2
2
2
-

4
8
4
1
1
1
2
1
2
3
1
38
35
-3
7
4
-3
7
6
-1
1
-1

C03
3
5
2
19
13
-6
3
3
2
1
-1
-

C04 C05-C06 C09-C10 C12-C13


1
1
2
5
3
1
1
1
3
2
-

20
20
1
-1
3
6
3
56
33
-23
6
12
6
10
4
-6
-

6
3
-3
2
2
1
1
1
-1
1
1
21
11
-10
5
3
-2
2
4
2
-

101 5 21 99 100 6 3 98

- 418 -

2
5
3
2
1
-1
1
2
1
28
20
-8
1
8
7
1
1
-

C14

C07-C08

1
1
3
1
-2
-

1
-1
1
-1
2
-2
1
-1
5
4
-1
2
1
-1
-

C48

23
20
-3
5
5
1
1
6
10
4
1
1
26
21
-5
4
1
-3
14
16
2
-

2
2
2
2
1
-1
1
1
-

- 419 -

C26 C30-C31
2
2
1
1
-

2
-2
1
-1
1
1
3
-3
1
1
-

C32

C33-C34

5
7
2
2
2
1
3
2
18
16
-2
1
1
4
1
-3
-

102
86
-16
18
18
2
-2
31
17
-14
1
1
26
19
-7
3
1
-2
2
2
192
199
7
16
19
3
68
76
8
2
1
-1

C25

9
12
3
1
-1
3
1
-2
3
1
-2
4
11
7
2
2
6
10
4
-

C23-C24

69
78
9
2
-2
14
12
-2
20
18
-2
6
4
-2
3
1
-2
161
150
-11
19
12
-7
73
56
-17
1
1

56
45
-11
1
7
6
8
10
2
20
24
4
5
-5
10
9
-1
45
53
8
17
14
-3
62
59
-3
2
2
-

C22

79
120
41
3
-3
25
34
9
1
1
29
33
4
5
2
-3
4
8
4
93
115
22
32
34
2
82
94
12
4
4

C18 C19-C21

3
3
2
2
3
2
-1
1
6
5
1
2
1
2
3
1
-

C17

58
64
6
1
-1
31
14
-17
20
25
5
4
1
-3
3
2
-1
78
66
-12
22
9
-13
52
36
-16
2
2
-

C16

11
18
7
1
1
5
6
1
1
1
10
14
4
1
2
1
3
3
39
48
9
9
9
8
8
1
1
-

C15

20
23
3
1
1
2
3
1
1
-1
27
22
-5
7
5
-2
9
11
2
-

C11

0145

0146

0147

0148

0150

0201

0202

0203

0204

0207

0301

0302

0303

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0150

98
99

0201

98
99

0202

98
99

0203

98
99

0204

98
99

0207

98
99

0301

98
99

0302

98
99

0303

98
99

C50

C50

C55

C53

C54

35
31
-4
5
12
7
11
16
5
1
1
1
5
4
17
15
-2
15
6
-9
10
29
19
3
-3

106
121
15
3
6
3
2
-2
29
21
-8
2
1
-1
3
1
-2
2
2
110
95
-15
39
37
-2
208
187
-21
1
-1

3
3
3
1
-2
1
2
1
-

52
47
-5
9
11
2
4
5
1
1
1
30
24
-6
3
2
-1
4
2
-2
1
2
1
84
66
-18
6
11
5
42
28
-14
-

20
14
-6
2
2
1
-1
4
4
1
1
18
31
13
1
-1
15
13
-2
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 420 -

0148

8
7
-1
1
2
1
2
3
1
1
1
8
5
-3
7
4
-3
7
4
-3
-

C44

98
99

1
1
2
1
-1
2
-2
-

0147

17
17
1
1
15
16
1
1
1
1
1
-

98
99

4
2
-2
2
2
1
1
5
6
1
3
3
-

0146

1
1
1
-1
-

C40-C41 C47, C49

98
99

C42

0145

C37-C38.3,
C38.8
3
4
1
1
-1
3
2
-1
2
-2
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
16
3
10
2
-6
-1
1
1
2
2
1
2
1
-2
1
-1
1
-1
8
1
12
4
4
3
1
-1
6
8
2
-

1
1
1
-1
1
1
1
1
-

C76

C77

C80

1
1
-

8
14
6
3
3
3
1
-2
1
-1
14
13
-1
3
1
-2
11
6
-5
-

15
16
1
1
1
1
-1
2
3
1
6
6
6
5
-1
16
4
-12
9
12
3
-

17
23
6
1
2
1
5
7
2
1
-1
5
1
-4
41
33
-8
6
3
-3
8
8
-

1
-1
1
-1
1
1
-

- 421 -

8
17
9
3
4
1
1
1
5
9
4
1
1
-

C73 C74-C75

C71 C70, C72

11
9
-2
3
1
-2
1
-1
4
2
-2
1
-1
25
14
-11
1
-1
3
1
-2
1
1

C69

23
30
7
1
2
1
1
2
1
1
2
1
19
15
-4
1
3
2
1
1
29
23
-6
7
7
22
16
-6
-

C65-C66,
C68
11
11
1
1
7
9
2
1
1
28
25
-3
5
4
-1
1
6
5
-

C64

1
1
1
1
1
1
1
-1
1
-1
-

C67

5
4
-1
1
-1
2
1
-1
1
1
-

C62 C60, C63

102
88
-14
1
-1
6
3
-3
2
1
-1
29
31
2
1
3
2
3
5
2
46
48
2
19
21
2
26
32
6
-

C61

0145

0146

0147

0148

0150

0201

0202

0203

0204

0207

0301

0302

0303

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0304

98
99

0305

98
99

0306

98
99

0307

98
99

0308

98
99

98
99

0312

98
99

0314

98
99

0315

98
99

0316

98
99

0317

98
99

0318

98
99

0319

98
99

0311

160
160
1,938
1,951
13
156
148
-8
111
27
-84
3
13
10
8
6
-2
12
5
-7
3
5
2
519
497
-22
1
1
27
39
12
20
22
2
1,671
1,698
27

C00 C01-C02
4
10
6
2
-2
3
3
-

2
-2
53
43
-10
2
1
-1
1
-1
7
9
2
28
44
16

C03
18
21
3
2
2
6
11
5

C04 C05-C06 C09-C10 C12-C13


5
5
1
1
3
2
-1

8
8
86
55
-31
1
1
2
1
-1
1
1
14
6
-8
1
1
39
59
20

21
17
-4
1
1
1
-1
3
5
2
9
11
2

101 5 21 99 100 6 3 98

- 422 -

18
22
4
1
1
1
-1
4
4
20
17
-3

C14

C07-C08

1
2
1
1
-1
1
-1
-

6
6
2
3
1
5
4
-1

C48

30
21
-9
143
144
1
25
30
5
33
7
-26
1
1
1
1
36
55
19
5
6
1
6
3
-3
170
193
23

15
11
-4
222
170
-52
6
1
-5
5
2
-3
1
-1
3
-3
55
55
3
1
-2
5
-5
224
202
-22

1
1
18
11
-7
1
1
1
1
11
5
-6
21
12
-9

1
2
1
34
35
1
3
1
-2
2
-2
1
1
4
3
-1
1
1
50
39
-11

1
4
3
1
1
2
4
2

17
10
-7
103
118
15
16
20
4
17
4
-13
1
-1
2
-2
32
36
4
2
2
1
4
3
111
113
2

- 423 -

C26 C30-C31
1
-1
-

3
5
2
1
-1
4
4
6
7
1

C32

C33-C34

1
-1
20
11
-9
6
3
-3
11
7
-4

15
15
195
205
10
16
9
-7
13
2
-11
1
4
3
3
1
-2
74
58
-16
4
1
-3
2
4
2
232
211
-21

C25

C23-C24

C22

1
2
1
13
8
-5
1
1
2
2
6
6
-

C18 C19-C21

10
17
7
84
85
1
14
7
-7
5
2
-3
1
1
1
1
40
41
1
2
6
4
3
2
-1
78
83
5

5
7
2
47
65
18
2
2
2
-2
1
1
18
15
-3
1
1
1
2
1
2
2
35
27
-8

1
1
45
35
-10
2
10
8
1
-1
1
-1
12
9
-3
31
42
11

C17

C16

C15

C11

0304

0305

0306

0307

0308

0311

0312

0314

0315

0316

0317

0318

0319

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0308

98
99

0311

98
99

0312

98
99

0314

98
99

0315

98
99

0316

98
99

0317

98
99

0318

98
99

0319

98
99

C47, C49

C44

C50

C50

C55

C53

C54

6
4
-2
3
2
-1

1
1
15
12
-3
1
-1
4
1
-3
11
8
-3

6
3
-3
65
72
7
16
5
-11
3
1
-2
3
3
1
1
20
22
2
2
9
7
1
1
47
33
-14

13
10
-3
178
201
23
18
24
6
8
1
-7
1
1
1
-1
1
-1
38
41
3
2
2
1
1
163
175
12

1
-1
3
1
-2
1
1
1
-1
1
2
1

1
-1
-

16
19
3
83
89
6
10
9
-1
5
5
3
4
1
22
20
-2
3
-3
1
1
54
38
-16

2
1
-1
28
42
14
6
5
-1
5
3
-2
1
1
18
37
19

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 424 -

0307

C40-C41

98
99

0306

20
30
10
1
-1
16
20
4

98
99

14
12
-2
1
2
1
6
8
2

0305

1
-1
1
-1
1
1

98
99

C42

0304

C37-C38.3,
C38.8
1
-1
4
6
2
1
1
7
2
-5

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
2
1
2
12
4
22
2
10
-2
1
1
-1
-1
5
2
1
-4
-2
18
1
18
2
1

1
1
1
1

C76

C77

C80

1
-1

3
1
-2
27
33
6
1
1
11
3
-8
1
-1
11
20
9

3
1
-2
31
36
5
1
1
10
5
-5
2
-2
1
1
15
10
-5

1
1
128
110
-18
1
-1
2
-2
1
1
5
8
3
49
51
2

1
2
1
3
1
-2

- 425 -

1
1
12
9
-3
4
2
-2
13
13
-

C73 C74-C75

1
1
1
1
1
-1
1
2
1

C71 C70, C72

3
3
11
17
6
2
-2
3
3
16
11
-5

C69

7
6
-1
51
40
-11
4
8
4
4
-4
1
2
1
1
-1
1
-1
19
18
-1
2
2
2
2
34
45
11

C65-C66,
C68
1
6
5
33
20
-13
1
1
5
6
1
29
23
-6

C64

1
-1
1
1
1
1
1
-1
4
-4

C67

3
2
-1
1
1
5
1
-4

C62 C60, C63

5
8
3
64
109
45
4
7
3
5
5
2
-2
38
43
5
1
5
4
1
1
55
77
22

C61

0304

0305

0306

0307

0308

0311

0312

0314

0315

0316

0317

0318

0319

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0320

98
99

0321

98
99

0401

98
99

0402

98
99

0403

98
99

0404

98
99

0406

98
99

0407

98
99

0501

98
99

0502

98
99

0503

98
99

0504

98
99

0505

98
99

577
684
107
713
1,249
536
617
791
174
677
723
46
452
545
93
62
42
-20
17
28
11
71
62
-9
1,118
1,286
168
1
-1
31
77
46
61
76
15
41
32
-9

C00 C01-C02
1
1
3
3
1
1
1
2
1
1
1
-

8
18
10
14
24
10
9
7
-2
11
10
-1
2
4
2
1
-1
16
12
-4
1
-1
1
1

C03
1
4
3
2
15
13
8
8
3
3
1
-1
6
9
3
-

C04 C05-C06 C09-C10 C12-C13


2
2
3
3
2
2
1
2
1
1
-1
2
1
-1
1
-1
-

13
17
4
15
31
16
10
13
3
16
7
-9
3
5
2
1
-1
1
-1
15
19
4
1
-1
2
1
-1
-

3
7
4
3
13
10
3
7
4
5
12
7
6
2
-4
5
11
6
2
2
1
-1
-

101 5 21 99 100 6 3 98

- 426 -

6
10
4
5
13
8
3
3
13
11
-2
5
3
-2
13
11
-2
-

C14

C07-C08

1
1
-

1
4
3
2
3
1
3
3
4
1
-3
1
-1
1
1
3
2
-1
-

C48

12
21
9
17
20
3
14
12
-2
7
11
4
7
8
1
1
1
26
21
-5
2
2
1
1

2
2
1
1
2
2
2
-2
-

- 427 -

C26 C30-C31
1
1
1
1
-

2
2
3
3
1
2
1
3
2
-1
1
1
1
1
2
4
2
1
1
-

C32

C33-C34

5
4
-1
5
6
1
1
2
1
3
5
2
3
4
1
1
1
1
-1
1
5
4
3
3
1
1

72
64
-8
103
166
63
101
152
51
86
92
6
75
100
25
16
8
-8
14
12
-2
127
161
34
1
21
20
2
6
4
4
1
-3

C25

6
16
10
14
11
-3
3
8
5
5
9
4
10
14
4
2
-2
1
1
7
14
7
2
2
-

C23-C24

85
83
-2
82
124
42
63
58
-5
96
84
-12
61
68
7
7
5
-2
4
4
92
140
48
2
5
3
2
5
3
2
3
1

40
52
12
45
87
42
19
46
27
26
30
4
30
28
-2
5
4
-1
4
7
3
5
6
1
80
69
-11
7
10
3
-

C22

68
51
-17
69
109
40
47
59
12
58
55
-3
51
49
-2
6
4
-2
7
7
6
8
2
98
148
50
2
3
1
11
14
3
5
4
-1

C18 C19-C21

2
2
4
6
2
1
2
1
2
3
1
2
3
1
1
1
4
4
-

C17

35
32
-3
34
65
31
48
53
5
45
46
1
29
45
16
7
4
-3
1
1
7
3
-4
71
61
-10
7
6
-1
1
14
13
2
3
1

C16

14
19
5
15
45
30
14
21
7
22
25
3
18
21
3
2
-2
1
-1
1
-1
28
37
9
3
3
5
1
-4
4
4
-

C15

1
16
15
21
33
12
13
22
9
13
16
3
10
13
3
1
1
27
35
8
2
2
1
2
1

C11

0320

0321

0401

0402

0403

0404

0406

0407

0501

0502

0503

0504

0505

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0403

98
99

0404

98
99

0406

98
99

0407

98
99

0501

98
99

0502

98
99

0503

98
99

0504

98
99

0505

98
99
98

C50

C50

C55

C53

C54

17
19
2
17
28
11
17
13
-4
31
32
1
5
27
22
3
-3
2
2
1
-1
22
23
1
3
5
2
6
3
-3
3
3
-

50
90
40
71
138
67
61
101
40
87
85
-2
24
35
11
1
-1
196
175
-21
4
1
-3
7
1
-6

2
-2
1
1
1
1

36
37
1
31
41
10
20
16
-4
24
29
5
33
25
-8
2
1
-1
6
10
4
3
3
75
68
-7
1
7
6
8
9
1
5
6
1

8
16
8
5
15
10
5
9
4
5
3
-2
4
5
1
3
-3
15
15
1
2
1
1
1

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 428 -

0402

6
6
4
4
7
4
-3
1
1
2
4
2
1
-1
6
8
2
1
1
-

C44

98
99

1
1
1
2
1
3
4
1
2
2
1
1
3
1
-2
-

0401

3
3
4
17
13
40
47
7
5
11
6
1
1
3
1
-2
8
4
-4
1
-1

98
99

5
3
-2
7
13
6
7
5
-2
3
2
-1
1
1
1
1
9
10
1
1
1
-

0321

1
-1
1
-1
1
1
1
1
2
2
-

C40-C41 C47, C49

98
99

C42

0320

C37-C38.3,
C38.8
1
1
1
6
5
1
3
2
3
3
1
1
1
1
4
5
1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
8
3
4
-4
-3
9
8
1
-1
1
3
1
2
-2
2
6
2
4
2
-2
8
4
-4
7
6
16
5
9
-1
1
2
-1
-2
-

2
2
1
1
1
2
1
-

- 429 -

4
6
2
6
17
11
1
3
2
2
2
2
3
1
1
1
2
13
11
1
1
-

2
1
-1
1
1
1
1
1
-1
1
1
1
1
-

7
5
-2
11
15
4
14
8
-6
9
18
9
10
9
-1
1
-1
23
33
10
2
1
-1
1
-1

1
1
1
-1
-

C76

C77

C80

1
1
-

6
6
18
16
-2
6
12
6
12
9
-3
4
4
13
14
1
-

6
9
3
9
14
5
12
15
3
6
6
8
6
-2
2
1
-1
20
15
-5
2
2
-

5
5
10
16
6
2
5
3
14
13
-1
1
6
5
4
1
-3
7
7
1
1
1
-1

8
4
-4
5
8
3
8
4
-4
5
8
3
3
4
1
1
1
1
3
2
5
8
3
1
1
1
1
2
-2

C73 C74-C75

10
10
15
34
19
21
20
-1
19
27
8
11
22
11
1
1
3
4
1
24
24
1
-1
4
2
-2
3
4
1
1
-1

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
1
1
1
1
1
1
-1
-

2
1
-1
4
2
-2
1
-1
2
2
3
3
-

C62 C60, C63

20
33
13
29
66
37
37
36
-1
30
34
4
17
15
-2
9
11
2
12
7
-5
42
69
27
3
4
1
4
4
2
-2

C61

0320

0321

0401

0402

0403

0404

0406

0407

0501

0502

0503

0504

0505

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0507

98
99

0509

98
99

98
99

0511

0512

98
99

0513

98
99

0515

98
99

0516

98
99

0602

98
99

0603

98
99

0604

98
99

0605

98
99

0606

98
99

0607 ()

98
99

237
248
11
35
42
7
65
43
-22
1
1
1
1
687
898
211
299
310
11
19
33
14
309
340
31
724
825
101
259
235
-24
454
558
104
9
7
-2

C00 C01-C02
2
1
-1
2
1
-1
-

1
1
1
1
14
21
7
9
9
7
6
-1
20
16
-4
1
4
3
5
2
-3
1
-1

C03
4
4
2
5
3
1
1
2
3
1
2
2
-

C04 C05-C06 C09-C10 C12-C13


1
1
3
1
-2
2
1
-1
2
1
-1
-

4
1
-3
1
1
3
3
12
14
2
5
9
4
5
13
8
13
16
3
2
1
-1
7
12
5
-

1
-1
1
-1
11
6
-5
3
5
2
2
-2
2
8
6
4
4
-

101 5 21 99 100 6 3 98

- 430 -

1
1
9
9
2
3
1
9
8
-1
1
1
1
1
-

C14

C07-C08

1
-1
1
-1
-

1
1
2
8
6
1
-1
2
2
2
2
1
-1
-

C48

27
37
10
2
7
5
7
5
-2
64
93
29
36
51
15
5
2
-3
33
48
15
89
104
15
27
24
-3
42
56
14
1
1

26
24
-2
4
13
9
12
7
-5
1
1
75
114
39
35
21
-14
3
3
35
32
-3
79
69
-10
28
33
5
37
49
12
2
2
-

5
-5
1
-1
1
5
4
1
1
4
6
2
9
3
-6
5
3
-2
3
3
-

5
2
-3
3
-3
2
-2
11
20
9
3
4
1
1
-1
7
5
-2
8
12
4
10
5
-5
9
11
2
-

1
1
1
1
1
1
1
1
-

17
20
3
1
-1
9
3
-6
33
52
19
19
14
-5
1
3
2
10
18
8
43
54
11
19
18
-1
25
47
22
1
-1

- 431 -

C26 C30-C31
1
1
3
-3
1
-1
-

1
1
4
2
-2
1
2
1
1
-1
3
3
-

C32

C33-C34

1
-1
1
-1
4
5
1
1
1
6
5
-1
1
-1
2
3
1
-

21
27
6
7
9
2
3
8
5
1
-1
65
81
16
14
16
2
46
43
-3
95
133
38
34
30
-4
54
50
-4
1
3
2

C25

C23-C24

C22

1
1
1
-1
1
-1
3
3
2
-2
1
1
4
4
1
1
1
2
1
-

C18 C19-C21

16
20
4
3
1
-2
2
1
-1
28
40
12
18
18
1
1
29
27
-2
40
34
-6
15
18
3
31
38
7
2
-2

3
6
3
1
-1
1
1
12
18
6
10
-10
2
2
9
11
2
23
26
3
13
14
1
18
22
4
1
1
-

7
7
1
-1
17
25
8
6
9
3
4
4
20
21
1
1
3
2
6
4
-2
-

C17

C16

C15

C11

0507

0509

0511

0512

0513

0515

0516

0602

0603

0604

0605

0606

0607

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0513

98
99

0515

98
99

0516

98
99

0602

98
99

0603

98
99

0604

98
99

0605

98
99

0606

98
99

0607

98
99

C50

C50

C55

C53

C54

7
8
1
1
1
10
2
-8
1
1
23
22
-1
15
14
-1
1
1
8
5
-3
20
27
7
16
4
-12
9
5
-4
-

21
21
2
1
-1
2
4
2
102
110
8
46
58
12
57
46
-11
97
107
10
20
20
69
103
34
-

1
-1
1
-1
-

1
1
-

24
18
-6
3
2
-1
4
3
-1
77
83
6
24
34
10
2
7
5
6
16
10
26
30
4
17
14
-3
47
47
-

4
6
2
1
-1
15
20
5
9
11
2
7
4
-3
4
11
7
13
16
3
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 432 -

0512

4
-4
1
-1
2
-2
3
-3
2
2
3
3
4
7
3
1
4
3
1
2
1
-

C44

98
99

3
3
1
1
1
-1
1
-1
-

0511

1
-1
1
-1
14
25
11
1
1
1
3
2
4
4
5
-5
-

98
99

1
1
2
8
6
2
2
1
1
3
3
1
4
3
2
-2
-

0509

1
1
1
1
-

C40-C41 C47, C49

98
99

C42

0507

C37-C38.3,
C38.8
1
1
1
1
3
3
2
2
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
3
-3
12
2
11
3
-1
1
1
1
1
-1
2
1
2
1
5
2
6
2
1
3
2
3
1
-1
7
2
10
3
-2
-

- 433 -

5
5
1
1
2
4
2
2
1
-1
1
1
-

1
-1
1
1
1
1
1
-1
-

8
6
-2
1
-1
11
12
1
10
7
-3
3
8
5
9
12
3
4
-4
5
9
4
-

1
1
-

C76

C77

C80

1
1
-

4
2
-2
2
-2
7
9
2
1
2
1
5
6
1
10
8
-2
1
1
2
5
3
-

7
4
-3
1
1
1
1
6
4
-2
3
3
1
-1
12
5
-7
9
6
-3
8
7
-1
9
6
-3
-

6
2
-4
8
9
1
4
1
-3
3
1
-2
4
4
1
1
5
3
-2
-

1
2
1
1
1
2
5
3
4
2
-2
6
4
-2
2
3
1
7
5
-2
-

C73 C74-C75

6
10
4
1
1
3
3
15
19
4
5
1
-4
1
2
1
5
6
1
12
22
10
8
3
-5
9
14
5
-

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
1
1
1
1
2
-2
1
1
-

1
-1
2
1
-1
1
1
2
2
1
-1
-

C62 C60, C63

11
15
4
3
1
-2
1
1
10
19
9
13
8
-5
4
12
8
8
11
3
36
47
11
7
3
-4
17
21
4
1
-1

C61

0507

0509

0511

0512

0513

0515

0516

0602

0603

0604

0605

0606

0607

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0608

98
99

0609

98
99

0610

98
99

0612

98
99

0613

98
99

0614

98
99

0615

98
99

0616

98
99

0618

98
99

0619

98
99

0701

98
99

0702

98
99

0703

98
99

88
49
-39
10
11
1
102
84
-18
82
131
49
7
9
2
535
530
-5
142
96
-46
2
-2
150
135
-15
34
25
-9
39
41
2
222
194
-28
1
1

C00 C01-C02
-

3
1
-2
5
12
7
3
-3
3
4
1
-

C03
1
2
1
-

C04 C05-C06 C09-C10 C12-C13


2
1
-1
1
1
-

1
3
2
1
1
13
8
-5
2
3
1
1
-1
1
1
2
-2
6
4
-2
-

2
2
1
-1
1
1
4
8
4
1
1
1
1
-

101 5 21 99 100 6 3 98

- 434 -

2
2
5
9
4
2
2
1
-1
2
-2
-

C14

C07-C08

1
-1
-

1
1
1
1
1
1
-

4
1
-3
1
1
10
7
-3
2
12
10
63
43
-20
7
6
-1
18
16
-2
6
2
-4
5
6
1
47
19
-28
-

1
1
1
1
4
4
2
1
-1
1
1
1
-1
4
2
-2
-

1
-1
1
1
5
5
10
8
-2
3
1
-2
6
2
-4
1
1
2
2
6
4
-2
-

2
2
-

- 435 -

C26 C30-C31
1
-1
-

1
1
2
2
1
2
1
-

C32

C33-C34

1
-1
1
1
4
3
-1
1
-1
1
-1
-

18
10
-8
1
2
1
7
2
-5
10
32
22
75
71
-4
10
9
-1
18
13
-5
4
2
-2
1
2
1
25
26
1
1
1

C48

9
2
-7
5
3
-2
4
2
-2
2
2
32
38
6
17
6
-11
11
15
4
3
2
-1
5
11
6
27
31
4
-

C25

5
4
-1
8
12
4
15
13
-2
3
2
-1
45
59
14
24
24
1
-1
24
16
-8
4
6
2
9
10
1
13
23
10
-

C23-C24

1
-1
2
2
2
-2
1
1
1
-1
2
-2
-

C22

2
2
2
-2
13
8
-5
6
8
2
1
1
28
38
10
6
14
8
16
12
-4
4
3
-1
5
3
-2
8
12
4
-

3
4
1
1
-1
4
3
-1
1
1
13
10
-3
3
3
3
6
3
1
-1
2
2
11
8
-3
-

1
-1
1
1
1
1
14
11
-3
1
-1
2
3
1
3
3
2
-2
1
2
1
-

C18 C19-C21

C17

C16

C15

C11

0608

0609

0610

0612

0613

0614

0615

0616

0618

0619

0701

0702

0703

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0613

98
99

0614

98
99

0615

98
99

0616

98
99

0618

98
99

0619

98
99

0701

98
99

0702

98
99

0703

98
99

C50

C50

C55

C53

C54

1
-1
1
1
6
7
1
1
2
1
1
4
3
13
12
-1
10
4
-6
6
10
4
3
3
12
4
-8
-

13
-13
1
2
1
10
8
-2
2
1
-1
44
47
3
19
12
-7
1
-1
13
10
-3
16
13
-3
-

1
-1
1
1
-

1
-1
-

5
1
-4
11
6
-5
6
4
-2
3
-3
43
24
-19
10
7
-3
2
1
-1
1
1
11
10
-1
-

3
-3
1
1
7
4
-3
1
1
1
1
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 436 -

0612

1
1
3
-3
1
-1
3
2
-1
2
-2
2
-2
-

C44

98
99

1
1
1
-1
-

0610

6
2
-4
1
1
2
1
-1
-

98
99

1
-1
3
3
5
2
-3
2
-2
-

0609

1
1
-

C40-C41 C47, C49

98
99

C42

0608

C37-C38.3,
C38.8
1
2
1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
2
2
-2
-2
4
1
9
1
5
1
-1
2
-2
-

- 437 -

2
1
-1
1
1
1
1
2
10
8
1
-1
1
1
-

1
1
1
1
-

1
-1
1
1
1
1
15
14
-1
1
-1
1
1
1
-1
1
-1
-

1
1
-

C76

C77

C80

1
1
1
-1
-

2
-2
3
-3
9
11
2
4
-4
1
2
1
4
-4
-

1
1
2
1
-1
4
4
10
7
-3
2
1
-1
4
6
2
2
8
6
-

2
1
-1
1
1
1
2
1
12
3
-9
1
-1
3
3
2
2
-

1
-1
1
-1
1
3
2
4
9
5
3
-3
2
1
-1
-

C73 C74-C75

2
5
3
1
2
1
5
6
1
8
8
17
20
3
1
2
1
7
7
2
1
-1
4
2
-2
4
11
7
-

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
-

1
1
1
-1
-

C62 C60, C63

9
6
-3
1
1
7
9
2
17
27
10
17
15
-2
9
-9
5
4
-1
4
2
-2
6
6
-

C61

0608

0609

0610

0612

0613

0614

0615

0616

0618

0619

0701

0702

0703

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0704

98
99

0705

98
99

0709

98
99

0710

98
99

0712

98
99

0801

98
99

0802

98
99

0803

98
99

0804

98
99

0805

98
99

0806

98
99

0808

98
99

0810

98
99

50
65
15
210
244
34
382
363
-19
24
26
2
4
9
5
311
433
122
1,483
1,550
67
5
-5
232
193
-39
358
422
64
1
-1
4,566
4,786
220
4,541
4,528
-13

C00 C01-C02
1
1
1
1
10
16
6
30
22
-8
12
17
5

2
2
4
4
6
4
-2
5
-5
58
62
4
1
-1
4
3
-1
144
121
-23
133
125
-8

C03
2
2
1
1
24
22
-2
1
-1
48
38
-10
35
28
-7

C04 C05-C06 C09-C10 C12-C13


1
1
1
4
3
13
13
7
17
10

3
2
-1
5
8
3
1
-1
9
9
87
86
-1
1
1
6
2
-4
177
164
-13
131
148
17

1
-1
2
-2
1
1
9
14
5
2
2
3
3
41
43
2
53
47
-6

101 5 21 99 100 6 3 98

- 438 -

1
1
3
-3
1
1
20
21
1
1
1
4
4
52
53
1
73
72
-1

C14

C07-C08

1
1
1
1
1
4
3
2
2

1
-1
3
-3
3
1
-2
2
-2
4
2
-2
1
1
1
1
17
11
-6
9
10
1

C48

3
5
2
21
34
13
41
33
-8
3
5
2
1
-1
22
61
39
122
122
1
-1
16
27
11
32
31
-1
326
370
44
282
333
51

16
11
-5
34
38
4
40
43
3
3
5
2
1
2
1
19
20
1
161
140
-21
25
20
-5
71
86
15
482
498
16
624
601
-23

1
-1
2
2
2
4
2
3
1
-2
14
22
8
2
-2
5
7
2
38
38
38
31
-7

2
3
1
8
9
1
12
7
-5
1
1
3
7
4
22
22
4
4
9
10
1
73
77
4
67
74
7

1
-1
2
2
2
2
4
1
-3
1
-1
1
2
1
11
9
-2
2
10
8

2
1
-1
7
14
7
24
21
-3
6
2
-4
1
1
23
21
-2
65
78
13
1
-1
24
16
-8
40
44
4
235
272
37
182
192
10

- 439 -

C26 C30-C31
1
-1
2
-2
2
3
1
2
3
1

1
1
4
1
-3
1
1
12
14
2
23
13
-10

C32

C33-C34

1
-1
2
3
1
11
16
5
1
-1
1
1
36
36
38
30
-8

8
9
1
30
32
2
40
46
6
1
6
5
1
-1
29
41
12
176
163
-13
30
31
1
29
60
31
534
508
-26
516
473
-43

C25

C23-C24

C22

1
-1
11
11
1
1
3
4
1
17
19
2
24
20
-4

C18 C19-C21

1
4
3
12
14
2
16
13
-3
1
2
1
10
17
7
37
43
6
2
-2
18
8
-10
22
22
204
237
33
161
165
4

2
3
1
8
8
11
12
1
2
-2
5
8
3
42
45
3
2
3
1
6
15
9
126
164
38
136
136
-

4
4
2
3
1
5
6
1
38
29
-9
1
2
1
6
3
-3
103
101
-2
85
94
9

C17

C16

C15

C11

0704

0705

0709

0710

0712

0801

0802

0803

0804

0805

0806

0808

0810

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0712

98
99

0801

98
99

0802

98
99

0803

98
99

0804

98
99

0805

98
99

0806

98
99

0808

98
99

0810

98
99

C50

C50

C55

C53

C54

3
2
-1
5
7
2
15
7
-8
1
-1
1
1
16
16
59
58
-1
3
4
1
11
12
1
94
105
11
99
99
-

2
5
3
8
16
8
40
50
10
1
1
84
125
41
154
159
5
27
19
-8
46
49
3
435
500
65
463
505
42

1
-1
2
-2
1
1
2
5
3
1
2
1

1
1

6
11
5
5
11
6
37
22
-15
9
9
75
102
27
11
9
-2
9
6
-3
176
161
-15
229
228
-1

2
2
2
1
-1
14
8
-6
4
8
4
33
38
5
8
4
-4
4
8
4
65
78
13
75
80
5

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 440 -

0710

2
2
2
-2
8
12
4
1
1
2
1
-1
24
26
2
33
20
-13

C44

98
99

1
1
7
4
-3
1
-1
1
1
15
14
-1
14
19
5

0709

1
1
2
1
-1
1
1
15
17
2
1
2
1
112
119
7
171
130
-41

98
99

1
1
1
1
2
1
-1
1
1
1
1
6
6
1
1
28
34
6
36
25
-11

0705

1
1
3
6
3
1
-1

C40-C41 C47, C49

98
99

C42

0704

C37-C38.3,
C38.8
2
-2
1
1
2
1
-1
1
-1
1
1
22
27
5
22
15
-7

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
2
1
3
1
-1
1
4
4
3
-4
1
1
1
3
2
32
5
33
5
1
3
-3
4
1
8
4
-1
48
5
50
9
2
4
47
16
56
8
9
-8

2
1
-1
4
9
5
3
2
-1

- 441 -

8
6
-2
2
-2
2
4
2
11
15
4
2
3
1
1
2
1
51
53
2
41
39
-2

1
-1
3
3
3
2
-1
4
2
-2

1
-1
2
3
1
2
3
1
23
25
2
4
1
-3
4
5
1
74
70
-4
115
104
-11

1
1
1
-1
1
-1
1
1
5
5
1
6
5

C76

C77

C80

1
-1
1
2
1

2
4
2
6
5
-1
1
-1
2
3
1
9
7
-2
5
1
-4
3
2
-1
85
78
-7
92
78
-14

1
1
3
4
1
7
7
6
2
-4
11
15
4
3
3
12
9
-3
57
55
-2
52
49
-3

2
1
-1
4
5
1
1
-1
3
7
4
25
24
-1
5
3
-2
4
2
-2
86
95
9
81
88
7

2
4
2
1
1
1
-1
3
-3
10
12
2
1
3
2
1
-1
47
53
6
42
40
-2

C73 C74-C75

1
-1
12
7
-5
12
10
-2
4
4
13
22
9
34
45
11
1
-1
5
7
2
8
10
2
92
119
27
97
110
13

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
1
1
-1
2
1
-1
7
4
-3
3
4
1

2
2
2
-2
5
4
-1
1
1
8
6
-2
9
10
1

C62 C60, C63

3
3
14
8
-6
22
35
13
1
1
1
1
22
31
9
32
41
9
22
11
-11
8
8
1
-1
295
288
-7
160
165
5

C61

0704

0705

0709

0710

0712

0801

0802

0803

0804

0805

0806

0808

0810

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0811

98
99

0812

98
99

0813

98
99

0814

98
99

0815

98
99

0816

98
99

0817

98
99

0901

98
99

0903

98
99

0906

98
99

0909

98
99

0910

98
99

0912

98
99

62
28
-34
8
10
2
512
578
66
691
755
64
336
367
31
17
-17
2
5
3
866
918
52
1,008
1,086
78
505
542
37
62
48
-14
90
96
6
7
3
-4

C00 C01-C02
1
-1
1
1
2
-2
2
-2
1
1
1
2
1
-

2
-2
8
10
2
14
10
-4
12
10
-2
14
24
10
25
15
-10
9
3
-6
1
1
-

C03
2
1
-1
2
2
3
4
1
3
4
1
1
-1
-

C04 C05-C06 C09-C10 C12-C13


1
1
2
-2
3
2
-1
3
3
1
2
1
-

3
1
-2
1
1
11
7
-4
6
7
1
10
11
1
20
23
3
29
16
-13
6
10
4
1
1
-

1
-1
3
5
2
2
6
4
4
3
-1
14
9
-5
9
12
3
4
3
-1
-

101 5 21 99 100 6 3 98

- 442 -

2
2
8
6
-2
13
3
-10
5
6
1
13
13
12
6
-6
7
4
-3
-

C14

C07-C08

2
2
-

1
2
1
3
1
-2
2
1
-1
2
1
-1
4
2
-2
2
2
-

C48

1
1
10
15
5
14
24
10
2
14
12
3
-3
5
8
3
19
15
-4
8
6
-2
8
7
-1
4
4
-

1
-1
1
1
1
1
1
1
2
2
1
1
1
1
-

- 443 -

C26 C30-C31
2
2
1
1
1
-1
-

1
1
1
2
1
1
1
3
2
-1
4
2
-2
1
-1
-

C32

C33-C34

3
2
-1
5
3
-2
1
-1
5
9
4
11
6
-5
1
6
5
3
3
-

14
6
-8
2
1
-1
49
40
-9
80
87
7
21
35
14
4
-4
1
1
90
96
6
103
103
46
54
8
8
13
5
-

C25

3
7
4
10
7
-3
5
1
-4
5
4
-1
16
8
-8
6
7
1
3
2
-1
2
1
-1
-

C23-C24

7
4
-3
3
3
76
76
167
167
23
24
1
3
-3
1
1
106
120
14
121
148
27
48
55
7
14
13
-1
1
1

C22

1
1
29
66
37
63
77
14
18
22
4
76
76
83
109
26
30
42
12
8
5
-3
-

3
1
-2
1
1
58
74
16
41
44
3
40
41
1
4
-4
1
-1
89
94
5
63
97
34
48
45
-3
11
12
1
1
1

C18 C19-C21

1
-1
1
1
1
1
4
4
4
2
-2
1
-1
3
1
-2
3
2
-1
2
2
1
1
-

C17

1
4
3
1
1
17
29
12
25
40
15
19
25
6
1
-1
50
47
-3
48
49
1
26
25
-1
1
-1
7
9
2
3
-3

C16

3
2
-1
16
17
1
12
14
2
5
16
11
31
29
-2
28
40
12
17
14
-3
3
3
-

C15

2
-2
1
-1
11
4
-7
14
20
6
6
8
2
21
14
-7
15
11
-4
6
6
2
-2
1
1
-

C11

0811

0812

0813

0814

0815

0816

0817

0901

0903

0906

0909

0910

0912

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

0815

98
99

0816

98
99

0817

98
99

0901

98
99

0903

98
99

0906

98
99

0909

98
99

0910

98
99

0912

98
99

C50

C50

C55

C53

C54

3
1
-2
15
21
6
13
12
-1
9
8
-1
32
26
-6
16
18
2
22
19
-3
11
11
2
2
1
-1

4
1
-3
1
1
49
59
10
70
64
-6
49
38
-11
2
2
59
89
30
69
101
32
73
65
-8
4
5
1
-

1
1
1
-1
1
1
-

2
-2
1
-1
-

2
1
-1
19
11
-8
26
33
7
32
24
-8
64
69
5
96
87
-9
55
49
-6
4
6
2
-

1
1
9
10
1
13
15
2
4
7
3
11
13
2
9
14
5
5
5
1
-1
2
-2
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 444 -

0814

1
3
2
1
6
5
1
7
6
3
3
4
2
-2
1
3
2
1
4
3
1
1
-

C44

98
99

1
-1
2
2
1
-1
2
-2
2
-2
-

0813

1
1
3
13
10
10
3
-7
10
8
-2
2
6
4
14
13
-1
-

98
99

1
-1
2
2
4
7
3
1
-1
4
3
-1
1
1
3
9
6
-

0812

2
2
-

C40-C41 C47, C49

98
99

C42

0811

C37-C38.3,
C38.8
1
1
3
2
-1
2
2
4
5
1
1
-1
1
-1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
3
1
5
2
2
1
8
1
7
-1
-1
3
7
4
5
7
1
2
1
7
4
8
4
1
1
8
2
7
2
1
1
1
-1
-

- 445 -

2
2
2
6
4
1
5
4
1
-1
4
1
-3
17
8
-9
2
5
3
2
1
-1
1
1
-

1
1
1
-1
1
-1
-

2
-2
9
13
4
2
4
2
3
4
1
22
22
26
16
-10
5
9
4
3
1
-2
2
-2
-

1
-1
1
-1
-

C76

C77

C80

1
1
-

4
4
10
12
2
6
4
-2
7
14
7
11
11
5
1
-4
1
-1
-

1
-1
10
7
-3
9
15
6
6
5
-1
8
11
3
11
14
3
7
7
12
8
-4
2
-2
-

1
-1
4
15
11
10
11
1
1
7
6
10
7
-3
19
22
3
8
9
1
9
4
-5
3
3
-

9
2
-7
7
4
-3
1
2
1
1
-1
7
7
8
10
2
1
1
3
2
-1
1
-1

C73 C74-C75

3
-3
1
1
30
22
-8
16
14
-2
8
5
-3
25
17
-8
45
33
-12
12
15
3
2
5
3
2
1
-1

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
1
-1
4
4
1
1
1
1
1
1
-

1
-1
3
1
-2
1
-1
1
1
1
3
2
2
-2
1
1
-

C62 C60, C63

4
1
-3
2
-2
37
32
-5
16
11
-5
11
13
2
1
1
40
37
-3
57
65
8
19
33
14
11
9
-2
-

C61

0811

0812

0813

0814

0815

0816

0817

0901

0903

0906

0909

0910

0912

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
0913

98
99

0914

98
99

0915

98
99

0916

98
99

1001

98
99

1002

98
99

1006

98
99

1007

98
99

1008

98
99

1013

98
99

1014

98
99

1018

98
99

1020

98
99

22
38
16
17
32
15
11
13
2
599
633
34
353
381
28
3,560
3,701
141
917
865
-52
136
167
31
38
21
-17
24
24
33
20
-13
370
358
-12
17
11
-6

C00 C01-C02
2
-2
2
2
22
24
2
8
2
-6
1
2
1
-

2
-2
1
1
1
7
6
9
13
4
126
105
-21
18
10
-8
4
6
2
1
-1
5
4
-1
-

C03
2
4
2
2
1
-1
50
49
-1
4
5
1
2
1
-1
-

C04 C05-C06 C09-C10 C12-C13


1
1
1
2
1
9
8
-1
1
2
1
1
1
-

4
13
9
13
20
7
151
176
25
41
19
-22
14
10
-4
1
-1
7
9
2
1
1

2
2
6
4
-2
30
42
12
9
8
-1
1
1
4
3
-1
1
1

101 5 21 99 100 6 3 98

- 446 -

1
1
1
1
4
8
4
4
13
9
56
50
-6
7
15
8
1
2
1
1
1
1
1
4
4
-

C14

C07-C08

1
1
2
-2
1
-1
1
1
-

2
-2
10
12
2
5
1
-4
-

C48

4
3
-1
1
5
4
1
2
1
55
60
5
27
37
10
266
315
49
71
73
2
9
17
8
8
5
-3
2
1
-1
62
60
-2
1
-1

1
1
4
5
1
1
3
2
67
70
3
52
45
-7
385
450
65
135
131
-4
11
11
4
2
-2
1
1
32
27
-5
3
4
1

4
6
2
2
2
43
43
12
9
-3
2
2
1
1

16
16
7
3
-4
46
51
5
11
11
3
-3
2
-2
5
4
-1
1
-1

3
1
-2
3
1
-2
1
-1

1
5
4
2
1
-1
58
70
12
16
18
2
161
140
-21
41
47
6
5
18
13
2
2
3
3
14
24
10
1
1

- 447 -

C26 C30-C31
2
-2
3
3
1
1
-

1
-1
10
4
-6
7
1
-6
2
-2
-

C32

C33-C34

4
4
1
7
6
37
23
-14
3
6
3
3
1
-2
1
1

3
4
1
2
6
4
1
2
1
79
88
9
53
59
6
400
382
-18
92
92
13
21
8
3
2
-1
1
5
4
35
21
-14
1
-1

C25

C23-C24

C22

1
1
5
4
-1
1
1
14
15
1
7
5
-2
-

C18 C19-C21

3
3
4
4
32
40
8
11
19
8
136
139
3
46
33
-13
5
6
1
4
2
-2
1
1
18
19
1
2
-2

2
7
5
3
1
-2
1
1
22
22
15
14
-1
105
91
-14
25
24
-1
6
5
-1
2
2
1
-1
15
12
-3
1
1

1
-1
4
8
4
7
6
-1
64
72
8
13
9
-4
2
4
2
10
16
6
1
-1

C17

C16

C15

C11

0913

0914

0915

0916

1001

1002

1006

1007

1008

1013

1014

1018

1020

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1001

98
99

1002

98
99

1006

98
99

1007

98
99

1008

98
99

1013

98
99

1014

98
99

1018

98
99

1020

98
99

C50

C50

C55

C53

C54

1
1
2
2
1
-1
13
9
-4
13
20
7
126
131
5
37
19
-18
4
9
5
5
1
-4
2
1
-1
13
10
-3
-

1
4
3
1
1
1
1
79
70
-9
20
19
-1
424
508
84
62
91
29
14
20
6
1
-1
4
3
-1
4
8
4
60
64
4
1
-1

3
1
-2
1
1
-

1
1
-

1
1
12
10
-2
23
16
-7
212
175
-37
65
50
-15
15
16
1
4
1
-3
10
7
-3
22
10
-12
14
13
-1
1
-1

6
6
1
2
1
45
57
12
20
13
-7
2
2
1
1
4
1
-3
3
-3
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 448 -

0916

1
1
1
-1
3
2
-1
1
1
22
22
2
3
1
1
1
1
-1
2
1
-1
-

C44

98
99

3
4
1
2
2
1
-1
1
1
-

0915

7
3
-4
1
-1
91
73
-18
5
10
5
2
-2
3
2
-1
-

98
99

10
6
-4
1
1
17
18
1
5
6
1
3
-3
1
-1

0914

1
2
1
1
-1
-

C40-C41 C47, C49

98
99

C42

0913

C37-C38.3,
C38.8
3
4
1
1
1
6
5
-1
2
2
1
-1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
4
3
4
1
-3
35
10
37
11
2
1
6
4
10
2
4
-2
1
1
-1
-1
1
-1
1
3
2
2
2
1
-1
-

C76

C77

C80

1
1
1
1
7
12
5
3
-3
41
45
4
8
9
1
2
2
3
4
1
3
1
-2

1
-1
1
1
9
5
-4
10
3
-7
25
33
8
13
15
2
2
2
2
4
2
-

1
-1
1
-1
-

1
1
1
1
1
-1
17
17
3
3
90
90
33
25
-8
3
1
-2
1
1
10
10
-

1
-1
3
3
-

C73 C74-C75

- 449 -

1
-1
6
7
1
3
-3
16
18
2
2
4
2
1
1
1
-1
-

5
6
1
-

C71 C70, C72

7
5
-2
2
3
1
21
26
5
9
8
-1
1
3
2
-

C69

1
2
1
1
1
1
1
13
16
3
11
20
9
64
64
33
27
-6
6
5
-1
3
3
12
14
2
-

C65-C66,
C68
1
1
2
-2
15
9
-6
4
3
-1
49
44
-5
12
18
6
1
1
8
6
-2
-

C64

1
1
1
-1
3
3
2
1
-1
1
-1
-

C67

2
-2
2
7
5
1
2
1
-

C62 C60, C63

1
1
1
3
2
3
-3
28
25
-3
21
19
-2
116
124
8
34
43
9
9
5
-4
15
10
-5
-

C61

0913

0914

0915

0916

1001

1002

1006

1007

1008

1013

1014

1018

1020

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1021

98
99

1022

98
99

1102

98
99

1103

98
99

1104

98
99

1105

98
99

1106

98
99

1107

98
99

1108

98
99

1201

98
99

1202

98
99

1203

98
99

1206

98
99

454
369
-85
151
155
4
122
163
41
113
113
71
58
-13
1
3
2
90
70
-20
101
119
18
127
140
13
53
50
-3
885
854
-31
77
130
53
17
22
5

C00 C01-C02
3
-3
1
1
1
1
5
6
1
1
1
-

12
-12
4
3
-1
2
2
3
2
-1
2
4
2
6
-6
4
4
23
32
9
1
2
1
-

C03
1
-1
2
2
2
2
2
2
10
14
4
-

C04 C05-C06 C09-C10 C12-C13


1
1
1
1
-

14
4
-10
4
3
-1
1
1
2
2
3
1
-2
4
4
3
3
9
2
-7
42
56
14
2
1
-1
-

2
3
1
1
1
1
-1
1
1
1
1
1
1
4
1
-3
8
8
1
-1
-

101 5 21 99 100 6 3 98

- 450 -

2
4
2
1
-1
1
1
2
-2
1
1
1
1
3
2
-1
11
12
1
2
2
-

C14

C07-C08

1
1
-

1
1
2
2
1
1
-

42
33
-9
11
5
-6
5
12
7
9
11
2
4
4
4
2
-2
1
3
2
17
16
-1
2
10
8
158
164
6
5
15
10
1
4
3

3
4
1
1
1
2
2
1
-1
1
-1
2
1
-1
1
1
9
2
-7
5
5
-

9
7
-2
1
-1
2
5
3
2
3
1
3
-3
1
1
3
3
1
-1
17
13
-4
3
3
1
1
-

1
1
1
1
1
1
-

- 451 -

C26 C30-C31
-

1
-1
1
-1
1
-1
1
1
1
-1
5
3
-2
-

C32

C33-C34

2
-2
2
3
1
2
1
-1
4
1
-3
1
1
1
1
11
10
-1
1
-1
-

55
64
9
23
17
-6
8
16
8
9
6
-3
8
14
6
4
2
-2
5
7
2
6
8
2
13
11
-2
102
101
-1
9
14
5
3
3
-

C48

19
30
11
14
8
-6
10
19
9
5
9
4
8
1
-7
4
4
9
5
-4
5
6
1
4
1
-3
44
30
-14
5
10
5
1
1
-

C25

31
49
18
12
20
8
11
20
9
8
12
4
9
4
-5
9
12
3
8
12
4
13
17
4
2
3
1
60
49
-11
14
18
4
1
4
3

C23-C24

5
2
-3
1
-1
2
2
6
1
-5
2
-2
-

C22

23
16
-7
13
10
-3
7
3
-4
6
9
3
2
5
3
2
2
2
5
3
8
8
2
4
2
25
18
-7
7
8
1
1
-1

16
17
1
4
3
-1
6
5
-1
4
7
3
2
1
-1
2
2
2
8
6
12
6
-6
2
2
23
19
-4
2
5
3
1
1

12
6
-6
3
3
3
-3
3
1
-2
4
1
-3
4
2
-2
6
1
-5
19
17
-2
1
1
-

C18 C19-C21

C17

C16

C15

C11

1021

1022

1102

1103

1104

1105

1106

1107

1108

1201

1202

1203

1206

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1104

98
99

1105

98
99

1106

98
99

1107

98
99

1108

98
99

1201

98
99

1202

98
99

1203

98
99

1206

98
99

C50

C50

C55

C53

C54

24
10
-14
4
9
5
4
11
7
6
7
1
3
3
6
4
-2
13
11
-2
2
5
3
4
-4
25
21
-4
9
9
3
1
-2

38
30
-8
10
16
6
13
19
6
12
5
-7
7
1
-6
1
1
22
11
-11
4
11
7
11
19
8
11
8
-3
87
111
24
4
10
6
1
-1

1
-1
1
1
1
1
-

65
24
-41
13
15
2
13
9
-4
19
16
-3
8
2
-6
10
7
-3
5
11
6
3
1
-2
1
1
48
40
-8
3
3
3
3

6
10
4
3
6
3
1
1
1
1
1
-1
2
2
9
6
-3
2
-2
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 452 -

1103

5
4
-1
1
-1
1
1
1
-1
1
1
1
1
3
5
2
1
1
-

C44

98
99

3
2
-1
1
1
1
-1
1
1
-

1102

5
2
-3
1
1
1
1
1
-1
1
1
4
5
1
1
-1

98
99

1
1
1
-1
1
-1
1
-1
4
1
-3
-

1022

1
2
1
1
1
-

C40-C41 C47, C49

98
99

C42

1021

C37-C38.3,
C38.8
1
-1
2
-2
6
5
-1
1
1

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
6
3
4
4
-2
1
1
1
1
1
1
1
1
3
1
-3
1
1
1
-1
1
1
1
1
7
10
3
1
-1
-

- 453 -

1
3
2
1
1
1
1
1
1
3
3
-

1
1
1
1
-

10
8
-2
7
5
-2
2
-2
1
-1
3
2
-1
8
9
1
24
11
-13
3
3
1
-1

4
2
-2
-

C76

C77

C80

1
-1
-

5
5
1
1
1
3
2
1
1
1
-1
1
1
1
1
2
2
10
11
1
2
2
-

1
-1
2
1
-1
3
-3
4
1
-3
1
1
1
-1
14
6
-8
-

6
1
-5
1
1
3
1
-2
1
1
5
6
1
1
1
1
1
11
14
3
1
-1
-

2
3
1
1
-1
1
1
1
1
2
2
1
1
8
5
-3
-

C73 C74-C75

9
8
-1
5
7
2
7
4
-3
8
8
1
4
3
2
2
5
4
-1
12
13
1
3
8
5
5
2
-3
19
21
2
6
4
-2
3
3

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
1
1
-1
-

1
-1
1
-1
1
1
1
-1
-

C62 C60, C63

9
9
6
10
4
19
26
7
9
6
-3
3
10
7
1
-1
6
2
-4
12
10
-2
5
8
3
8
2
-6
22
17
-5
5
10
5
3
-3

C61

1021

1022

1102

1103

1104

1105

1106

1107

1108

1201

1202

1203

1206

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1207

98
99

1210

98
99

1214

98
99

1215

98
99

1216

98
99

1301

98
99

1302

98
99

1303

98
99

1304

98
99

1305

98
99

1308

98
99

1401

98
99

1402

98
99

1,926
2,120
194
2
8
6
1,482
1,443
-39
1,599
1,619
20
26
126
100
138
152
14
1,084
1,077
-7
1
-1
173
170
-3
141
183
42
167
193
26
302
378
76
2,647
2,731
84

C00 C01-C02
19
22
3
9
9
8
8
1
1
5
2
-3
2
2
4
3
-1
12
11
-1

64
53
-11
33
46
13
30
33
3
2
5
3
25
30
5
1
1
2
-2
7
5
-2
3
7
4
48
65
17

C03
25
27
2
11
18
7
9
9
5
7
2
1
-1
2
-2
2
2
2
2
23
13
-10

C04 C05-C06 C09-C10 C12-C13


5
7
2
4
2
-2
3
4
1
1
1
3
3
2
-2
1
1
4
11
7

82
95
13
1
1
72
46
-26
37
47
10
2
-2
40
34
-6
7
3
-4
4
2
-2
5
13
8
5
6
1
89
73
-16

16
22
6
10
16
6
6
12
6
8
15
7
1
3
2
3
3
2
2
5
5
15
13
-2

101 5 21 99 100 6 3 98

- 454 -

31
25
-6
19
24
5
29
25
-4
2
1
-1
11
24
13
4
2
-2
3
1
-2
2
5
3
16
20
4

C14

C07-C08

2
-2
1
1
1
-1
1
-1

8
4
-4
2
3
1
2
2
1
1
5
1
-4
3
3
4
7
3

C48

104
155
51
1
1
112
110
-2
123
186
63
1
20
19
16
16
73
73
14
15
1
9
11
2
16
16
52
54
2
194
227
33

318
303
-15
268
238
-30
289
300
11
18
35
17
28
20
-8
210
179
-31
1
-1
21
28
7
10
18
8
39
23
-16
21
16
-5
383
378
-5

27
24
-3
1
1
11
16
5
12
15
3
1
-1
2
2
18
11
-7
1
1
1
1
2
2
27
36
9

35
28
-7
36
29
-7
20
22
2
2
2
2
2
21
23
2
1
2
1
2
-2
1
2
1
4
7
3
49
34
-15

1
1
3
3
2
1
-1
1
1
1
-1
3
3
1
-1
2
5
3

94
105
11
86
97
11
141
134
-7
1
6
5
8
13
5
47
68
21
7
15
8
3
5
2
1
17
16
29
28
-1
165
179
14

- 455 -

C26 C30-C31
1
1
1
1
1
-1
1
1
-

5
6
1
6
2
-4
6
3
-3
3
3
1
-1
1
1
10
1
-9

C32

C33-C34

10
7
-3
9
11
2
12
8
-4
8
5
-3
1
1
1
-1
13
8
-5

202
193
-9
2
2
192
189
-3
208
184
-24
3
8
5
7
15
8
179
161
-18
31
18
-13
12
13
1
8
18
10
34
53
19
297
292
-5

C25

C23-C24

C22

5
10
5
5
6
1
7
8
1
1
-1
3
3
1
1
1
1
1
1
3
3
14
8
-6

C18 C19-C21

76
67
-9
57
46
-11
60
68
8
9
9
3
9
6
42
42
8
6
-2
2
2
5
12
7
17
23
6
112
101
-11

48
52
4
3
3
32
24
-8
61
45
-16
4
4
3
4
1
33
37
4
7
4
-3
4
4
7
4
-3
1
3
2
48
51
3

26
29
3
26
21
-5
17
13
-4
5
5
13
25
12
1
1
1
-1
4
6
2
2
3
1
38
33
-5

C17

C16

C15

C11

1207

1210

1214

1215

1216

1301

1302

1303

1304

1305

1308

1401

1402

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1216

98
99

1301

98
99

1302

98
99

1303

98
99

1304

98
99

1305

98
99

1308

98
99

1401

98
99

1402

98
99

C50

C50

C55

C53

C54

72
87
15
50
60
10
55
53
-2
1
5
4
14
14
38
39
1
11
15
4
4
11
7
4
10
6
11
17
6
103
109
6

152
206
54
108
117
9
83
110
27
1
18
17
10
9
-1
53
59
6
5
8
3
9
19
10
10
27
17
27
34
7
223
253
30

2
1
-1
1
1
1
-1
1
-1

1
-1
1
1
-

127
149
22
39
47
8
86
57
-29
5
5
24
15
-9
40
35
-5
8
8
7
4
-3
16
8
-8
15
10
-5
113
121
8

28
35
7
14
17
3
15
16
1
1
1
3
2
-1
6
19
13
1
1
1
4
3
5
3
-2
29
46
17

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 456 -

1215

7
10
3
8
7
-1
3
6
3
1
1
1
-1
4
8
4
1
-1
1
1
3
2
-1
17
12
-5

C44

98
99

1
2
1
1
1
1
1
3
3
1
1
1
-1
8
2
-6

1214

28
49
21
36
23
-13
24
21
-3
8
3
-5
1
-1
1
1
1
7
6
33
38
5

98
99

9
7
-2
9
6
-3
9
6
-3
1
1
13
6
-7
1
-1
1
-1
1
-1
9
15
6

1210

1
-1
1
3
2
2
2
1
-1
5
-5

C40-C41 C47, C49

98
99

C42

1207

C37-C38.3,
C38.8
8
4
-4
2
3
1
3
1
-2
7
4
-3
1
1
18
7
-11

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
16
3
19
4
3
1
11
1
9
3
-2
2
13
10
-3
1
1
1
3
2
7
1
11
4
-1
1
1
1
-1
1
-1
5
2
1
-3
1
34
2
29
2
-5
-

1
2
1
2
-2
3
3

- 457 -

9
16
7
2
10
8
13
8
-5
1
2
1
6
14
8
1
1
3
3
2
3
1
24
32
8

1
-1
5
1
-4
2
1
-1
4
-4

56
45
-11
47
36
-11
22
19
-3
1
1
2
3
1
12
7
-5
1
-1
59
69
10
1
2
1
12
11
-1
67
67
-

2
-2
1
1
2
-2
1
2
1
3
3
-

C76

C77

C80

2
2
-

21
25
4
22
23
1
12
19
7
4
4
13
10
-3
3
-3
2
-2
1
-1
1
6
5
27
21
-6

20
24
4
19
13
-6
13
12
-1
3
3
1
1
9
14
5
2
-2
1
1
1
-1
3
5
2
30
42
12

35
44
9
22
17
-5
39
45
6
1
1
1
-1
19
22
3
4
6
2
1
1
1
4
3
3
5
2
79
84
5

8
15
7
8
5
-3
6
11
5
1
1
11
6
-5
2
2
2
-2
2
4
2
31
33
2

C73 C74-C75

56
54
-2
35
44
9
52
47
-5
1
1
4
3
-1
32
24
-8
15
8
-7
3
7
4
10
5
-5
15
23
8
99
95
-4

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
1
1
1
1
2
2
2
3
1
1
1
2
2
3
3
-

2
2
2
1
-1
1
1
2
6
4

C62 C60, C63

60
84
24
41
41
60
40
-20
2
1
-1
39
38
-1
13
17
4
5
7
2
10
4
-6
18
19
1
118
141
23

C61

1207

1210

1214

1215

1216

1301

1302

1303

1304

1305

1308

1401

1402

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1404

98
99

1408

98
99

1409

98
99

1410

98
99

1501

98
99

1502

98
99

1503

98
99

1508

98
99

1509

98
99

1510

98
99

1601

98
99

1603

98
99

1604

98
99

294
332
38
3,485
3,645
160
746
788
42
611
611
27
24
-3
128
103
-25
113
117
4
264
293
29
33
31
-2
1,834
2,060
226
171
112
-59
2,839
2,850
11
345
420
75

C00 C01-C02
8
12
4
1
-1
1
1
6
11
5
30
16
-14
1
1

1
1
77
79
2
7
10
3
1
5
4
1
1
1
-1
2
2
1
-1
33
44
11
109
121
12
4
1
-3

C03
21
29
8
2
2
1
1
1
-1
18
10
-8
42
32
-10
-

C04 C05-C06 C09-C10 C12-C13


1
-1
6
2
-4
1
-1
2
5
3
11
9
-2
-

1
3
2
88
86
-2
4
7
3
5
8
3
1
1
1
-1
3
4
1
1
1
47
52
5
161
192
31
10
4
-6

2
-2
29
29
1
2
1
2
3
1
2
1
-1
2
2
23
21
-2
23
26
3
1
1
-

101 5 21 99 100 6 3 98

- 458 -

1
1
40
36
-4
2
-2
1
8
7
1
-1
2
2
18
15
-3
32
39
7
3
3

C14

C07-C08

1
-1
1
-1
1
-1
-

2
1
-1
13
14
1
2
2
2
2
3
3
3
3
8
5
-3
-

C48

35
24
-11
205
204
-1
111
111
67
59
-8
3
3
8
5
-3
12
15
3
25
24
-1
6
11
5
122
156
34
19
12
-7
156
200
44
34
60
26

14
14
418
446
28
164
137
-27
73
76
3
3
3
8
13
5
17
16
-1
39
42
3
4
1
-3
287
347
60
8
6
-2
371
351
-20
47
41
-6

3
3
31
36
5
16
11
-5
6
6
3
2
-1
1
-1
4
3
-1
19
14
-5
24
19
-5
7
6
-1

2
2
76
82
6
22
11
-11
15
10
-5
4
4
1
-1
4
10
6
34
34
1
1
53
39
-14
3
9
6

3
8
5
1
-1
1
-1
1
6
5
2
1
-1
1
2
1

22
35
13
155
176
21
69
78
9
75
81
6
3
3
3
6
3
9
7
-2
17
29
12
5
5
90
93
3
12
19
7
109
131
22
35
46
11

- 459 -

C26 C30-C31
2
1
-1
1
1
1
2
1
1
2
1
1
1
-

1
1
6
13
7
1
1
2
1
-1
1
-1
1
-1
6
2
-4
15
5
-10
1
1
-

C32

C33-C34

1
-1
32
20
-12
2
2
1
1
15
14
-1
28
20
-8
1
1
-

29
34
5
405
415
10
80
97
17
82
31
-51
3
3
34
27
-7
11
13
2
39
24
-15
4
3
-1
225
212
-13
13
15
2
240
235
-5
45
47
2

C25

C23-C24

C22

9
14
5
4
7
3
2
1
-1
2
-2
4
13
9
9
14
5
1
3
2

C18 C19-C21

6
6
106
105
-1
51
47
-4
28
27
-1
3
1
-2
15
11
-4
9
9
24
19
-5
1
2
1
56
68
12
8
4
-4
92
80
-12
22
17
-5

12
6
-6
61
55
-6
31
30
-1
7
13
6
1
1
1
3
2
1
1
1
6
5
1
-1
45
44
-1
3
5
2
69
77
8
7
13
6

1
3
2
77
83
6
9
13
4
10
9
-1
1
1
2
5
3
1
-1
28
36
8
1
1
78
67
-11
5
10
5

C17

C16

C15

C11

1404

1408

1409

1410

1501

1502

1503

1508

1509

1510

1601

1603

1604

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1501

98
99

1502

98
99

1503

98
99

1508

98
99

1509

98
99

1510

98
99

1601

98
99

1603

98
99

1604

98
99

C50

C50

C55

C53

C54

9
7
-2
98
94
-4
22
22
19
25
6
1
1
3
1
-2
25
31
6
28
23
-5
1
1
82
132
50
6
6
120
126
6
12
12
-

34
64
30
466
451
-15
48
77
29
80
96
16
1
3
2
9
2
-7
5
3
-2
17
24
7
1
1
130
149
19
56
20
-36
345
364
19
34
31
-3

2
2
1
1
1
1
-

54
45
-9
185
173
-12
21
15
-6
29
41
12
1
-1
1
1
5
1
-4
14
14
3
4
1
94
78
-16
21
11
-10
80
89
9
18
14
-4

17
17
59
66
7
4
4
18
15
-3
2
4
2
2
2
19
33
14
1
1
33
26
-7
2
3
1

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 460 -

1410

2
-2
22
20
-2
2
1
-1
1
1
2
2
1
2
1
2
3
1
9
8
-1
14
22
8
2
1
-1

C44

98
99

8
5
-3
1
-1
1
1
5
2
-3
8
8
1
-1

1409

100
92
-8
4
4
16
2
-14
2
2
2
1
-1
40
46
6
76
76
3
1
-2

98
99

1
1
15
25
10
10
10
1
4
3
1
1
11
19
8
19
15
-4
3
1
-2

1408

2
2
1
1
1
-1
1
1
3
1
-2
2
3
1
1
1

C40-C41 C47, C49

98
99

C42

1404

C37-C38.3,
C38.8
23
17
-6
6
5
-1
1
2
1
1
1
10
13
3
10
5
-5
1
-1

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
7
2
6
3
-1
1
29
9
55
7
26
-2
4
4
11
2
14
1
3
-1
2
1
2
1
15
6
14
5
-1
-1
1
-1
32
9
23
2
-9
-7
3
2
-1
-

2
9
7
1
1
2
4
2
6
8
2
-

- 461 -

1
1
25
35
10
1
1
1
6
5
2
2
6
17
11
21
20
-1
1
1
-

5
6
1
1
1
1
1
2
1
-1
3
1
-2
-

2
1
-1
133
173
40
18
19
1
6
9
3
2
-2
1
-1
1
-1
3
7
4
106
98
-8
1
-1
102
98
-4
5
6
1

2
3
1
3
2
-1
1
4
3
-

C76

C77

C80

1
1
1
1
1
1

5
2
-3
46
63
17
4
10
6
3
1
-2
1
1
2
2
3
2
-1
25
20
-5
24
33
9
3
3
-

1
3
2
32
42
10
3
1
-2
5
6
1
1
-1
2
1
-1
1
1
3
2
-1
18
21
3
1
-1
34
30
-4
3
8
5

10
8
-2
89
83
-6
8
10
2
7
6
-1
4
1
-3
1
1
4
2
-2
42
47
5
3
-3
55
48
-7
4
9
5

6
6
30
29
-1
3
3
4
3
-1
1
1
3
5
2
13
12
-1
1
-1
22
14
-8
1
3
2

C73 C74-C75

13
21
8
120
117
-3
27
27
13
22
9
3
1
-2
9
7
-2
9
10
1
9
13
4
57
63
6
7
5
-2
72
62
-10
8
23
15

C71 C70, C72

C69

C65-C66,
C68

C64

C67

2
5
3
1
-1
1
1
1
1
1
2
1
2
7
5
-

2
2
5
6
1
3
-3
1
-1
2
2
1
-1
2
5
3
1
1
-

C62 C60, C63

10
11
1
107
119
12
4
8
4
13
11
-2
1
3
2
17
8
-9
3
4
1
6
6
3
-3
48
69
21
9
6
-3
83
79
-4
15
32
17

C61

1404

1408

1409

1410

1501

1502

1503

1508

1509

1510

1601

1603

1604

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1605

98
99

1609

98
99

1610

98
99

98
99

1613

98
99

1615

98
99

1616

98
99

1618

98
99

1619

98
99

1621

98
99

1622

98
99

1624

98
99

1627

98
99

1611

C00 C01-C02

C03

C04 C05-C06 C09-C10 C12-C13

C14

C07-C08

1,242
1,392
150
216
211
-5
240
249
9
7
-7
414
430
16
2,629
2,775
146
16
6

4
8
4
1
1
6
6
-

26
35
9
3
3
1
2
1
1
3
2
54
49
-5
1

13
13
7
19
12
-

2
1
-1
1
1
1
1
3
7
4
-

48
34
-14
2
2
4
1
-3
1
3
2
61
60
-1
-

5
4
-1
1
1
2
1
-1
2
2
22
15
-7
-

9
8
-1
2
2
1
1
27
22
-5
-

7
7
-

2
3
1
1
-1
12
4
-8
-

-10
3
2
-1
290
317
27
16
7
-9
18
15
-3
584
674
90
26
359
333

9
3
-6
-

1
3
3
15
14
-1
4
4

1
-1
7
4
-3
1
1

1
4
3
1
1

10
3
-7
1
1
31
26
-5
1
1

1
1
6
6
2
2

3
3
2
6
4
3
3

1
1
-

1
1
-

101 5 21 99 100 6 3 98

- 462 -

C48

28
20
-8
3
10
7
3
5
2
1
-1
2
3
1
59
52
-7
1
2
1
4
5
1
3
3

2
3
1
1
2
1
6
5
-1
1
1
1
1
-

- 463 -

C26 C30-C31
2
2
1
-1
1
-1
-

1
-1
1
1
1
-1
5
6
1
2
-2
1
-1
-

C32

C33-C34

2
6
4
2
1
-1
2
2
4
4
38
28
-10
5
1
-4
4
4
5
5

112
136
24
22
20
-2
38
41
3
2
-2
41
39
-2
357
353
-4
4
-4
15
19
4
4
2
-2
39
45
6
22
22

C25

13
20
7
3
2
-1
3
2
-1
2
2
34
26
-8
2
1
-1
6
6
-

C23-C24

227
179
-48
25
26
1
29
32
3
32
27
-5
327
335
8
2
1
-1
2
-2
23
36
13
3
-3
80
87
7
2
40
38

65
93
28
15
16
1
15
16
1
14
22
8
123
128
5
1
-1
14
16
2
1
-1
27
41
14
1
14
13

C22

111
141
30
23
23
28
25
-3
36
57
21
182
214
32
2
1
-1
17
19
2
1
1
51
77
26
34
34

C18 C19-C21

6
10
4
1
-1
1
1
1
3
2
14
14
1
1
2
3
1
2
2

C17

53
63
10
17
5
-12
13
15
2
21
14
-7
125
115
-10
1
1
15
8
-7
24
13
-11
10
10

C16

35
37
2
6
4
-2
3
5
2
6
7
1
74
79
5
1
-1
1
10
9
1
-1
17
18
1
5
5

C15

11
19
8
2
6
4
6
7
1
4
3
-1
50
59
9
6
4
-2
1
-1
15
16
1
1
7
6

C11

1605

1609

1610

1611

1613

1615

1616

1618

1619

1621

1622

1624

1627

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1613

98
99

1615

98
99

1616

98
99

1618

98
99

1619

98
99

1621

98
99

1622

98
99

1624

98
99

1627

98
99

C50

C50

C55

C53

C54

39
49
10
3
2
-1
10
9
-1
13
12
-1
82
82
1
-1
1
1
9
7
-2
3
1
-2
31
30
-1
11
11

152
184
32
18
34
16
30
19
-11
2
-2
154
162
8
319
364
45
106
119
13
2
1
-1
88
107
19
17
62
45

1
1
1
-1
2
1
-1
1
1

2
2
-

75
110
35
25
13
-12
3
6
3
46
30
-16
95
110
15
1
1
12
17
5
14
12
-2
38
40
2
19
19

32
38
6
5
3
-2
2
1
-1
8
5
-3
46
52
6
2
3
1
2
-2
4
5
1
7
7

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 464 -

1611

7
7
1
1
1
2
1
2
2
9
17
8
1
-1
2
3
1
-

C44

98
99

1
-1
2
5
3
-

1610

1
3
2
1
1
5
3
-2
29
30
1
2
2
8
8

98
99

2
1
-1
2
1
-1
14
14
1
3
2
1
1
1
1

1609

2
1
-1
1
6
5
1
1
-

C40-C41 C47, C49

98
99

C42

1605

C37-C38.3,
C38.8
2
7
5
1
-1
1
1
2
2
8
14
6
3
-3
1
1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
29
11
24
8
-5
-3
8
1
2
-6
-1
3
3
2
1
1
-1
-1
29
8
35
6
6
-2
3
1
3
-1
2
2
3
4
1
10
1
10
1

2
2
2
1
-1
1
1
1
1

- 465 -

2
4
2
1
1
3
3
21
24
3
1
5
4
1
2
1
2
2

5
2
-3
1
-1
1
-1
-

7
7
1
2
1
5
2
-3
2
-2
2
2
41
38
-3
5
1
-4
10
10
15
15

1
-1
1
-1
-

C76

C77

C80

1
1
-

7
8
1
2
2
2
2
2
2
43
61
18
1
1
4
11
7
-

13
16
3
1
3
2
3
1
-2
3
2
-1
21
24
3
13
12
-1
3
3

13
15
2
3
1
-2
7
6
-1
3
2
-1
59
56
-3
1
1
4
1
-3
6
10
4
1
7
6

8
8
2
4
2
3
3
1
1
32
34
2
2
2
5
5
9
9

C73 C74-C75

42
29
-13
16
11
-5
9
4
-5
15
9
-6
61
77
16
1
-1
5
9
4
1
1
22
27
5
2
17
15

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
1
-1
4
3
-1
2
-2
1
1

2
1
-1
2
-2
1
1
3
4
1
1
1
2
2

C62 C60, C63

20
37
17
1
6
5
12
24
12
1
7
6
105
109
4
5
-5
13
15
2
16
24
8
2
28
26

C61

1605

1609

1610

1611

1613

1615

1616

1618

1619

1621

1622

1624

1627

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1701

98
99

1702

98
99

1703

98
99

1704

98
99

1705

98
99

1707

98
99

1708

98
99

1709

98
99

1714

98
99

1801

98
99

1802

98
99

1901

98
99

1903

98
99

25
50
25
55
66
11
20
31
11
4,622
4,652
30
135
114
-21
76
69
-7
41
37
-4
5
8
3
2,296
2,452
156
27
58
31
145
173
28
170
437
267
222
239
17

C00 C01-C02
18
22
4
7
18
11
2
-2
1
2
1

1
2
1
118
104
-14
2
1
-1
2
-2
63
71
8
1
1
2
1
-1
5
18
13
2
4
2

C03
1
1
33
34
1
18
30
12
5
5
-

C04 C05-C06 C09-C10 C12-C13


9
7
-2
9
10
1
1
1
2
2
-

3
2
-1
154
115
-39
3
3
1
1
1
-1
1
-1
92
78
-14
2
2
1
1
5
17
12
2
3
1

3
-3
65
38
-27
1
-1
1
-1
32
31
-1
1
1
2
16
14
-

101 5 21 99 100 6 3 98

- 466 -

55
58
3
1
1
34
52
18
1
2
1
1
14
13
2
-2

C14

C07-C08

3
2
-1
1
-1
2
1
-1
1
-1

4
8
4
11
11
1
2
1
-

C48

2
3
1
7
14
7
2
7
5
298
388
90
25
25
5
10
5
7
6
-1
2
1
-1
143
176
33
2
9
7
19
20
1
10
36
26
31
30
-1

2
2
3
4
1
1
1
803
852
49
20
14
-6
17
13
-4
1
2
1
2
2
380
401
21
4
7
3
37
44
7
13
32
19
22
22
-

37
35
-2
2
2
3
-3
24
21
-3
1
2
1
1
3
2
2
-2

1
1
1
1
80
73
-7
2
1
-1
1
2
1
1
1
36
54
18
1
-1
6
3
-3
1
3
2
5
1
-4

12
7
-5
1
-1
7
5
-2
1
-1
1
-1
-

1
3
2
3
6
3
2
1
-1
242
306
64
9
12
3
3
9
6
1
-1
153
141
-12
3
1
-2
11
14
3
8
24
16
9
16
7

- 467 -

C26 C30-C31
1
3
2
1
1
-

18
11
-7
2
5
3
2
3
1
-

C32

C33-C34

45
47
2
1
-1
1
-1
15
23
8
1
1
3
7
4
1
1
-

3
3
7
7
394
415
21
16
7
-9
4
7
3
2
2
226
227
1
1
3
2
21
17
-4
28
52
24
9
13
4

C25

C23-C24

C22

1
1
1
1
16
19
3
1
-1
6
7
1
1
-1
1
1
-

C18 C19-C21

4
4
6
6
1
3
2
159
145
-14
7
7
6
3
-3
2
4
2
90
77
-13
2
2
10
12
2
8
6
-2
13
13
-

2
4
2
2
3
1
2
2
131
86
-45
5
6
1
7
8
1
4
4
86
92
6
1
2
1
3
9
6
7
14
7
6
3
-3

1
-1
2
1
-1
1
-1
114
88
-26
1
4
3
33
45
12
1
1
1
4
3
2
13
11
2
3
1

C17

C16

C15

C11

1701

1702

1703

1704

1705

1707

1708

1709

1714

1801

1802

1901

1903

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1705

98
99

1707

98
99

1708

98
99

1709

98
99

1714

98
99

1801

98
99

1802

98
99

1901

98
99

1903

98
99

C50

C50

C55

C53

C54

2
3
1
5
11
6
4
4
140
139
-1
5
3
-2
4
3
-1
8
3
-5
1
1
48
61
13
4
10
6
5
6
1
8
23
15
31
35
4

6
10
4
1
1
1
1
314
349
35
5
10
5
1
-1
15
11
-4
106
138
32
6
17
11
5
3
-2
21
62
41
32
30
-2

2
2
2
1
-1
1
-1
-

2
1
-1
-

5
5
5
3
-2
7
5
-2
270
218
-52
6
1
-5
6
2
-4
94
91
-3
1
-1
3
9
6
12
18
6
19
26
7

2
1
-1
76
89
13
18
19
1
1
4
3
4
11
7

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 468 -

1704

23
19
-4
1
-1
15
8
-7
1
1
1
1

C44

98
99

8
8
4
4
1
1
-

1703

118
108
-10
1
1
1
1
26
26
3
-3
-

98
99

16
33
17
10
11
1
-

1702

6
3
-3
1
-1
1
2
1
1
1
-

C40-C41 C47, C49

98
99

C42

1701

C37-C38.3,
C38.8
27
17
-10
1
-1
1
1
16
13
-3
1
1
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
59
9
74
16
15
7
1
1
14
1
14
7
6
1
1
2
1
-1
3
1
-2
-

7
7
-

- 469 -

30
29
-1
1
1
19
24
5
1
3
2
-

4
3
-1
1
-1
5
2
-3
1
1
-

123
109
-14
2
2
1
-1
106
89
-17
1
-1
2
2
2
2
3
5
2

2
1
-1
1
1
1
-1
-

C76

C77

C80

1
1
1
1
-

1
-1
69
68
-1
1
-1
1
-1
23
21
-2
2
2
1
3
2
3
1
-2

1
-1
1
-1
1
-1
45
40
-5
3
3
1
-1
38
22
-16
1
1
1
1
8
9
1
4
2
-2

101
92
-9
2
1
-1
1
1
2
2
1
1
64
86
22
1
2
1
2
2
5
4
-1

38
53
15
2
-2
18
30
12
2
1
-1
1
1
1
1
-

C73 C74-C75

4
9
5
1
1
128
118
-10
6
4
-2
5
2
-3
2
2
76
84
8
1
1
2
3
1
6
21
15
8
8
-

C71 C70, C72

C69

C65-C66,
C68

C64

C67

2
7
5
3
1
-2
1
1

8
13
5
2
4
2
1
1
-

C62 C60, C63

1
2
1
5
3
-2
3
5
2
188
173
-15
6
4
-2
8
6
-2
2
2
114
115
1
1
1
4
3
-1
11
22
11
1
2
1

C61

1701

1702

1703

1704

1705

1707

1708

1709

1714

1801

1802

1901

1903

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
1904

98
99

1905

98
99

1908

98
99

1909

98
99

1910

98
99

1913

98
99

1914

98
99

1915

98
99

1918

98
99

2001

98
99

2002

98
99

2003

98
99

2004

98
99

719
740
21
7
3
-4
52
51
-1
10
19
9
65
96
31
478
523
45
327
313
-14
11
7
-4
22
-22
68
51
-17
96
80
-16
343
472
129
17
5
-12

C00 C01-C02
2
-2
1
4
3
2
2
3
7
4
-

7
6
-1
3
3
3
-3
12
10
-2
3
1
-2
1
1
1
-1
13
12
-1
-

C03
2
2
5
5
1
1
2
5
3
-

C04 C05-C06 C09-C10 C12-C13


1
1
2
1
-1
1
-1
1
-1
3
1
-2
-

13
8
-5
2
3
1
2
2
17
21
4
4
4
2
2
1
-1
4
4
3
2
-1
17
38
21
-

2
3
1
1
-1
1
1
3
4
1
1
1
3
-3
12
5
-7
-

101 5 21 99 100 6 3 98

- 470 -

1
3
2
1
1
1
1
6
6
1
1
1
-1
1
3
2
15
14
-1
-

C14

C07-C08

1
-1
1
1
1
1
-

2
2
1
-1
1
2
1
2
2
1
-1
2
1
-1
-

75
57
-18
4
4
2
2
1
12
11
95
72
-23
40
47
7
1
1
4
-4
12
16
4
10
4
-6
47
54
7
4
-4

12
7
-5
5
3
-2
1
1
6
4
-2
7
2
-5
1
-1
1
1
6
4
-2
-

18
24
6
3
5
2
5
5
8
8
7
6
-1
1
-1
4
5
1
3
8
5
-

2
2
1
-1
1
1
-

- 471 -

C26 C30-C31
1
1
1
1
-

1
1
1
-1
1
1
1
1
-

C32

C33-C34

2
1
-1
1
1
1
4
3
3
9
6
2
2
1
-1
1
-1
1
2
1
3
7
4
-

97
82
-15
4
-4
7
9
2
6
7
1
15
12
-3
73
65
-8
31
20
-11
5
-5
10
7
-3
5
5
51
68
17
2
-2

C48

42
51
9
1
1
2
3
1
4
4
20
19
-1
29
21
-8
4
-4
4
4
12
6
-6
9
25
16
1
1

C25

54
72
18
5
8
3
1
3
2
4
6
2
31
52
21
35
37
2
1
-1
3
3
9
7
-2
28
32
4
-

C23-C24

7
1
-6
1
-1
3
2
-1
5
2
-3
1
-1
4
4
1
3
2
-

C22

33
40
7
1
-1
2
2
1
2
1
9
6
-3
15
28
13
19
18
-1
1
-1
6
3
-3
8
4
-4
25
26
1
-

16
15
-1
2
1
-1
3
4
1
1
2
1
2
2
24
27
3
9
16
7
1
-1
4
3
-1
6
6
18
16
-2
4
-4

8
10
2
2
-2
2
1
-1
13
17
4
6
7
1
2
2
4
21
17
-

C18 C19-C21

C17

C16

C15

C11

1904

1905

1908

1909

1910

1913

1914

1915

1918

2001

2002

2003

2004

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

1910

98
99

1913

98
99

1914

98
99

1915

98
99

1918

98
99

2001

98
99

2002

98
99

2003

98
99

2004

98
99

C50

C50

C55

C53

C54

29
32
3
1
-1
5
2
-3
18
16
-2
31
18
-13
1
-1
1
-1
3
1
-2
5
7
2
2
2
-

69
107
38
2
1
-1
2
2
7
7
24
32
8
18
18
2
-2
10
9
-1
20
31
11
1
1

1
-1
-

72
49
-23
1
-1
1
3
2
14
28
14
37
38
1
10
2
-8
5
3
-2
5
2
-3
14
24
10
-

9
5
-4
1
1
3
7
4
8
2
-6
2
-2
6
9
3
-

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 472 -

1909

3
7
4
2
-2
1
3
2
4
2
-2
1
1
2
-2
-

C44

98
99

1
1
1
1
1
1
1
-1
-

1908

15
14
-1
1
-1
1
-1
6
6
1
1
4
2
-2
1
-1

98
99

3
3
1
-1
1
1
-

1905

2
-2
1
2
1
-

C40-C41 C47, C49

98
99

C42

1904

C37-C38.3,
C38.8
1
-1
2
2
1
-1
2
2
-

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
5
2
8
1
3
-1
1
-1
1
1
1
6
5
1
1
1
1
2
-2
2
1
1
1
-1
4
3
-1
-

1
-1
1
-1
-

C76

C77

C80

13
12
-1
2
-2
3
3
2
-2
1
1
2
3
1
-

7
16
9
1
1
2
-2
4
8
4
5
4
-1
1
-1
1
-1
1
1
5
4
-1
-

15
13
-2
1
-1
3
5
2
2
3
1
3
3
-

1
-1
-

- 473 -

2
4
2
2
2
2
4
2
2
2
-

C73 C74-C75

1
-1
1
1
-

C71 C70, C72

2
4
2
1
1
2
5
3
1
-1
1
3
2
-

C69

30
23
-7
3
1
-2
8
9
1
25
17
-8
9
15
6
6
3
-3
2
3
1
7
12
5
1
-1

C65-C66,
C68
8
10
2
1
1
9
8
-1
2
8
6
1
1
1
4
3
-

C64

1
1
1
1
-

C67

1
-1
1
-1
-

C62 C60, C63

36
45
9
1
1
1
-1
2
9
7
19
14
-5
9
10
1
1
-1
7
4
-3
9
7
-2
3
13
10
3
1
-2

C61

1904

1905

1908

1909

1910

1913

1914

1915

1918

2001

2002

2003

2004

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

C44.0


Total
2101

98
99

2102

98
99

2103

98
99

2104

98
99

2105

98
99

2106

98
99

2201

98
99

98
99

59
56
-3
11
15
4
470
527
57
19
31
12
1,336
1,395
59
12
3
-9
30
28
-2
121,965
128,444
6,479

C00 C01-C02

C03

C04 C05-C06 C09-C10 C12-C13

4
4
16
15
-1
402
417
15

3
5
2
1
1
14
20
6
782
893
111

1
1
6
6
221
267
46

10
8
-2
1
1
53
41
-12
2,660
2,616
-44

3
-3
12
15
3
1
1
70
66
-4
3,424
3,366
-58

1
-1
3
2
-1
23
23
1,031
1,034
3

101 5 21 99 100 6 3 98

- 474 -

1
1
4
6
2
1
1
32
41
9
1,233
1,330
97

C14

C07-C08

1
1
37
40
3

9
5
-4
374
327
-47

3
6
3
3
-3
1
2
-1
-2
12
64
20
51
8
-13
2
2
2
1
-1
68
162
77
150
9
-12
1
1
7
1
4
1
-3
6,570 14,695
7,348 14,746
778
51

7
7
8
11
3
1
-1
1
1
1,136
1,154
18

1
-1
1
1
8
12
4
1
1
30
32
2
1
-1
2,230
2,242
12

6
1
-5
166
204
38

- 475 -

C26 C30-C31
1
1
45
55
10

5
3
-2
333
289
-44

C32

C33-C34

16
16
847
865
18

15
11
-4
2
2
47
43
-4
4
4
149
137
-12
3
-3
4
6
2
13,862
13,843
-19

C48

C25

C23-C24

C22

3
4
2
6
-1
2
2
2
39
3
54
3
15
1
3
2
6
80
13
85
7
5
1
3
2
460 9,571
472 11,112
12 1,541

4
6
2
5
5
34
42
8
1
5
4
66
62
-4
5
2
-3
3
1
-2
5,653
5,671
18

4
3
-1
22
21
-1
2
2
47
49
2
2
4
2
3,067
3,319
252

C18 C19-C21

1
1
8
4
-4
1
1
20
34
14
3
-3
2,258
2,438
180

C17

C16

C15

C11

2101

2102

2103

2104

2105

2106

2201

98 99
NUMBER OF CANCER FROM PRIMARY ANATOMIC SITES REPORTED BY THE
PARTICIPANTS OF THE CANCER REGISTRY, 2009 AND 2010 ( CONTINUED )

98
99

2105

98
99

2106

98
99

2201

98
99

98
99

1
-1
1
1
65
51
-14

C53

2
1
1
-2
3
-3
52
8
1
35
15
1
-17
7
1
-1
55
10
48
18
-7
8
2
3
1
14 6,510 1,891
12 6,204 2,255
-2 -306
364

101 5 21 99 100 6 3 98
(Leukemia) ICD-O-3 M-CODE p.497

- 476 -

C54

2104

2
5
2
3
4
2
1
-1
2
1
2
1
1
18
51
1
23
82
5
31
2
1
1
-1
1
6
31
78
2
41
122
-4
10
44
1
-1
1
1
2
-1
1
676 3,632 13,744
684 3,788 15,615
8
156 1,871

C55

98
99

C50

2103

1
1
1
-1
3
2
-1
246
242
-4

C50

98
99

3
1
8
2
5
1
1
1
14
42
7
46
-7
4
1
-1
645 2,212
726 2,213
81
1

C44

2102

1
1
1
1
61
83
22

C40-C41 C47, C49

98
99

C42

2101

C37-C38.3,
C38.8
1
2
1
3
6
3
1
1
446
397
-49

C38.4

C56,
C51-C52,
C57.0-C57.4 C57.7-C57.9
1
1
6
2
4
1
-2
-1
8
1
13
2
5
1
1,315
285
1,470
271
155
-14

1
2
1
102
149
47

2
3
1
9
17
8
809
1,037
228

- 477 -

1
-1
1
-1
105
75
-30

1
-1
4
1
-3
30
33
3
1
-1
3,158
3,195
37

1
-1
78
63
-15

C76

C77

C80

10
16
6

5
3
-2
27
12
-15
1
-1
1,618
1,760
142

1
1
4
4
15
15
1
1
1,367
1,379
12

3
6
3
1
-1
24
18
-6
1,897
1,976
79

1
1
2
2
15
12
-3
1
-1
1,093
1,182
89

C73 C74-C75

1
4
3
7
13
6
1
-1
34
28
-6
3,293
3,339
46

C71 C70, C72

C69

C65-C66,
C68

C64

C67

1
-1
2
2
117
119
2

1
3
2
2
2
1
-1
234
222
-12

C62 C60, C63

3
3
1
1
24
18
-6
4
5
1
39
57
18
1
-1
1
1
5,284
5,872
588

C61

2101

2102

2103

2104

2105

2106

2201

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

PRIMARY ANATOMIC SITES


Gender

C00-C80


ALL SITES

Male

9,881 10,234 10,919 11,322 13,615 13,041 15,630 14,133 17,196 18,811 19,609

Female

7,922

Total

C00-C14

Male

C00-C14

1,604

1,761

1,648

2,003

2,291

2,370

443

430

447

408

473

440

485

451

534

588

585

Total

1,692

1,792

1,795

1,721

1,955

2,044

2,246

2,099

2,537

2,879

2,955

Male

453

541

574

582

718

760

879

865

1,087

1,309

1,397

ORAL CAVITY, OROPHARYNX AND


HYPOPHARYNX

Female

99

79

113

81

119

118

139

124

160

176

173

552

620

687

663

837

878

1,018

989

1,247

1,485

1,570

17

20

26

21

23

26

35

29

34

54

48

10

Total

24

23

31

26

32

32

45

35

41

62

53

Male

123

145

162

147

213

175

217

223

303

362

374

33

20

38

27

34

44

42

51

52

69

71

Total

156

165

200

174

247

219

259

274

355

431

445

Male

25

22

24

18

31

41

36

43

59

73

64

Female

13

12

13

11

10

Total

38

25

31

25

34

48

48

56

67

84

74

Male

13

12

14

15

23

20

22

26

30

31

Female

Total

10

17

15

14

17

24

25

26

28

37

35

Male

157

196

208

229

242

309

354

337

403

481

530

26

35

43

29

41

43

46

33

56

55

57

Total

183

231

251

258

283

352

400

370

459

536

587

Male

40

54

45

50

62

50

54

67

74

96

100

Female

10

12

15

11

18

15

16

Total

50

66

54

56

77

58

65

75

92

111

116

Male

82

86

90

98

118

131

148

132

177

201

237

10

Total

88

88

95

103

126

138

157

138

187

208

243

Male

14

15

12

11

12

13

Female

Total

10

21

19

15

18

16

17

Male

40

40

31

28

44

47

35

45

68

66

46

Female

26

30

25

32

33

25

38

34

48

45

50

Total

66

70

56

60

77

72

73

79

116

111

96

Female

C44.0

OROPHARYNX

C12-C13

HYPOPHARYNX

C14

Female

PHARYNX AND ILL-DEFINED


SITES IN LIP, ORAL CAVITY AND
PHARYNX

C07-C08

MAJOR SALIVARY GLANDS

Female

Female

OTHER AND UNSPECIFIED


PARTS OF MOUTH

C09-C10

Male

Female

FLOOR OF MOUTH

C05-C06

17,803 18,201 19,398 19,540 23,408 22,691 26,985 24,494 30,197 33,210 34,502
1,482

GUM

C04

9,650 11,355 10,361 13,001 14,399 14,893

1,313

TONGUE

C03

9,793

1,348

LIPexcludes skin of lip C44.0

C01-C02

8,218

1,362

Total

C00

8,479

1,249

LIP, ORAL CAVITY AND PHARYNX

7,967

1. 96 ICD-O-3 M-CODE P.497


2. ICD-O-3

C00-C06C09-C10C12-C14

- 478 -

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

2010

20,395 21,450 24,617 26,691 29,712 32,275 33,777 34,599 36,705 36,590 40,885 41,062 43,334 45,378 46,287 49,966 50,892

ICD-O-3

C00-C80

15,284 16,083 18,520 20,500 22,265 24,108 25,144 25,625 26,456 26,767 30,075 30,683 32,272 33,926 35,486 38,854 39,757
35,679 37,533 43,137 47,191 51,977 56,383 58,921 60,224 63,161 63,357 70,960 71,745 75,606 79,304 81,773 88,820 90,649
2,552 2,675 3,034 3,340
587

587

638

652

3,688 4,099
699

752

4,319 4,405 4,700 5,202 5,695 5,623


745

812

738

756

861

894

6,147 6,524 6,788 7,328 7,353


913

973

939 1,025 1,014

3,139 3,262 3,672 3,992

4,387 4,851

5,064 5,217 5,438 5,958 6,556 6,517

7,060 7,497 7,727 8,353 8,367

1,586 1,684 2,004 2,263

2,554 2,965

3,161 3,266 3,518 3,959 4,450 4,377

4,916 5,212 5,509 5,998 6,028

165

182

238

243

1,751 1,866 2,242 2,506

251

295

2,805 3,260

298

322

333

353

395

415

3,459 3,588 3,851 4,312 4,845 4,792

450

480

441

555

5,366 5,692 5,950 6,553 6,560

72

88

88

101

115

142

148

125

123

146

158

143

164

170

191

210

11

20

14

16

13

14

19

12

14

28

16

24

21

23

24

27

18

70

92

102

104

114

129

161

160

139

151

162

182

164

187

194

218

228

435

484

523

587

707

806

825

902

899 1,117 1,212 1,225

59

65

99

94

84

123

123

133

136

494

549

622

681

791

929

948 1,035 1,035 1,249 1,386 1,390

79

92

106

141

156

166

209

220

217

240

269

282

342

340

409

350

384

15

12

23

20

17

29

23

31

27

33

25

25

35

48

41

45

61

94

104

129

161

173

195

232

251

244

273

294

307

377

388

450

395

445

41

30

37

59

55

84

78

82

78

80

96

105

113

126

145

124

151

11

14

10

12

10

14

17

10

15

13

52

34

40

73

61

93

88

87

90

83

106

119

130

132

155

139

164

600

656

793

893

50

53

72

79

650

709

865

972

127

108

133

171

189

221

237

280

283

330

396

379

473

494

539

623

586

20

16

11

25

26

25

26

27

33

46

37

40

45

51

48

49

135

128

149

182

214

247

262

306

310

363

442

416

513

539

590

671

635

232

221

294

301

367

375

393

408

510

511

599

561

708

782

762

861

921

15

12

12

19

15

14

30

23

19

19

16

24

21

241

228

302

308

382

387

405

427

525

525

629

584

727

801

778

885

942

13

21

30

23

31

26

35

34

53

51

64

43

47

28

46

45

68

15

22

33

25

35

29

39

42

60

55

65

45

50

30

48

50

72

68

55

65

75

80

102

86

97

100

102

94

105

116

116

112

154

131

47

46

50

45

49

66

70

96

74

58

91

80

95

76

102

123

105

115

101

115

120

129

168

156

193

174

160

185

185

211

192

214

277

236

948 1,172
87

79

1,035 1,251

174

165

1,242 1,192 1,353 1,507 1,668 1,624


82

88

95

106

93

125

1,324 1,280 1,448 1,613 1,761 1,749

- 479 -

C00-C142

532

59

132

C00-C14

1,282 1,454 1,446 1,632 1,583


185

202

176

239

C00

C01-C02

222

1,467 1,656 1,622 1,871 1,805

1,808 1,824 1,992 2,172 2,125


130

135

121

152

C03

C04

C05-C06

144

1,938 1,959 2,113 2,324 2,269


C09-C10

C12-C13

C14

C07-C08

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

Male

756

781

743

703

720

797

847

738

848

916

927

Female

318

321

309

295

321

297

308

293

326

367

362

Total

1,074

1,102

1,052

998

1,041

1,094

1,155

1,031

1,174

1,283

1,289

PRIMARY ANATOMIC SITES


Gender

C11

NASOPHARYNX

C15-C26,

Male

4,594

4,723

5,031

5,356

6,451

6,111

7,383

6,498

7,973

8,561

8,859

C48

DIGESTIVE ORGANS AND


PERITONEUM

Female

1,749

1,909

1,960

2,074

2,624

2,513

2,975

2,749

3,646

4,005

4,128

Total

6,343

6,632

6,991

7,430

9,075

8,624 10,358

Male

447

430

408

460

465

459

525

466

560

598

610

55

50

43

42

51

43

55

56

62

83

63

Total

502

480

451

502

516

502

580

522

622

681

673

Male

1,444

1,375

1,513

1,446

1,757

1,546

1,761

1,546

1,789

1,915

1,851

541

565

582

580

701

610

734

648

865

870

829

Total

1,985

1,940

2,095

2,026

2,458

2,156

2,495

2,194

2,654

2,785

2,680

Male

23

36

31

45

56

44

71

57

63

69

81

Female

22

28

21

25

39

41

49

29

47

40

52

Total

45

64

52

70

95

85

120

86

110

109

133

Male

946

1,053

1,097

1,224

1,502

1,372

1,739

1,528

1,966

2,253

2,403

Female

706

766

832

875

1,076

1,089

1,196

1,159

1,507

1,670

1,817

COLON, RECTUM, RECTOSIGMOID


JUNCTION AND ANUS

Total

1,652

1,819

1,929

2,099

2,578

2,461

2,935

2,687

3,473

3,923

4,220

Male

478

551

571

630

779

740

912

812

1,012

1,157

1,235

Female

382

391

461

494

571

604

652

609

788

918

1,001

Total

860

942

1,032

1,124

1,350

1,344

1,564

1,421

1,800

2,075

2,236

Male

468

502

526

594

723

632

827

716

954

1,096

1,168

Female

324

375

371

381

505

485

544

550

719

752

816

RECTUM, RECTOSIGMOID
JUNCTION AND ANUS

Total

792

877

897

975

1,228

1,117

1,371

1,266

1,673

1,848

1,984

Male

1,462

1,548

1,697

1,880

2,282

2,315

2,814

2,506

3,097

3,172

3,287

LIVER AND INTRAHEPATIC BILE


DUCTS

Female

249

314

289

362

509

462

622

607

814

961

943

Total

1,711

1,862

1,986

2,242

2,791

2,777

3,436

3,113

3,911

4,133

4,230

Male

65

74

81

90

112

117

151

129

157

145

230

50

74

74

75

81

87

110

90

140

149

192

Total

115

148

155

165

193

204

261

219

297

294

422

Male

166

170

178

181

225

219

269

222

280

346

343

90

86

91

90

124

136

153

125

164

179

179

Total

256

256

269

271

349

355

422

347

444

525

522

Male

26

27

20

22

34

31

38

34

46

46

36

RETROPERITONEUM AND
PERITONEUM

Female

20

17

19

18

30

34

42

20

31

37

36

Total

46

44

39

40

64

65

80

54

77

83

72

C15

ESOPHAGUS

C16

STOMACH

C17

SMALL INTESTINE

C18-C21

C18

COLON

C19-C21

C22

C23-C24

Female

Female

GALLBLADDER AND EXTRAHEPATIC


Female
BILE DUCTS

C25

PANCREAS

C48

Female

9,247 11,619 12,566 12,987

1. 96 ICD-O-3 M-CODE P.497

- 480 -

1994

1995

1996

1997

898

936

965 1,002

375

359

350

364

1,273 1,295 1,315 1,366

1998

1999

2000

2001

1,054 1,032 1,072 1,042


399

391

377

394

1,453 1,423 1,449 1,436

2002

2003

2004

2005

2006

2007

1,082 1,141 1,151 1,141 1,115 1,196


331

345

375

399

368

417

1,413 1,486 1,526 1,540 1,483 1,613

2008

2009

2010

ICD-O-3

1,167 1,176 1,194 C11


396

347

377

1,563 1,523 1,571

8,963 9,647 11,038 12,052 13,568 14,463 15,120 15,597 16,598 16,227 18,173 18,151 18,983 19,810 20,020 21,360 22,112 C15-C26, C48
4,358 4,556 5,361 6,150

6,748 7,368 7,766 7,988

8,495 8,541 9,609 9,650 10,161 10,517 10,953 11,832 12,143

13,321 14,203 16,399 18,202 20,316 21,831 22,886 23,585 25,093 24,768 27,782 27,801 29,144 30,327 30,973 33,192 34,255
659

791

819

870

917

66

64

90

76

92

92

701

723

881

895

962 1,009 1,082 1,258

1,310 1,356 1,535 1,528 1,767 1,860

2,034 2,064 2,238

1,755 1,948 2,056 2,072

2,212 2,262 2,212 2,365

2,485 2,214 2,391 2,255 2,403 2,364

2,340 2,423 2,415 C16

901 1,022 1,122

1,079 1,124 1,140 1,137

1,209 1,143 1,294 1,244 1,276 1,330

1,299 1,454 1,439

2,581 2,849 3,078 3,194

3,291 3,386 3,352 3,502

3,694 3,357 3,685 3,499 3,679 3,694

3,639 3,877 3,854

826

999 1,167
83

91

1,193 1,246 1,431 1,430 1,652 1,719

1,891 1,915 2,091 C15

635

117

110

104

98

115

141

143

149

147

65

69

89

105

116

127

137

140

162

155

159

170

166

199

199

203

190 C17

51

55

58

74

60

87

91

96

93

127

126

92

101

123

132

130

135

116

124

147

179

176

214

228

236

255

282

285

262

267

322

331

333

325

2,517 2,555 3,070 3,321

3,790 4,077 4,372 4,321

4,744 4,765 5,623 5,657 5,915 6,324

6,440 7,259 8,143 C18-C21

1,895 1,928 2,276 2,524

2,889 3,050 3,296 3,320

3,507 3,622 4,231 4,253 4,561 4,686

4,877 5,404 5,897

4,412 4,483 5,346 5,845

6,679 7,127 7,668 7,641

8,251 8,387 9,854 9,910 10,476 11,010 11,317 12,663 14,040

1,325 1,316 1,681 1,722

2,032 2,227 2,398 2,341

2,602 2,535 3,135 3,153 3,323 3,610

3,634 4,293 4,871 C18

1,013 1,095 1,314 1,384

1,627 1,781 1,865 1,913

1,974 2,098 2,466 2,592 2,707 2,820

3,014 3,423 3,764

2,338 2,411 2,995 3,106

3,659 4,008 4,263 4,254

4,576 4,633 5,601 5,745 6,030 6,430

6,648 7,716 8,635

1,192 1,239 1,389 1,599

1,758 1,850 1,974 1,980

2,142 2,230 2,488 2,504 2,592 2,714

2,806 2,966 3,272 C19-C21

962 1,140

1,262 1,269 1,431 1,407

1,533 1,524 1,765 1,661 1,854 1,866

1,863 1,981 2,133

2,074 2,072 2,351 2,739

3,020 3,119 3,405 3,387

3,675 3,754 4,253 4,165 4,446 4,580

4,669 4,947 5,405

3,426 3,790 4,332 4,958

5,701 6,129 6,365 6,564

6,926 6,732 7,382 7,525 7,526 7,802

7,721 7,984 7,751 C22

1,079 1,187 1,382 1,752

1,979 2,285 2,386 2,558

2,671 2,691 2,930 2,948 3,102 3,201

3,338 3,453 3,272

4,505 4,977 5,714 6,710

7,680 8,414 8,751 9,122

9,597 9,423 10,312 10,473 10,628 11,003 11,059 11,437 11,023

882

833

193

211

216

236

289

312

326

326

365

357

433

375

395

457

447

499

486 C23-C24

179

185

200

242

244

282

292

304

355

293

339

372

372

374

421

452

438

372

396

416

478

533

594

618

630

720

650

772

747

767

831

868

951

924

313

361

414

459

518

557

636

640

643

690

676

671

841

842

881

981

937 C25

198

184

276

300

330

370

379

390

462

479

502

542

559

582

642

700

706

511

545

690

759

848

927 1,015 1,030

45

39

57

66

62

73

59

59

71

55

65

58

74

84

77

78

80 C48

42

37

51

51

64

59

77

67

72

64

71

83

63

58

67

65

77

87

76

108

117

126

132

136

126

143

119

136

141

137

142

144

143

157

1,105 1,169 1,178 1,213 1,400 1,424

- 481 -

1,523 1,681 1,643

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

Male

15

10

18

15

10

15

17

18

Female

16

13

11

14

15

16

16

17

Total

31

19

15

15

31

19

29

25

31

33

35

Male

1,773

1,852

1,984

2,087

2,458

2,343

2,750

2,472

2,994

3,291

3,337

RESPIRATORY SYSTEM AND


INTRATHORACIC ORGANS

Female

603

575

657

698

859

793

1,016

922

1,159

1,236

1,259

Total

2,376

2,427

2,641

2,785

3,317

3,136

3,766

3,394

4,153

4,527

4,596

Male

73

72

68

44

74

91

72

75

73

99

72

NASAL CAVITIES, ACCESSORY


SINUSES, MIDDLE EAR AND INNER
EAR

Female

41

24

38

30

46

34

38

36

54

55

51

Total

114

96

106

74

120

125

110

111

127

154

123

Male

194

185

211

234

294

254

250

224

278

317

282

11

11

14

13

23

11

22

10

22

19

15

Total

205

196

225

247

317

265

272

234

300

336

297

Male

1,481

1,558

1,661

1,752

2,039

1,930

2,370

2,100

2,572

2,792

2,887

523

527

583

631

759

722

921

844

1,053

1,099

1,137

Total

2,004

2,085

2,244

2,383

2,798

2,652

3,291

2,944

3,625

3,891

4,024

Male

10

11

19

18

14

12

10

Female

11

14

Total

12

17

19

26

29

19

26

16

Male

19

34

43

47

39

49

39

59

66

69

84

Female

22

10

17

17

23

19

24

27

25

49

50

Total

41

44

60

64

62

68

63

86

91

118

134

Male

Male

303

302

299

293

342

283

343

340

382

366

429

Female

172

203

186

223

249

199

270

220

255

288

289

Total

475

505

485

516

591

482

613

560

637

654

718

Male

43

64

44

56

65

91

106

64

85

90

84

BONES, JOINTS AND ARTICULAR


CARTILAGE

Female

35

33

44

36

53

59

71

47

72

74

70

Total

78

97

88

92

118

150

177

111

157

164

154

Male

73

76

83

75

91

82

107

93

109

98

110

Female

30

39

48

47

48

77

69

59

69

87

107

CONNECTIVE,
SUBCUTANEOUS
AND OTHER SOFT TISSUES

Total

103

115

131

122

139

159

176

152

178

185

217

PRIMARY ANATOMIC SITES


Gender

C26

OTHER AND ILL-DEFINED SITES


WITHIN DIGESTIVE ORGANS AND
PERITONEUM

C30-C39

C30-C31

C32

LARYNX

C33-C34

TRACHEA, BRONCHUS AND LUNG

C38.4

PLEURA

C37-C38.3,

C38.8

THYMUS, HEART AND MEDIASTINUM

C39

Female

Female

Female
OTHER AND ILL-DEFINED SITES
WITHIN RESPIRATORY SYSTEM AND
Total
INTRATHORACIC ORGANS
3

C42

LEUKEMIA

C40-C41

C47, C49

1. 96 ICD-O-3 M-CODE P.497


3. ICD-O-3 M-CODE p.497

- 482 -

ICD-O-3

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

14

15

13

16

10

14

15

13

13

10

11

19

24

18

19 C26

22

15

11

19

22

25

12

12

18

12

22

34

25

32

36

30

19

25

21

28

36

40

18

25

25

28

23

41

58

43

51

2010

3,531 3,640 4,241 4,469

4,848 5,252 5,626 5,541

5,664 5,693 6,480 6,576 6,769 7,139

7,226 7,834 7,630 C30-C39

1,337 1,379 1,661 1,768

2,005 2,222 2,289 2,410

2,608 2,574 2,871 3,046 3,314 3,557

3,648 4,256 4,131

4,868 5,019 5,902 6,237

6,853 7,474 7,915 7,951

8,272 8,267 9,351 9,622 10,083 10,696 10,874 12,090 11,761


119 C30-C31

84

84

79

100

74

98

132

99

99

91

109

114

129

106

132

129

39

26

41

40

46

49

61

50

56

51

52

34

56

45

54

78

53

123

110

120

140

120

147

193

149

155

142

161

148

185

151

186

207

172

345

361

368

395

397

431

485

506

513

465

529

530

542

546

548

591

602 C32

18

19

29

29

16

23

23

23

26

27

32

21

36

25

30

32

33

363

380

397

424

413

454

508

529

539

492

561

551

578

571

578

623

635

3,025 3,104 3,673 3,856

4,280 4,593 4,867 4,799

4,931 4,996 5,699 5,783 5,930 6,287

6,389 6,888 6,697 C33-C34

1,229 1,283 1,524 1,642

1,865 2,086 2,128 2,263

2,440 2,405 2,691 2,885 3,110 3,377

3,444 3,997 3,918

4,254 4,387 5,197 5,498

6,145 6,679 6,995 7,062

7,371 7,401 8,390 8,668 9,040 9,664

9,833 10,885 10,615

14

13

15

16

16

21

14

18

21

16

18

34

45

32

30

43 C38.4

11

17

10

15

19

10

18

20

20

21

19

28

22

27

27

21

29

51

55

39

45

62

71

77

108

103

81

114

121

123

103

120

127

131

134

155

125

196

168 C37-C38.3,

46

47

60

52

73

61

70

66

77

85

91

95

95

100

112

134

108 C38.8

117

124

168

155

154

175

191

189

180

205

218

226

229

255

237

330

276

1 C39

446

489

488

507

515

562

620

616

831

862

876

925

915

993

941 1,124 1,087 C42

319

342

356

369

392

396

447

431

563

556

599

646

639

656

715

765

831

844

876

907

958 1,067 1,047

87

86

93

89

96

87

82

96

88

72

86

115

79

86

91

99

89 C40-C41

46

63

66

62

65

56

76

70

74

49

68

74

77

78

80

87

74

133

149

159

151

161

143

158

166

162

121

154

189

156

164

171

186

163

128

149

155

145

182

189

206

243

241

197

229

228

247

263

258

310

276 C47, C49

96

85

131

137

140

159

164

140

164

189

192

180

172

160

182

212

232

224

234

286

282

322

348

370

383

405

386

421

408

419

423

440

522

508

1,394 1,418 1,475 1,571 1,554 1,649

- 483 -

791

736

1,656 1,915 1,823

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

Male

283

250

289

255

281

288

365

329

393

462

455

Female

196

165

212

139

203

214

278

266

304

368

377

Total

479

415

501

394

484

502

643

595

697

830

832

Male

35

26

32

28

29

23

34

38

42

54

54

Female

14

14

20

13

27

17

24

25

33

47

42

Total

49

40

52

41

56

40

58

63

75

101

96

Male

248

224

257

227

252

265

331

291

351

408

401

SKIN (excludes MALIGNANT


MELANOMA)

Female

182

151

192

126

176

197

254

241

271

321

335

Total

430

375

449

353

428

462

585

532

622

729

736

1,080

1,071

1,175

1,144

1,314

1,425

1,705

1,617

1,991

2,265

2,399

15

15

18

10

10

14

18

19

Female

2,720

2,674

2,728

2,402

2,614

2,626

2,896

2,547

3,079

3,345

3,369

Female

35

30

30

25

40

53

54

35

43

33

23

Female

2,282

2,262

2,281

1,921

2,072

2,075

2,173

1,924

2,279

2,484

2,471

Female

121

124

163

157

143

162

215

181

262

311

325

Female

202

179

192

246

310

267

378

334

415

407

462

Female

80

79

62

53

49

69

76

73

80

110

88

299

305

344

332

457

453

590

574

709

794

937

PRIMARY ANATOMIC SITES


Gender

C44

SKIN

C44

SKIN, MALIGNANT MELANOMA

C44

C50

Female

FEMALE BREAST

C50

Male

MALE BREAST

C51-C58

FEMALE GENITAL ORGANS

C55

UTERUS, NOS

C53

CERVIX UTERI

C54

CORPUS UTERI

C56,

C57.0-C57.4

OVARY, FALLOPIAN TUBE AND


BROAD LIGAMENT

C57.7-C57.9

C51-C52,

VAGINA, VULVA, OTHER AND


UNSPECIFIED FEMALE GENITAL
ORGANS

C60-C63

Male

MALE GENITAL ORGANS

1. 96 ICD-O-3 M-CODE P.497


4. ICD-O-3 C44 M-87203 - M-87903

- 484 -

ICD-O-3

1994

1995

1996

1997

1998

1999

2000

2001

2002

532

483

646

715

808

904

892

982

1,128

958 1,216 1,140 1,305 1,359

1,390 1,611 1,575 C44

421

451

540

625

742

724

760

867

918

809 1,001 1,078 1,125 1,153

1,223 1,363 1,403

953

934 1,186 1,340

2,046 1,767 2,217 2,218 2,430 2,512

2,613 2,974 2,978

1,550 1,628 1,652 1,849

2003

2004

2005

2006

2007

2008

2009

2010

4
125 C44

51

38

72

60

77

90

79

85

102

72

99

92

103

111

103

142

39

43

53

64

70

76

79

75

77

71

91

83

81

92

88

123

87

90

81

125

124

147

166

158

160

179

143

190

175

184

203

191

265

212

481

445

574

655

731

814

813

897

1,026

382

408

487

561

672

648

681

792

841

863

853 1,061 1,216

2,515 2,847 3,122 3,640

24

18

12

23

3,277 3,446 3,991 4,100

35

17

2,359 2,461 2,942 2,871

886 1,117 1,048 1,202 1,248

1,287 1,469 1,450 C44

738

995 1,044 1,061

1,135 1,240 1,316

1,403 1,462 1,494 1,689

1,867 1,624 2,027 2,043 2,246 2,309

2,422 2,709 2,766

3,811 4,539 4,680 4,888

5,088 5,378 6,322 6,713 7,019 7,770

8,320 9,041 9,655 C50

24

29

25

27

4,337 4,392 4,472 4,178

11

11

12

2,976 2,965 2,915 2,551

38

31

910

48

49

47

38

3,904 3,924 4,306 4,124 4,210 4,252

18

2,191 2,097 2,365 2,017 1,868 1,812

36

49

39 C50

4,498 4,631 4,822 C51-C58

11

8 C55

1,774 1,808 1,680 C53

327

344

399

495

550

553

627

714

786

814

918 1,025 1,182 1,190

1,435 1,515 1,737 C54

480

514

546

633

677

732

791

789

815

860

886

1,117 1,141 1,245 C56,

932 1,032 1,074

C57.0-C57.4

76

110

99

94

123

131

127

118

107

151

129

144

120

158

166

156

152 C51-C52
C57.7-C57.9

954 1,148 1,365 1,661

1,925 2,177 2,315 2,376

2,633 2,535 3,050 3,045 3,421 3,690

- 485 -

3,957 4,344 4,661 C60-C63

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

Male

204

216

271

260

353

363

484

480

597

669

803

Male

51

36

40

38

50

44

55

34

59

66

70

Male

44

53

33

34

54

46

51

60

53

59

64

Male

533

529

650

621

782

710

903

873

1,026

1,160

1,195

Female

233

216

263

242

311

345

421

411

460

540

615

Total

766

745

913

863

1,093

1,055

1,324

1,284

1,486

1,700

1,810

Male

393

382

425

412

503

478

592

570

666

750

753

Female

139

112

159

137

179

170

206

193

237

264

289

Total

532

494

584

549

682

648

798

763

903

1,014

1,042

140

147

225

209

279

232

311

303

360

410

442

94

104

104

105

132

175

215

218

223

276

326

Total

234

251

329

314

411

407

526

521

583

686

768

Male

71

68

120

108

132

133

143

160

184

215

205

Female

39

47

45

55

62

79

93

96

86

112

118

Total

110

115

165

163

194

212

236

256

270

327

323

Male

69

79

105

101

147

99

168

143

176

195

237

Female

55

57

59

50

70

96

122

122

137

164

208

PRIMARY ANATOMIC SITES


Gender

C61

PROSTATE GLAND

C62

TESTIS

C60,C63

PENIS AND OTHER MALE GENITAL


ORGANS

C64-C68

URINARY TRACT

C67

BLADDER

C64-C66,

Male

C68

KIDNEY AND OTHER URINARY


TRACT

Female

C64

KIDNEY

C65-C66,
C68

C69

RENAL PELVIS AND OTHER


URINARY TRACTexcludes bladder
and kidney

Total

124

136

164

151

217

195

290

265

313

359

445

Male

23

18

19

21

21

23

22

22

31

27

24

Female

25

13

15

14

18

17

19

25

27

26

24

Total

48

31

34

35

39

40

41

47

58

53

48

Male

185

172

169

205

226

208

250

258

308

289

324

BRAIN AND OTHER PARTS OF


CENTRAL NERVOUS SYSTEM

Female

119

113

119

143

180

175

185

166

208

213

200

Total

304

285

288

348

406

383

435

424

516

502

524

Male

169

158

159

186

204

199

233

238

283

267

289

Female

108

104

105

131

167

151

167

153

189

193

178

Total

277

262

264

317

371

350

400

391

472

460

467

Male

16

14

10

19

22

17

20

25

22

35

Female

11

14

12

13

24

18

13

19

20

22

OTHER AND UNSPECIFIED PARTS


OF NERVOUS SYSTEM

Total

27

23

24

31

35

33

35

33

44

42

57

EYE AND LACRIMAL GLAND

C70-C72

C71

BRAIN

C70, C72

1. 96 ICD-O-3 M-CODE P.497

- 486 -

1994

1995

1996

1997

1998

820 1,012 1,242 1,536 1,773

1999

2000

2001

2002

2003

2004

2,010 2,132 2,191 2,414 2,318 2,840

2005

2006

2007

2008

2009

2010

ICD-O-3

2,820 3,173 3,462 3,680 4,083 4,392 C61

79

82

59

64

81

94

106

102

120

112

121

133

156

144

180

170

55

54

64

61

71

73

77

83

99

105

89

92

92

84

97

91

178 C62

91 C60,C63

2,091 2,002 2,178 2,139 2,209 2,374

2,441 2,516 2,618 2,676 2,752 2,780 C64-C68

992

1,118 1,210 1,224 1,210 1,336 1,365

1,414 1,537 1,529 1,595 1,716 1,661

2,016 1,968 2,275 2,660 2,827

3,209 3,212 3,402 3,349 3,545 3,739

3,855 4,053 4,147 4,271 4,468 4,441

1,296 1,249 1,293 1,287 1,312 1,441

1,404 1,444 1,497 1,507 1,444 1,427 C67

1,350 1,322 1,525 1,708 1,835


666

646

750

952

834

808

950 1,065 1,156

309

291

349

434

413

1,143 1,099 1,299 1,499 1,569

477

492

524

508

533

543

1,773 1,741 1,817 1,795 1,845 1,984

548

597

607

580

590

537

1,952 2,041 2,104 2,087 2,034 1,964


1,037 1,072 1,121 1,169 1,308 1,353 C64-C66

516

514

575

643

679

795

753

885

852

897

933

357

355

401

518

579

641

718

700

702

803

822

873

869

976 1,161 1,258

265

265

294

319

330

378

380

414

404

410

438

513

499

539

617

630

678 C64

133

151

165

198

214

205

218

202

212

232

258

266

281

289

289

356

350

398

416

459

517

544

583

598

616

616

642

696

779

780

828

906

986 1,028

251

249

281

324

349

417

373

471

448

487

495

524

573

582

552

678

675 C65-C66

224

204

236

320

365

436

500

498

490

571

564

600

659

633

726

770

774 C68

475

453

517

644

714

853

873

969

938 1,058 1,059

26

25

24

24

25

30

39

34

35

20

30

30

29

30

38

24

39 C69

22

30

19

21

21

25

29

32

14

19

16

18

22

24

15

24

22

48

55

43

45

46

55

68

66

49

39

46

48

51

54

53

48

61

341

290

325

352

330

400

392

388

383

359

375

368

395

385

412

439

445 C70-C72

226

199

229

228

276

266

303

297

261

246

291

297

320

291

310

288

344

567

489

554

580

606

666

695

685

644

605

666

665

715

676

722

727

789

313

275

310

325

294

370

362

352

337

327

350

333

357

345

374

394

420 C71

204

174

204

204

250

244

266

271

228

214

257

252

289

250

267

236

314

517

449

514

529

544

614

628

623

565

541

607

585

646

595

641

630

734

28

15

15

27

36

30

30

36

46

32

25

35

38

40

38

45

25 C70, C72

22

25

25

24

26

22

37

26

33

32

34

45

31

41

43

52

30

50

40

40

51

62

52

67

62

79

64

59

80

69

81

81

97

55

1,436 1,471 1,585 1,554 1,700 1,755

- 487 -

866

940

922 1,015 1,126 1,124 C68

1,903 2,012 2,043 2,184 2,434 2,477

1,124 1,232 1,215 1,278 1,448 1,449

72 99
NUMERICAL COMPARISON OF CANCER FROM PRIMARY ANATOMIC SITES, 1983 TO 2010
CONTINUED

ICD-O-3

Year

1983

1984

1985

1986

1987

1988

1989

1990

1991

1992

1993

63

82

78

77

95

78

89

114

135

196

201

Female

202

226

281

243

314

288

354

343

476

597

667

Total

265

308

359

320

409

366

443

457

611

793

868

Male

15

24

15

22

24

18

13

31

32

24

Female

19

18

11

17

28

25

16

Total

16

22

29

24

41

42

29

30

59

57

40

Male

38

30

30

36

84

49

54

50

51

60

47

Female

29

15

32

29

56

62

72

32

63

47

41

Total

67

45

62

65

140

111

126

82

114

107

88

Male

41

41

90

110

174

147

306

262

288

368

406

Female

46

53

64

87

135

120

198

186

251

256

288

Total

87

94

154

197

309

267

504

448

539

624

694

Male

282

354

361

405

483

368

457

412

513

626

699

Female

177

185

205

228

253

185

241

236

279

386

408

Total

459

539

566

633

736

553

698

648

792

1,012

1,107

PRIMARY ANATOMIC SITES


Gender

C73

Male

THYROID GLAND

C74-C75

OTHER ENDOCRINE GLANDS

C76

OTHER AND ILL-DEFINED SITES

C80

UNKNOWN PRIMARY SITES

MALIGNANT LYMPHOMA

1. 96 ICD-O-3 M-CODE P.497


5.

- 488 -

ICD-O-3

1994

1995

1996

1997

1998

1999

2000

2001

2002

2003

2004

2005

2006

2007

2008

2009

185

181

202

196

238

224

291

273

367

312

356

377

422

437

427

546

593

630

704

775

902 1,004

978 1,012 1,097 1,012 1,200 1,179

1,273 1,445 1,548 1,859 1,838

778

811

906

971 1,140 1,228

1,269 1,285 1,464 1,324 1,556 1,556

1,695 1,882 1,975 2,405 2,409

31

34

30

43

35

37

51

34

47

29

40

35

27

30

30

35

25 C74-C75

18

22

28

32

28

30

29

27

27

33

26

22

30

32

29

28

26

49

56

58

75

63

67

80

61

74

62

66

57

57

62

59

63

51

40

27

11

9 C76

27

32

67

59

13

13

11

16

10

11

18

12

10

15

467

463

511

525

636

678

710

614

634

628

584

602

599

519

504

471

538 C80

311

314

370

369

431

433

470

442

426

464

396

404

445

392

360

433

391

778

777

881

894 1,067 1,111

980 1,006

1,044

911

864

904

929

683

720

863

776

881

959

993 1,131 1,165 1,247 1,254 1,350

1,415 1,445 1,488 1,635 1,659

419

419

498

567

631

570

664

930

1,006 1,087 1,060 1,257 1,256

1,657 1,896 2,021 2,120 2,191 2,280

2,421 2,532 2,548 2,892 2,915

1,102 1,139 1,361 1,343 1,512 1,529

1,180 1,056 1,060 1,092

765

856

873

- 489 -

937

2010

571 C73

ICD-O-3

INTERNATIONAL RULES FOR MULTIPLE PRIMARY CANCERS (ICD-O-3)

1.
2.

3. ICD-O-3 T-code Table 1


Table 2
C00 LipC03 Gum
Table 1
C06.9
Multifocal tumors
multifocal
tumors
4. 2 3

4.1 systemicmulticentric

Table 2 group 15 Kaposi sarcoma group 8-14


tumours of the haematopoietic system
4.2 morphology
Table 2
Table 2

2Table 2group (5)


(14)(17)

- 490 -

ICD-O-3

INTERNATIONAL RULES FOR MULTIPLE PRIMARY CANCERS (ICD-O-3) (CONTINUED)


1. The recognition of the existence of two or more primary cancers dose not depend
on time.
2. A primary cancer is one that originates in a primary site or tissue and is not an
extension, nor a recurrence, nor a metastasis.
3. Only one tumour shall be recognised as arising in an organ or pair of organs or
tissue.
Some groups of codes are considered to be a single organ for the purposes of
defining multiple tumours.

These topography code groups are shown in Table 1.

Multifocal tumours that is, discrete masses apparently not in continuity with other
primary cancers originating in the same primary site or tissue, for example
bladder are counted as a single cancer.
4. Rule 3 dose not apply in two circumstances:
4.1. Systemic (or multicentric) cancers potentially involving many different organs
are only counted once in any individual. These are Kaposi sarcoma (group
15 in Table 2) and tumours of the haematopoietic system (group 8-14 in
Table 2).
4.2. Neoplasms of different morphology should be regarded as multiple cancers
(even if they are diagnosed simultaneously in the same site).
If the morphological diagnoses fall into one category in Table 2, and arise in
the same primary site, they are considered to be the same morphology for
the purpose of counting multiple primaries. If the morphological diagnoses
fall into two or more of the categories in Table 2, even if they concern the
same site, the morphology is considered to be different, and two or more
cases should be counted.
Single tumours containing several different histologies which fall into one
histological group in Table 2 are registered as a single case, using the
numerically highest ICD-O morphology code.
If, however, one morphology is not specific (group (5), (14) and (17)) and a
specific morphology is available, the case should be reported with the
specific histology and the non-specific diagnosis should be ignored.

- 491 -

ICD-O-3

INTERNATIONAL RULES FOR MULTIPLE PRIMARY CANCERS (ICD-O-3) (CONTINUED)


Table 1. Groups of topography codes considered a single site in the definition
of multiple cancers
ICD-O-2/3
site code

Label

If diagnosed at different times,


code first diagnosis. If
diagnosed at the same time use
codes given below.

C01

Base of tongue

C02

Other and unspecified parts of tongue

C00

Lip

C03

Gum

C04

Floor of mouth

C05

Palate

C06

Other and unspecified parts of mouth

C09

Tonsil

C10

Oropharynx

C12

Pyriform sinus

C13

Hypopharynx

C14

Other and ill-defined sites in lip, oral cavity


and pharynx

C19

Rectosigmoid junction

C20

Rectum

C23

Gallbladder

C24

Other and unspecified parts of biliary tract

C33

Trachea

C34

Bronchus and lung

C40

Bones, joints and articular cartilage of limbs

C41

Bones, joints and articular cartilage of other


and unspecified sites

C65

Renal pelvis

C66

Ureter

C67

Bladder

C68

Other and unspecified urinary organs

C02.9

C06.9

C14.0

C20.9

C24.9

C34.9

- 492 -

C41.9

C68.9

ICD-O-3

INTERNATIONAL RULES FOR MULTIPLE PRIMARY CANCERS (ICD-O-3) (CONTINUED)


Table 2. Groups of malignant neoplasms considered to be histologically
different for the purpose of defining multiple tumours (adapted from Berg JW.
Morphologic classification of human cancer. In: Schottenfeld D & Fraumeni JF
nd
Jr. Cancer Epidemiology and Prevention, 2 edition, Chapter 3 of Section 1:
Basic Concepts. Oxford, New York, Oxford University Press, pp. 28-44, 1994).

Group
Carcinomas
1. Squamous and transitional cell carcinoma

8051-8084, 8120-8131

2. Basal cell carcinomas

8090-8110

3. Adenocarcinomas

8140-8149, 8160-8162, 8190-8221, 8260-8337,


8350-8551, 8570-8576, 8940-8941

4. Other specific carcinomas

8030-8046, 8150-8157, 8170-8180, 8230-8255,


8340-8347, 8560-8562, 8580-8671

(5) Unspecified carcinomas (NOS)

8010-8015, 8020-8022, 8050

6. Sarcomas and soft tissue tumours

8680-8713, 8800-8921, 8990-8991, 9040-9044,


9120-9125, 9130-9136, 9141-9252, 9370-9373,
9540-9582

7. Mesothelioma

9050-9055

Tumours of haematopoietic and lymphoid tissues


8. Myeloid

9840, 9861-9931, 9945-9946, 9950, 9961-9964,


9980-9987

9. B-cell neoplasms

9670-9699, 9728, 9731-9734, 9761-9767, 9769,


9823-9826, 9833, 9836, 9940

10. T-cell and NK-cell neoplasms

9700-9719, 9729, 9768, 9827-9831, 9834, 9837,


9948

11. Hodgkin lymphoma

9650-9667

12. Mast-cell Tumours

9740-9742

13. Histiocytes and Accessory Lymphoid cells

9750-9758

(14) Unspecified types

9590-9591, 9596, 9727, 9760, 9800-9801, 9805,


9820, 9832, 9835, 9860, 9960, 9970, 9975,
9989

15. Kaposi sarcoma

9140

16. Other specified types of cancer

8720-8790, 8930-8936, 8950-8983, 9000-9030,


9060-9110, 9260-9365, 9380- 9539

(17) Unspecified types of cancer

8000-8005

- 493 -

()

- 494 -

99
POPULATION DEMOGRAPHY OF TAIWAN IN 2010

495 --- 495

115,065 (0.99%)

85+

125,778 (1.09%)

188,509 (1.62%)

80-84

175,596 (1.52%)

234,614 (2.02%)

75-79

262,595 (2.28%)

298,770 (2.57%)

70-74

350,116 (3.04%)

351,553 (3.02%)

65-69

385,297 (3.34%)

500,740 (4.30%)

60-64

526,541 (4.57%)

773,674 (6.65%)

55-59

798,855 (6.93%)

883,709 (7.60%)

50-54

896,683 (7.78%)

952,466 (8.19%)

45-49

952,402 (8.26%)

932,140 (8.01%)

40-44

930,305 (8.07%)

889,468 (7.64%)

35-39

902,236 (7.83%)

1,012,113 (8.70%)

30-34

1,016,997 (8.82%)

953,304 (8.19%)

25-29

933,395 (8.10%)

821,067 (7.06%)

20-24

765,670 (6.64%)

836,734 (7.19%)

15-19

771,420 (6.69%)

782,666 (6.73%)

10-14

719,248 (6.24%)

605,233 (5.20%)

5-9

553,071 (4.80%)

503,400 (4.33%)

0-4

460,693 (4.00%)

11,635,225 (100.00%)

Total

11,526,898 (100.00 %)

1976 2000

1976

2000

04

12,000

8,800

59

10,000

8,700

10 14

9,000

8,600

15 19

9,000

8,500

20 24

8,000

8,200

25 29

8,000

7,900

30 34

6,000

7,600

35 39

6,000

7,200

40 44

6,000

6,600

45 49

6,000

6,000

50 54

5,000

5,400

55 59

4,000

4,600

60 64

4,000

3,700

65 69

3,000

3,000

70 74

2,000

2,200

75 79

1,000

1,500

80 84

500

900

85

500

600

100,000

100,000

1976 ( Segi 1960) 2000 World Health


Organization's publication: Discussion Paper 31: Age Standardization of
Rates: A New WHO Standard (PDF)

- 496 -

WHO 2008
WHO 2008
HEMATOPOIETIC AND LYMPHOID TUMORS

2008 WHO Classification

ICD-O-3 codes

Leukemia and myeloid neoplasm , total


AML
AML with recurrent genetic abnormalities
AML with myelodysplasia-related changes
Therapy-related myeloid neoplasms
Acute myeloid leukemia, NOS
Other acute myeloid leukemia
Myeloid sarcoma
Myeloid proliferations related to Down Syndrome
Blastic plasmacytoid dendritic cell neoplasm
ALL
B lymphoblastic leukemia / lymphoma
T lymphoblastic leukemia / lymphoma
CML
CLL
Acute leukemias of ambiguous lineage
Myeloproliferative neoplasms
Myelodysplastic syndromes
Acute biphenotypic leukemia
Other Leukemia
Leukemia, NOS

98663/98713/98963/98973/98653/98693/
99113
98953
99203
98613
98403/98673/98703/98723/98733/98743/
98913/99103/99313
99303
98983
97273
98113/98123/98133/98143/98153/98163/
98173/98183(C42, except for C422)
98373(C42, except for C422)
98633/98753/98763/99453/99463/99633/
99643
98233(C42, except for C422)
98013/98063/98073/98083/98093
97401/97403/97413/97423/99503/99613/
99623/99653/99663/99673/99753
99803/99823/99833/99853/99863/99893/
99913/99923
98273(C42, except for C422)
-

98663/98713/98963/98973
98953
99203
98613
98403/98673/98703/98723/98733/
98743/98913/99103/99313
99303
97273
98353/98363
98373
98633/98753/98763/99453/99463/
99633/99643
98233
98013
97401/97403/97413/97423/99503/
99603/99613/99623/99753
99803/99823/99833/99843/99853/
99863/99873/99893
98053
98203/98323/98603
98003

Lymphoid neoplasms, total


Hodgkin lymphoma
Non-Hodgkin lymphoma
B-cell lymphoid neoplasms
Marginal zone lymphoma (splenic, nodal and
MALT)
Lymphoplasmacytic lymphoma
Follicular lymphoma
Mantle cell lymphoma
Burkitt lymphoma
Diffuse large B-cell lymphoma (any subtype)
Primary mediastinal (thymic) large B-cell
lymphoma
Other B-cell lymphomas
T/NK-cell lymphoid neoplasms
Extranodal NK/T cell lymphoma, nasal or other
type
Cutaneous T cell lymphoma (Including Mycosis
fungoides/Szary syndrome)
Enteropathy-type T-cell lymphoma
Hepatosplenic T-cell lymphoma
Subcutaneous panniculitis-like T-cell Lymphoma
Peripheral T-cell lymphoma, NOS
Angioimmunoblastic T-cell lymphoma
Anaplastic large cell lymphoma
Adult T-cell lymphoma/leukemia
Other T-cell lymphomas
Plasma cell neoplasm
Other LPD
Other LPD
Histiocytic and dendritic cell neoplasms
Malignant lymphoma, NOS and others

96503/96513/96523/96533/96543/96553/
96593/96633

96503/96513/96523/96533/96593/
96613/96623/96633/96643/96653/
96673

96893/96993

96893/96993

96713/97613
95973/96903
96733
96873
96803/96843/96883/97123/97373/97353/
97383
96793

96713/97613
96753/96903/96913/96953/96983
96733
96873/98263
96803/96843

95963/96783/98333/99403/97623;
98113/98123/98133/98143/98153/98163/
98173/98183/98233 (except for C42 but
not C422)

95963/96703/96783/97283/98333/
99403

97193

97193

97003/97013/97093/97183/97263

97003/97013/97093/97183

97173
97163
97083
97023
97053
97143
98273
98343/99483/98313;98373 (except for
C42 but not C422)
97313/97323/97343

97173
97163
97083
97023
97053
97143
98273
97293/98343/99483

97243/97253/99713
97513/97553/97563/97573/97583/97593

97513/97553/97563/97573/97583
95903/95913/97503/97543/97603/
97643

- 497 -

96793

97313/97323/97333/97343

- 498 -

99
15

- 499 -

- 500 -

99 15

................................................................................................................ 501
....................................................................................... 506
99 .................................... 513
..................................................... 517

................................. 517
..................................................... 517
...................................... 518
0~39 1 ....................... 518
40~59 ....................... 519
60 1 .................... 519
..................................................... 521

................................. 521
..................................................... 521
...................................... 522
0~39 1 ....................... 522
40~59 ....................... 523
60 1 .................... 523
..................................................... 525

................................. 525
..................................................... 525
...................................... 526
0~39 1 ....................... 526
40~59 ....................... 527
60 1 .................... 527
............................................. 529

.......................... 529
............................................. 529

-i-


...................................................................................................................... 530
0~49 .................. 531
50~69 1 .............. 531
70 .............. 532
..................................................... 533

................................. 533
...................................... 534
0~49 ......................... 534
50~69 ....................... 535
70 ...................... 535
..................................................... 537

................................. 537
..................................................... 537
................. 538
0~49 ......................... 539
50~69 1 ..................... 539
70 ...................... 540
........................................................ 541

.................................... 541
........................................................ 541
.................... 542
0~49 ............................ 543
50~69 1 ......................... 543
70 ......................... 544
..................................................... 545

................................. 545
..................................................... 545
...................................... 546

- ii -

0~49 1 ....................... 546


50~69 ....................... 547
70 1 .................... 547

MAC .......................................... 548


..................................................... 549

................................. 549
..................................................... 549
...................................... 550
0~49 1 ....................... 550
50~69 ....................... 551
70 1 .................... 551

MAC .......................................... 552


........................................................ 553

.................................... 553
........................................................ 553
(C220) .. 554
(C220)0~49 .................. 556
(C220)50~64 1 2 ............. 556
(C220)65 ........ 558
BCLC(C220) 2 ...................... 558
(C221) .. 560
(C221)0~49 .................. 561
(C221)50~64 1 2 ......... 561
(C221)65 .... 562
..................................................... 565

................................. 565
..................................................... 565
() .................. 566
() 0~49 1 ... 566

- iii -

() 50~69 .. 567
() 70 1 567
() 568
..................................................... 569

................................. 569
..................................................... 569
...................................... 570
0~34 1 ....................... 570
35~49 ....................... 572
50~69 1 ..................... 572
70 ...................... 574
............................................. 577

FIGO ............................................ 577

........... 578
............................................. 578
FIGO ............................ 579
0~29 FIGO ............................. 580
30~49 FIGO ............ 581
50~69 FIGO ............ 582
70 FIGO ........... 583
............................... 584
0~29 1 .......................... 584
30~49 ............ 585
50~69 1 ......... 585
70 ........... 586
............................................. 587

.......................... 587
............................................. 587
............................... 588

- iv -

0~39 1 ................ 588


40~59 ................ 589
60 1 ............. 589
FIGO ............................ 590
................................................. 591

............................. 591
................................................. 591
................................... 592
0~39 1 .................... 592
40~59 ................... 593
60 1 ................ 593
FIGO ............................... 594
............................................. 595

.......................... 595
............................................. 595
......... 596
0~59 .................. 598
60~74 1 .............. 598
................................................. 603

............................. 603
................................................. 603
............. 604
0~49 ..................... 606
50~69 1 .................. 606
70 .................. 608
.......................................... 611
Ann Arbor ................................... 611
Ann Arbor ................. 612
0~39 Ann Arbor ... 613

-v-

40~59 Ann Arbor . 614


60 Ann Arbor 615

- vi -

71 10

68
50

85 7
Cancer Registry System, CRS
200

20

92 5 21

90
15 Taiwan
Cancer Center Data Base, TCDBAmerican College
of Surgeons Commission on Cancer FORDS Facility
Oncology Registry Data Standards

92

91 1 1

91
15 5

93 10 27
- 93 1
1 91~93
94~95
- 501 -

65
20
(94~95 )

FORDS95

9533
9611
953350

6
97
98
159915

9291
91~99322,75391159217
9330943395339643
974498549976
94~9994959698

9915

- 502 -

94~99

94 95 96 97 98 99

()

()

- 503 -

94 95 96 97 98 99

()

- 504 -

94 95 96 97 98 99

- 505 -

68 1 1
International Classification of Diseases for OncologyICD-O
5 2 3
68
-1976 ICD-O, 1976 79 Field Trial, 1988
ICD-O-FT, 1988 91 ICD-O, Third Edition
ICD-O-3, 2000

478

Case
Class 0

Includes

Class 1

(Staff physician)

Class 2

Class 3



- 506 -

Case

Includes

Class 4

68

Class 5

Class 6

(Staff physician)

Class 7

Class 8

death certificate onlyDCO

Class 9

(1) 91 1
1 1
2
(2) 039

AJCC TNM

AJCC

4 4
TNM stage
group
1 2 AJCC
- 507 -

coding scheme TNM TN


M
AJCC
TNM
AJCC
TNM
prefix/suffix descriptor
AJCC TNM
AJCC


TNM 999

pediatric staging AJCC


TNM 88 888 AJCC
88 888

first course of treatment

No therapy

Cancer recurrencedisease-free
intervalremission

Palliative therapy
palliative care

- 508 -

discharge plan

established
protocolaccepted management guidelines


4
4

subsequent treatment

99

(1)
1 2 P.516
(2) ICD-O-3

- 509 -

ICD-O-3

Oral cavity

C000-C009

Lip

C020-C023C028-C029

Other and unspecified parts of tongue

C030-C031C039

Gum

C040-C041C048-C049

Floor of mouth

C050

Hard palate

C058-C059

Overlapping lesion of palate / Palate

C060-C062C068-C069

Other and unspecified parts of mouth

C019

Base of tongue

C024

Lingual tonsil

C051

Soft palate

C052

Uvula

C090-C091C098-C099

Tonsil

C100-C104C108-C109

Oropharynx

C142

Waldeyer ring

C148

Overlapping lesion of lip, oral cavity and

Oropharynx

pharynx
Hypopharynx

C129

Pyriform sinus

C130-C132C138-C139

Hypopharynx

C140

Pharynx,NOS

C079

Parotid gland

C080

Submandibular gland

C081

Sublingual gland

C089

Major salivary gland, NOS

Nasopharynx

C110-C119

Nasopharynx

Esophagus

C150-C155C158-C159

Esophagus

Stomach

C160-C166C168-C169

Stomach

Colon

C180-C189

Colon

Rectum

C199

Rectosigmoid junction

C209

Rectum

C220

Liver

C221

Intrahepatic bile duct

Lung

C340-C343C348-C349

Bronchus and Lung

Breast

C500-C509

Breast

Salivary

Liver

- 510 -

ICD-O-3

Cervix

C530-C531C538-C539

Cervix uteri

Corpus Uteri

C540

Isthmus uteri

C541

Endometrium

C542

Myometrium

C543

Fundus uteri

C549

Corpus uteri

C559

Uterus,NOS

Ovary

C569

Ovary

Prostate

C619

Prostate gland

Bladder

C670-C679

Bladder

Lymphoma

M-code: 9650-9667

Hodgkin lymphoma

M-code: 9670-96999761 Non-Hodgkin B-cell lymphoma


9826983399409596
M-code: 9700-97299827

Non-Hodgkin T/NK-cell lymphoma

M-code: 9750-97609764 Other Malignant lymphoma


9590-9591
(3) ICD-O-3 9140
9590-9992
(4)

99 99
99 93,569 1

69,757
90.72%

- 511 -

99

(%)*

6413

6258

97.58

4985

4110

798

77

4294

61

1765

1718

97.34

1362

1238

124

1274

59

1289

1248

96.82

972

885

84

918

57

289

270

93.43

230

198

32

205

46

2246

2127

94.70

1573

1415

158

1448

58

2986

2782

93.17

2141

1932

200

1974

61

5006

4567

91.23

3576

3229

326

21

3314

66

11076

9715

87.71

8215

7258

884

73

7439

75

7201

6424

89.21

5420

4783

604

33

4906

75

14099

13247

93.96

10421

9396

982

43

9644

67

13226

12107

91.54

9918

9002

870

46

9337

65

14674

14146

96.40

11884

9665

2102

117

10124

72

5934

5273

88.86

4522

4158

358

4240

69

2127

2048

96.29

1733

1531

190

12

1564

65

1409

1334

94.68

1163

1094

66

1107

59

5556

5017

90.30

4265

3538

688

39

3719

62

3157

2694

85.33

2352

2139

210

2191

61

2868

2594

90.45

2157

1969

182

1969

60

101321

93569

92.35

76889

67540

8858

491

69757

76

10.00% 87.84% 11.52%

0.64%

90.72%

*(%)

0-35-69

99 1 1
12

- 512 -

99
1 99 ()

neoadjuvant ?

th

199 (AJCC_7 )

2 99

FIGO ?

AJCC

FIGO 0~IV

FIGO

FIGO 0~IV

299 FIGO

- 513 -

3 99

FIGO ?

AJCC

FIGO 0~IV

FIGO

FIGO 0~IV

399 FIGO

4 99

ANN ARBOR ?

ANN ARBOR

ANN ARBOR 0~IV

499

- 514 -

- 515 -

- 516 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
2
2
21
94
261
491

0
0
0
2
4
7
7
16
20

0
0
0
4
6
28
101
277
511

602
711
630
384
283
201
103
71
29

33
51
58
43
39
50
31
30
18

635
762
688
427
322
251
134
101
47

3885

409

4294

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

4294

100.00

4294

100.00

0
I
II
III
IV

14
1047
857
526
1565
285

0.33
24.38
19.96
12.25
36.45
6.64

23
1266
747
382
1051
825

0.54
29.48
17.4
8.9
24.48
19.21

4294
22
1286
797
436
1537
216

100.00
0.51
29.95
18.56
10.15
35.79
5.03

- 99 (AJCC_7th) 1

0
4

I
5

II
2

12

798

58

44

22

927

II

180

429

87

67

763

III

88

114

150

111

463

IV

55

111

92

836

1095

10

1126

714

373

1037

3260

Kappa=0.5602
Kappa

- 517 -

III

IV

0
I

47.07

266

6.19

419

9.76

22 100.00

0.00

0.00

84.21

75

5.83

55

4.28

79

9.91

4294 2021

22

1286 1083

140

3.26

61

1.42

254

5.92

0.00

0.00

0.00

35

2.72

0.31

0.54

73

9.16

10

1.25

10

980 22.82

19

0.44

112

2.61

22

0.51

0.00

0.00

0.00

0.00

10

0.78

0.00

12

0.93

0.39

1.25

14

1.76

0.13

14

1.76

0.50

17

3.90

0.00

11

2.52

0.69

II

797

526

66.00

66

8.28

III

436

122

27.98

26

5.96

109 25.00

134 30.73

1.61

1.61

IV

1537

130

8.46

85

5.53

159 10.34

735 47.82

115

7.48

37

2.41

210 13.66

15

0.98

46

2.99

0.33

M0

1498

130

8.68

84

5.61

159 10.61

729 48.66

101

6.74

35

2.34

199 13.28

11

0.73

45

3.00

0.33

M1

39

0.00

2.56

0.00

6 15.38

14 35.90

5.13

11 28.21

4 10.26

2.56

0.00

216

138

63.89

14

6.48

17

7.87

0.00

29 13.43

2.31

1.39

1.85

1.39

1.39

0~39 1

226

54.33

12

2.88

36

8.65

3 100.00

0.00

0.00

89.78

3.65

2.92

59

70.24

1.19

48

12

25.00

IV

125

13

10.40

M0

125

13

M1

19

416

137

123

II

84

III

111 26.68

0.72

0.48

13

3.13

0.00

12

2.88

0.24

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3.65

0.00

0.00

0.00

0.00

0.00

0.00

8.33

10 11.90

0.00

1.19

2.38

0.00

4.76

0.00

0.00

9 18.75

24 50.00

2.08

0.00

0.00

0.00

2.08

2.08

4.80

15 12.00

72 57.60

1.60

0.80

11

8.80

0.00

4.00

0.00

10.40

4.80

15 12.00

72 57.60

1.60

0.80

11

8.80

0.00

4.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

16

84.21

0.00

5.26

0.00

0.00

0.00

0.00

0.00

2 10.53

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5
6

- 518 -


40~59 1

1175

45.26

178

6.86

244

9.40

13 100.00

0.00

0.00

3.91

24

2596

13

767

641

83.57

49

6.39

30

II

465

302

64.95

44

9.46

III

271

75

27.68

19

IV

954

64

6.71

M0

925

64

M1

29

126

654 25.19

83

3.20

15

0.58

162

6.24

0.35

65

2.50

11

0.42

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3.13

0.26

0.52

0.78

0.00

0.91

0.52

52 11.18

48 10.32

0.86

0.22

1.72

0.00

1.08

0.22

7.01

65 23.99

86 31.73

1.48

0.37

12

4.43

0.00

2.95

0.37

56

5.87

89

9.33

494 51.78

71

7.44

0.94

135 14.15

0.73

29

3.04

0.00

6.92

55

5.95

89

9.62

488 52.76

61

6.59

0.76

127 13.73

0.54

29

3.14

0.00

0.00

3.45

0.00

6 20.69

10 34.48

6.90

8 27.59

6.90

0.00

0.00

80

63.49

10

7.94

6.35

0.00

1.59

16 12.70

3.97

1.59

1.59

0.79

60 1

620

48.36

76

5.93

6 100.00

0.00

0.00

1282

382

319

83.51

21

5.50

21

5.50

II

248

165

66.53

21

8.47

20

8.06

III

117

35

29.91

5.98

IV

458

53

11.57

23

M0

448

53

11.83

M1

10

71

42

139 10.84

215 16.77

54

4.21

44

3.43

79

6.16

10

0.78

35

2.73

10

0.78

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1.57

0.52

0.79

1.05

0.00

1.31

0.26

15

6.05

2.42

3.23

1.61

0.40

2.02

1.21

35 29.91

24 20.51

1.71

5.13

4.27

0.00

1.71

0.85

5.02

55 12.01

169 36.90

42

9.17

27

5.90

64 13.97

1.75

12

2.62

1.09

23

5.13

55 12.28

169 37.72

38

8.48

27

6.03

61 13.62

1.34

11

2.46

1.12

0.00

0.00

0.00

0.00

4 40.00

0.00

3 30.00

20.00

1 10.00

0.00

59.15

5.63

8 11.27

1.41

0.00

1.41

11 15.49

0.00

2.82

2.82

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 519 -

- 520 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

1
0
0
1
0
2
7
59
120

0
1
1
0
0
2
3
2
6

1
1
1
1
0
4
10
61
126

199
226
199
121
85
54
41
25
9

21
21
14
13
14
7
12
4
4

220
247
213
134
99
61
53
29
13

1149

125

1274

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

1274

100.00

1274

100.00

0
I
II
III
IV

3
172
187
173
645
94

0.24
13.5
14.68
13.58
50.63
7.38

7
120
79
61
163
844

0.55
9.42
6.2
4.79
12.79
66.25

%
1274
7
164
161
170
630
142

100.00
0.55
12.87
12.64
13.34
49.45
11.15

- 99 (AJCC_7th) 1

0
2

I
0

II
0

III
0

IV
0

80

96

II

17

50

11

86

III

11

25

13

50

IV

18

125

157

103

78

58

149

391

Kappa=0.6125
Kappa

- 521 -

1274

198 15.54

63

4.95

65

5.10

257 20.17

121

9.50

38

2.98

1 14.29

0.00

8.54

14

8.54

13

1.02

32

2.51

0.55

0.00

0.00

0.00

0.00

5.49

0.00

4.27

0.00

480 37.68

5 71.43

0.00

0.00

1 14.29

164

93 56.71

11

6.71

10

6.10

II

161

34 21.12

3.11

14

8.70

23 14.29

26 16.15

5.59

47 29.19

0.00

1.24

0.62

III

170

17 10.00

2.35

11

6.47

31 18.24

15

8.82

2.35

83 48.82

1.18

1.18

0.59

IV

630

14

2.22

16

2.54

20

3.17

156 24.76

49

7.78

10

1.59

335 53.17

1.43

17

2.70

0.63

M0

591

14

2.37

16

2.71

19

3.21

151 25.55

35

5.92

10

1.69

320 54.15

1.35

15

2.54

0.51

M1

39

0.00

0.00

2.56

5 12.82

14 35.90

0.00

15 38.46

2.56

5.13

2.56

142

27 19.01

10

7.04

40 28.17

16 11.27

0.70

1.41

2.82

0.70

35 24.65

3.66

14

4.23

0~39 1

79

8 10.13

2.53

7.59

0.00

0.00

0.00

3 37.50

0.00

2 25.00

II

14

2 14.29

0.00

III

1 16.67

0.00

IV

44

2.27

M 0

41

2.44

M 1

0.00

1 14.29

9 11.39

3.80

0.00

0.00

0.00

0.00

1 12.50

0.00

7.14

5 35.71

0.00

2 33.33

2.27

2.27

15 34.09

2.44

2.44

15 36.59

0.00

0.00

1 14.29

3 42.86

20 25.32

0.00

2 28.57

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2 25.00

0.00

0.00

0.00

7.14

5 35.71

0.00

0.00

0.00

0.00

0.00

3 50.00

0.00

0.00

0.00

6.82

4.55

21 47.73

0.00

0.00

0.00

2.44

4.88

20 48.78

0.00

0.00

0.00

2 66.67

0.00

1 33.33

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

31 39.24

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 522 -


40~59 1

806

123 15.26

40

4.96

40

4.96

176 21.84

4 66.67

0.00

0.00

107

64 59.81

8.41

6.54

II

92

21 22.83

5.43

III

104

8.65

2.88

IV

418

1.67

11

M0

393

1.78

M1

25

0.00

79

18 22.78

65

8.06

18

2.23

1 16.67

1 16.67

0.00

2.80

5.61

8.41

7.61

16 17.39

9.78

5.77

22 21.15

5.77

2.63

15

3.59

110 26.32

33

11

2.80

14

3.56

106 26.97

23

0.00

4.00

12 15.19

6.33

319 39.58

0.50

19 2.36

0.25

0.00

0.00

0 0.00

0.00

3.74

0.00

5 4.67

0.00

2.17

30 32.61

0.00

2 2.17

0.00

0.00

55 52.88

0.00

2 1.92

0.96

7.89

1.44

225 53.83

0.96

7 1.67

0.00

5.85

1.53

217 55.22

0.76

6 1.53

0.00

4 16.00

10 40.00

0.00

8 32.00

4.00

1 4.00

0.00

24 30.38

10 12.66

1.27

0.00

3 3.80

1.27

6.33

60 1

389

67 17.22

21

5.40

19

4.88

1 100.0

0.00

0.00

0.00

49

26 53.06

4.08

2.04

6.12

II

55

11 20.00

0.00

7 12.73

III

60

7 11.67

1.67

IV

168

3.57

2.38

M 0

157

3.82

M 1

11

0.00

56

16 28.57

61 15.68

17

4.37

0.00

7 14.29

5 10.20

6 10.91

12 21.82

8.33

7 11.67

9 15.00

2.38

31 18.45

13

2.55

2.55

30 19.11

11

0.00

0.00

14 25.00

3.57

2.31

13

3.34

1.29

0.00

0.00

0.00

0.00

6.12

0.00

4.08

0.00

6 10.91

12 21.82

0.00

0.00

1.82

6.67

25 41.67

3.33

0.00

0.00

7.74

1.19

89 52.98

2.98

10

5.95

2.38

7.01

1.27

83 52.87

3.18

5.73

1.91

9.09

2 18.18

0.00

6 54.55

0.00

9.09

9.09

14 25.00

6 10.71

0.00

3.57

1.79

0.00

0.00

130 33.42

47 12.08

1.79

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 523 -

- 524 -

0
0
0
0
0
0
4
25
82

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
1
0
0

0
0
0
0
0
0
5
25
82

3
3
3
2
0
3
1
2
1
19

144
176
158
98
74
57
43
22
16
899

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

147
179
161
100
74
60
44
24
17
918

%
918
100.00

0
I
II
III
IV

3
46
62
130
645
32

%
918
100.00

0.33
5.01
6.75
14.16
70.26
3.49

1
12
17
32
177
679

%
918
100.00

0.11
1.31
1.85
3.49
19.28
73.97

4
48
56
117
662
31

0.44
5.23
6.1
12.75
72.11
3.38

- 99 (AJCC_7th) 1

0
0

I
0

II
0

III
0

IV
0

II

22

III

15

23

40

IV

12

143

159

11

15

31

172

229

Kappa=0.4626
Kappa

- 525 -

918

50

5.45

10

1.09

34

3.70

1 25.00

0.00

0.00

48

9 18.75

0.00

4.17

II

56

8 14.29

0.00

8.93

III

117

5.13

0.00

IV

662

17

2.57

10

1.51

M0

605

17

2.81

M1

57

0.00

31

9 29.03

197 21.46

37

4.03

478 52.07

18

1.96

0.00

0.00

0.00

1 25.00

0.00

1 25.00

1 25.00

6.25

2.08

8 16.67

25 52.08

0.00

0.00

0.00

8.93

1.79

7.14

28 50.00

1.79

7.14

0.00

4.27

22 18.80

2.56

3.42

69 58.97

2.56

2.56

1.71

22

3.32

161 24.32

49

7.40

20

3.02

348 52.57

11

1.66

18

2.72

0.91

1.49

22

3.64

159 26.28

29

4.79

20

3.31

319 52.73

1.16

17

2.81

0.99

1.75

0.00

20 35.09

0.00

29 50.88

7.02

1.75

0.00

0.00

0.00

6 19.35

3.23

7 22.58

9.68

9.68

0.00

6.45

6.10

3.16

56

3.51

29

0.98

0~39 1

30

3.33

3.33

0.00

30.00

3.33

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

0.00

0.00

0.00

0.00

0.00

III

0.00

0.00

0.00

0.00

0.00

IV

29

3.45

3.45

0.00

31.03

M 0

27

3.70

3.70

0.00

33.33

M 1

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3.33

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1 100.0

0.00

0.00

0.00

3.45

0.00

16 55.17

0.00

0.00

3.45

0.00

0.00

15 55.56

0.00

0.00

3.70

0.00

1 50.00

0.00

1 50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

17 56.67

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 526 -


40~59 1

569

32

5.62

1.23

16

2.81

1 33.33

0.00

0.00

35

7 20.00

0.00

2.86

II

35

5 14.29

0.00

III

62

6.45

0.00

IV

418

10

2.39

M0

386

10

2.59

M1

32

16

124 21.79

38

6.68

21

3.69

308 54.13

1.05

0.00

0.00

0.00

1 33.33

5.71

2.86

5 14.29

19 54.29

8.57

5 14.29

0.00

2.86

4.84

15 24.19

3.23

1.67

2.15

99 23.68

34

8.13

1.81

2.33

97 25.13

21

0.00

0.00

0.00

5 31.25

0.00

0.00

3 18.75

6.25

2.46

0.53

0.00

1 33.33

0.00

0.00

0.00

0.00

18 51.43

0.00

8.57

0.00

3.23

36 58.06

0.00

0.00

0.00

13

3.11

230 55.02

1.20

1.91

0.72

5.44

13

3.37

215 55.70

0.78

2.07

0.78

13 40.63

0.00

15 46.88

6.25

0.00

0.00

0.00

4 25.00

6.25

2 12.50

0.00

6.25

14

60 1

319

17

5.33

0.63

18

5.64

0.00

0.00

0.00

13

2 15.38

0.00

7.69

II

21

3 14.29

0.00

III

54

3.70

0.00

IV

215

2.79

M 0

192

3.13

M 1

23

15

64 20.06

17

5.33

16

5.02

0.00

0.00

0.00

7.69

0.00

9.52

0.00

3.70

7 12.96

0.93

13

6.05

0.52

13

6.77

0.00

4.35

0.00

4 26.67

0.00

0.00

3 20.00

12

3.76

15

4.70

0.00

0.00

0.00

1 100.0

3 23.08

6 46.15

0.00

0.00

0.00

4.76

3 14.29

10 47.62

4.76

4.76

0.00

1.85

3.70

32 59.26

5.56

5.56

3.70

53 24.65

14

6.51

3.26

102 47.44

2.79

10

4.65

0.93

53 27.60

4.17

3.65

89 46.35

2.08

4.69

1.04

6 26.09

0.00

13 56.52

8.70

4.35

0.00

6.67

3 20.00

2 13.33

6.67

0.00

0.00

6.67

153 47.96

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 527 -

1.57

- 528 -

0
0
0
2
1
3
4
8
13

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
2
4
2
4
13
11

0
0
0
4
5
5
8
21
24

9
7
4
10
3
10
5
4
3
91

11
16
18
8
8
4
10
8
0
114

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

20
23
22
18
11
14
15
12
3
205

%
205
100.00

I
II
III
IV

25
33
18
48
81

%
205
100.00

12.2
16.1
8.78
23.41
39.51

45
51
25
37
47

%
205
100.00

21.95
24.88
12.2
18.05
22.93

43
53
26
56
27

20.98
25.85
12.68
27.32
13.17

- 99 (AJCC_7th) 1

0
20

I
1

II
1

III
0

IV
22

20

18

27

II

17

III

25

29

IV

23

24

16

32

95

23

20

22

20

Kappa=0.6725
Kappa

- 529 -

205

74 36.10

1.95

66 32.20

25

15 60.00

0.00

9 36.00

II

33

15 45.45

0.00

III

18

4 22.22

IV

48

8.33

81

40 19.51

0.98

1.46

3.90

0.49

2.44

0.98

4.00

0.00

0.00

0.00

0.00

0.00

0.00

9 27.27

8 24.24

0.00

0.00

0.00

0.00

3.03

0.00

0.00

9 50.00

4 22.22

0.00

0.00

5.56

0.00

0.00

0.00

6.25

10 20.83

14 29.17

4.17

4.17

7 14.58

2.08

6.25

4.17

36 44.44

1.23

29 35.80

13 16.05

0.00

1.23

0.00

0.00

1.23

0.00

205

74 36.10

1.95

66 32.20

40 19.51

0.98

1.46

3.90

0.49

2.44

0.98

45

25 55.56

0.00

17 37.78

6.67

0.00

0.00

0.00

0.00

0.00

0.00

II

51

21 41.18

0.00

22 43.14

8 15.69

0.00

0.00

0.00

0.00

0.00

0.00

III

25

8 32.00

0.00

10 40.00

7 28.00

0.00

0.00

0.00

0.00

0.00

0.00

IV

37

6 16.22

2.70

12 32.43

18 48.65

0.00

0.00

0.00

0.00

0.00

0.00

47

14 29.79

6.38

5 10.64

8.51

4.26

6.38

8 17.02

2.13

5 10.64

4.26

205

74 36.10

1.95

66 32.20

40 19.51

0.98

1.46

3.90

0.49

2.44

0.98

43

25 58.14

0.00

16 37.21

4.65

0.00

0.00

0.00

0.00

0.00

0.00

II

53

21 39.62

0.00

22 41.51

9 16.98

0.00

0.00

0.00

0.00

1.89

0.00

III

26

8 30.77

0.00

10 38.46

7 26.92

0.00

0.00

3.85

0.00

0.00

0.00

IV

56

6 10.71

5.36

12 21.43

18 32.14

3.57

3.57

7 12.50

1.79

5.36

3.57

27

14 51.85

3.70

6 22.22

4 14.81

0.00

3.70

0.00

3.70

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 530 -


0~49 1

87

29 33.33

0.00

28 32.18

23

14 60.87

0.00

8 34.78

II

29

9 31.03

0.00

III

10

2 20.00

IV

17

0.00

4 50.00

22 25.29

1.15

1.15

3.45

0.00

3.45

0.00

4.35

0.00

0.00

0.00

0.00

0.00

0.00

12 41.38

7 24.14

0.00

0.00

0.00

0.00

3.45

0.00

0.00

3 30.00

5 50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3 17.65

9 52.94

5.88

0.00

3 17.65

0.00

5.88

0.00

0.00

2 25.00

0.00

1 12.50

0.00

1 12.50

0.00

0.00

0.00

50~69 1

74

27 36.49

2.70

23 31.08

18

10 55.56

0.00

7 38.89

II

16

7 43.75

0.00

III

10

4 40.00

IV

21

3 14.29

3 33.33

14 18.92

1.35

0.00

5.41

1.35

1.35

1.35

5.56

0.00

0.00

0.00

0.00

0.00

0.00

7 43.75

2 12.50

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3 30.00

2 20.00

0.00

0.00

1 10.00

0.00

0.00

0.00

4.76

4 19.05

6 28.57

4.76

0.00

3 14.29

4.76

4.76

4.76

1 11.11

2 22.22

3 33.33

0.00

0.00

0.00

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 531 -


70 1

44

18 40.91

4.55

15

34.09

9.09

0.00

4.55

2.27

0.00

2.27

2.27

1 50.00

0.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

5 62.50

0.00

37.50

0.00

0.00

0.00

0.00

0.00

0.00

0.00

III

2 33.33

0.00

66.67

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IV

18

3 16.67

2 11.11

27.78

3 16.67

0.00

2 11.11

5.56

0.00

5.56

5.56

10

7 70.00

20.00

1 10.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 532 -

0
0
0
8
7
19
76
95
150

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
1
3
3
10
25
28
39

0
0
1
11
10
29
101
123
189

54
60
52
28
19
19
15
7
2
365

150
193
151
90
54
41
35
8
6
1083

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

204
253
203
118
73
60
50
15
8
1448

1448

100.00

1448

100.00

0.00

0.00

I
II
III
IV

145
282
471
521
29

10.01
19.48
32.53
35.98
2

15
4
8
15
1406

1.04
0.28
0.55
1.04
97.1

%
1448
0
146
284
476
521
21

100.00
0.00
10.08
19.61
32.87
35.98
1.45

- 99 (AJCC_7th) 1

- 533 -

143

9.88

1116 77.07

0.28

39

2.69

15

1.04

30 20.69

0.00

2.76

0.69

1448

0.62

0.21

20

1.38

45

3.11

54

3.73

145

3.45

0.69

10

6.90

0.00

2.76

90 62.07

II

282

0.00

0.00

0.71

11

3.90

2.13

22

7.80

232 82.27

0.00

1.77

1.42

III

471

0.21

0.00

0.00

13

2.76

13

2.76

18

3.82

409 86.84

0.21

11

2.34

1.06

IV

521

0.00

0.19

0.00

18

3.45

30

5.76

13

2.50

443 85.03

0.58

1.54

0.96

M0

423

0.00

0.00

0.00

13

3.07

13

3.07

1.89

377 89.13

0.47

1.18

1.18

M1

98

0.00

1.02

0.00

5.10

17 17.35

5.10

66 67.35

1.02

3.06

0.00

29

3 10.34

3.45

8 27.59

0.00

0.00

11 37.93

0.00

3 10.34

3.45

6.90

0~49

668

1.05

0.15

0.45

19

2.84

17

2.54

38

5.69

568 85.03

0.00

11

1.65

0.60

55

5.45

0.00

1.82

0.00

5.45

28 50.91

19 34.55

0.00

1.82

0.00

II

134

0.00

0.00

0.00

3.73

0.75

2.24

122 91.04

0.00

1.49

0.75

III

242

0.41

0.00

0.00

2.89

1.65

1.65

218 90.08

0.00

2.07

1.24

IV

225

0.00

0.00

0.00

2.22

4.00

1.33

208 92.44

0.00

0.00

0.00

M0

190

0.00

0.00

0.00

2.11

1.58

1.05

181 95.26

0.00

0.00

0.00

M1

35

0.00

0.00

0.00

2.86

6 17.14

2.86

27 77.14

0.00

0.00

0.00

12

3 25.00

8.33

2 16.67

0.00

0.00

3 25.00

0.00

2 16.67

0.00

8.33

1
2
3 ()

4
5

- 534 -


50~69

647

0.31

0.15

68

2.94

II

126

0.00

III

192

IV

246

M0

16

2.47

22

3.40

25

3.86

63

9.74

486 75.12

0.31

21

3.25

1.39

1.47

8 11.76

0.00

1.47

44 64.71

9 13.24

0.00

4.41

0.00

0.00

1.59

3.97

3.97

11

8.73

99 78.57

0.00

1.59

1.59

0.00

0.00

0.00

3.13

2.08

2.08

171 89.06

0.00

2.60

1.04

0.00

0.00

0.00

10

4.07

14

5.69

1.63

206 83.74

0.81

2.03

2.03

192

0.00

0.00

0.00

3.13

2.60

1.04

170 88.54

0.52

1.56

2.60

M1

54

0.00

0.00

0.00

7.41

9 16.67

3.70

36 66.67

1.85

3.70

0.00

15

0.00

0.00

6 40.00

6.67

0.00

0.00

6 40.00

0.00

6.67

6.67

70

133

0.00

0.75

0.75

3.01

12

9.02

42

31.58

22

0.00

0.00

4.55

0.00

0.00

18

81.82

II

22

0.00

0.00

0.00

4.55

0.00

III

37

0.00

0.00

0.00

0.00

5 13.51

IV

50

0.00

2.00

0.00

6.00

M0

41

0.00

0.00

0.00

M1

0.00

1 11.11

0.00

0.00

0.00

0.00

1.50

5.26

1.50

9.09

0.00

0.00

4.55

36.36

11 50.00

0.00

4.55

4.55

10

27.03

20 54.05

2.70

2.70

0.00

7 14.00

12.00

29 58.00

2.00

6.00

0.00

7.32

5 12.20

9.76

26 63.41

2.44

4.88

0.00

0.00

2 22.22

22.22

3 33.33

0.00

11.11

0.00

0.00

0.00

0.00

2 100.0

0.00

0.00

62 46.62

0.00

1
2
3 ()

4
5

- 535 -

- 536 -

0
0
0
0
1
2
9
49
175

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
1
1
7

0
0
0
0
1
2
10
50
182

5
14
13
11
18
12
18
13
13
126

278
344
325
211
149
110
83
65
47
1848

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

283
358
338
222
167
122
101
78
60
1974

%
1974
100.00


0
I
II
III
IV

13
120
341
929
472
99

%
1974
100.00

0.66
6.08
17.27
47.06
23.91
5.02

9
125
219
177
56
1388

%
1974
100.00

0.46
6.33
11.09
8.97
2.84
70.31

16
147
327
944
474
66

0.81
7.45
16.57
47.82
24.01
3.34

- 99 (AJCC_7th) 1

0
1

I
3

II
0

III
0

IV
0

50

66

II

34

89

36

161

III

28

106

120

261

IV

48

51

116

204

160

55

543

Kappa=0.3916
Kappa

- 537 -

1974

188

9.52

43

2.18

29

1.47

420 21.28

105

5.32

128

6.48

849 43.01

89

4.51

93

4.71

30

1.52

13

4 30.77

0.00

0.00

0.00

0.00

0.00

4 30.77

0.00

3 23.08

2 15.38

120

66 55.00

1.67

1.67

5.83

2.50

5.83

24 20.00

0.83

3.33

3.33

II

341

65 19.06

16

4.69

17

4.99

83 24.34

10

2.93

19

5.57

110 32.26

1.76

14

4.11

0.29

III

929

23

2.48

20

2.15

0.75

277 29.82

22

2.37

59

6.35

453 48.76

40

4.31

23

2.48

0.54

IV

472

1.69

0.21

0.64

33

6.99

68

14.41

37

7.84

252 53.39

33

6.99

30

6.36

1.48

99

22 22.22

4.04

0.00

20 20.20

2.02

6.06

6.06

9.09

19 19.19

11 11.11

43

2.18

29

1.47

420 21.28

105

5.32

128

6.48

849 43.01

89

4.51

93

4.71

30

1.52

1 11.11

0.00

2 22.22

0.00

0.00

0.00

0.00

0.00

0.00

1974

188

9.52

6 66.67

125

91 72.80

0.80

2.40

30 24.00

0.00

0.00

0.00

0.00

0.00

0.00

II

219

59 26.94

15

6.85

16

7.31

129 58.90

0.00

0.00

0.00

0.00

0.00

0.00

III

177

13

7.34

21 11.86

2.82

136 76.84

0.00

0.56

0.56

0.00

0.00

0.00

IV

56

8.93

5.36

5.36

24 42.86

5.36

3.57

14 25.00

1.79

0.00

1.79

1388

14

1.01

0.14

0.14

99

7.13

102

7.35

125

9.01

834 60.09

88

6.34

93

6.70

29

2.09

1974

188

9.52

43

2.18

29

1.47

420 21.28

105

5.32

128

6.48

849 43.01

89

4.51

93

4.71

30

1.52

16

6 37.50

6.25

0.00

0.00

0.00

0.00

4 25.00

0.00

3 18.75

2 12.50

147

93 63.27

0.68

2.04

4.76

2.04

4.76

24 16.33

0.68

2.72

2.72

II

327

59 18.04

15

4.59

16

4.89

77 23.55

10

3.06

19

5.81

110 33.64

1.83

14

4.28

0.31

III

944

14

1.48

22

2.33

0.53

301 31.89

22

2.33

59

6.25

453 47.99

40

4.24

23

2.44

0.53

IV

474

1.90

0.63

0.63

32

6.75

68

14.35

37

7.81

252 53.16

33

6.96

30

6.33

1.48

66

7 10.61

1.52

3.03

4.55

3.03

9.09

9.09

9 13.64

19 28.79

11 16.67

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 538 -


0~49 1

528

1 16.67

40

II

81

III

279

IV

104

18

46

8.71

15

2.84

0.95

1 16.67

0.00

25 62.50

0.00

2.50

15 18.52

7.41

0.36

2.87

0.96

3 16.67

143 27.08

26

4.92

18

3.41

236 44.70

16

3.03

0.00

0.00

0.00

2 33.33

7.50

2.50

0.00

9 22.50

3.70

29 35.80

0.00

1.23

0.00

104 37.28

2.51

14

0.00

0.00

17 16.35

0.00

5.56

2 11.11

4.81

5.56

3.03

1.33

0.00

2 33.33

0.00

0.00

0.00

2.50

21 25.93

0.00

7.41

0.00

5.02

134 48.03

2.51

1.43

0.00

1.92

68 65.38

4.81

1.92

3.85

5.56

2 11.11

4 22.22

16

2 11.11

2 11.11

50~69 1

106

9.77

25

2.30

18

1.66

1085

4 50.00

0.00

0.00

78

51 65.38

1.28

2.56

II

172

34 19.77

3.49

10

III

519

1.54

14

2.70

IV

286

1.75

22

4 18.18

253 23.32

61

5.62

52

4.79

488 44.98

37

3.41

35

3.23

0.00

0.00

0.00

2 25.00

0.00

0.00

2 25.00

5.13

0.00

3.85

11 14.10

1.28

3.85

2.56

5.81

46 26.74

2.33

3.49

63 36.63

0.58

0.58

0.58

0.77

178 34.30

12

2.31

22

4.24

257 49.52

14

2.70

1.54

0.39

1.05

0.70

24

8.39

45 15.73

20

6.99

151 52.80

19

6.64

16

5.59

0.35

4.55

0.00

4.55

4.55

4 18.18

9.09

7 31.82

9.09

0.00

10

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 539 -

0.92


70 1

361

36

9.97

0.83

1.66

24

6.65

18

4.99

1 50.00

0.00

0.00

0.00

0.00

29

17 58.62

0.00

0.00

0.00

6.90

II

74

10 13.51

4.05

4.05

2.70

III

146

3.42

0.00

0.68

19 13.01

IV

84

3.57

0.00

1.19

26

0.00

0.00

3.85

58 16.07

36

9.97

42 11.63

13

3.60

0.00

0.00

1 50.00

0.00

4 13.79

4 13.79

0.00

3.45

3.45

8.11

12 16.22

26 35.14

6.76

9.46

0.00

2.05

23 15.75

62 42.47

19 13.01

11

7.53

2.05

3.57

7.14

15 17.86

33 39.29

9 10.71

12 14.29

2.38

0.00

3.85

4 15.38

3 11.54

10 38.46

7 26.92

0.00

125 34.63

0.00

1(99 )(AJCC_7th) 1
2
3 ()

4
5

- 540 -

0
0
1
0
0
5
10
31
50

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
2
0
7
19
32
50

0
0
1
2
0
12
29
63
100

81
103
125
114
122
162
157
159
118
1251

102
175
229
200
201
240
315
318
186
2063

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

183
278
354
314
323
402
472
477
304
3314

%
3314
100.00


0
I
II
III
IV

19
741
569
483
894
608

%
3314
100.00

0.57
22.36
17.17
14.57
26.98
18.35

27
649
435
745
415
1043

%
3314
100.00

0.81
19.58
13.13
22.48
12.52
31.47

34
734
513
850
993
190

1.03
22.15
15.48
25.65
29.96
5.73

- 99 (AJCC_7th) 1

0
6

I
5

II
0

III
0

IV
0

11

432

121

72

641

II

51

195

220

25

491

III

43

279

51

381

IV

296

310

15

502

359

579

379

1834

Kappa=0.5457
Kappa

- 541 -

3314 1203 36.30 782 23.60

11

0.33

213

6.43

0.00

0.00

0.00

468 14.12

26

0.78

83

2.50

216

6.52

0.00

0.00

0.00

0.00

264

7.97

48

1.45

7 36.84

0.00

19

12

63.16

741

501

67.61

128 17.27

0.13

30

4.05

17

2.29

0.00

0.81

12

1.62

36

4.86

10

1.35

II

569

218

38.31

201 35.33

0.00

71 12.48

19

3.34

0.88

1.41

17

2.99

22

3.87

1.41

III

483

150

31.06

167 34.58

0.41

63 13.04

35

7.25

1.66

17

3.52

23

4.76

13

2.69

1.04

IV

894

53

5.93

129 14.43

0.45

22

2.46

379 42.39

11

1.23

48

5.37

104 11.63

11

1.23

608

269

44.24

157 25.82

0.66

27

4.44

2.96

0.33

0.66

31

5.10

82 13.49

14

2.30

3314 1203 36.30 782 23.60

11

0.33

213

6.43

468 14.12

26

0.78

83

2.50

216

6.52

264

7.97

48

1.45

27

649

575

88.60

II

435

223

III

745

IV

27 100.00

18

133 14.88

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

60

9.24

0.15

13

2.00

0.00

0.00

0.00

0.00

0.00

0.00

51.26

171 39.31

0.23

40

9.20

0.00

0.00

0.00

0.00

0.00

0.00

271

36.38

338 45.37

0.67

129 17.32

0.00

0.13

0.13

0.00

0.00

0.00

415

68

16.39

194 46.75

0.96

27

6.51

78 18.80

0.00

10

2.41

19

4.58

14

3.37

0.24

1043

39

3.74

1.82

0.00

0.38

390 37.39

25

2.40

72

6.90

197 18.89

250 23.97

47

4.51

3314 1203 36.30 782 23.60

11

0.33

213

6.43

468 14.12

26

0.78

83

2.50

216

6.52

264

7.97

48

1.45

7 20.59

0.00

19

34

27

79.41

0.00

0.00

0.00

0.00

0.00

0.00

0.00

734

578

78.75

61

8.31

0.14

13

1.77

17

2.32

0.00

0.82

12

1.63

36

4.90

10

1.36

II

513

223

43.47

169 32.94

0.19

41

7.99

19

3.70

0.97

1.56

17

3.31

22

4.29

1.56

III

850

273

32.12

342 40.24

0.47

130 15.29

35

4.12

0.94

17

2.00

23

2.71

13

1.53

0.59

IV

993

73

7.35

201 20.24

0.40

29

2.92

379 38.17

11

1.11

48

4.83

133 13.39

104 10.47

11

1.11

190

29

15.26

0.53

0.00

1.05

2.11

31 16.32

82 43.16

14

7.37

4.74

18

9.47

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 542 -


0~49 1

390

106

27.18

0.00

75

59

II

50

III

138 35.38

0.26

0.00

0.00

0.00

78.67

11 14.67

0.00

4.00

19

38.00

23 46.00

0.00

109

23

21.10

54 49.54

0.92

IV

146

2.05

48 32.88

0.00

3.42

10

20.00

2 20.00

0.00

0.00

40 10.26

70 17.95

0.00

1.54

11

2.82

16

4.10

0.51

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2.67

0.00

7 14.00

2.00

0.00

0.00

0.00

0.00

0.00

25 22.94

2.75

0.00

0.00

0.92

0.92

0.92

66 45.21

0.00

4.11

6.16

5.48

0.68

0.00

0.00

1 10.00

5 50.00

0.00

0.00

50~69 1

1237

461 37.27

0.32

112

9.05

0.00

0.00

0.00

2.33

354 28.62

177 14.31

0.32

35

2.83

31

2.51

47

3.80

12

0.97

0.00

0.00

0.00

0.00

0.00

0.00

1.33

0.00

0.67

1.00

1.67

1.00

16

16 100.0

300

245 81.67

30 10.00

0.33

II

204

87 42.65

79 38.73

0.00

25 12.25

0.98

0.49

0.98

0.98

2.94

0.00

III

314

82 26.11

148 47.13

0.32

65 20.70

10

3.18

0.32

1.59

0.32

0.32

0.00

IV

367

21

94 25.61

0.54

15

4.09

158 43.05

0.54

26

7.08

24

6.54

24

6.54

0.27

36

0.00

0.00

0.00

0.00

2.78

11 30.56

5.72

10 27.78

8.33

8.33

8 22.22

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 543 -


70 1

1655

634

38.31

278 16.80

0.30

56

3.38

216 13.05

22

1.33

42

2.54

174 10.51

194 11.72

34

2.05

5 31.25

0.00

16

11

68.75

0.00

0.00

0.00

0.00

0.00

0.00

0.00

355

272

76.62

19

5.35

0.00

0.56

13

3.66

0.00

1.13

2.54

29

8.17

1.97

II

257

117

45.53

67 26.07

0.39

3.11

16

6.23

1.56

2.33

15

5.84

15

5.84

3.11

III

420

168

40.00

136 32.38

0.48

37

8.81

22

5.24

1.67

12

2.86

21

5.00

11

2.62

0.95

IV

464

49

10.56

52 11.21

0.22

1.94

150 32.33

1.94

16

3.45

100 21.55

69 14.87

1.94

143

17

11.89

0.70

0.00

15 10.49

1.40

2.80

29 20.28

65 45.45

4.20

2.80

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 544 -

0
1
0
1
3
18
42
63
114

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
1
2
15
43
62
84

0
1
0
2
5
33
85
125
198

183
325
402
373
439
395
403
291
269
3287

192
396
545
550
563
504
481
425
254
4152

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

375
721
947
923
1002
899
884
716
523
7439

7439

100.00

7439

100.00

7439

100.00

196
1015
1197
1952
1550
1529

2.63
13.64
16.09
26.24
20.84
20.55

651
1087
1753
1865
1142
941

8.75
14.61
23.56
25.07
15.35
12.65

672
1136

9.03
15.27

1695
1937
1643
236

24.39
26.04
22.09
3.17

0
I
II
III
IV

- 99 (AJCC_7th) 1

0
I
II
III
IV

145
57
6
11
2
221

I
24
518
115
126
4
787

II
2
190
631
637
19
1479

Kappa=0.5220
Kappa

- 545 -

III
2
171
356
1015
25
1569

IV
0
8
20
87
992
1107

173
944
1128
1876
1042
5163

128

1.72

380

5.11

13

0.17

53

0.71

181

2.43

227

3.05

61

0.82

0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV

0
1
0
1
0
0
0
0
1
1
2
0

0.00
0.09
0.00
0.07
0.00
0.00
0.00
0.00
0.08
0.21
0.12
0.00

0
1
0
17
8
9
0
0
22
16
53
2

0.00
0.09
0.00
1.11
4.91
7.50
0.00
0.00
1.68
3.35
3.23
0.85

0 0.00
6 0.53
2 33.33
6 0.39
1 0.61
1 0.83
4 100.0
0 0.00
6 0.46
7 1.47
337 20.51
10 4.24

0
1
0
1
0
1
0
0
1
0
8
1

0.00
0.09
0.00
0.07
0.00
0.83
0.00
0.00
0.08
0.00
0.49
0.42

0
0
0
3
0
0
0
0
5
3
41
1

0.00
0.00
0.00
0.20
0.00
0.00
0.00
0.00
0.38
0.63
2.50
0.42

1
2
0
8
5
3
0
0
7
6
129
20

0.15
0.18
0.00
0.52
3.07
2.50
0.00
0.00
0.53
1.26
7.85
8.47

17 2.53
29 2.55
1 16.67
17 1.11
3 1.84
2 1.67
0 0.00
2 1.36
21 1.60
5 1.05
68 4.14
62 26.27

2
9
0
3
1
1
0
0
3
2
17
23

0.30
0.79
0.00
0.20
0.61
0.83
0.00
0.00
0.23
0.42
1.03
9.75

649
1019
2
766
51
33
0
15
175
60
164
92

96.58
89.70
33.33
50.20
31.29
27.50
0.00
10.20
13.37
12.58
9.98
38.98

3
68
1
704
94
70
0
130
1068
377
824
25

0.45
5.99
16.67
46.13
57.67
58.33
0.00
88.44
81.59
79.04
50.15
10.59

0.08

672
1136
6
1526
163
120
4
147
1309
477
1643
236

7439 3026 40.68 3364 45.22

0~49 1

824

0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV

67
89
0
134
15
14
1
15
152
77
245
15

227 27.55
67
84
0
44
0
2
0
0
8
4
11
7

100.0
94.38
0.00
32.84
0.00
14.29
0.00
0.00
5.26
5.19
4.49
46.67

507

61.53

0.00

27

0
0.00
4
4.49
0
0.00
87 64.93
11 73.33
11 78.57
0
0.00
15 100.00
138 90.79
68 88.31
170 69.39
3 20.00

0
0
0
0
0
0
0
0
0
0
0
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

0 0.00
0 0.00
0 0.00
2 1.49
4 26.67
1 7.14
0 0.00
0 0.00
4 2.63
4 5.19
12 4.90
0 0.00

3.28

38

4.61

0.12

0.97

0.61

1.09

0.24

0 0.00
0 0.00
0 0.00
1 0.75
0 0.00
0 0.00
1 100.0
0 0.00
1 0.66
1 1.30
33 13.47
1 6.67

0
0
0
0
0
0
0
0
0
0
1
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.41
0.00

0
0
0
0
0
0
0
0
0
0
7
1

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.86
6.67

0
0
0
0
0
0
0
0
0
0
5
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
2.04
0.00

0 0.00
1 1.12
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
1 0.66
0 0.00
5 2.04
2 13.33

0
0
0
0
0
0
0
0
0
0
1
1

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.41
6.67

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 546 -


50~69 1

158

4.40

0.06

14

0.39

27

0.75

63

1.75

17

0.47

0
I
II
IIA
IIB
IIC
III
IIIA
IIIB
IIIC
IV

0
1
0
1
0
0
0
0
0
0
1
0

0.00
0.15
0.00
0.15
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00

0
0
0
5
3
3
0
0
13
8
24
2

0.00
0.00
0.00
0.73
4.62
8.11
0.00
0.00
2.22
3.65
3.48
2.08

0 0.00
0 0.00
1 25.00
1 0.15
0 0.00
0 0.00
0 0.00
0 0.00
1 0.17
2 0.91
152 22.06
1 1.04

0
0
0
0
0
0
0
0
0
0
1
1

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.15
1.04

0
0
0
1
0
0
0
0
0
1
12
0

0.00
0.00
0.00
0.15
0.00
0.00
0.00
0.00
0.00
0.46
1.74
0.00

0
1
0
1
0
0
0
0
1
0
23
1

0.00
0.15
0.00
0.15
0.00
0.00
0.00
0.00
0.17
0.00
3.34
1.04

6 1.34
11 1.62
1 25.00
4 0.59
0 0.00
0 0.00
0 0.00
0 0.00
6 1.03
1 0.46
16 2.32
18 18.75

0
4
0
0
0
0
0
0
0
0
5
8

0.00
0.59
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.73
8.33

441
627
1
312
13
6
0
7
29
17
45
55

98.44
92.21
25.00
45.81
20.00
16.22
0.00
7.87
4.96
7.76
6.53
57.29

1
36
1
356
49
28
0
82
535
190
410
10

0.22
5.29
25.00
52.28
75.38
75.68
0.00
92.13
91.45
86.76
59.51
10.42

1.61

58

448
680
4
681
65
37
0
89
585
219
689
96

0.08

3593 1553 43.22 1698 47.26

70 1

1.42

184

6.09

10

0.33

31

1.03

149

4.93

155

5.13

0
I
II
IA
IB
IIC
III
I IA
I IB
I IC
IV

0
0
0
0
0
0
0
0
1
1
1
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.17
0.55
0.14
0.00

0
1
0
10
1
5
0
0
5
4
17
0

0.00
0.27
0.00
1.41
1.20
7.25
0.00
0.00
0.87
2.21
2.40
0.00

0 0.00
6 1.63
1 50.00
4 0.56
1 1.20
1 1.45
3 100.0
0 0.00
4 0.70
4 2.21
152 21.44
8 6.40

0
1
0
1
0
1
0
0
1
0
6
0

0.00
0.27
0.00
0.14
0.00
1.45
0.00
0.00
0.17
0.00
0.85
0.00

0
0
0
2
0
0
0
0
5
2
22
0

0.00
0.00
0.00
0.28
0.00
0.00
0.00
0.00
0.87
1.10
3.10
0.00

1 0.64
1 0.27
0 0.00
7 0.98
5 6.02
3 4.35
0 0.00
0 0.00
6 1.05
6 3.31
101 14.25
19 15.20

141
308
1
410
38
25
0
8
138
39
108
30

89.81
83.92
50.00
57.67
45.78
36.23
0.00
18.60
24.13
21.55
15.23
24.00

2
28
0
261
34
31
0
33
395
119
244
12

1.27
7.63
0.00
36.71
40.96
44.93
0.00
76.74
69.06
65.75
34.41
9.60

43

157
367
2
711
83
69
3
43
572
181
709
125

0.10

3022 1246 41.23 1159 38.35

11 7.01
17 4.63
0 0.00
13 1.83
3 3.61
2 2.90
0 0.00
2 4.65
14 2.45
4 2.21
47 6.63
42 33.60

42

1.39

2 1.27
5 1.36
0 0.00
3 0.42
1 1.20
1 1.45
0 0.00
0 0.00
3 0.52
2 1.10
11 1.55
14 11.20

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 547 -


MAC

722

293 40.58

87

84 96.55

305

C
D

407 56.37

0.00

15

2.08

0.69

0.00

0.14

0.00

0.14

0.00

3.45

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

160 52.46

141 46.23

0.00

0.98

0.33

0.00

0.00

0.00

0.00

0.00

251

39 15.54

203 80.88

0.00

3.59

0.00

0.00

0.00

0.00

0.00

0.00

79

10 12.66

60 75.95

0.00

3.80

5.06

0.00

1.27

0.00

1.27

0.00

MAC AJCC ()
1
2 ()

3
4

- 548 -

0
0
0
0
5
6
27
56
80

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
1
2
8
18
37
56

0
0
0
1
7
14
45
93
136

124
217
250
223
257
236
208
170
122
1929

183
292
415
409
434
374
321
237
138
2977

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

307
509
665
632
691
610
529
407
260
4906


0
I
II
III
IV

%
4906
100.00

%
4906
100.00

102
953
786
1301
920
844

329
947
842
1229
649
910

2.08
19.43
16.02
26.52
18.75
17.2

6.71
19.3
17.16
25.05
13.23
18.55

%
4906
100.00
331
972
887
1520
956
240

6.75
19.81
18.08
30.99
19.49
4.89

- 99 (AJCC_7th) 1

II

III

IV

72

16

88

40

467

133

184

830

II

125

310

219

17

678

III

144

291

644

33

1116

IV

10

13

580

605

123

754

744

1060

636

3317

Kappa=0.5025
Kappa

- 549 -

4906 1701 34.67 1396 28.45

68

1.39

0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV

2
25
0
10
0
1
3
11
4
5
7

0.60
2.57
0.00
1.31
0.00
2.13
1.51
1.13
1.16
0.52
2.92

331
972
3
763
74
47
199
977
344
956
240

316
738
2
304
17
8
15
96
32
62
111

95.47
75.93
66.67
39.84
22.97
17.02
7.54
9.83
9.30
6.49
46.25

1
61
1
224
29
18
100
419
137
399
7

0.30
6.28
33.33
29.36
39.19
38.30
50.25
42.89
39.83
41.74
2.92

1024 20.87
4
76
0
166
16
10
68
365
139
149
31

1.21
7.82
0.00
21.76
21.62
21.28
34.17
37.36
40.41
15.59
12.92

178

3.63

40

0.82

2 0.60
6 0.62
0 0.00
2 0.26
1 1.35
1 2.13
4 2.01
5 0.51
6 1.74
142 14.85
9 3.75

1
6
0
6
1
2
1
5
2
16
0

0.30
0.62
0.00
0.79
1.35
4.26
0.50
0.51
0.58
1.67
0.00

249

5.08

66

1.35

149

3.04

35

0.71

0 0.00
30 3.09
0 0.00
37 4.85
4 5.41
5 10.64
5 2.51
53 5.42
19 5.52
90 9.41
6 2.50

0
2
0
2
3
1
0
5
3
39
11

0.00
0.21
0.00
0.26
4.05
2.13
0.00
0.51
0.87
4.08
4.58

4 1.21
25 2.57
0 0.00
10 1.31
3 4.05
1 2.13
3 1.51
13 1.33
1 0.29
40 4.18
49 20.42

1
3
0
2
0
0
0
5
1
14
9

0.30
0.31
0.00
0.26
0.00
0.00
0.00
0.51
0.29
1.46
3.75

0~49 1

603

0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV

27
111
1
68
15
7
19
119
57
134
45

182 30.18
27
87
1
20
2
1
2
8
3
3
28

100.0
78.38
100.0
29.4
13.33
14.29
10.53
6.72
5.26
2.24
62.22

167

27.69

0.83

0
6
0
23
8
4
9
39
22
55
1

0.00
5.41
0.00
33.82
53.33
57.14
47.37
32.77
38.60
41.04
2.22

0
2
0
0
0
0
1
1
0
0
1

0.00
1.80
0.00
0.00
0.00
0.00
5.26
0.84
0.00
0.00
2.22

169 28.03
0
10
0
23
5
2
7
62
27
29
4

0.00
9.01
0.00
33.82
33.33
28.57
36.84
52.10
47.37
21.64
8.89

24

3.98

0.33

36

5.97

0.33

0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
1 1.75
23 17.16
0 0.00

0
0
0
0
0
0
0
0
0
2
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.00

0 0.00
3 2.70
0 0.00
2 2.94
0 0.00
0 0.00
0 0.00
9 7.56
4 7.02
16 11.94
2 4.44

0
0
0
0
0
0
0
0
0
2
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
0.00

12

1.99

0.66

0 0.00
3 2.70
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
0 0.00
2 1.49
7 15.56

0
0
0
0
0
0
0
0
0
2
2

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.49
4.44

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 550 -


50~69 1

2497

884 35.40

761 30.48

27

1.08

572 22.91

64

0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV

208
424
0
123
3
4
4
31
10
17
60

0
32
1
124
11
8
58
222
75
226
4

2
13
0
5
0
0
0
2
1
1
3

0.93
2.39
0.00
1.39
0.00
0.00
0.00
0.40
0.56
0.22
2.83

1
47
0
87
6
2
40
207
83
80
19

0 0.00
1 0.18
0 0.00
2 0.55
0 0.00
0 0.00
2 1.87
2 0.40
1 0.56
54 12.08
2 1.89

214
544
1
361
21
20
107
498
178
447
106

97.20
77.94
0.00
34.07
14.29
20.00
3.74
6.22
5.62
3.80
56.60

0.00
5.88
100.0
34.35
52.38
40.00
54.21
44.58
42.13
50.56
3.77

0.47
8.64
0.00
24.10
28.57
10.00
37.38
41.57
46.63
17.90
17.92

2.56

11

0.44

108

4.33

10

0.40

53

2.12

0.28

0 0.00
14 2.57
0 0.00
16 4.43
0 0.00
3 15.00
2 1.87
23 4.62
7 3.93
40 8.95
3 2.83

0
0
0
0
0
0
0
1
0
9
0

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.20
0.00
2.01
0.00

3 1.40
12 2.21
0 0.00
2 0.55
1 4.76
1 5.00
0 0.00
6 1.20
0 0.00
16 3.58
12 11.32

0
0
0
0
0
0
0
2
0
2
3

0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.40
0.00
0.45
2.83

0 0.00
1 0.18
0 0.00
2 0.55
0 0.00
2 10.00
1 0.93
2 0.40
1 0.56
2 0.45
0 0.00

70 1

1806

635 35.16

468

25.91

36

1.99

0
I
II
IIA
IIB
IIC
IIIA
IIIB
IIIC
IV

81
227
1
161
12
3
9
57
19
42
23

1
23
0
77
10
6
33
158
40
118
2

1.11
7.26
0.00
23.05
26.32
30.00
45.21
43.89
36.70
31.47
2.25

0
10
0
5
0
1
2
8
3
4
3

0.00
3.15
0.00
1.50
0.00
5.00
2.74
2.22
2.75
1.07
3.37

90
317
1
334
38
20
73
360
109
375
89

90.00
71.61
100.0
48.20
31.58
15.00
12.33
15.83
17.43
11.20
25.84

283 15.67
3
19
0
56
5
6
21
96
29
40
8

3.33
5.99
0.00
16.77
13.16
30.00
28.77
26.67
26.61
10.67
8.99

4.98

27

1.50

105

5.81

2 2.22
5 1.58
0 0.00
0 0.00
1 2.63
1 5.00
2 2.74
3 0.83
4 3.67
65 17.33
7 7.87

1
5
0
4
1
0
0
3
1
12
0

1.11
1.58
0.00
1.20
2.63
0.00
0.00
0.83
0.92
3.20
0.00

90

0 0.00
13 4.10
0 0.00
19 5.69
4 10.53
2 10.00
3 4.11
21 5.83
8 7.34
34 9.07
1 1.12

54

2.99

0 0.00
2 0.63
0 0.00
2 0.60
3 7.89
1 5.00
0 0.00
4 1.11
3 2.75
28 7.47
11 12.36

84

4.65

24

1.33

1 1.11
10 3.15
0 0.00
8 2.40
2 5.26
0 0.00
3 4.11
7 1.94
1 0.92
22 5.87
30 33.71

1
3
0
2
0
0
0
3
1
10
4

1.11
0.95
0.00
0.60
0.00
0.00
0.00
0.83
0.92
2.67
4.49

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 551 -


MAC

484

152 31.40

63

46 73.02

212

173

36

13

2.69

156 32.23

0.41

0.00

0.62

0.00

0.41

0.00

7.94

1.59

11 17.46

0.00

0.00

0.00

0.00

0.00

0.00

85 40.09

49 23.11

12

5.66

64 30.19

0.47

0.00

0.47

0.00

0.00

0.00

20 11.56

85 49.13

0.00

66 38.15

0.00

0.00

0.00

0.00

1.16

0.00

17 47.22

0.00

15 41.67

2.78

0.00

5.56

0.00

0.00

0.00

2.78

156 32.23

MAC AJCC ()
1
2 ()

3
4

- 552 -

8
2
2
1
9
27
72
166
326

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

5
0
2
0
2
6
15
28
36

13
2
4
1
11
33
87
194
362

71
151
285
322
456
529
477
286
164
2835

587
760
1059
878
844
814
658
402
194
6809

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

658
911
1344
1200
1300
1343
1135
688
358
9644


I
II
III
IV

%
9644
100.00

%
9644
100.00

3334
1908
2498
1552
352

1046
765
404
205
7224

34.57
19.78
25.9
16.09
3.65

10.85
7.93
4.19
2.13
74.91

%
9644
100.00
2859
2238
2518
1585
444

29.65
23.21
26.11
16.44
4.6

- 99 (AJCC_7th) 1

0
0

I
0

II
0

III
0

IV
0

910

432

59

14

1415

II

76

266

44

15

401

III

27

44

278

20

369

IV

148

162

1015

746

389

197

2347

Kappa=0.5140
Kappa

- 553 -


(C220) 1 2

8859

2384

26.91

1073

12.11

2270

25.62

251

2.83

992

11.20

804

9.08

236

2.66

3206

1455

45.38

736

22.96

596

18.59

123

3.84

68

2.12

153

4.77

53

1.65

II

1799

404

22.46

272

15.12

759

42.19

109

6.06

68

3.78

132

7.34

28

1.56

III

2449

389

15.88

47

1.92

710

28.99

12

0.49

485

19.80

304

12.41

99

4.04

IV

1153

35

3.04

12

1.04

178

15.44

0.26

331

28.71

172

14.92

48

4.16

252

101

40.08

2.38

27

10.71

1.59

40

15.87

43

17.06

3.17

8859

2384

26.91

1073

12.11

2270

25.62

251

2.83

992

11.20

804

9.08

236

2.66

973

971

99.79

0.21

0.00

0.00

0.00

0.00

0.00

II

714

713

99.86

0.14

0.00

0.00

0.00

0.00

0.00

III

385

385

100.00

0.00

0.00

0.00

0.00

0.00

0.00

IV

102

43

42.16

0.98

11

10.78

1.96

8.82

1.96

0.98

6685

272

4.07

1069

15.99

2259

33.79

249

3.72

983

14.70

802

12.00

235

3.52

8859

2384

26.91

1073

12.11

2270

25.62

251

2.83

992

11.20

804

9.08

236

2.66

2752

1001

36.37

736

26.74

596

21.66

123

4.47

68

2.47

153

5.56

53

1.93

II

2122

727

34.26

272

12.82

759

35.77

109

5.14

68

3.20

132

6.22

28

1.32

III

2460

400

16.26

47

1.91

710

28.86

12

0.49

485

19.72

304

12.36

99

4.02

IV

1167

49

4.20

12

1.03

178

15.25

0.26

331

28.36

172

14.74

48

4.11

358

207

57.82

1.68

27

7.54

1.12

40

11.17

43

12.01

2.23

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()

8
9

- 554 -

10

353

3.98

250

2.82

95

1.07

21

0.24

22

0.25

11

0.12

20

0.23

77

0.87

0.16

13

0.41

0.00

0.06

0.03

0.00

0.00

0.03

10

0.56

10

0.56

0.06

0.22

0.06

0.00

0.00

0.06

179

7.31

125

5.10

45

1.84

11

0.45

0.33

0.33

0.24

21

0.86

147

12.75

98

8.50

44

3.82

0.26

12

1.04

0.26

14

1.21

53

4.60

12

4.76

1.59

1.98

0.40

0.00

0.00

0.00

0.40

353

3.98

250

2.82

95

1.07

21

0.24

22

0.25

11

0.12

20

0.23

77

0.87

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

5.88

1.96

2.94

0.00

0.00

0.00

0.98

21

20.59

347

5.19

248

3.71

92

1.38

21

0.31

22

0.33

11

0.16

19

0.28

56

0.84

353

3.98

250

2.82

95

1.07

21

0.24

22

0.25

11

0.12

20

0.23

77

0.87

0.18

13

0.47

0.00

0.07

0.04

0.00

0.00

0.04

10

0.47

10

0.47

0.05

0.19

0.05

0.00

0.00

0.05

179

7.28

125

5.08

45

1.83

11

0.45

0.33

0.33

0.24

21

0.85

147

12.60

98

8.40

44

3.77

0.26

12

1.03

0.26

14

1.20

53

4.54

12

3.35

1.12

1.40

0.28

0.00

0.00

0.00

0.28

10

- 555 -


(C220)0~49 1 2

1278

437

34.19

100

7.82

268

20.97

28

2.19

135

10.56

93

7.28

31

2.43

302

151

50.00

68

22.52

50

16.56

13

4.30

0.99

2.65

1.99

II

268

131

48.88

27

10.07

70

26.12

13

4.85

3.36

3.36

1.12

III

423

93

21.99

0.71

113

26.71

0.24

64

15.13

48

11.35

15

3.55

IV

218

15

6.88

0.46

32

14.68

0.46

56

25.69

22

10.09

2.75

67

47

70.15

1.49

4.48

0.00

4.48

8.96

1.49

(C220)50~64 1 2

3207

1033

32.21

375

11.69

796

24.82

87

2.71

279

8.70

225

7.02

69

2.15

977

290

29.68

256

26.20

166

16.99

33

3.38

13

1.33

34

3.48

12

1.23

II

808

311

38.49

95

11.76

290

35.89

44

5.45

15

1.86

34

4.21

10

1.24

III

871

166

19.06

14

1.61

253

29.05

0.80

145

16.65

89

10.22

31

3.56

IV

433

18

4.16

2.08

79

18.24

0.23

101

23.33

57

13.16

13

3.00

118

80

67.80

0.85

6.78

1.69

4.24

11

9.32

2.54

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()

8
9

- 556 -

10

87

6.81

41

3.21

25

1.96

0.23

0.31

0.16

0.23

21

1.64

0.66

0.33

0.00

0.00

0.00

0.00

0.00

0.00

1.49

0.00

0.37

0.37

0.00

0.00

0.00

0.00

39

9.22

22

5.20

12

2.84

0.47

0.47

0.24

0.24

1.65

39

17.89

17

7.80

11

5.05

0.00

0.92

0.46

0.92

13

5.96

4.48

1.49

1.49

0.00

0.00

0.00

0.00

1.49

146

4.55

95

2.96

41

1.28

0.22

0.28

0.19

0.16

34

1.06

0.10

0.31

0.00

0.00

0.10

0.00

0.00

0.00

0.25

0.74

0.00

0.12

0.00

0.00

0.00

0.00

79

9.07

48

5.51

18

2.07

0.46

0.34

0.57

0.11

0.92

60

13.86

38

8.78

19

4.39

0.46

1.15

0.23

0.92

26

6.00

3.39

0.00

3.39

0.00

0.00

0.00

0.00

0.00

10

- 557 -

10


(C220)65 1 2

4374

914

20.90

598

13.67

1206

27.57

136

3.11

578

13.21

486

11.11

136

3.11

1473

392

26.61

412

27.97

380

25.80

77

5.23

52

3.53

111

7.54

35

2.38

II

1046

285

27.25

150

14.34

399

38.15

52

4.97

44

4.21

89

8.51

15

1.43

III

1166

141

12.09

30

2.57

344

29.50

0.34

276

23.67

167

14.32

53

4.55

IV

516

16

3.10

0.39

67

12.98

0.19

174

33.72

93

18.02

29

5.62

173

80

46.24

2.31

16

9.25

1.16

32

18.50

26

15.03

2.31

BCLC(C220) 2

8469

2281

26.93

1052

12.42

2201

25.99

249

2.94

933

11.02

716

8.45

223

2.63

332

135

40.66

122

36.75

47

14.16

15

4.52

0.30

2.41

1.20

2826

1109

39.24

707

25.02

684

24.20

158

5.59

32

1.13

94

3.33

25

0.88

A1

10

70.00

10.00

20.00

0.00

0.00

0.00

0.00

A2

66.67

16.67

16.67

0.00

0.00

0.00

0.00

A3

0.00

0.00

0.00

0.00

0.00

0.00

0.00

A4

13

23.08

0.00

10

76.92

0.00

0.00

0.00

0.00

1992

679

34.09

112

5.62

779

39.11

48

2.41

109

5.47

131

6.58

50

2.51

2364

322

13.62

78

3.30

588

24.87

26

1.10

429

18.15

267

11.29

82

3.47

926

22

2.38

31

3.35

90

9.72

0.22

362

39.09

216

23.33

62

6.70

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 10111214161719 p.563
5 0405 15 p.563
6
7 ()

8
9

- 558 -

120

2.74

114

2.61

29

0.66

11

0.25

0.21

0.07

12

0.27

22

0.50

0.14

0.61

0.00

0.14

0.00

0.00

0.00

0.07

0.38

0.38

0.00

0.19

0.10

0.00

0.00

0.10

61

5.23

55

4.72

15

1.29

0.43

0.26

0.17

0.34

0.51

48

9.30

43

8.33

14

2.71

0.19

0.97

0.19

1.55

14

2.71

2.89

1.73

0.00

0.58

0.00

0.00

0.00

0.00

10

338

3.99

244

2.88

89

1.05

18

0.21

22

0.26

11

0.13

18

0.21

74

0.87

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.07

12

0.42

0.00

0.04

0.00

0.00

0.04

0.04

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

34

1.71

29

1.46

0.30

0.30

0.05

0.15

0.10

0.15

264

11.17

149

6.30

68

2.88

0.17

17

0.72

0.30

10

0.42

53

2.24

38

4.10

54

5.83

15

1.62

0.76

0.43

0.11

0.54

17

1.84

10

- 559 -

10


(C221) 1 2

785

188

23.95

136

17.32

42

5.35

135

17.20

179

22.80

80

10.19

20

2.55

0.64

128

83

64.84

0.78

0.00

24

18.75

10

7.81

4.69

3.13

0.00

II

109

36

33.03

14

12.84

2.75

17

15.60

21

19.27

14

12.84

3.67

0.00

III

49

10.20

13

26.53

6.12

12.24

13

26.53

14.29

4.08

0.00

IV

399

28

7.02

100

25.06

28

7.02

71

17.79

112

28.07

46

11.53

10

2.51

1.00

100

36

36.00

8.00

8.00

17

17.00

23

23.00

7.00

0.00

1.00

785

188

23.95

136

17.32

42

5.35

135

17.20

179

22.80

80

10.19

20

2.55

0.64

73

60

82.19

0.00

0.00

13

17.81

0.00

0.00

0.00

0.00

II

51

43

84.31

0.00

0.00

15.69

0.00

0.00

0.00

0.00

III

19

14

73.68

0.00

0.00

21.05

0.00

5.26

0.00

0.00

IV

103

32

31.07

8.74

1.94

46

44.66

8.74

2.91

0.97

0.97

539

39

7.24

127

23.56

40

7.42

64

11.87

170

31.54

76

14.10

19

3.53

0.74

785

188

23.95

136

17.32

42

5.35

135

17.20

179

22.80

80

10.19

20

2.55

0.64

107

70

65.42

0.93

0.00

16

14.95

10

9.35

5.61

3.74

0.00

II

116

44

37.93

14

12.07

2.59

16

13.79

21

18.10

14

12.07

3.45

0.00

III

58

14

24.14

13

22.41

5.17

10.34

13

22.41

12.07

3.45

0.00

IV

418

34

8.13

100

23.92

28

6.70

84

20.10

112

26.79

46

11.00

10

2.39

0.96

86

26

30.23

9.30

9.30

13

15.12

23

26.74

8.14

0.00

1.16

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 ()

5
6
7

- 560 -


(C221)0~49 1 2

87

29

33.33

24

27.59

3.45

22

25.29

3.45

4.60

2.30

0.00

13

10

76.92

7.69

0.00

15.38

0.00

0.00

0.00

0.00

II

14

57.14

21.43

0.00

14.29

0.00

7.14

0.00

0.00

III

33.33

33.33

0.00

0.00

33.33

0.00

0.00

0.00

IV

50

12.00

19

38.00

4.00

16

32.00

4.00

6.00

4.00

0.00

57.14

0.00

14.29

28.57

0.00

0.00

0.00

0.00

(C221)50~64 1 2

248

61

24.60

59

23.79

12

4.84

66

26.61

29

11.69

17

6.85

1.61

0.00

31

26

83.87

0.00

0.00

12.90

0.00

3.23

0.00

0.00

II

38

16

42.11

15.79

2.63

23.68

5.26

7.89

2.63

0.00

III

23

26.09

30.43

4.35

21.74

8.70

8.70

0.00

0.00

IV

136

5.88

42

30.88

6.62

42

30.88

21

15.44

11

8.09

2.21

0.00

20

25.00

20.00

5.00

30.00

20.00

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 ()

5
6
7

- 561 -


(C221)65 1 2

450

98

21.78

53

11.78

27

6.00

47

10.44

147

32.67

59

13.11

14

3.11

1.11

63

34

53.97

0.00

0.00

10

15.87

10

15.87

7.94

6.35

0.00

II

64

20

31.25

7.81

3.13

7.81

19

29.69

10

15.63

4.69

0.00

III

32

21.88

15.63

6.25

3.13

10

31.25

15.63

6.25

0.00

IV

232

20

8.62

39

16.81

17

7.33

26

11.21

89

38.36

32

13.79

2.16

1.72

59

17

28.81

6.78

10.17

8.47

19

32.20

11.86

0.00

1.69

1 (99 )(AJCC_7th) 1
2

3 1320~2930~353850~5559~6165667590 p.563
4 ()

5
6
7

- 562 -

LIVER AND INTRAHEPATIC BILE DUCTS


C22.0C22.1
(Except for M9727, 9733, 9741-9742, 9764-9809, 9832, 9840-9931, 9945-9946, 9950-9967, 9975-9992)

Codes
00

None; no surgery of primary site; autopsy ONLY

10

Local tumor destruction, NOS


11 Photodynamic therapy (PDT)
12 Electrocautery; fulguration (includes use of hot forceps for tumor destruction)
13 Cryosurgery
14 Laser
15 Transcatheter arterial embolization (TAE)
16 Alcohol (Percutaneous Ethanol Injection-PEI) /acetic acid
17 Heat-Radio-frequency ablation (RFA)
18 Any combination of 15,16 or 17
19 Other (ultrasound)
No specimen sent to pathology from surgical events 1019.

20

Wedge or segmental resection, NOS


21 Wedge resection
22 Segmental resection, NOS
23 One
24 Two
25 Three
26 Segmental resection AND local tumor destruction TAE onl y
27 Segmental resection AND local tumor destruction PEI /acetic acid only
28 Segmental resection AND local tumor destruction RFA only
29 Segmental resection AND local tumor destructions
Specimen sent to pathology from surgical events 2026.

30

Lobectomy, NOS
31 Right lobectomy
32 Left lobectomy
33 Lobectomy AND local tumor destruction TAE only
34 Lobectomy AND local tumor destruction PEI /acetic acid only
35 Lobectomy AND local tumor destruction RFA only
38 Lobectomy AND local tumor destructions

50

Extended lobectomy, NOS (extended: resection of a single lobe plus a segment of another lobe)
51 Extended Right lobectomy
52 Extended Left lobectomy
53 Extended lobectomy AND local tumor destruction TAE only
54 Extended lobectomy AND local tumor destruction PEI /acetic acid only
55 Extended lobectomy AND local tumor destruction RFA only
59 Extended lobectomy AND local tumor destructions

60

Hepatectomy, NOS
61 Total hepatectomy and transplant

65

Excision of a bile duct (for an intra-hepatic bile duct primary only)


66 Excision of a bile duct PLUS partial hepatectomy

75

Bile duct and hepatectomy WITH transplant

90

Surgery, NOS

99

Unknown if surgery performed; death certificate ONLY

- 563 -

- 564 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
1
3
5
29
53
119

0
1
0
0
1
5
22
44
123

0
1
0
1
4
10
51
97
242

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

247
398
593
611
727
849
974
812
408
5829

222
325
442
415
417
483
437
334
237
3508

469
723
1035
1026
1144
1332
1411
1146
645
9337

9337

100.00

9337

100.00

9337

100.00

5
1255
451
1702
5689
235

0.05
13.44
4.83
18.23
60.93
2.52

4
1139
306
369
1207
6312

0.04
12.2
3.28
3.95
12.93
67.6

4
1298
462
1731
5719
123

0.04
13.9
4.95
18.54
61.25
1.32

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

1
0
0
1
0
2

1
860
80
88
6
1035

0
99
149
40
1
289

1
79
49
221
3
353

0
14
11
17
1159
1201

3
1052
289
367
1169
2880

Kappa=0.7475
Kappa

- 565 -


() 1

8263 1154 13.97 748

9.05

81

0.98

371

4.49 2916 35.29 345

4.18 453

5.48

0.00

0.00

0.00

1 25.00

1026 12.42

483

5.85 523

6.33 163

1.97

0.00

0.00

0.00

3 75.00

0.00

0.00

0.00

I 1266

918 72.51

175

13.82

0.63

0.71

36

2.84

39

3.08

11

0.87

0.71

0.55

38

3.00

16

1.26

16

II

441

90 20.41

166

37.64

12

2.72

30

6.80

52 11.79

20

4.54

3.63

1.59

13

2.95

29

6.58

1.36

IIIA

770

49

6.36

172

22.34

13

1.69

90 11.69

173 22.47

43

5.58 109 14.16

38

4.94

20

2.60

50

6.49

13

1.69

IIIB

735

0.82

29

3.95

0.68

36

259 35.24

43

5.85 202 27.48

56

7.62

22

2.99

62

8.44

15

2.04

IV 4951

59

1.19

197

3.98

43

0.87

201

914 18.46

406

6.48 109

2.20

29 30.21

9.38

0.00

96

4.90

4.06 2391 48.29 198

4.00 112

2.26

5.21

2.08

3.13

4.17

2.08

8.20 321

15 15.63

23 23.96

4.17

() 0~49 1

104

13.13

0.88

71

8.96

0.00

0.00

0.00

0.00

792

156

124 79.49

26

16.67

0.64

0.64

II

38

5 13.16

23

60.53

2.63

IIIA

52

3.85

18

34.62

IIIB

80

1.25

7.50

IV

449

1.34

28

17

8 47.06

146 18.43

233 29.42

1.14

60

7.58

0.00

0.00

0.00

0.00

0.00

0.64

7 18.42

0.00

0.00

3.85

13 25.00

5.77

1.25

8 10.00

20 25.00

6.24

0.45

42

9.35

209 46.55

17.65

0.00

0.00

5.88

122 15.40

13

1.64

24

3.03

0.38

0.00

0.00

0.00

0.00

0.00

0.00

1.92

0.00

0.00

0.00

0.00

5.26

0.00

0.00

11 21.15

1.92

0.00

3.85

0.00

3.75

33 41.25

6.25

0.00

3.75

0.00

1.34

14

3.12

116 25.84

12

2.67

11

2.45

0.67

0.00

5.88

5.88

3 17.65

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 566 -


() 50~69 1

3460 596 17.23 448 12.95

25

0.72

221

6.39 1162 33.58

86

2.49 210

6.07

501 14.48

60

1.73 116

3.35

35

1.01

3 75.00

0.00

0.00

0.00

1 25.00

0.00

0.00

0.00

0.00

0.00

0.00

627

502 80.06

99

15.79

0.48

0.32

0.80

0.64

0.48

0.64

0.00

0.64

0.16

II

202

38 18.81

110

54.46

2.48

17

8.42

12

5.94

1.49

2.48

0.50

0.99

3.96

0.50

IIIA

330

19

5.76

114

34.55

1.52

69 20.91

51 15.45

1.52

49 14.85

10

3.03

0.30

1.82

0.30

IIIB

271

0.37

15

5.54

0.37

19

92 33.95

2.58 102 37.64

16

5.90

0.37

15

5.54

0.74

IV 1993

23

1.15

105

5.27

11

0.55

111

5.57 1000 50.18

67

3.36

49

2.46

468 23.48

54

2.71

76

3.81

29

1.46

10 30.30

15.15

0.00

0.00

6.06

6.06

7 21.21

3.03

33

7.01

9.09

3.03

6.06

() 70 1

4011

412 10.27

196

4.89

49

1.22

79

0.00

0.00

0.00

403 10.05

1.97 1521 37.92 250

6.23 183

4.56

0.00

0.00

0.00

0.00

0.00

0.00

410 10.22 383

9.55 125

3.12

0.00

0.00

483

292 60.46

50

10.35

0.83

1.24

31

6.42

35

7.25

1.45

1.04

1.45

31

6.42

15

3.11

II

201

47 23.38

33

16.42

2.99

2.99

40 19.90

17

8.46

11

5.47

2.99

11

5.47

19

9.45

2.49

IIIA

388

28

7.22

40

10.31

1.55

2.06

119 30.67

38

9.79

49 12.63

27

6.96

19

4.90

42 10.82

12

3.09

IIIB

384

1.04

2.08

0.78

2.34

147 38.28

33

8.59

67 17.45

35

9.11

21

5.47

44 11.46

13

3.39

IV 2509

30

1.20

64

2.55

30

1.20

48

1.91 1182 47.11 125

4.98

49

1.95

9.33

77

3.07

11 23.91

2.17

0.00

4.35

4.35

0.00

13 28.26

6.52

46

4.35

330 13.15
0

0.00

340 13.55 234


12 26.09

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 567 -


()

490

1.22

11

2.24

0.61

23

4.69

191

38.98

25

5.10

71

14.49

87

17.76

31

6.33

31

6.33

11

2.24

331

1.21

1.51

0.91

16

4.83

149

45.02

16

4.83

14

4.23

66

19.94

26

7.85

24

7.25

2.42

159

1.26

3.77

0.00

4.40

42

26.42

5.66

57

35.85

21

13.21

3.14

4.40

1.89

1
2 ()

3
4

- 568 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
0
0
1

0
0
0
1
16
82
251
538
1193

0
0
0
1
16
82
251
538
1194

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

0
9
5
1
1
5
6
2
4
34

1947
1837
1535
946
717
492
273
162
100
10090

1947
1846
1540
947
718
497
279
164
104
10124

10124

100.00

10124

100.00

10124

100.00

1350
2976
3569
780
573
876

13.33
29.4
35.25
7.7
5.66
8.65

1481
3168
3037
1296
296
846

14.63
31.29
30
12.8
2.92
8.36

1522
3169
3210
1485
605
133

15.03
31.3
31.71
14.67
5.98
1.31

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

972
155
63
4
0
1194

268
1983
612
43
1
2907

40
614
2033
163
5
2855

8
105
661
437
2
1213

0
2
19
13
257
291

1288
2859
3388
660
265
8460

Kappa=0.5407
Kappa

- 569 -

10124

1582

15.63

1604

15.84

1030

10.17

2084

20.58

857

8.47

1106

10.92

238

2.35

1522

512

33.64

0.59

359

23.59

0.39

449

29.50

0.59

120

7.88

IA

3069

694

22.61

483

15.74

515

16.78

504

16.42

242

7.89

270

8.80

92

3.00

IB

100

10

10.00

27

27.00

8.00

37

37.00

2.00

7.00

0.00

II

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

IIA

2163

218

10.08

582

26.91

86

3.98

525

24.27

80

3.70

364

16.83

14

0.65

IIB

1046

64

6.12

252

24.09

26

2.49

313

29.92

24

2.29

175

16.73

0.48

III

1485

51

3.43

168

11.31

23

1.55

623

41.95

21

1.41

205

13.80

0.27

IV

605

1.16

63

10.41

0.66

67

11.07

1.49

67

11.07

0.00

133

26

19.55

19

14.29

6.77

6.77

30

22.56

6.77

2.26

0~34 1

350

30

8.57

52

14.86

33

9.43

99

28.29

28

8.00

18

5.14

12

3.43

46

10

21.74

0.00

12

26.09

0.00

15

32.61

0.00

15.22

IA

116

17

14.66

13

11.21

15

12.93

34

29.31

7.76

3.45

4.31

IB

0.00

0.00

0.00

25.00

25.00

25.00

0.00

II

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIA

77

2.60

22

28.57

5.19

22

28.57

0.00

9.09

0.00

IIB

43

0.00

10

23.26

2.33

16

37.21

0.00

6.98

0.00

III

43

2.33

6.98

0.00

24

55.81

0.00

6.98

0.00

IV

17

0.00

23.53

0.00

11.76

0.00

0.00

0.00

0.00

0.00

25.00

0.00

75.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2

- 570 -

910

8.99

228

2.25

32

0.32

97

0.96

14

0.14

217

2.14

30

0.30

95

0.94

0.39

0.00

0.13

0.00

0.00

44

2.89

0.13

0.26

193

6.29

0.07

0.03

0.00

0.00

58

1.89

0.16

10

0.33

9.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

209

9.66

0.14

0.14

0.05

0.00

49

2.27

0.37

21

0.97

143

13.67

0.76

0.00

0.10

0.00

21

2.01

0.48

0.86

312

21.01

28

1.89

0.27

11

0.74

0.00

13

0.88

0.27

18

1.21

33

5.45

187

30.91

21

3.47

84

13.88

13

2.15

15

2.48

0.83

30

4.96

3.76

0.00

0.75

0.00

0.75

17

12.78

0.75

2.26

59

16.86

1.43

0.00

1.43

0.00

2.57

0.00

0.00

0.00

0.00

0.00

0.00

0.00

4.35

0.00

0.00

15

12.93

0.00

0.00

0.00

0.00

3.45

0.00

0.00

25.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

18

23.38

0.00

0.00

0.00

0.00

2.60

0.00

0.00

12

27.91

0.00

0.00

0.00

0.00

2.33

0.00

0.00

12

27.91

0.00

0.00

0.00

0.00

0.00

0.00

0.00

5.88

29.41

0.00

29.41

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3 ()

4
5

- 571 -


35~49 1

3679

450

12.23

599

186

31.05

IA

1180

206

17.46

IB

47

8.51

II

IIA

748

IIB

383

III

635

971

26.39

259

7.04

324

8.81

94

2.56

17.26

408

11.09

0.83

172

28.71

0.33

151

25.21

0.33

56

9.35

208

17.63

193

16.36

264

22.37

75

6.36

94

7.97

28

2.37

13

27.66

4.26

25

53.19

0.00

2.13

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

32

4.28

226

30.21

28

3.74

239

31.95

19

2.54

96

12.83

0.94

1.83

98

25.59

1.57

158

41.25

0.26

52

13.58

0.26

502

1.00

54

10.76

0.20

255

50.80

0.80

63

12.55

0.20

IV

176

0.57

23

13.07

1.14

24

13.64

1.70

13

7.39

0.00

44

20.45

18.18

9.09

9.09

13.64

6.82

2.27

50~69 1

5051

723

14.31

833

16.49

503

9.96

955

761

267

35.09

0.53

166

21.81

IA

1513

335

22.14

247

16.33

276

IB

42

7.14

12

28.57

18.91

426

8.43

674

0.53

237

31.14

18.24

197

13.02

118

11.90

11

26.19

13.34

118

2.34

0.66

53

6.96

7.80

165

10.91

56

3.70

2.38

9.52

0.00

II

0.00

0.00

0.00

0.00

0.00

0.00

IIA

1070

73

6.82

305

28.50

36

3.36

251

23.46

33

3.08

232

21.68

0.37

IIB

509

18

3.54

131

25.74

1.77

131

25.74

13

2.55

108

21.22

0.39

III

767

15

1.96

88

11.47

0.91

321

41.85

0.91

109

14.21

0.26

IV

328

0.91

34

10.37

0.00

37

11.28

1.22

46

14.02

0.00

60

15.00

11

18.33

6.67

5.00

13

21.67

8.33

1.67

1 100.00

1 (99 )(AJCC_7th) 1
2

- 572 -

1.96

0.24

25

0.68

0.08

81

2.20

10

0.27

0.24

0.50

0.00

0.00

0.00

0.00

20

3.34

0.17

0.17

86

7.29

0.00

0.00

0.00

0.00

23

1.95

0.08

0.17

4.26

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

81

10.83

0.00

0.00

0.00

0.00

15

2.01

0.40

0.27

52

13.58

0.26

0.00

0.00

0.00

1.57

0.26

0.00

96

19.12

12

2.39

0.00

0.60

0.00

1.20

0.20

0.20

3.98

59

33.52

5.11

22

12.50

1.70

3.41

1.14

1.14

4.55

0.00

0.00

0.00

0.00

11.36

2.27

2.27

491

9.72

125

2.47

12

0.24

53

1.05

0.12

97

1.92

12

0.24

23

0.46

0.26

0.00

0.00

0.00

0.00

20

2.63

0.13

0.26

89

5.88

0.13

0.07

0.00

0.00

23

1.52

0.20

0.07

14.29

0.00

0.00

0.00

0.00

0.00

0.00

0.00

72

8.94

329

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

106

9.91

0.19

0.09

0.00

0.00

19

1.78

0.28

0.47

74

14.54

0.79

0.00

0.20

0.00

11

2.16

0.79

0.59

188

24.51

12

1.56

0.13

0.91

0.00

0.91

0.00

0.39

23

7.01

105

32.01

2.44

45

13.72

1.52

2.74

0.30

2.44

5.00

0.00

1.67

0.00

1.67

13.33

0.00

1.67

3 ()

4
5

- 573 -


70 1

1044

379

36.30

84

8.05

86

8.24

59

5.65

144

13.79

90

8.62

14

1.34

116

49

42.24

0.00

7.76

0.00

46

39.66

1.72

3.45

IA

260

136

52.31

15

5.77

31

11.92

3.46

40

15.38

2.69

1.15

IB

42.86

28.57

14.29

0.00

0.00

14.29

0.00

II

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIA

268

111

41.42

29

10.82

18

6.72

13

4.85

28

10.45

29

10.82

1.12

IIB

111

39

35.14

13

11.71

10

9.01

7.21

10

9.01

12

10.81

1.80

III

173

30

17.34

23

13.29

15

8.67

23

13.29

10

5.78

30

17.34

0.58

IV

84

3.57

2.38

2.38

4.76

2.38

9.52

0.00

25

32.00

0.00

0.00

8.00

32.00

4.00

4.00

1 (99 )(AJCC_7th) 1
2

- 574 -

31

2.97

26

2.49

11

1.05

14

1.34

0.48

30

2.87

0.77

63

6.03

0.86

0.00

1.72

0.00

0.00

1.72

0.00

0.86

0.38

2.69

1.15

0.00

0.00

0.00

0.00

3.08

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1.49

0.37

0.75

0.37

0.00

13

4.85

0.75

14

5.22

4.50

2.70

0.00

0.00

0.00

2.70

0.00

5.41

16

9.25

2.31

1.73

0.58

0.00

0.00

1.73

14

8.09

2.38

18

21.43

4.76

12

14.29

5.95

0.00

2.38

20

23.81

0.00

0.00

0.00

0.00

0.00

16.00

0.00

4.00

3 ()

4
5

- 575 -

- 576 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
0
0
0

0
0
0
1
48
159
444
469
530

0
0
0
1
48
159
444
469
530

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

0
0
0
0
0
0
0
0
0
0

546
489
426
297
270
214
168
113
66
4240

546
489
426
297
270
214
168
113
66
4240

FIGO
FIGO

4240

100.00

0
I
I A
IA1
IA2
I B
IB1
IB2
I I
IIA
IIB
III
IIIA
IIIB
IVA
IVB

2664
5
21
156
15
40
427
93
5
126
236
6
18
142
53
95
138

62.83
0.12
0.5
3.68
0.35
0.94
10.07
2.19
0.12
2.97
5.57
0.14
0.42
3.35
1.25
2.24
3.25

:- 99 FIGO 2

- 577 -

4240

100.00

4240

100.00

4240

100.00

2371
582
280
231
192
584

55.92
13.73
6.6
5.45
4.53
13.77

2646
519
79
122
60
814

62.41
12.24
1.86
2.88
1.42
19.2

2753
590
290
297
210
100

64.93
13.92
6.84
7
4.95
2.36

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

2177
7
1
0
0
2185

58
379
25
6
0
468

4
35
27
6
1
73

1
51
25
32
0
109

0
7
1
9
40
57

2240
479
79
53
41
2892

Kappa=0.7879
Kappa

- 578 -


FIGO 1

4240

3114

73.44 49

1.16

104

2.45

240

5.66

22

0.52

157

3.70

374

8.82

15

0.35

122

2.88

43

1.01

0 2664

2645

99.29

0.00

0.15

0.00

0.00

0.00

0.00

0.00

15

0.56

0.00

80.00

0.00

0.00

0.00

0.00

0.00

0.00

1 20.00

0.00

0.00

IA

21

18

85.71

0.00

9.52

0.00

0.00

0.00

0.00

0.00

0.00

4.76

IA1

156

147

94.23

0.00

1.92

2.56

0.00

0.64

0.00

0.00

0.00

0.64

IA2

15

11

73.33

0.00

3 20.00

6.67

0.00

0.00

0.00

0.00

0.00

0.00

IB

40

18

45.00

5.00

7.50

7 17.50

0.00

5 12.50

2.50

0.00

2.50

7.50

IB1

427

211

49.41 19

4.45

56 13.11

89 20.84

0.00

35

8.20

12

2.81

0.00

1.17

0.00

IB2

93

9.68 13

13.98

11 11.83

33 35.48

2.15

2.15

20 21.51

0.00

3.23

0.00

II

20.00

0.00

1 20.00

1 20.00

0.00

1 20.00

1 20.00

0.00

0.00

IIA

126

16

12.70

4.76

4.76

35 27.78

1.59

24 19.05

33 26.19

0.00

3.17

0.00

IIB

236

0.42

1.27

2.54

37 15.68

0.42

37 15.68

146 61.86

0.42

1.69

0.00

III

83.33

0.00

0.00

0.00

0.00

0.00

1 16.67

0.00

0.00

0.00

IIIA

18

11.11

0.00

0.00

5.56

0.00

5 27.78

8 44.44

0.00

11.11

0.00

IIIB

142

2.11

1.41

1.41

20 14.08

2.11

20 14.08

85 59.86

0.00

3.52

1.41

IVA

53

9.43

0.00

5.66

7.55

0.00

15 28.30

21 39.62

5.66

3.77

0.00

IVB

95

2.11

3.16

3.16

7.37

14 14.74

10 10.53

45 47.37

6.32

1.05

4.21

138

16

11.59

0.72

0.72

0.72

2.17

0.00

1.45

0.00

1.45

80 57.97

32 23.19

1 99 FIGO 2
2
3 ()

4
5

- 579 -


0~29 FIGO 1

208

189

90.87

1.44

0.00

1.92

0.00

0.00

0.48

0.00

4.33

0.96

184

183

99.46

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.54

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA1

2 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA2

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IB

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IB1

60.00

0.00

0.00

40.00

0.00

0.00

0.00

0.00

0.00

0.00

IB2

0.00

2 100.0

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIA

0.00

1 100.0

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIB

50.00

0.0

0.00

0.00

0.00

0.00

50.00

0.00

0.00

0.00

III

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIA

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIB

0.00

0.00

0.00

100.00

0.00

0.00

0.00

0.00

0.00

0.00

IVA

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IVB

0.00

0.00

0.00

100.00

0.00

0.00

0.00

0.00

0.00

0.00

10

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

8 80.00

20.00

1 99 FIGO 2
2
3 ()

4
5

- 580 -


30~49 FIGO 1

1989

1701

85.52

23

1.16

24

1.21

94

4.73

0.40

0 1479

1471

99.46

0.00

0.07

0.00

0.40

83

4.17

0.00

0.00

0.05

36

1.81

11

0.55

0.00

0.00

0.47

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA

88.89

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

11.11

IA1

85

84

98.82

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1.18

IA2

6 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IB

12

66.67

8.33

8.33

16.67

0.00

0.00

0.00

0.00

0.00

0.00

IB1

159

95

59.75

4.40

15

9.43

34

21.38

0.00

3.14

0.63

0.00

1.26

0.00

IB2

41

12.20

17.07

4.88

18

43.90

2.44

0.00

19.51

0.00

0.00

0.00

II

50.00

0.00

0.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

IIA

25

28.00

12.00

4.00

11

44.00

0.00

0.00

8.00

0.00

4.00

0.00

IIB

52

0.00

3.85

3.85

15

28.85

1.92

0.00

32

61.54

0.00

0.00

0.00

III

5 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIA

25.00

0.00

0.00

25.00

0.00

0.00

50.00

0.00

0.00

0.00

IIIB

32

0.00

3.13

3.13

25.00

3.13

3.13

20

62.50

0.00

0.00

0.00

IVA

11.11

0.00

0.00

22.22

0.00

11.11

55.56

0.00

0.00

0.00

IVB

26

3.85

3.85

3.85

7.69

19.23

3.85

13

50.00

3.85

3.85

0.00

42

16.67

2.38

0.00

0.00

0.00

0.00

0.00

0.00

25

59.52

21.43

1 99 FIGO 2
2
3 ()

4
5

- 581 -


50~69 FIGO 1

1482

982

66.26

20

1.35

54

3.64

125

8.43

0.61

37

2.50

205

13.83

0.13

35

2.36

13

0.88

799

792

99.12

0.00

0.13

0.00

0.00

0.00

0.00

0.00

0.75

0.00

3 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA

10

90.00

0.00

10.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA1

60

53

88.33

0.00

5.00

5.00

0.00

1.67

0.00

0.00

0.00

0.00

IA2

55.56

0.00

33.33

11.11

0.00

0.00

0.00

0.00

0.00

0.00

IB

16

43.75

6.25

12.50

12.50

0.00

6.25

6.25

0.00

0.00

12.50

IB1

206

95

46.12

11

5.34

29

14.08

50

24.27

0.00

13

6.31

2.43

0.00

1.46

0.00

IB2

36

8.33

11.11

19.44

13

36.11

2.78

0.00

22.22

0.00

0.00

0.00

II

0.00

0.00

0.00

0.00

0.00

100.0

0.00

0.00

0.00

0.00

IIA

56

12.50

3.57

3.57

20

35.71

1.79

8.93

19

33.93

0.00

0.00

0.00

IIB

121

0.00

0.00

2.48

19

15.70

0.00

5.79

90

74.38

0.00

1.65

0.00

III

0.00

0.00

0.00

0.00

0.00

0.00

100.0

0.00

0.00

0.00

IIIA

0.00

0.00

0.00

0.00

0.00

0.00

80.00

0.00

20.00

0.00

IIIB

70

1.43

1.43

1.43

10

14.29

1.43

5.71

50

71.43

0.00

2.86

0.00

IVA

12

8.33

0.00

0.00

16.67

0.00

16.67

58.33

0.00

0.00

0.00

IVB

37

0.00

2.70

2.70

10.81

16.22

8.11

20

54.05

2.70

0.00

2.70

40

15.00

0.00

2.50

2.50

0.00

0.00

0.00

2.50

21

52.50

10

25.00

1 99 FIGO 2
2
3 ()

4
5

- 582 -


70 FIGO 1

561

242

43.14

0.53

26

4.63

17

3.03

0.89

112

19.96

202

199

98.51

0.00

0.99

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA

50.00

0.00

1 50.00

0.00

0.00

IA1

88.89

0.00

0.00

11.11

0.00

IA2

0.00

0.00

0.00

0.00

IB

12

25.00

0.00

0.00

3 25.00

IB1

57

18

31.58

1.75

12 21.05

IB2

14

7.14

0.00

II

0.00

IIA

44

4.55

IIB

61

III

IIIA

85 15.15

12

2.14

42

7.49

17

3.03

0.00

0.00

0.50

0.00

0.00

1 100.0

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

33.33

0.00

0.00

8.33

8.33

5.26

0.00

17

29.82

6 10.53

0.00

0.00

0.00

2 14.29

2 14.29

0.00

14.29

4 28.57

0.00

3 21.43

0.00

0.00

1 50.00

0.00

0.00

0.00

1 50.00

0.00

0.00

0.00

6.82

9.09

2.27

19

43.18

12 27.27

0.00

6.82

0.00

0.00

1.64

1.64

4.92

0.00

30

49.18

23 37.70

1.64

3.28

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

11.11

0.00

0.00

0.00

0.00

55.56

2 22.22

0.00

1 11.11

0.00

IIIB

39

5.13

0.00

0.00

2.56

2.56

15

38.46

15 38.46

0.00

7.69

5.13

IVA

32

9.38

0.00

9.38

0.00

0.00

12

37.50

9 28.13

9.38

6.25

0.00

IVB

31

3.23

3.23

3.23

0.00

9.68

19.35

12 38.71

4 12.90

0.00

9.68

46

6.52

0.00

0.00

0.00

0.00

4.35

0.00

4.35

4.35

26 56.52

11 23.91

1 99 FIGO 2
2
3 ()

4
5

- 583 -

4240

3114

73.44

49

1.16

104

2.45

240

5.66

22

0.52

157

3.70

374

8.82

0 2753

2641

95.93

0.00

0.15

0.00

0.00

0.07

7.12

22

15

0.35

122

2.88

43

1.01

0.00

0.00

81

2.94

25

0.91

3.73

0.17

1.53

0.34

590

378

64.07

16

2.71

62 10.51

56

9.49

0.34

42

II

290

20

6.90

2.07

16

5.52

59 20.34

0.69

54 18.62

127 43.79

0.00

2.07

0.00

III

297

14

4.71

20

6.73

10

3.37

86 28.96

1.01

28

9.43

130 43.77

0.00

1.68

0.34

IV

210

10

4.76

2.86

2.86

31 14.76

15

7.14

30 14.29

92 43.81

10

4.76

2.38

2.38

100

51

51.00

1.00

6.00

0.00

4.00

8.00

1.00

3.00

16 16.00

10 10.00

0~29 1

208

189

90.87

1.44

0.00

1.92

0.00

0.00

0.48

0.00

4.33

0.96

192

182

94.79

0.00

0.00

0.00

0.00

0.00

0.00

0.00

4.17

1.04

62.50

2 25.00

0.00

12.50

0.00

0.00

0.00

0.00

0.00

0.00

II

50.00

1 50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

III

0.00

0.00

0.00

100.00

0.00

0.00

0.00

0.00

0.00

0.00

IV

0.00

0.00

0.00

50.00

0.00

0.00

50.00

0.00

0.00

0.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1 50.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 584 -


30~49 1

1989

1701

85.52

23

1.16

24

1.21

94

4.73

0.40

0 1510

1471

97.42

0.00

0.07

0.00

0.40

83

4.17

0.00

0.00

0.05

36

1.81

11

0.55

0.00

0.00

30

1.99

0.53

246

185

75.20

3.66

16

6.50

24

9.76

0.41

2.03

0.81

0.00

0.81

0.81

II

56

14.29

7.14

5.36

16

28.57

1.79

0.00

24

42.86

0.00

0.00

0.00

III

91

7.69

7.69

3.30

38

41.76

1.10

1.10

34

37.36

0.00

0.00

0.00

IV

49

4.08

4.08

2.04

13

26.53

10.20

4.08

22

44.90

2.04

2.04

0.00

37

28

75.68

2.70

0.00

8.11

0.00

0.00

2.70

0.00

8.11

2.70

50~69 1

1482

982

66.26

20

1.35

54

3.64

125

8.43

0.61

37

2.50

205

13.83

0.13

35

2.36

13

0.88

819

78

9.52

0.00

0.12

0.00

0.00

0.00

0.00

0.00

21

2.56

0.98

255

161

63.14

1.96

34

13.33

27

10.59

0.39

14

5.49

10

3.92

0.00

1.18

0.00

II

143

6.29

0.70

10

6.99

35

24.48

0.70

11

7.69

74

51.75

0.00

1.40

0.00

III

147

2.72

11

7.48

2.04

43

29.25

0.68

4.08

78

53.06

0.00

0.68

0.00

IV

78

1.28

3.85

1.28

16

20.51

7.69

7.69

41

52.56

1.28

2.56

1.28

40

18

45.00

0.00

12.50

10.00

0.00

0.00

5.00

2.50

15.00

10.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 585 -


70 1

561

242

43.14

0.53

26

4.63

17

3.03

0.89

112

19.96

232

199

85.78

0.00

0.86

0.00

0.00

0.86

81

27

33.33

0.00

12 14.81

4.94

0.00

23

II

89

2.25

0.00

3.37

8.99

0.00

III

57

5.26

3.51

7.02

5.26

IV

81

8.64

1.23

4.94

1.23

21

19.05

0.00

4.76

4.76

85 15.15

12

2.14

42

7.49

17

3.03

0.00

0.00

22

9.48

3.02

28.40

10 12.35

1.23

4.94

0.00

43

48.31

29 32.58

0.00

4.49

0.00

1.75

21

36.84

18 31.58

0.00

7.02

1.75

4.94

22

27.16

28 34.57

9.88

2.47

4.94

0.00

4.76

0.00

3 14.29

6 28.57

5 23.81

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 586 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
0
0
0

0
0
0
0
2
20
45
59
123

0
0
0
0
2
20
45
59
123

0
0
0
0
0
0
0
0
0
0

243
333
314
169
119
66
45
18
8
1564

243
333
314
169
119
66
45
18
8
1564

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

1564

100.00

1564

100.00

1564

100.00

5
710
75
92
79
603

0.32
45.4
4.8
5.88
5.05
38.55

5
1059
94
189
81
136

0.32
67.71
6.01
12.08
5.18
8.7

5
1084
100
196
104
75

0.32
69.31
6.39
12.53
6.65
4.8

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

2
0
0
0
0
2

2
605
27
16
4
654

1
22
34
5
0
62

0
38
8
63
4
113

0
8
0
2
49
59

5
673
69
86
57
890

Kappa=0.6356
Kappa

- 587 -

1564 865

55.31

100.0

0.00

I 1084 767

70.76

79

II

100

18

18.00

III

196

19

IV

104

75

182 11.64

274 17.52

162 10.36

11

0.70

10

0.64

0.58

0.38

23

1.47

9 0.58

13

0.83

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

7.29

181 16.70

28

2.58

0.00

0.55

0.00

0.09

0.65

2 0.18

13

1.20

6.00

53 53.00

17 17.00

0.00

2.00

1.00

0.00

2.00

1 1.00

0.00

9.69

58 29.59

26 13.27

87 44.39

1.02

0.00

1.53

0.51

0.00

0 0.00

0.00

17

16.35

31 29.81

29 27.88

6.73

0.96

4.81

2.88

2.88

3 2.88

0.00

39

52.00

8 10.67

2.67

1.33

0.00

1.33

11 14.67

3 4.00

0.00

4.81

9 12.00

1.33

0~39 1

126

69

54.76

0.00

0.00

86

61

70.93

II

14.29

III

13

IV

12

18 14.29

18 14.29

5.56

0.00

0.00

0.00

0.00

1.59

0.79

11

8.73

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

5.81

9 10.47

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

5 71.43

1 14.29

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

6 46.15

3 23.08

4 30.77

0.00

0.00

0.00

0.00

0.00

0.00

0.00

25.00

3 37.50

0.00

2 25.00

0.00

0.00

0.00

0.00

0.00

1 12.50

0.00

41.67

4 33.33

8.33

0.00

0.00

0.00

0.00

2 16.67

0 0.00

0.00

0.00

11 12.79

1 (99 )(AJCC_7th) 1
2
3 ()

4
5
6

- 588 -


40~59 1

1013 593

58.54

100.0

0.00

716

532

74.30

57

II

68

13

19.12

III

129

IV

51

44

116 11.45

164 16.19

110 10.86

0.49

0.30

0.39

0.10

11

1.09

5 0.49

0.10

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

7.96

100 13.97

18

2.51

0.00

0.28

0.00

0.00

0.56

2 0.28

0.14

5.88

38 55.88

12 17.65

0.00

0.00

0.00

0.00

0.00

1 1.47

0.00

6.20

37 28.68

18 13.95

63 48.84

0.00

0.00

2.33

0.00

0.00

0 0.00

0.00

15.69

15 29.41

16 31.37

7.84

1.96

1.96

1.96

1.96

1 1.96

0.00

27

61.36

2.27

0.00

0.00

0.00

6 13.64

1 2.27

0.00

6.82

5.88

5 11.36

2.27

60 1

425

203

47.76

0.00

0.00

282

174

61.70

17

II

25

16.00

III

54

11

20.37

15 27.78

IV

45

15.56

13 28.89

19

36.84

48 11.29

92 21.65

45 10.59

1.41

1.65

1.18

1.18

10

2.35 3

0.71

0.24

0.00

0.00

0.00

0.00

0.00

0.00

0.00 0

0.00

0.00

6.03

72 25.53

10

3.55

0.00

1.42

0.00

0.35

1.06 0

0.00

0.35

8.00

10 40.00

4 16.00

0.00

8.00

4.00

0.00

8.00 0

0.00

0.00

9.26

20 37.04

3.70

0.00

0.00

1.85

0.00 0

0.00

0.00

4.44

11 24.44

6.67

0.00

8.89

4.44

4.44 1

2.22

0.00

5.26

5.26

0.00

5.26

3 15.79 2

10.53

0.00

5.26

3 15.79

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5
6

- 589 -


FIGO 1

1564 865

55.31

182

11.64

274 17.52

162

10.36

11

0.70

10

0.64

0.58

0.38

23

1.47

9 0.58

13

0.83

718 434

60.45

75

10.45

133 18.52

70

9.75

0.28

0.14

0.28

0.00

0.14

0 0.00

0.00

0.00

16.67

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

83.33

0.00

IA

119

85

71.43

11

9.24

20 16.81

1.68

0.00

0.00

0.00

0.00

0.84

0 0.00

0.00

IB

64

23

35.94

6.25

27 42.19

10

15.63

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IC

14

35.71

14.29

5 35.71

14.29

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

II

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IIA

0.00

33.33

1 33.33

33.33

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IIB

100.0
1
0

III

11

9.09

27.27

0.00

54.55

0.00

0.00

9.09

0.00

0.00

0 0.00

0.00

IIIA

16.67

33.33

0.00

50.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IIIB

33.33

0.00

0.00

66.67

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IIIC

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IV

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

IVB

0.00

50.00

0.00

50.00

0.00

0.00

0.00

0.00

0.00

0 0.00

0.00

614 310

50.49

80

13.03

87 14.17

64

10.42

1.47

1.47

0.98

0.98

21

3.42

9 1.47

13

2.12

1 FIGO - 99 FIGO 3
2
3 ()

4
5
6

- 590 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
0
0
0

0
2
10
11
31
28
42
87
108

0
2
10
11
31
28
42
87
108

0
0
0
0
0
0
0
0
0
0

169
162
164
90
67
65
40
25
6
1107

169
162
164
90
67
65
40
25
6
1107

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

1107

100.00

1107

100.00

1107

100.00

0
204
43
264
141
455

0.00
18.43
3.88
23.85
12.74
41.1

0
403
81
366
132
125

0.00
36.4
7.32
33.06
11.92
11.29

0
402
82
386
163
74

0.00
36.31
7.41
34.87
14.72
6.68

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

0
0
0
0
0
0

0
173
8
12
1
194

0
5
29
7
1
42

0
13
4
204
3
224

0
0
0
12
103
115

0
191
41
235
108
575

Kappa=0.8327
Kappa

- 591 -

1107

220

19.87

801

72.36

0.00

20

1.81

42

3.79

0.27

13

1.17

0.54

0.18

402

140

34.83

260

64.68

0.00

0.50

0.00

0.00

0.00

0.00

0.00

II

82

10.98

71

86.59

0.00

1.22

0.00

0.00

1.22

0.00

0.00

III

386

21

5.44

339

87.82

0.00

1.81

12

3.11

0.00

1.55

0.26

0.00

IV

163

11

6.75

102

62.58

0.00

5.52

29

17.79

1.84

3.68

1.23

0.61

74

39

52.70

29

39.19

0.00

1.35

1.35

0.00

0.00

4.05

1.35

0~39 1

211

71

33.65

138

65.40

0.00

0.47

0.47

0.00

0.00

0.00

0.00

110

45

40.91

65

59.09

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

10

0.00

10 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

III

51

9.80

44

86.27

0.00

1.96

1.96

0.00

0.00

0.00

0.00

IV

12

8.33

11

91.67

0.00

0.00

0.00

0.00

0.00

0.00

0.00

28

20

71.43

28.57

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 592 -


40~59 1

603

98

16.25

472

78.28

0.00

16

2.65

1.00

0.50

0.50

0.50

0.33

235

69

29.36

164

69.79

0.00

0.85

0.00

0.00

0.00

0.00

0.00

II

47

14.89

40

85.11

0.00

0.00

0.00

0.00

0.00

0.00

0.00

III

211

3.79

196

92.89

0.00

2.37

0.47

0.00

0.47

0.00

0.00

IV

78

3.85

57

73.08

0.00

10.26

5.13

3.85

2.56

0.00

1.28

32

11

34.38

15

46.88

0.00

3.13

3.13

0.00

0.00

9.38

3.13

60 1

293

51

17.41

191

65.19

0.00

1.02

35

11.95

0.00

10

3.41

1.02

0.00

57

26

45.61

31

54.39

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

25

8.00

21

84.00

0.00

4.00

0.00

0.00

4.00

0.00

0.00

III

124

6.45

99

79.84

0.00

0.81

10

8.06

0.00

4.03

0.81

0.00

IV

73

9.59

34

46.58

0.00

1.37

25

34.25

0.00

5.48

2.74

0.00

14

57.14

42.86

0.00

0.00

0.00

0.00

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2
3 ()

4
5

- 593 -


FIGO 1

1107

220

19.87

801

72.36

0.00

20

1.81

42

3.79

0.27

13

1.17

0.54

0.18

478

100

20.92

364

76.15

0.00

1.67

0.63

0.00

0.63

0.00

0.00

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IA

36

16

44.44

20

55.56

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IB

50.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IC

22

0.00

22 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

II

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIA

40.00

60.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIB

0.00

5 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIC

0.00

5 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

III

50.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIA

22.22

77.78

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIB

0.00

6 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

IIIC

45

4.44

91.11

0.00

2.22

2.22

0.00

0.00

0.00

0.00

IV

0.00

8 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

482

96

19.92

0.00

11

2.28

38

7.88

0.62

10

2.07

1.24

0.41

316

65.56

41

1 FIGO - 99 FIGO 3
2
3 ()

4
5

- 594 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
0
0
0
0
0
0
4

0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
4

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

18
67
192
344
551
756
766
681
340
3719

0
0
0
0
0
0
0
0
0
0

18
67
192
344
551
756
766
681
340
3719

3719

100.00

3719

100.00

3719

100.00

0
393
1421
481
1233
191

0.00
10.57
38.21
12.93
33.15
5.14

0
30
304
200
134
3051

0.00
0.81
8.17
5.38
3.6
82.04

0
338
1377
594
1243
167

0.00
9.09
37.03
15.97
33.42
4.49

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

0
0
0
0
0
0

0
15
8
1
0
24

0
50
200
26
1
277

0
15
127
47
5
194

0
0
13
4
110
127

0
80
348
78
116
622

Kappa=0.3989
Kappa

- 595 -

1
2
3
4
5

Hyperthermia

3719

574

15.43

100

2.69

0.11

267

7.18

232

6.24

415

11.16

178

4.79

393

84

21.37

13

3.31

0.25

94

23.92

18

4.58

49

12.47

35

8.91

II

1421

364

25.62

50

3.52

0.14

94

6.62

93

6.54

117

8.23

95

6.69

III

481

74

15.38

33

6.86

0.21

1.25

38

7.90

27

5.61

21

4.37

IV

1233

11

0.89

0.24

0.00

14

1.14

69

5.60

194

15.73

23

1.87

191

41

21.47

0.52

0.00

59

30.89

14

7.33

28

14.66

2.09

3719

574

15.43

100

2.69

0.11

267

7.18

232

6.24

415

11.16

178

4.79

30

26

86.67

0.00

0.00

6.67

0.00

6.67

0.00

II

304

289

95.07

0.00

0.00

2.63

0.66

1.64

0.00

III

200

194

97.00

0.50

0.00

0.00

1.50

0.50

0.00

IV

134

21

15.67

0.00

0.00

2.99

14

10.45

16

11.94

0.75

3051

44

1.44

99

3.24

0.13

253

8.29

213

6.98

391

12.82

177

5.80

3719

574

15.43

100

2.69

0.11

267

7.18

232

6.24

415

11.16

178

4.79

338

34

10.06

13

3.85

0.30

91

26.92

18

5.33

47

13.91

35

10.36

II

1377

315

22.88

50

3.63

0.15

99

7.19

94

6.83

117

8.50

95

6.90

III

594

188

31.65

33

5.56

0.17

1.01

38

6.40

28

4.71

21

3.54

IV

1243

15

1.21

0.24

0.00

14

1.13

69

5.55

195

15.69

23

1.85

167

22

13.17

0.60

0.00

57

34.13

13

7.78

28

16.77

2.40

(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90

- 596 -

10

11

692

18.61

1013

27.24

44

1.18

20

0.54

149

4.01

24

0.65

0.19

20

5.09

38

9.67

0.25

1.02

32

8.14

1.02

0.00

269

18.93

255

17.95

0.14

0.14

66

4.64

12

0.84

0.00

157

32.64

104

21.62

0.21

0.00

14

2.91

0.62

0.42

239

19.38

595

48.26

38

3.08

14

1.14

24

1.95

0.32

0.41

3.66

21

10.99

1.05

0.00

13

6.81

0.52

0.00

692

18.61

1013

27.24

44

1.18

20

0.54

149

4.01

24

0.65

0.19

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.50

0.00

0.00

0.00

0.00

0.00

34

25.37

40

29.85

0.75

0.00

0.00

0.75

1.49

658

21.57

972

31.86

43

1.41

20

0.66

149

4.88

23

0.75

0.16

692

18.61

1013

27.24

44

1.18

20

0.54

149

4.01

24

0.65

0.19

20

5.92

38

11.24

0.30

1.18

32

9.47

1.18

0.00

268

19.46

255

18.52

0.15

0.15

66

4.79

12

0.87

0.00

157

26.43

102

17.17

0.17

0.00

14

2.36

0.51

0.34

241

19.39

598

48.11

38

3.06

14

1.13

24

1.93

0.32

0.40

3.59

20

11.98

1.20

0.00

13

7.78

0.60

0.00

6
7 30/

8 ()

9
10
11

- 597 -


0~59 1

Hyperthermia

281

118

41.99

3.20

0.00

2.85

11

3.91

13

4.63

10

3.56

22

40.91

13.64

0.00

4.55

0.00

0.00

18.18

II

105

67

63.81

2.86

0.00

2.86

0.95

2.86

2.86

III

57

36

63.16

5.26

0.00

1.75

3.51

0.00

1.75

IV

89

4.49

0.00

0.00

0.00

7.87

10

11.24

1.12

25.00

0.00

0.00

37.50

12.50

0.00

12.50

60~74 1

1
2
3
4
5

412

24.95

1651

142

21

II

624

225

III

350

IV

Hyperthermia

118

7.15

124

7.51

82

4.97

61

3.69

0.18

91

5.51

14.79

4.93

0.70

30

21.13

6.34

13

9.15

16

11.27

36.06

26

4.17

0.16

34

5.45

45

7.21

31

4.97

46

7.37

139

39.71

25

7.14

0.29

1.14

24

6.86

2.29

13

3.71

472

10

2.12

0.42

0.00

0.42

33

6.99

65

13.77

1.27

63

17

26.98

1.59

0.00

21

33.33

11.11

11.11

1.59

(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90

- 598 -

10

11

42

14.95

56

19.93

0.36

0.00

3.20

1.07

0.36

0.00

0.00

0.00

0.00

18.18

4.55

0.00

12

11.43

10

9.52

0.00

0.00

1.90

0.95

0.00

15.79

3.51

0.00

0.00

3.51

1.75

0.00

21

23.60

43

48.31

1.12

0.00

1.12

0.00

1.12

0.00

12.50

0.00

0.00

0.00

0.00

0.00

351

21.26

320

19.38

15

0.91

10

11

0.30

56

3.39

10

0.61

0.18

13

9.15

16

11.27

0.00

2.11

12

8.45

0.70

0.00

123

19.71

54

8.65

0.00

0.16

32

5.13

0.96

0.00

94

26.86

35

10.00

0.00

0.00

1.43

0.29

0.29

121

25.64

211

44.70

15

3.18

0.21

0.42

0.42

0.42

0.00

6.35

0.00

0.00

7.94

0.00

0.00

1
7 30/

8 ()

9
10
11

- 599 -


75 1

1
2
3
4
5

Hyperthermia

1787

44

2.46

30

1.68

0.06

168

9.40

103

5.76

278

15.56

86

4.81

174

2.30

1.72

0.00

60

34.48

5.17

34

19.54

15

8.62

II

648

23

3.55

21

3.24

0.15

62

9.57

48

7.41

83

12.81

46

7.10

III

187

13

6.95

2.67

0.00

0.53

12

6.42

20

10.70

3.74

IV

682

0.15

0.15

0.00

12

1.76

29

4.25

120

17.60

16

2.35

96

3.13

0.00

0.00

33

34.38

5.21

21

21.88

2.08

(99 )(AJCC_7th) 1
30~80
14 24
Hyperthermia 16 26
10151718192021222325 90

- 600 -

299

16.73

637

35.65

28

1.57

15

0.84

84

4.70

11

0.62

0.17

4.02

22

12.64

0.57

0.57

16

9.20

1.15

0.00

133

20.52

191

29.48

0.31

0.15

32

4.94

0.77

0.00

54

28.88

65

34.76

0.53

0.00

3.74

0.53

0.53

99

14.52

344

50.44

22

3.23

13

1.91

21

3.08

0.29

0.29

6.25

15

15.63

2.08

0.00

8.33

1.04

0.00

11

10

6
7 30/

8 ()

9
10
11

- 601 -

- 602 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

0
0
1
1
2
2
10
14
43

0
0
0
0
0
0
1
7
8

0
0
1
1
2
2
11
21
51

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

73
97
158
147
181
213
281
196
145
1564

26
40
68
60
87
117
96
72
45
627

99
137
226
207
268
330
377
268
190
2191

2191

100.00

2191

100.00

2191

100.00

537
726
346
131
177
274

24.51
33.14
15.79
5.98
8.08
12.51

260
224
108
61
78
1460

11.87
10.22
4.93
2.78
3.56
66.64

639
734
318
139
197
164

29.16
33.5
14.51
6.34
8.99
7.49

0
I
II
III
IV

:-(99 )(AJCC_7th) 1

II
III
IV

II

III

IV

151
28
12
2
3
196

6
161
18
10
0
195

0
9
64
11
3
87

1
5
21
21
5
53

0
3
11
8
47
69

158
206
126
52
58
600

Kappa=0.6548
Kappa

- 603 -

(TURBT)

(TURBT)

(TURBT)

(TURBT)

2191

455

20.77

121

5.52

908

41.44

59

2.69

42

1.92

0.14

70

3.19

537

118

21.97

1.12

295

54.93

0.00

0.37

0.00

0.00

726

118

16.25

22

3.03

337

46.42

0.83

0.69

0.14

0.69

II

346

86

24.86

40

11.56

92

26.59

24

6.94

17

4.91

0.58

24

6.94

III

131

17

12.98

26

19.85

19

14.50

12

9.16

10

7.63

0.00

17

12.98

IV

177

46

25.99

2.82

53

29.94

11

6.21

2.82

0.00

17

9.60

274

70

25.55

22

8.03

112

40.88

2.19

1.09

0.00

2.55

2194

455

20.77

121

5.52

908

41.44

59

2.69

42

1.92

0.14

70

3.19

260

62

23.85

3.46

144

55.38

0.38

0.77

0.00

0.00

224

37

16.52

27

12.05

110

49.11

2.68

0.45

0.45

0.45

II

108

20

18.52

43

39.81

16

14.81

7.41

0.93

0.00

6.48

III

61

3.28

25

40.98

4.92

19

31.15

3.28

1.64

4.92

IV

78

15

19.23

10

12.82

13

16.67

16

20.51

2.56

1.28

10.26

1460

319

21.85

0.48

622

42.60

0.62

34

2.33

0.00

51

3.49

2191

20.77

121

639

144

22.54

1.41

353

55.24

0.16

0.47

0.00

0.00

734

122

16.62

27

3.68

331

45.10

0.68

0.82

0.14

0.54

II

318

83

26.10

44

13.84

80

25.16

2.20

16

5.03

0.00

27

8.49

III

139

16

11.51

25

17.99

19

13.67

21

15.11

11

7.91

0.72

18

12.95

IV

197

51

25.89

10

5.08

52

26.40

17

8.63

2.03

0.51

19

9.64

164

39

23.78

3.66

73

44.51

4.88

1.22

0.00

1.22

455

5.52

908

41.44

59

2.69

42

1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610

- 604 -

1.92

0.14

70

3.19

16

0.73

20

0.91

404

18.44

37

1.69

11

0.50

28

1.28

10

0.46

0.32

0.00

0.00

96

17.88

0.93

0.00

1.12

0.93

0.74

0.00

0.00

210

28.93

13

1.79

0.14

0.69

0.14

0.28

1.45

0.87

44

12.72

1.73

0.00

0.58

0.29

0.00

4.58

2.29

12

9.16

2.29

2.29

1.53

0.00

0.76

2.26

11

6.21

2.82

10

5.65

2.26

2.82

0.56

0.00

0.36

1.09

37

13.50

0.00

1.09

2.92

0.73

0.00

16

0.73

20

0.91

404

18.44

37

1.69

11

0.50

28

1.28

10

0.46

0.32

0.00

0.00

42

16.15

0.00

0.00

0.00

0.00

0.00

0.00

0.00

41

18.30

0.00

0.00

0.00

0.00

0.00

1.85

0.00

11

10.19

0.00

0.00

0.00

0.00

0.00

9.84

0.00

0.00

0.00

0.00

0.00

0.00

0.00

8.97

2.56

2.56

1.28

0.00

1.28

0.00

0.00

0.07

18

1.23

308

21.10

36

2.47

11

0.75

27

1.85

10

0.68

0.48

16

0.73

20

0.91

404

18.44

37

1.69

11

0.50

28

1.28

10

0.46

0.32

0.00

0.00

109

17.06

0.78

0.00

0.94

0.78

0.63

0.00

0.00

216

29.43

13

1.77

0.14

0.68

0.14

0.27

0.63

0.94

47

14.78

1.89

0.00

0.63

0.31

0.00

4.32

2.16

10

7.19

2.16

2.16

1.44

0.00

0.72

3.55

11

5.58

2.54

10

5.08

2.03

2.54

0.51

0.00

0.61

1.83

17

10.37

0.00

1.83

4.88

1.22

0.00

4 01 16 27 p.610
5
6 ()

7
8
9

- 605 -


0~49 1

(TURBT)

(TURBT)

(TURBT)

(TURBT)

188

37

19.68

18

9.57

76

40.43

10

5.32

0.53

0.00

1.60

59

16

27.12

3.39

35

59.32

0.00

0.00

0.00

0.00

73

12.33

8.22

27

36.99

1.37

1.37

0.00

1.37

II

23

30.43

21.74

17.39

8.70

0.00

0.00

4.35

III

0.00

50.00

12.50

25.00

0.00

0.00

12.50

IV

14

21.43

0.00

21.43

35.71

0.00

0.00

0.00

11

18.18

9.09

54.55

0.00

0.00

0.00

0.00

50~69 1

(TURBT)

(TURBT)

(TURBT)

(TURBT)

838

148

17.66

51

6.09

357

42.60

28

3.34

0.36

0.12

25

2.98

285

59

20.70

1.40

154

54.04

0.35

0.00

0.00

0.00

270

37

13.70

14

5.19

119

44.07

0.74

0.37

0.00

0.37

II

110

22

20.00

17

15.45

33

30.00

0.91

1.82

0.00

10

9.09

III

53

7.55

11

20.75

13.21

14

26.42

0.00

0.00

15.09

IV

67

17

25.37

4.48

19

28.36

7.46

0.00

1.49

8.96

53

16.98

3.77

25

47.17

9.43

0.00

0.00

0.00

1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610

- 606 -

2.66

0.53

31

16.49

1.60

0.00

1.06

0.00

0.53

0.00

0.00

8.47

0.00

0.00

0.00

0.00

1.69

0.00

0.00

23

31.51

4.11

0.00

2.74

0.00

0.00

8.70

0.00

8.70

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

21.43

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

9.09

9.09

0.00

0.00

0.00

0.00

0.00

0.84

0.72

178

21.24

17

2.03

0.12

10

1.19

0.48

0.24

0.00

0.00

55

19.30

1.05

0.00

1.40

1.40

0.35

0.00

0.00

91

33.70

1.48

0.00

0.00

0.00

0.37

0.00

0.91

21

19.09

2.73

0.00

0.00

0.00

0.00

7.55

1.89

3.77

3.77

0.00

0.00

0.00

0.00

4.48

5.97

2.99

7.46

0.00

2.99

0.00

0.00

0.00

0.00

13.21

0.00

1.89

7.55

0.00

0.00

4 01 16 27 p.610
5
6 ()

7
8
9

- 607 -


70 1

(TURBT)

(TURBT)

(TURBT)

(TURBT)

1165

270

23.18

52

4.46

475

40.77

21

1.80

38

3.26

0.17

42

3.61

295

69

23.39

1.02

164

55.59

0.00

1.02

0.00

0.00

391

76

19.44

1.79

185

47.31

0.51

1.02

0.26

0.51

II

185

54

29.19

22

11.89

43

23.24

2.16

14

7.57

0.00

16

8.65

III

78

12

15.38

10

12.82

11

14.10

6.41

11

14.10

1.28

11.54

IV

116

31

26.72

6.03

30

25.86

6.03

3.45

0.00

13

11.21

100

28

28.00

3.00

42

42.00

3.00

2.00

0.00

2.00

1 (99 )(AJCC_7th) 1
2 (TURBT) 20~27 p.610
3 30~90 p.610

- 608 -

0.34

13

1.12

195

16.74

17

1.46

10

0.86

16

1.37

0.52

0.34

0.00

0.00

49

16.61

0.68

0.00

0.68

0.34

0.68

0.00

0.00

102

26.09

1.53

0.26

0.77

0.26

0.26

0.00

1.08

24

12.97

1.62

0.00

1.08

0.54

0.00

2.56

2.56

10.26

1.28

3.85

2.56

0.00

1.28

0.86

6.03

2.59

4.31

3.45

2.59

0.86

0.00

1.00

2.00

9.00

0.00

2.00

4.00

2.00

0.00

4 01 16 27 p.610
5
6 ()

7
8
9

- 609 -

Bladder
C670C679
(Except for M9727, 9733, 9741-9742, 9764-9809, 9832, 9840-9931, 9945-9946, 9950-9967, 9975-9992)

Codes
00 None; no surgery of primary site; autopsy ONLY
10 Local tumor destruction, NOS
11 Photodynamic therapy (PDT)
12 Electrocautery; fulguration (includes use of hot forceps for tumor destruction)
13 Cryosurgery
14 Laser
15 Intravesical therapy
16 Bacillus Calmette-Guerin (BCG) or other immunotherapy
[SEER NoteCode BCG as both surgery and immunotherapy]

No specimen sent to pathology from surgical events 1016


20 Local tumor excision, NOS
26 Polypectomy
27 Excisional biopsy
[SEER NoteCode TURB as 27]

30
50
60

Any combination of 20 or 2627 WITH


21 Photodynamic therapy (PDT)
22 Electrocautery
23 Cryosurgery
24 Laser ablation
25 Laser excision
Partial cystectomy
Simple/total/complete cystectomy
Complete cystectomy with reconstruction
[SEER NoteUse code 71 for cystoprostatectomy.]

61 Radical cystectomy PLUS ileal conduit


62 Radical cystectomy PLUS continent reservoir or pouch, NOS
63 Radical cystectomy PLUS abdominal pouch (cutaneous)
64 Radical cystectomy PLUS in situ pouch (orthotopic)
When the procedure is described as a pelvic exenteration for males, but the prostate is not
removed, the surgery should be coded as a cystectomy (code 60-64).
70 Pelvic exenteration, NOS
71 Radical cystectomy including anterior exenteration
[SEER NoteUse code 71 for cystoprostatectomy.]

For females, includes removal of bladder, uterus, ovaries, entire vaginal wall, and entire urethra.
For males, includes removal of the prostate. When a procedure is described as a pelvic
exenteration for males, but the prostate is not removed, the surgery should be coded as a
cystectomy (code 60-64).
72 Posterior exenteration
For females, also includes removal of vagina, rectum and anus. For males, also includes
prostate, rectum and anus.
73 Total exenteration
Includes all tissue and organs removed for an anterior and posterior
exenteration. [SEER NoteIncludes removal of all pelvic contents and pelvic lymph nodes. The
lymph node dissection should also be coded under Scope of Regional Lymph Node Surgery (
#4.16 or 4.17).]

74 Extended exenteration
Includes pelvic blood vessels and/or bony pelvis
80 Cystectomy, NOS
Specimen sent to pathology from surgical events 20-80.
90 Surgery, NOS
99 Unknown if surgery performed; death
- 610 -

00-04
05-09
10-14
15-19
20-24
25-29
30-34
35-39
40-44

8
10
22
25
26
37
38
41
43

3
5
4
13
20
47
36
32
45

11
15
26
38
46
84
74
73
88

45-49
50-54
55-59
60-64
65-69
70-74
75-79
80-84
85

66
88
118
94
104
111
118
92
76
1117

51
73
85
83
78
89
92
59
37
852

117
161
203
177
182
200
210
151
113
1969

Ann Arbor 1

1
1A
1B
1E
2
2A
2B
2E
3
3A
3B
3E
3S
4
4A
4B

B T/NK

156

100.00

1425

100.00

265

100.00

123

100.00

7
2
0
0
34
7
3
0
14
2
3
0
0
24
1
2
57

4.49
1.28
0.00
0.00
21.79
4.49
1.92
0.00
8.97
1.28
1.92
0.00
0.00
15.38
0.64
1.28
36.54

150
14
2
13
172
21
3
10
166
31
7
3
1
238
22
14
558

10.53
0.98
0.14
0.91
12.07
1.47
0.21
0.70
11.65
2.18
0.49
0.21
0.07
16.70
1.54
0.98
39.16

15
1
2
6
23
4
2
1
33
2
6
2
0
53
3
2
110

5.66
0.38
0.75
2.26
8.68
1.51
0.75
0.38
12.45
0.75
2.26
0.75
0.00
20.00
1.13
0.75
41.51

12
0
0
1
6
2
1
0
8
1
3
1
0
31
1
2
54

9.76
0.00
0.00
0.81
4.88
1.63
0.81
0.00
6.50
0.81
2.44
0.81
0.00
25.20
0.81
1.63
43.90

1 99 4

- 611 -


Ann Arbor 1

1969

90

4.57

26

1.32

25

1.27

197

10.01

219

11.12 49

2.49 1106

56.17

36

1.83

156

7.92

23

1.17

42

2.13

184

21

11.41

1.63

11

5.98

26

14.13

30

16.30 16

8.70

51

27.72

2.17

18

9.78

1.09

1.09

1A

17

5.88

0.00

0.00

41.18

5.88

11.76

29.41

0.00

5.88

0.00

0.00

1B

25.00

0.00

0.00

0.00

25.00

25.00

25.00

0.00

0.00

0.00

0.00

1E

20

5.00

5.00

10.00

15.00

20.00

0.00

30.00

0.00

15.00

0.00

0.00

235

2.55

2.13

0.85

33

14.04

40

17.02

1.70

122

51.91

1.28

16

6.81

0.85

0.85

2A

34

5.88

0.00

0.00

11.76

8.82

2.94

20

58.82

0.00

2.94

2.94

5.88

2B

0.00

11.11

0.00

0.00

11.11

0.00

66.67

0.00

0.00

0.00

11.11

2E

11

0.00

18.18

0.00

36.36

9.09

0.00

27.27

0.00

0.00

9.09

0.00

221

2.26

0.90

0.45

11

4.98

21

9.50

0.90

153

69.23

0.90

18

8.14

0.90

1.81

3A

36

0.00

0.00

0.00

16.67

5.56

0.00

26

72.22

0.00

5.56

0.00

0.00

3B

19

0.00

0.00

0.00

10.53

0.00

0.00

14

73.68

0.00

15.79

0.00

0.00

3E

16.67

0.00

16.67

16.67

0.00

0.00

33.33

16.67

0.00

0.00

0.00

3S

0.00

0.00

0.00

0.00

0.00

0.00

1 100.00

0.00

0.00

0.00

0.00

346

1.45

0.87

0.00

20

5.78

32

9.25

1.45

241

69.65

17

4.91

15

4.34

0.87

1.45

4A

27

0.00

0.00

0.00

7.41

3.70

0.00

19

70.37

0.00

11.11

7.41

0.00

4B

20

5.00

0.00

0.00

5.00

15.00

0.00

15

75.00

0.00

0.00

0.00

0.00

779

46

5.91

1.16

1.03

77

9.88

79

10.14 18

2.31

421

54.04

1.16

76

9.76

10

1.28

26

3.34

1 99 4
2
3 ()

4
5
6

- 612 -


0~39 Ann Arbor 1

367

20

5.45

1.09

1.91

37

10.08

82

22.34

30

16.67

0.00

16.67

10.00

26.67

10.00

1A

0.00

0.00

0.00

20.00

0.00

1B

0.00

0.00

0.00

0.00

0.00

1E

25.00

0.00

0.00

0.00

60

0.00

0.00

0.00

10.00

2A

10

10.00

0.00

0.00

2B

0.00

20.00

0.00

2E

0.00

0.00

29

0.00

3.45

3A

0.00

3B

0.00

3E

3S

50.68

0.00

15

4.09

0.82

1.63

16.67

0.00

3.33

0.00

0.00

0.00

80.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

25.00

0.00

50.00

0.00

0.00

0.00

0.00

23

38.33

0.00

31

51.67

0.00

0.00

0.00

0.00

0.00

20.00

0.00

70.00

0.00

0.00

0.00

0.00

0.00

20.00

0.00

40.00

0.00

0.00

0.00

20.00

0.00

50.00

50.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

3.45

24.14

0.00

20

68.97

0.00

0.00

0.00

0.00

0.00

0.00

42.86

14.29

0.00

42.86

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2 100.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

41

0.00

0.00

0.00

7.32

10

24.39

4.88

23

56.10

0.00

2.44

2.44

2.44

4A

0.00

0.00

0.00

0.00

0.00

0.00

2 100.00

0.00

0.00

0.00

0.00

4B

0.00

0.00

0.00

0.00

0.00

0.00

2 100.00

0.00

0.00

0.00

0.00

168

13

7.74

1.19

1.19

19

11.31

28

16.67

1.19

0.00

13

7.74

1.19

2.38

1.91 186

83

49.40

1 99 4
2
3 ()

4
5
6

- 613 -


40~59 Ann Arbor 1

569

24

4.22

1.58

1.23

67

11.78

67

11.78

13

65

9.23

1.54

3.08

14

21.54

14

21.54

10.77

1A

0.00

0.00

0.00

50.00

16.67

16.67

1B

0.00

0.00

0.00

0.00

0.00

1E

0.00

11.11

22.22

22.22

22.22

54

3.70

1.85

0.00

16.67

2A

0.00

0.00

0.00

28.57

2B

0.00

0.00

0.00

2E

0.00

20.00

0.00

48

2.08

0.00

3A

11

0.00

0.00

3B

0.00

3E

33.33

3S

119

4A
4B

2.28 323

56.77

0.53

43

7.56

1.05

1.23

14

21.54

0.00

7.69

1.54

1.54

0.00

0.00

16.67

0.00

0.00

0.00

1 100.00

0.00

0.00

0.00

0.00

0.00

11.11

0.00

11.11

0.00

0.00

12.96

0.00

29

53.70

1.85

5.56

3.70

0.00

14.29

0.00

42.86

0.00

0.00

0.00

14.29

0.00

0.00

0.00

2 100.00

0.00

0.00

0.00

0.00

40.00

0.00

0.00

40.00

0.00

0.00

0.00

0.00

0.00

4.17

12.50

0.00

32

66.67

0.00

12.50

0.00

2.08

0.00

18.18

9.09

0.00

72.73

0.00

0.00

0.00

0.00

0.00

0.00

25.00

0.00

0.00

75.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

66.67

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

0.00

2.52

1.68

0.00

5.88

11

9.24

0.00

93

78.15

0.00

2.52

0.00

0.00

10

0.00

0.00

0.00

10.00

0.00

0.00

70.00

0.00

0.00

2 20.00

0.00

14.29

0.00

0.00

14.29

14.29

0.00

57.14

0.00

0.00

0.00

0.00

218

10

4.59

1.38

1.38

21

9.63

23

10.55

2.29 122

55.96

0.92

24

11.01

0.46

1.83

1 99 4
2
3 ()

4
5
6

- 614 -


60 Ann Arbor 1

6.78 29

2.81

597

57.79

33

3.19

98

9.49

14

1.36

29

2.81

1033

46

4.45

13

1.26

11

1.06

93

9.00

70

89

10

11.24

2.25

4.49

10.11

8.99

6.74

32

35.96

4.49

12

13.48

1.12

1.12

1A

16.67

0.00

0.00

50.00

0.00

16.67

16.67

0.00

0.00

0.00

0.00

1B

33.33

0.00

0.00

0.00

33.33

33.33

0.00

0.00

0.00

0.00

0.00

1E

0.00

0.00

0.00

14.29

14.29

0.00

42.86

0.00

28.57

0.00

0.00

121

3.31

3.31

1.65

18

14.88

10

8.26

3.31

62

51.24

1.65

13

10.74

0.00

1.65

2A

17

5.88

0.00

0.00

11.76

0.00

5.88

10

58.82

0.00

5.88

5.88

5.88

2B

0.00

0.00

0.00

0.00

0.00

0.00

2 100.00

0.00

0.00

0.00

0.00

2E

0.00

25.00

0.00

25.00

0.00

0.00

25.00

0.00

0.00

1 25.00

0.00

144

2.78

0.69

0.69

5.56

5.56

1.39

101

70.14

1.39

12

8.33

1.39

2.08

3A

18

0.00

0.00

0.00

5.56

0.00

0.00

15

83.33

0.00

11.11

0.00

0.00

3B

13

0.00

0.00

0.00

7.69

0.00

0.00

69.23

0.00

23.08

0.00

0.00

3E

0.00

0.00

33.33

33.33

0.00

0.00

0.00

33.33

0.00

0.00

0.00

3S

0.00

0.00

0.00

0.00

0.00

0.00

1 100.00

0.00

0.00

0.00

0.00

186

1.08

0.54

0.00

10

5.38

11

5.91

1.61

125

67.20

17

9.14

11

5.91

1.08

2.15

4A

15

0.00

0.00

0.00

6.67

6.67

0.00

10

66.67

0.00

20.00

0.00

0.00

4B

11

0.00

0.00

0.00

0.00

18.18

0.00

81.82

0.00

0.00

0.00

0.00

393

23

5.85

1.02

0.76

37

9.41

28

7.12

11

2.80

216

54.96

1.78

39

9.92

1.78

18

4.58

1 99 4
2
3 ()

4
5
6

- 615 -

You might also like